
<html lang="en"     class="pb-page"  data-request-id="0f0fcbc7-0818-442e-bc60-e53718a43dcb"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2020.63.issue-19;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c01116"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design, Synthesis, and Structure–Activity Relationships of Indoline-Based Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-Like 2 (Keap1-Nrf2) Protein–Protein Interaction Inhibitors" /></meta><meta name="dc.Creator" content="Hai-Shan  Zhou" /></meta><meta name="dc.Creator" content="Lv-Bin  Hu" /></meta><meta name="dc.Creator" content="Han  Zhang" /></meta><meta name="dc.Creator" content="Wen-Xin  Shan" /></meta><meta name="dc.Creator" content="Yan  Wang" /></meta><meta name="dc.Creator" content="Xue  Li" /></meta><meta name="dc.Creator" content="Tian  Liu" /></meta><meta name="dc.Creator" content="Jing  Zhao" /></meta><meta name="dc.Creator" content="Qi-Dong  You" /></meta><meta name="dc.Creator" content="Zheng-Yu  Jiang" /></meta><meta name="dc.Description" content="The Keap1 (Kelch-like ECH-associated protein 1)-Nrf2 (nuclear factor erythroid 2-related factor 2)-ARE (antioxidant response element) pathway is the major defending mechanism against oxidative stre..." /></meta><meta name="Description" content="The Keap1 (Kelch-like ECH-associated protein 1)-Nrf2 (nuclear factor erythroid 2-related factor 2)-ARE (antioxidant response element) pathway is the major defending mechanism against oxidative stre..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 9, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01116" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01116" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01116" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01116" /></link>
        
    
    

<title>Design, Synthesis, and Structure–Activity Relationships of Indoline-Based Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-Like 2 (Keap1-Nrf2) Protein–Protein Interaction Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01116" /></meta><meta property="og:title" content="Design, Synthesis, and Structure–Activity Relationships of Indoline-Based Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-Like 2 (Keap1-Nrf2) Protein–Protein Interaction Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0033.jpeg" /></meta><meta property="og:description" content="The Keap1 (Kelch-like ECH-associated protein 1)-Nrf2 (nuclear factor erythroid 2-related factor 2)-ARE (antioxidant response element) pathway is the major defending mechanism against oxidative stresses, and directly disrupting the Keap1-Nrf2 protein–protein interaction (PPI) has been an attractive strategy to target oxidative stress-related diseases, including cardiovascular diseases. Here, we describe the design, synthesis, and structure–activity relationships (SARs) of indoline-based compounds as potent Keap1-Nrf2 PPI inhibitors. Comprehensive SAR analysis and thermodynamics-guided optimization identified 19a as the most potent inhibitor in this series, with an IC50 of 22 nM in a competitive fluorescence polarization assay. Further evaluation indicated the proper drug-like properties of 19a. Compound 19a dose-dependently upregulated genes and protein level of Nrf2 as well as its downstream markers and showed protective effects against lipopolysaccharide-induced injury in both H9c2 cardiac cells and mouse models. Collectively, we reported here a novel indoline-based Keap1-Nrf2 PPI inhibitor as a potential cardioprotective agent." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01116"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01116">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01116&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01116&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01116&amp;href=/doi/10.1021/acs.jmedchem.0c01116" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 11149-11168</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01062" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01050" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Structure–Activity Relationships of Indoline-Based Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-Like 2 (Keap1-Nrf2) Protein–Protein Interaction Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Hai-Shan Zhou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hai-Shan Zhou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hai-Shan++Zhou">Hai-Shan Zhou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lv-Bin Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lv-Bin Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lv-Bin++Hu">Lv-Bin Hu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Han Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Han Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Han++Zhang">Han Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wen-Xin Shan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wen-Xin Shan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wen-Xin++Shan">Wen-Xin Shan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yan Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yan Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Wang">Yan Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xue Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xue Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xue++Li">Xue Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tian Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tian Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tian++Liu">Tian Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jing Zhao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jing Zhao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Zhao">Jing Zhao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qi-Dong You</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qi-Dong You</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#60190f151104205156534e030f0d"><span class="__cf_email__" data-cfemail="e29b8d979386a2d3d4d1cc818d8f">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qi-Dong++You">Qi-Dong You</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8587-0122" title="Orcid link">http://orcid.org/0000-0002-8587-0122</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Zheng-Yu Jiang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zheng-Yu Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#33595a525d54495b565d544a46504346730205001d505c5e"><span class="__cf_email__" data-cfemail="aec4c7cfc0c9d4c6cbc0c9d7dbcddedbee9f989d80cdc1c3">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zheng-Yu++Jiang">Zheng-Yu Jiang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1671-1582" title="Orcid link">http://orcid.org/0000-0002-1671-1582</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01116&amp;href=/doi/10.1021%2Facs.jmedchem.0c01116" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 11149–11168</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 9, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 June 2020</li><li><span class="item_label"><b>Published</b> online</span>9 September 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 October 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01116" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01116</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 <span class="NLM_copyright-holder">American Chemical Society</span></strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D11149%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHai-Shan%2BZhou%252C%2BLv-Bin%2BHu%252C%2BHan%2BZhang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D19%26contentID%3Dacs.jmedchem.0c01116%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BIndoline-Based%2BKelch-like%2BECH-Associated%2BProtein%2B1-Nuclear%2BFactor%2B%2528Erythroid-Derived%2B2%2529-Like%2B2%2B%2528Keap1-Nrf2%2529%2BProtein%25E2%2580%2593Protein%2BInteraction%2BInhibitors%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D11168%26publicationDate%3DOctober%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01116"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1367</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01116" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Structure–Activity Relationships of Indoline-Based Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-Like 2 (Keap1-Nrf2) Protein–Protein Interaction Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hai-Shan&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Lv-Bin&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Han&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Wen-Xin&quot;,&quot;last_name&quot;:&quot;Shan&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Xue&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Tian&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Qi-Dong&quot;,&quot;last_name&quot;:&quot;You&quot;},{&quot;first_name&quot;:&quot;Zheng-Yu&quot;,&quot;last_name&quot;:&quot;Jiang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;11149-11168&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01116&quot;},&quot;abstract&quot;:&quot;The Keap1 (Kelch-like ECH-associated protein 1)-Nrf2 (nuclear factor erythroid 2-related factor 2)-ARE (antioxidant response element) pathway is the major defending mechanism against oxidative stresses, and directly disrupting the Keap1-Nrf2 protein–protein interaction (PPI) has been an attractive strategy to target oxidative stress-related diseases, including cardiovascular diseases. Here, we describe the design, synthesis, and structure–activity relationships (SARs) of indoline-based compounds as potent Keap1-Nrf2 PPI inhibitors. Comprehensive SAR analysis and thermodynamics-guided optimization identified 19a as the most potent inhibitor in this series, with an IC50 of 22 nM in a competitive fluorescence polarization assay. Further evaluation indicated the proper drug-like properties of 19a. Compound 19a dose-dependently upregulated genes and protein level of Nrf2 as well as its downstream markers and showed protective effects against lipopolysaccharide-induced injury in both H9c2 cardiac cells and mouse mo&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01116&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01116" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01116&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01116" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01116&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01116" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01116&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01116&amp;href=/doi/10.1021/acs.jmedchem.0c01116" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01116" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01116" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01116%26sid%3Dliteratum%253Aachs%26pmid%3D32902980%26genre%3Darticle%26aulast%3DZhou%26date%3D2020%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BIndoline-Based%2BKelch-like%2BECH-Associated%2BProtein%2B1-Nuclear%2BFactor%2B%2528Erythroid-Derived%2B2%2529-Like%2B2%2B%2528Keap1-Nrf2%2529%2BProtein%25E2%2580%2593Protein%2BInteraction%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D19%26spage%3D11149%26epage%3D11168%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/jmcmar.2020.63.issue-19/20201008/jmcmar.2020.63.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0033.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The Keap1 (Kelch-like ECH-associated protein 1)-Nrf2 (nuclear factor erythroid 2-related factor 2)-ARE (antioxidant response element) pathway is the major defending mechanism against oxidative stresses, and directly disrupting the Keap1-Nrf2 protein–protein interaction (PPI) has been an attractive strategy to target oxidative stress-related diseases, including cardiovascular diseases. Here, we describe the design, synthesis, and structure–activity relationships (SARs) of indoline-based compounds as potent Keap1-Nrf2 PPI inhibitors. Comprehensive SAR analysis and thermodynamics-guided optimization identified <b>19a</b> as the most potent inhibitor in this series, with an IC<sub>50</sub> of 22 nM in a competitive fluorescence polarization assay. Further evaluation indicated the proper drug-like properties of <b>19a</b>. Compound <b>19a</b> dose-dependently upregulated genes and protein level of Nrf2 as well as its downstream markers and showed protective effects against lipopolysaccharide-induced injury in both H9c2 cardiac cells and mouse models. Collectively, we reported here a novel indoline-based Keap1-Nrf2 PPI inhibitor as a potential cardioprotective agent.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The human body is surrounded by endogenous and exogenous electrophilic substances, including reactive oxygen species (ROS) and reactive nitrogen species (RNS).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Sustained high levels of ROS and RNS can induce detrimental oxidative stress, which lead to tissue damage.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2−4)</a> To resist such damage, cells have evolved the sophisticated cytoprotective system that can up-regulate cytoprotective factors to maintain body homeostasis.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Many detoxification and antioxidant enzymes, such as superoxide dismutase (SOD), NADPH: quinone oxidoreductase 1 (NQO-1), heme oxygenase-1 (HO-1), glutamate-cysteine ligase-modifier subunits (GCLM), and transcriptionally regulated by the upstream antioxidant response element (ARE), are the major components of body’s defense system.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Nrf2 (nuclear factor erythroid 2-related factor 2), binding to ARE and regulating the transcription of these oxidative stress related genes, is the chief regulator of this cytoprotective system.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Keap1 (Kelch-like ECH-associated protein-1), identified as a repressor of Nrf2, inhibits the activity of Nrf2 via ubiquitination of Nrf2 under basal conditions.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> However, upon stress conditions, modification of several highly sensitive cysteines in Keap1 leads to the dissociation of Nrf2 from Keap1, thereby preventing ubiquitination of Nrf2.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> As a result, Nrf2 accumulates and translocates into the nucleus, which then binds to ARE and up-regulates the expression of cytoprotective factors, ultimately protecting cells (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Therefore, the Keap1-Nrf2-ARE pathway is a key pathway for cells to resist oxidation and maintain cell homeostasis, and Nrf2 activation agents may be developed as therapeutic drugs for a series of diseases related to oxidative stress.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic diagram for the regulation of Nrf2 activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Many electrophilic Nrf2 activators have been developed as potential therapeutic agents (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B), such as dimethyl fumarate (DMF, <b>1</b>),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> sulforaphane (SFN, <b>2</b>),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> bardoxolone methyl (CDDO-Me, <b>3</b>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and RTA-408 (<b>4</b>),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> which can form covalent bonds to cysteine residues in the target Keap1 protein.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, these activators may react with other cysteine-rich proteins to increase the uncertainty in further clinical development.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Alternatively, directly interfering the Keap1-Nrf2 protein–protein interaction (PPI) is regarded as a more attractive approach to active Nrf2.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33">(24−33)</a> Direct inhibitors of Keap1-Nrf2 PPI do not require a covalent group, which may enhance selectivity and specificity.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The binding between Keap1 and Nrf2 is confined to the interactions between the Kelch domain of Keap1 and the two Nrf2 motifs with low affinity (DLG) and high affinity (ETGE) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> On the basis of co-crystal structures of the Keap1-Nrf2 ETGE complex, the binding pocket of Keap1 can be artificially subdivided into five subpockets, namely, P1–P5: P1 and P2 contain most of the polar residues (Arg483, Ser508, Ser363, Arg380, and Arg415); P4 and P5 mainly contain nonpolar residues, including Tyr525, Gln530, Tyr572, Tyr334, and Phe577; and the P3 subpocket consists of small polar and nonpolar residues (Gly509, Ala556, Ser602, and Ser555).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Benefiting from the availability of these crystal structures of the Kelch domain of Keap1, various Keap1-Nrf2 PPI inhibitors, including peptides<a onclick="showRef(event, 'ref37 ref38 ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40 ref41 ref42">(37−42)</a> and nonpeptide small molecules,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> have been reported and their therapeutic potential have been explored in several <i>in vivo</i> models.<a onclick="showRef(event, 'ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46">(44−46)</a> Among them, the 1,4-diaminonaphthalene core-based compounds represent a main type of Keap1-Nrf2 PPI inhibitors. Based on the hit compound <b>5a</b> discovered by Marcotte et al. (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C),<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a><i>N</i>-acetic acid groups were introduced into the both sulfonamides of <b>5a</b>, and compound <b>5b</b> was obtained with significant improvement in activity.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> To improve the physicochemical and drug-like properties of these naphthalene-based Keap1-Nrf2 inhibitors, further structure optimizations have been carried out, including bioisosteres replacement (compounds <b>5c</b> and <b>5d</b>),<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> asymmetrical substituent (compounds <b>6a</b> and <b>6b</b>),<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> naphthalene scaffold replacement (compounds <b>7a</b> and <b>7b</b>),<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53,54)</a> and prodrug modification.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Other potent inhibitors with the 3-phenylpropanoic acid core have been reported by Davies et al.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The representative compound <b>8a</b>, with drug-like physicochemical properties, showed potent Nrf2 activation effects in cellular and <i>in vivo</i> models. Recently, the research group from Biogen disclosed a novel series of noncovalent Nrf2 activators with the benzotriazole moiety.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The representative analogue <b>8b</b> showed impressive oral PK and good Nrf2-dependent gene inductions in kidney.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of representative Nrf2 activators. (A) Subpockets of the Keap1 binding cavity based on the Keap1-Nrf2 ETGE complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1X2R">1X2R</a>); (B) electrophilic activators of Nrf2; (C) representative non-electrophilic Keap1-Nrf2 PPI inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Myocarditis is classified as an inflammatory disease of the heart muscle and is an important cause of sudden death, especially in children and younger patients.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> It has been reported that viral infection, bacterial infection, rheumatic carditis, and autoimmunity are the major contributors of myocarditis.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> In etiological consideration, myocarditis is characterized by the overexpression of inflammatory cytokines and oxidative mediators.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> By controlling the release of inflammatory cytokines and regulating the transcription of antioxidant enzymes, such as HO-1 and NQO1, the Nrf2-ARE pathway plays a critical role in the regulation of oxidative stress and inflammation in tissue damage.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Recent studies have reported that Keap1-Nrf2 inhibitors could exert cardioprotective effects through anti-inflammatory and antioxidant effects,<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62,63)</a> and the Keap1-Nrf2 signaling may be a potential target for developing new cardioprotective drugs.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><div class="NLM_p last">Here, we describe the design, synthesis, and structure–activity relationship (SAR) of a series of new indoline-based Keap1-Nrf2 PPI inhibitors. Replacing the acetic acid groups with acylsulfonamide moieties retained the high Keap1-Nrf2 inhibitory activity. The representative analogue <b>19a</b> (structure seen in the Abstract) exhibited potent Keap1 inhibitory activity, favorable drug-like properties, high Nrf2 activation effects in cell-based assays, and effective cardioprotective effects against lipopolysaccharide (LPS)-induced injury both <i>in vitro</i> and <i>in vivo</i>. This study provides a potent Keap1-Nrf2 PPI inhibitor with the novel indoline scaffold and without acetic acid groups as a potential cardioprotective agent.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Discovery of Initial Hit Compound <b>10a</b> as the Keap1-Nrf2 Inhibitor</h3><div class="NLM_p">The Keap1-Nrf2-ARE signaling has emerged as a potential target to mediate some diseases related to oxidative stress and inflammation, and numerous Nrf2 activators have been identified, including electrophilic and noncovalent compounds. Particularly, more and more noncovalent Keap1-Nrf2 PPI inhibitors have been developed and some of them exhibit therapeutic potential in multiple animal models.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> In an effort to discover a new scaffold for Keap1-Nrf2 inhibitors, we replaced the naphthalene ring with a benzene ring based on the structure reported previously by our group.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Then, a small hydrophobic methyl group was added to the core phenyl ring to compensate for the loss of hydrophobic effects on binding activity to some extent and fragment <b>9</b> was designed and synthesized. <b>9</b> showed weak inhibitory activity in Keap1-Nrf2 PPI determined by fluorescence polarization (FP) assay (IC<sub>50</sub> = 450 μM). Despite the weak activity, this fragment contained a phenyl ring other than the naphthalene ring and the potency of such fragment can be further enhanced by means of structure optimization. By analyzing the reported potent inhibitors, we thought that introduction of hydrophobic groups (such as methoxy group substituted aniline, as shown in the compounds <b>5a–5c</b>) may increase interactions with the Keap1 cavity. Inspired by the potent inhibitor <b>8a</b>, the meta position of the core phenyl ring may be a favorable site to elicit a new substituent group. Then, we introduced a 3-methoxyaniline moiety into compound <b>9</b> and compound <b>10a</b> was obtained with enhanced activity (assessed by a FP assay, IC<sub>50</sub> = 102 μM, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design of compound <b>10a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> SAR of Core Phenyl Ring of Phenylenediamine Compounds</h3><div class="NLM_p">To improve the potency of Keap1-Nrf2 inhibition, we explored the effects of various substituents in the core phenyl ring of compound <b>10a</b> on its activity using FP assay, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. First, the methyl group was introduced at different positions of the phenyl ring, and it resulted in target compounds <b>10b</b>–<b>10e</b>. Substitutions at the 4- and 5-position (<b>10b</b> and <b>10c</b>) as well as analogue <b>10e</b> without the methyl substituent showed similar activity compared with <b>10a</b>, while 2-position substitution (<b>10d</b>) gave a nearly 3-fold increase in inhibitory activity. Then, trifluoromethyl, fluorine, and methoxy were introduced at 2-position and compounds <b>10f–10h</b> were obtained. The electron-donating substituents were more suitable than electron-withdrawing substituents at this position, and all of them showed decreased potency compared with <b>10d</b>. Moreover, the 1,4-phenylenediamine analogue <b>10i</b> gave an abolished activity, indicating the necessity of the 1,3-substituted core phenyl ring.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effects of Core Phenyl Modifications on Keap1-Nrf2 Inhibition</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0022.gif" alt="" id="GRAPHIC-d7e596-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0023.gif" alt="" id="gr21" /></img><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Design of Compounds with Indoline Core</h3><div class="NLM_p">We hypothesized that the core phenyl ring of <b>10d</b> may occupy the P3 subpocket to stabilize the binding conformation just like the naphthalene ring of compound <b>5</b>. Therefore, we supposed the cyclization of the secondary amine with the methyl moiety of the core phenyl ring may obtain beneficial conformation restriction, resulting in compound <b>11a</b>. Inspiringly, as shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, indoline <b>11a</b> showed approximately 2-fold improvement in IC<sub>50</sub> compared with <b>10d</b>. Subsequent replacement of the indoline core with indole ring (<b>12</b>) and 1,2,3,4-tetrahydroquinoline ring (<b>13</b>) both decreased activity, indicating the rationality of the five-membered alkyl ring. Then, we explored the effects of substituents on the benzene sulfonamide fragment on inhibitory activity and compounds <b>11b–11f</b> were synthesized (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Unfortunately, these common substituents exhibited abolished activity, manifesting the importance of the 2,4,6-trimethyl substitution on the benzene in this scaffold. The effects of the linker X between the indoline ring and phenyl ring were investigated next. We chose amide, sulfamide, and methylene as the linker, and compounds <b>14a–c</b> were synthesized. The sulfonyl (<b>14b</b>) and methylene (<b>14c</b>) analogues exhibited comparable inhibitory activity to <b>11a</b>, while the amide derivative <b>14a</b> showed significant loss of potency, indicating the requirement of certain orientation for the linker (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Finally, we chose the methylene analogue <b>14c</b> as a hit for further optimization in consideration of synthetical accessibility and diversity.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design of indoline compound <b>11a</b> and initial SAR investigation of this structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because the exact binding mode of this chemotype with Keap1 was not available, the effects of different substituents on the benzyl moiety of <b>14c</b> on Keap1-Nrf2 PPI inhibition were systematically evaluated and derivatives <b>14d–14z</b> were obtained. The SAR data of these compounds are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. Generally, most substituents led to abolished activity. Substitutions at para- and ortho-positions (<b>14d–14i</b>) resulted in decreased inhibitory activity with respect to <b>14c</b>. Then, the 3-position-substituted compounds (<b>14k–14s</b>) and disubstituted analogues (<b>14t–14z</b>) also exhibited no improvement in potency, implying that original 3-methoxy is optimal.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effects of Benzyl Substituents on Keap1-Nrf2 Inhibition</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0024.gif" alt="" id="GRAPHIC-d7e704-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> ± SE (μM)</th><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> ± SE (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14c</b></td><td class="colsep0 rowsep0" align="left">3-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">16.4±0.26</td><td class="colsep0 rowsep0" align="left"><b>14o</b></td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="left">24.8±0.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14d</b></td><td class="colsep0 rowsep0" align="left">4-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">98.0±1.49</td><td class="colsep0 rowsep0" align="left"><b>14p</b></td><td class="colsep0 rowsep0" align="left">3-Ph</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14e</b></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"><b>14q</b></td><td class="colsep0 rowsep0" align="left">3-OCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14f</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"><b>14i</b></td><td class="colsep0 rowsep0" align="left">3-OCH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14g</b></td><td class="colsep0 rowsep0" align="left">4-Br</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"><b>14s</b></td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">27.2±0.84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14h</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"><b>14t</b></td><td class="colsep0 rowsep0" align="left">3,5-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">22.2±0.97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14i</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"><b>14u</b></td><td class="colsep0 rowsep0" align="left">2,3-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">98.2±2.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14j</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">42.0±1.03</td><td class="colsep0 rowsep0" align="left"><b>14v</b></td><td class="colsep0 rowsep0" align="left">3,5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14k</b></td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"><b>14w</b></td><td class="colsep0 rowsep0" align="left">3-F-5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14l</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"><b>14x</b></td><td class="colsep0 rowsep0" align="left">3,4-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14m</b></td><td class="colsep0 rowsep0" align="left">3-Br</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"><b>14y</b></td><td class="colsep0 rowsep0" align="left">3-Br-5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14n</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"><b>14z</b></td><td class="colsep0 rowsep0" align="left">3-OCH<sub>3</sub>-5-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div></div><div class="NLM_p">Then, we investigated the binding mode of this chemotype with Keap1 using a docking study of <b>14c</b> to the Keap1 Kelch domain.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> On the basis of the SAR data obtained above, we hypothesized that the 3-methoxy-substituted benzyl moiety probably occupied a narrow pocket. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A, the carboxylic acid moiety of <b>14c</b> can insert into the P2 subpockets and interact with Arg415 and Arg380 by hydrogen bonds and electrostatic interactions. The 2,4,6-trimethyl substituted phenyl ring moiety can occupy the hydrophobic pocket P5, interacting with Tyr572, Tyr334, and Phe577. The indoline core can occupy the P3 subpocket similar to the naphthalene core. Interestingly, the 3-methoxyl substituted benzyl moiety is inserted into the narrow and polar P1 subpocket other than the P4 hydrophobic pocket. This predicated binding mode also explained why most substituents led to abolished activity.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Proposed binding mode of compound <b>14c</b> with Keap1 using molecular docking and design of acyl sulfonamide derivatives. (A) Binding mode of <b>14c</b> with Keap1 using a docking method. The docking site was derived from the position of the small-molecular ligand cocrystallized in the binding site of Keap1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XMB">4XMB</a>). The ligand is represented as sticks. Hydrogen bonds are represented by green dashed lines, and electrostatic interactions are represented by orange dashed lines. The π–π interactions are represented by pink dashed lines. The carbon atoms of small molecules and Keap1 residues are colored cyan and purple, respectively. (B) Design of acyl sulfonamide derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Design and Optimization of Indoline Compounds with Acyl Sulfonamides</h3><div class="NLM_p">Inspection of the binding mode of <b>14c</b> suggested that the benzylic carbon is close to Arg415 and carboxyl group can be introduced at this position. Thus, compound <b>15</b> was designed and synthesized (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01116/suppl_file/jm0c01116_si_001.csv" class="ext-link">S1</a>). <b>15</b> showed approximately 7-fold improvement in IC<sub>50</sub>. Considering the undesired effect of the carboxy group on physicochemical properties and penetrability of Keap1-Nrf2 inhibitors, we performed a bioisosteric replacement method to improve the drug-like properties of indoline compounds. It is reported that acyl sulfonamide with chemical and enzymatic stability is a favorable replacement of the carboxyl group.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Thus, the <i>N</i>-acylsulfonamide moiety was built by direct coupling of the carboxylic acid with different substituted sulfonamides and resulted in analogues <b>16a–16z</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B).</div><div class="NLM_p">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, the alkyl analogues (<b>16b</b> and <b>16c</b>) and aromatic heterocycles (<b>16d</b> and <b>16e</b>) showed no improvement compared with <b>15</b>, whereas phenyl substituent <b>16a</b> exhibited slightly better potency, indicating that the acyl-sulfonamide phenyl is a favorable substitute of carboxylic acid. In order to confirm the rationality of this optimization, the thermodynamic data of compounds <b>15</b> and <b>16a</b> were determined using a tracer displacement assay.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> As shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, the value of binding enthalpy of <b>15</b> is positive (Δ<i>H</i> = 0.69 kJ/mol), which is compensated by significantly large negative values for −<i>T</i>Δ<i>S</i>, indicating that the binding is solely entropy-driven, whereas the negative values of Δ<i>H</i> and −<i>T</i>Δ<i>S</i> of <b>16a</b> suggested the favorable enthalpy and entropy contributions in the binding of <b>16a</b> to Keap1.<a onclick="showRef(event, 'ref68 ref69 ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref68 ref69 ref70 ref71">(68−71)</a> Encouraged by these results, an exhaustive SAR exploration of the aromatic ring was performed and target compounds <b>16f–16z</b> were synthesized. Generally, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, the phenyl ring can tolerate a variety of substituents. The substitutions at para- and ortho-positions showed better performance, whereas the substituent at the meta-position was not preferred for Keap1 inhibition (<b>16g</b>, <b>16m</b>, and <b>16n</b>). Among them, the analogues <b>16g</b> with the 4-methyl substitute and <b>16l</b> with 2-methoxy substitution exhibited the most potent inhibitory activity. Then, disubstituted analogues were designed and synthesized based on the results obtained above (<b>16v–16y</b>). Interestingly, derivatives <b>16w</b> and <b>16x</b> exhibited sub-micromolar potency. The most potent analogue <b>16w</b> with 2-methoxy-4-methyl substitutions gave an IC<sub>50</sub> value as low as 0.23 μM. The naphthalene <b>16z</b> showed slightly decreased potency. The thermodynamic data of representative compounds showed that most of these compounds exhibited favorable binding enthalpy and entropy in the binding to Keap1 (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effects of Sulfonamide Substitutions on Keap1-Nrf2 Inhibition</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0025.gif" alt="" id="GRAPHIC-d7e1184-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0026.gif" alt="" id="gr22" /></img><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Thermodynamics Data<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> for Representative Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> ± SE (μM)</th><th class="colsep0 rowsep0" align="center" char=".">Δ<i>G</i> (kJ/mol)</th><th class="colsep0 rowsep0" align="center" char=".">Δ<i>H</i> (kJ/mol)</th><th class="colsep0 rowsep0" align="center" char=".">–<i>T</i>Δ<i>S</i> (kJ /mol)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char="±">2.37 ± 0.06</td><td class="colsep0 rowsep0" align="char" char=".">–31.9</td><td class="colsep0 rowsep0" align="char" char=".">0.69</td><td class="colsep0 rowsep0" align="char" char=".">–32.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="char" char="±">1.82 ± 0.09</td><td class="colsep0 rowsep0" align="char" char=".">–33.0</td><td class="colsep0 rowsep0" align="char" char=".">–19.4</td><td class="colsep0 rowsep0" align="char" char=".">–13.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16g</b></td><td class="colsep0 rowsep0" align="char" char="±">1.39 ± 0.11</td><td class="colsep0 rowsep0" align="char" char=".">–33.7</td><td class="colsep0 rowsep0" align="char" char=".">–23.8</td><td class="colsep0 rowsep0" align="char" char=".">–9.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16h</b></td><td class="colsep0 rowsep0" align="char" char="±">2.86 ± 0.21</td><td class="colsep0 rowsep0" align="char" char=".">–31.2</td><td class="colsep0 rowsep0" align="char" char=".">4.36</td><td class="colsep0 rowsep0" align="char" char=".">–35.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16l</b></td><td class="colsep0 rowsep0" align="char" char="±">1.32 ± 0.10</td><td class="colsep0 rowsep0" align="char" char=".">–34.0</td><td class="colsep0 rowsep0" align="char" char=".">–22.3</td><td class="colsep0 rowsep0" align="char" char=".">–11.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16m</b></td><td class="colsep0 rowsep0" align="char" char="±">1.79 ± 0.11</td><td class="colsep0 rowsep0" align="char" char=".">–32.8</td><td class="colsep0 rowsep0" align="char" char=".">–3.58</td><td class="colsep0 rowsep0" align="char" char=".">–29.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16w</b></td><td class="colsep0 rowsep0" align="char" char="±">0.23 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">–37.5</td><td class="colsep0 rowsep0" align="char" char=".">–23.6</td><td class="colsep0 rowsep0" align="char" char=".">–13.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16x</b></td><td class="colsep0 rowsep0" align="char" char="±">0.64 ± 0.08</td><td class="colsep0 rowsep0" align="char" char=".">–34.4</td><td class="colsep0 rowsep0" align="char" char=".">–18.8</td><td class="colsep0 rowsep0" align="char" char=".">–15.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">The thermodynamic data of compounds were determined by FP assay as described in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01116/suppl_file/jm0c01116_si_001.csv" class="ext-link">Supporting Information</a>. Δ<i>H</i>, Δ<i>S</i>, and Δ<i>G</i> refer to the changes in binding enthalpy, entropy, and total Gibbs free energy, respectively.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Effects of Benzene Side Chain Sulfonamide Substituents (R) on Keap1-Nrf2 Inhibition</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0027.gif" alt="" id="GRAPHIC-d7e1363-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0028.gif" alt="" id="gr23" /></img><div></div></div><div class="NLM_p">Then, the binding mode of <b>16w</b> was elucidated by the docking study and the result gave the reason for the increased activity of compound <b>16w</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). As expected, the NH of the acyl sulfonamide located at the P1 subsite and formed crucial electrostatic interaction with Arg483 of Keap1. Furthermore, the carbonyl and sulfonyl fragments increased the hydrogen bonding interactions with Ser508 and Ser555, respectively. Moreover, the phenyl ring can form a π–π stacking interaction with Tyr525 and the rest of compound <b>16w</b> can bind to Keap1 in a similar way as the compound <b>14c</b>. Interestingly, the 2-methoxy-4-methyl substitutions of the phenyl ring can probably locate the acyl sulfonamide moiety at an appropriate position for binding.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Proposed binding mode of compounds <b>16w</b> (A) and <b>19a</b> (B) with Keap1 using molecular docking. The docking site was derived from the position of the small-molecular ligand cocrystallized in the binding site of Keap1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XMB">4XMB</a>). The ligand is represented as sticks. Hydrogen bonds are represented by green dashed lines, and electrostatic interactions are represented by orange dashed lines. The π–π interactions are represented by pink dashed lines. The carbon atoms of small molecules and Keap1 residues are colored cyan and purple, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Reinspection of the binding mode of <b>16w</b> gave an idea that the carboxy group can also be replaced with the bioisostere to increase additional interactions with Keap1. Encouraged by the favorable result of the introduction of the acyl sulfonamide moiety, we replaced the carboxy group of <b>16w</b> with the acyl sulfonamide isostere by the similar method described above and resulted in the derivative <b>17a</b> with diacyl sulfonamide groups (structure shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). The FP assay gave the positive result that <b>17a</b> exhibited comparable activity with the highly potent Keap1-Nrf2 inhibitor <b>5b</b> reported previously.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> We then installed several common substituents in the phenyl ring of <b>17a</b>, and analogues <b>17b–17h</b> were synthesized (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). The 4-methoxy <b>17b</b> showed comparable potency to 2,4,6-trimethyl <b>17a</b>. The thermodynamic data exhibited that both <b>17a</b> and <b>17b</b> are more potent than <b>16w</b> (Δ<i>G</i> ∼ −40.1 kJ/mol for <b>17a</b> and Δ<i>G</i> ∼ −40.0 kJ/mol for <b>17b</b>, whereas Δ<i>G</i> ∼ −37.5 kJ/mol for <b>16w</b> at 296 K, <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Effects of Benzene Sulfonamide Substituents (R) on Keap1-Nrf2 Inhibition</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0029.gif" alt="" id="GRAPHIC-d7e1478-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> ± SE (μM)</th><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> ± SE (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="left">2,4,6-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.058 ± 0.001</td><td class="colsep0 rowsep0" align="left"><b>17e</b></td><td class="colsep0 rowsep0" align="left">4-NHCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.23 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="left">4-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.064 ± 0.001</td><td class="colsep0 rowsep0" align="left"><b>17f</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.16 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17c</b></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.11 ± 0.01</td><td class="colsep0 rowsep0" align="left"><b>17g</b></td><td class="colsep0 rowsep0" align="left">3-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.15 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17d</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char="±">0.58 ± 0.08</td><td class="colsep0 rowsep0" align="left"><b>17h</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.24 ± 0.05</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Thermodynamic Data<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> of Compounds <b>17a</b>, <b>17b</b>, and <b>19a</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> ± SE (μM)</th><th class="colsep0 rowsep0" align="center" char=".">Δ<i>G</i> (kJ/mol)</th><th class="colsep0 rowsep0" align="center" char=".">Δ<i>H</i> (kJ/mol)</th><th class="colsep0 rowsep0" align="center" char=".">–<i>T</i>Δ<i>S</i> (kJ /mol)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="char" char="±">0.058 ± 0.001</td><td class="colsep0 rowsep0" align="char" char=".">–40.1</td><td class="colsep0 rowsep0" align="char" char=".">–31.3</td><td class="colsep0 rowsep0" align="char" char=".">–8.84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="char" char="±">0.064 ± 0.001</td><td class="colsep0 rowsep0" align="char" char=".">–40.0</td><td class="colsep0 rowsep0" align="char" char=".">–28.2</td><td class="colsep0 rowsep0" align="char" char=".">–11.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="char" char="±">0.022 ± 0.001</td><td class="colsep0 rowsep0" align="char" char=".">–43.1</td><td class="colsep0 rowsep0" align="char" char=".">–26.5</td><td class="colsep0 rowsep0" align="char" char=".">–16.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">The thermodynamic data of compounds were determined from FP assay as described in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01116/suppl_file/jm0c01116_si_001.csv" class="ext-link">Supporting Information</a>. Δ<i>H</i>, Δ<i>S</i>, and Δ<i>G</i> refer to the changes in binding enthalpy, entropy, and total Gibbs free energy, respectively.</p></div></div></div><div class="NLM_p">The impact of sulfonamide substitutions (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>) was subsequently examined based on the structure of <b>17b</b>. Alkyl (<b>18a–18c</b>) and heterocycles (<b>18d</b> and <b>18e</b>) substitutions exhibited decreased activity compared with <b>17b</b>, indicating the priority of aromatic ring at this position.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Effects of Sulfonamide Substitutions (R) on Keap1-Nrf2 Inhibition</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0030.gif" alt="" id="GRAPHIC-d7e1744-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0031.gif" alt="" id="gr24" /></img><div></div></div><div class="NLM_p">Thus, further modifications of the side chain phenyl ring were performed (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>). The SAR data revealed that the para-position can tolerate several substituents, while the meta- and ortho-positions are not suitable for substitution (<b>19a–19i</b>). Among them, the 4-methoxy analogue <b>19a</b> showed potent Keap1-Nrf2 inhibitory activity with an IC<sub>50</sub> of 22 nM in the FP assay. The thermodynamic data of <b>19a</b> also gave a satisfactory character that the binding of <b>19a</b> to Keap1 is primarily enthalpy-driven (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). The docking study of compound <b>19a</b> to Keap1 gave a similar binding mode as <b>16w</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B), while the 4-methoxyphenyl substituted acyl sulfonamide moiety afforded sufficient interactions with P2 subpocket.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Effects of Side Chain Phenyl Ring Modifications (R) on Keap1-Nrf2 Inhibition</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0032.gif" alt="" id="GRAPHIC-d7e1788-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> ± SE (μM)</th><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="left">IC<sub>50</sub> ± SE (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.064 ± 0.001</td><td class="colsep0 rowsep0" align="left"><b>19e</b></td><td class="colsep0 rowsep0" align="left">4-CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.19 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="left">4-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.022 ± 0.001</td><td class="colsep0 rowsep0" align="left"><b>19f</b></td><td class="colsep0 rowsep0" align="left">4-OH</td><td class="colsep0 rowsep0" align="left">0.51 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.12 ± 0.01</td><td class="colsep0 rowsep0" align="left"><b>19g</b></td><td class="colsep0 rowsep0" align="left">4-OCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.048 ± 0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19c</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char="±">0.13 ± 0.02</td><td class="colsep0 rowsep0" align="left"><b>19h</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19d</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.40 ± 0.06</td><td class="colsep0 rowsep0" align="left"><b>19i</b></td><td class="colsep0 rowsep0" align="left">3-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Biophysical Characterization of Selected Compounds Binding to Keap1</h3><div class="NLM_p">To recheck thermodynamic parameters obtained from the tracer displacement assay, the isothermal titration calorimetry (ITC) assay was used to test representative compounds <b>15</b>, <b>16w</b>, and <b>19a</b>. Consistent with the data obtained by the tracer displacement assay, compound <b>15</b> was dominated by entropic effects, while compounds <b>16w</b> and <b>19a</b> were primarily enthalpy-driven (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). Meanwhile, the ITC assay gave a <i>K</i><sub>d</sub> of 58.4 nM of <b>19a</b> to Keap1 Kelch domain, similar with the potent diacetic compounds.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> To further inspect the Keap1 binding properties of <b>19a</b>, the biolayer interferometry (BLI) technique was applied to monitor the binding kinetics of <b>19a</b> and gave a <i>K</i><sub>d</sub> of 26.4 nM consistent with the ITC data (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). The binding curves and the association rate constant (<i>k</i><sub>on</sub>) indicated a fast binding process of <b>19a</b> to Keap1, while a relatively slow dissociation rate constant (<i>k</i><sub>off</sub>) gave the low <i>K</i><sub>d</sub> value. These binding assays together confirmed the direct and tight binding of <b>19a</b> to Keap1.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Keap1 Binding Properties of selected compounds. (A) ITC titration profiles of Keap1 Kelch Domain with compounds <b>15</b>, <b>16w</b>, and <b>19a</b> (<b>15</b>: 0.02 mM Keap1 Kelch domain was titrated with 0.2 mM compound <b>15</b>; <b>16w</b>: 0.02 mM Keap1 Kelch domain was titrated with 0.2 mM compound <b>16w</b>; <b>19a</b>: 0.02 mM Keap1 Kelch domain was titrated with 0.2 mM compound <b>19a</b>). The thermodynamic parameters of the interaction of Keap1 with compounds as determined by the ITC assay were listed in the table. <i>N</i> is the stoichiometric coefficient. <i>K</i><sub>d</sub> is the binding constant. Δ<i>H</i>, Δ<i>S</i>, and Δ<i>G</i> refer to the changes in binding enthalpy, entropy, and total Gibbs free energy, respectively. Δ<i>G</i> is calculated according to the equation Δ<i>G</i> = Δ<i>H</i> – <i>T</i>Δ<i>S</i>, where <i>T</i> is the absolute temperature used for the ITC experiment. (B) BLI dose–response curve reflecting the direct binding of <b>19a</b> to Keap1. The binding kinetics parameters were listed in the table. <i>K</i><sub>d</sub> value is calculated by <i>k</i><sub>dis</sub>/<i>k</i><sub>on</sub>. Concentrations: 100, 50, 20, and 5 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Drug-like Properties of Selected Compounds</h3><div class="NLM_p">Metabolic stability is a prior consideration of developing non-electrophilic Keap1-Nrf2 inhibitors.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> On the basis of their good in vitro potency, we evaluated the stability of compounds <b>17a</b>, <b>17b</b>, and <b>19a</b> in human liver microsomes. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>, compounds <b>17b</b> and <b>19a</b> exhibited good human microsomal stability, while <b>17a</b> was relatively metabolically unstable in human liver microsomes.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. <i>In Vitro</i> Metabolic Stability in Human Liver Microsomes and PAMPA Permeability Data<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a> of Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="±">cpd</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameters</th><th class="colsep0 rowsep0" align="center" char="±"><b>17a</b></th><th class="colsep0 rowsep0" align="center" char="±"><b>17b</b></th><th class="colsep0 rowsep0" align="center" char="±"><b>19a</b></th><th class="colsep0 rowsep0" align="center"><b>5b</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">45 min remaining (%)</td><td class="colsep0 rowsep0" align="char" char="±">48.7 ± 3.35</td><td class="colsep0 rowsep0" align="char" char="±">85.7 ± 1.07</td><td class="colsep0 rowsep0" align="char" char="±">74.4 ± 8.45</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (min)</td><td class="colsep0 rowsep0" align="char" char="±">44.0 ± 5.10</td><td class="colsep0 rowsep0" align="char" char="±">226 ± 10.1</td><td class="colsep0 rowsep0" align="char" char="±">151 ± 11.6</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Clint (mL/kg)</td><td class="colsep0 rowsep0" align="char" char="±">39.4 ± 3.14</td><td class="colsep0 rowsep0" align="char" char="±">7.64 ± 0.28</td><td class="colsep0 rowsep0" align="char" char="±">11.4 ± 3.17</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PAMPA permeability</td><td class="colsep0 rowsep0" align="char" char="±">3.79 ± 0.43</td><td class="colsep0 rowsep0" align="char" char="±">4.51 ± 0.91</td><td class="colsep0 rowsep0" align="char" char="±">5.27 ± 0.37</td><td class="colsep0 rowsep0" align="left">0.19 ± 0.01</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup><sup>a</sup></sup><p class="last">Average of two runs ± standard deviation (SD). PAMPA permeability values were determined at pH 7.4 (10<sup>–6</sup> cm/s).</p></div></div></div><div class="NLM_p">Mainly because of the polar binding pocket of the Keap1 binding domain, most of the Keap1-Nrf2 PPI inhibitors contain carboxyl usually meaning unfavorable penetrability and affecting the performance in cellular and <i>in vivo</i> assay (such as <b>5b</b>). Compounds <b>17a</b>, <b>17b</b>, and <b>19a</b> were selected to profile in a parallel artificial membrane permeability assay (PAMPA). Compared to the bis-carboxylic acid inhibitor, <b>5b</b>, acyl sulfonamides analogues <b>17a</b>, <b>17b</b>, and <b>19a</b> showed comparatively better PAMPA permeability (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>).</div><div class="NLM_p">Further cytochrome P450 (CYP) inhibition determination showed that <b>19a</b> had no serious inhibition on the five major isozymes (<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>). We then studied the <i>in vivo</i> PK profiles of compounds <b>19a</b>. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a></a>, intravenous (iv) administration (5 mg/kg) of <b>19a</b> displayed favorable PK parameters (4 h of half-life and high exposure in plasma). With the potent inhibitory activity in FP assay and drug-like properties both <i>in vitro</i> and <i>in vivo</i>, compound <b>19a</b> was selected for further biological evaluation.</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. CYP450 Isozyme Inhibition<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a> of <b>19a</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">isozymes</th><th class="colsep0 rowsep0" align="center">% inhibition</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP450 isozymes: CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4</td><td class="colsep0 rowsep0" align="left">8.75, 30.26, 19.80, 19.89, 46.86</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup><sup>a</sup></sup><p class="last">Performed at 10 μM concentration.</p></div></div></div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. <i>In Vivo</i> PK Profiles<a class="ref internalNav" href="#t12fn1" aria-label="a">a</a> of <b>19a</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameters</th><th class="colsep0 rowsep0" align="center" char="."><b>19a</b> (5 mg/kg iv)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μg/L)</td><td class="colsep0 rowsep0" align="char" char=".">78,160.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0–<i>t</i>)</sub> (h·μg/L)</td><td class="colsep0 rowsep0" align="char" char=".">47,032.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0–∞)</sub> (h·μg/L)</td><td class="colsep0 rowsep0" align="char" char=".">47,041.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">4.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT<sub>(0–∞)</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">1.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Vz (L/kg)</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CLz (L/h/kg)</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t12fn1"><div class="footnote" id="t12fn1"><sup><sup>a</sup></sup><p class="last"><i>C</i><sub>max</sub> = maximum plasma concentration; <i>T</i><sub>max</sub> = time to reach maximum plasma concentration; AUC = area under plasma concentration–time curve; <i>t</i><sub>1/2</sub> = half-life; MRT = mean residence time; Vz = apparent volume of distribution; CLz = apparent clearance.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Compound <b>19a</b> Significantly Activated Nrf2-Regulated Cytoprotective Defense System <i>In Vitro</i></h3><div class="NLM_p">As mentioned above, Keap1-mediated negative regulation of Nrf2 can be antagonized by Keap1-Nrf2 inhibitors, followed by activation of the Nrf2-regulated cytoprotective defense system. <b>19a</b> with potent Keap1 binding affinity was chosen to evaluate cellular Nrf2 activation effects. First, we evaluated the relative potency of <b>19a</b> in comparison to the known Nrf2 activator SFN using an ARE-luciferase reporter assay. HepG2-ARE cells that had been stably transfected with a luciferase reporter were treated with different concentrations (0.01, 0.1, 1, 5, 10, and 20 μM) of <b>19a</b> or SFN for the indicated times. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">Table <a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">13</a></a>, <b>19a</b> increased the induction of ARE in a concentration-dependent manner and induced the luciferase activity by 8.3-fold over the dimethyl sulfoxide (DMSO) control at a maximal concentration of 20 μM, much more potent than SFN. We then investigated the effects of <b>19a</b> on the Nrf2-regulated genes expression in H9c2 cardiac cells, including <i>NEFL2L</i> (encoding Nrf2 protein), <i>HO-1</i>, <i>NQO-1</i>, and <i>GCLM</i>. The quantitative real-time PCR (qRT-PCR) results showed that treatment with 0.1–10 μM <b>19a</b> for 12 h strongly increased the transcription of Nrf2 and the Nrf2-regulated genes in a concentration-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A). Moreover, the time-course study showed that the Nrf2 activation effects started after 4 h of <b>19a</b> treatment and continued for more than 24 h (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B). In line with these results, the evaluation of the Nrf2 and Nrf2-downstream proteins by western blotting demonstrated that treatment of the H9c2 cells with 0.1–10 μM <b>19a</b> elevated protein levels of Nrf2, HO-1, NQO1, and GCLM in a concentration-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C,D).</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Nrf2 activation effects of <b>19a</b> on H9c2 cells. (A) Cells were exposed to <b>19a</b> at various concentrations for 12 h, (B) cells were exposed to 10 μM <b>19a</b> at various time points; the mRNA levels of Nrf2 and Nrf2-targeted genes were determined by qRT-PCR analysis. GAPDH was used to normalize the expression of these genes. Additional H9c2 cells were treated with DMSO for use as the blank control. The values shown are the means ± SEM (<i>n</i> = 3 independent observations). ***<i>p</i> < 0.001, **<i>p</i> < 0.01, and *<i>p</i> < 0.05, one-way ANOVA with Tukey–Kramer posttest. (C) Cells were exposed to <b>19a</b> at various concentrations for 12 h, (D) cells were exposed to 10 μM <b>19a</b> at various time points, the protein levels of Nrf2 and Nrf2-regulated proteins were determined by western blot analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl13"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 13. Induction of ARE Activity in HepG2-ARE-C8 Cells<a class="ref internalNav" href="#t13fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char="±">ARE induction folds</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center" char="±">0.01 μM</th><th class="colsep0 rowsep0" align="center" char="±">0.1 μM</th><th class="colsep0 rowsep0" align="center" char="±">1 μM</th><th class="colsep0 rowsep0" align="center" char="±">5 μM</th><th class="colsep0 rowsep0" align="center" char="±">10 μM</th><th class="colsep0 rowsep0" align="center" char="±">20 μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="char" char="±">1.53 ± 0.18</td><td class="colsep0 rowsep0" align="char" char="±">1.85 ± 0.24</td><td class="colsep0 rowsep0" align="char" char="±">2.39 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">4.97 ± 0.56</td><td class="colsep0 rowsep0" align="char" char="±">6.93 ± 0.63</td><td class="colsep0 rowsep0" align="char" char="±">8.35 ± 0.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>SFN</b></td><td class="colsep0 rowsep0" align="char" char="±">1.18 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">1.28 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">1.50 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">1.93 ± 0.29</td><td class="colsep0 rowsep0" align="char" char="±">2.47 ± 0.22</td><td class="colsep0 rowsep0" align="char" char="±">3.56 ± 0.26</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t13fn1"><div class="footnote" id="t13fn1"><sup><sup>a</sup></sup><p class="last">Values shown are mean ± SD (<i>n</i> = 3, 12 h of treatment). Cells were exposed to compounds tested for their ability to increase levels of relative luciferase units.</p></div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Compound <b>19a</b> Showed Cytoprotective Effects against LPS-Induced Injury in H9c2 Cells</h3><div class="NLM_p">LPS has been proven to be a key stimulus for sepsis models, and that sepsis-induced myocarditis models have been widely used for screening of drugs for the treatment and prevention of myocarditis <i>in vitro</i> and <i>in vivo</i>.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Therefore, we evaluated the effects of <b>19a</b> on LPS-induced cardiac injury in both cellular and <i>in vivo</i> models. First, we used the MTT assay to examine the protective effects of <b>19a</b> against the LPS-induced cell damage. No apparent cytotoxicity was observed toward H9c2 cells with compound <b>19a</b> at concentrations up to 100 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01116/suppl_file/jm0c01116_si_001.csv" class="ext-link">Supporting Information</a>, Figure S3). As shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A, the viability of cardiac cells was reduced to approximately 70% after treatment of LPS (1 μg/mL), while pretreatment with <b>19a</b> showed favorable cytoprotective effects in a concentration-dependent manner. Inflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6, facilitated the development of sepsis-induced myocarditis. As shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B–D, exposure to LPS could cause an obvious increase of inflammatory factors (including IL-1β, IL-6, and TNF-α) compared with vehicle control, while pretreatment with <b>19a</b> remarkably decreased the secretion of these inflammatory factors.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effects of <b>19a</b> against LPS-induced injury in H9c2 cells. (A) Concentration-dependent protective effects of <b>19a</b> against the LPS-induced cell damage. Cells were pretreated with 0.1–10 μM <b>19a</b> for 12 h and then exposed to 1 μg/mL LPS for an additional 12 h. The cell viability was determined by the MTT assay. (B–D) Cells were pretreated with 1–10 μM <b>19a</b> for 12 h and then exposed to 1 μg/mL LPS for an additional 12 h, and the ratios of IL-1β (B), IL-6 (C), and TNF-α (D) were determined. The values shown are the means ± SEM (<i>n</i> = 3 independent observations). **<i>p</i> < 0.01 and ***<i>p</i> < 0.001, one-way ANOVA with the Tukey–Kramer post-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We further investigated the antioxidative activity of compound <b>19a</b>. The Glutathione (GSH)-based antioxidant system is mediated by the Keap1-Nrf2-ARE pathway; thus, the GSH/GSSG ratio was measured. As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A, the ratio decreased after LPS treatment, while pretreatment with <b>19a</b> could up-regulate this ratio obviously. Then, we investigated the effect of <b>19a</b> on the LPS-induced augment of ROS level in H9c2 cells. The fluorogenic cellular ROS indicator c-H2DCF-DA was used to stain the cells. As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B, the living cell fluorescence microscopic signal was significantly enhanced after treatment with 1 μg/mL LPS and this increase could be remarkably suppressed by 10 μM <b>19a</b> pretreatment, which indicated its protective effect against the oxidative stress in the H9c2 cells.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Antioxidative effects of <b>19a</b> against LPS-induced injury in H9c2 cells. (A) GSH/GSSG ratio in H9c2 cells was measured. The H9c2 cells were pretreated with 0.1–10 μM <b>19a</b> for 12 h and then exposed to 1 μg/mL LPS for an additional 12 h. The values shown are the means ± SEM (<i>n</i> = 3 independent observations). *<i>p</i> < 0.05, **<i>p</i> < 0.01, one-way ANOVA with Tukey–Kramer posttest. (B) Living cell microscopy. The H9c2 cells were pretreated with 10 μM <b>19a</b> for 12 h and then exposed to 1 μg/mL LPS for an additional 12 h. After this treatment, the H9c2 cells were stained with 10 μM cH2DCF-DA for 20 min at 37 °C and living cell fluorescence microscopy was performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Compound <b>19a</b> Showed Cardioprotective Effects against LPS-Induced Injury <i>In Vivo</i></h3><div class="NLM_p">To evaluate the therapeutic potential of compound <b>19a</b><i>in vivo</i>, the LPS-induced mouse model of cardiac injury was used to test the protective effects of compound <b>19a</b>. We first evaluated the histological changes of the heart tissue by hematoxylin and eosin (H&E) staining. Following intraperitoneal (ip) administration to the male C57BL/6 mice at 15 mg/kg LPS, the animals showed typical inflammatory changes including swollen myocardial cells, inflammatory cells infiltration, and expansion of muscle gap relative to the control group (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A). Moreover, several red blood cells leaking into intermuscular space were also observed in the model group. In contrast, pretreatment with <b>19a</b> (ip) significantly ameliorated the damage and inflammation in the heart tissue even at 10 mg/kg. Moreover, these ameliorations by <b>19a</b> were also reflected by the low histological disease scores (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01116/suppl_file/jm0c01116_si_001.csv" class="ext-link">Supporting Information</a>, Figure S4). To confirm the anti-inflammatory effects of compound <b>19a</b><i>in vivo</i>, we next examined several representative inflammatory factors in serum including IL-1β, IL-6, and TNF-α using ELISAs. The results showed that even 10 mg/kg dose of compound <b>19a</b> significantly decreased the levels of these inflammatory factors (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B–D). Taken together, these results demonstrated that <b>19a</b> could protect against LPS-induced heart tissue injury and inflammation <i>in vivo</i>.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Protective effects of <b>19a</b> against LPS-challenged damage in the mouse heart tissues. (A) Representative photomicrographs (400×) of H&E-stained heart sections from mice. The levels of serum IL-1β (B), IL-6 (C), and TNF-α (D) were measured (<i>n</i> = 8 mice/group). The values shown are the means ± SEM *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001, one-way ANOVA with the Tukey–Kramer post-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To ascertain the engagement of the Nrf2 pathway by compound <b>19a</b><i>in vivo</i>, the protein expression of Nrf2, HO-1, NQO1, and GCLM in the heart tissue was examined by immunohistochemical staining. As shown in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>A, administration of 10 mg/kg <b>19a</b> increased the protein levels of Nrf2 together with its downstream cytoprotective proteins HO-1, NQO1, and GCLM in the heart tissue, and the high dose of <b>19a</b> (40 mg/kg) exhibited more potent effects, which further confirmed the <i>in vivo</i> Nrf2-ARE activation effects of <b>19a</b>. LPS-induced ROS play significant roles in the inflammatory as well as the oxidative tissue injury.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Thus, we examined the ROS level which indicates the antioxidant effects of <b>19a</b>. As shown in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>B, treatment with <b>19a</b> reduced the ROS level elevated by LPS. The GSH/GSSG ratio was reduced in the LPS-treated mice, while treatment with <b>19a</b> up-regulated this ratio significantly (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>C). Collectively, the decreased ROS level combined with the increased GSH/GSSG ratio confirmed the <i>in vivo</i> antioxidant capacity of <b>19a</b>.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Antioxidative effects of <b>19a</b> against LPS-challenged damage in the mouse heart tissues. (A) Immunohistochemical detection of Nrf2 together with its target proteins HO-1, NQO1, and GCLM levels in the heart tissue from mice. Magnifications × 200. The ROS level (B) and the GSH/GSSG ratio (C) were measured in the mouse hearts. The values shown are the means ± SEM **<i>p</i> < 0.01, and ***<i>p</i> < 0.001, one-way ANOVA with the Tukey–Kramer post-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chemistry</h3><div class="NLM_p">Hit compound <b>9</b> was synthesized (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) starting from commercially available 2-nitrotoluene. The nitro group was reduced by hydrogen and Pd/C and then was sulfonylated with 2,4,6-trimethylphenylsulfonyl chloride to give intermediate <b>20</b>. Reaction with ethyl bromoacetate in the presence of K<sub>2</sub>CO<sub>3</sub> gave <b>21</b> and hydrolysis of the ester group yielded the target compound <b>9</b>.</div><figure id="sch1" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Target Compound <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>, Pd/C, MeOH, r.t., 2 h; (b) 2,4,6-trimethylphenylsulfonyl chloride, pyridine, THF, r.t., 10 h, 72%; (c) BrCH<sub>2</sub>COOCH<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 2 h, 74%; (d) LiOH, MeOH/H<sub>2</sub>O, 4 h, 75%.</p></p></figure><div class="NLM_p">Compounds with the phenylenediamine core were synthesized according to <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The phenol groups of substituted 3-nitrophenol <b>22a–h</b> reacted with Tf<sub>2</sub>O to obtain intermediates <b>23a–h</b> and then were coupled with 3-methoxyaniline to give compounds <b>24a–h</b>. The nitro group of <b>24a–h</b> was reduced to amine analogues <b>25a–h</b> by hydrogen and Pd/C, and the subsequent condensation with 2,4,6-trimethylphenylsulfonyl chloride yielded compounds <b>26a–h</b>, respectively. Reaction with methyl bromoacetate in the presence of K<sub>2</sub>CO<sub>3</sub> in DMF by nucleophilic substitution gave compounds <b>27a–h</b>. The ester groups of <b>27a–h</b> were then hydrolyzed by LiOH in MeOH/H<sub>2</sub>O to give target compounds <b>10a–10h</b>. 1,4-Phenylenediamine analogue <b>10i</b> was synthesized similar to <b>10a–10h</b>, while the initial material is 4-nitrophenol.</div><figure id="sch2" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Target Compound <b>10a–10i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Tf<sub>2</sub>O, TEA, DCM, 0 °C to r.t. 2 h, 60–75%; (b) Pd(AcO)<sub>2</sub>, Xantphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 38–75%; (c) H<sub>2</sub>, Pd/C, MeOH, r.t. 2 h; (d) 2,4,6-trimethylphenylsulfonyl chloride, pyridine, THF, r.t. 10 h, 50–70%; (e) BrCH<sub>2</sub>COOCH<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 2 h, 80–85%; (d) LiOH, MeOH/H<sub>2</sub>O, 4 h, 70–90%.</p></p></figure><div class="NLM_p">Compounds with the indoline core were synthesized according to <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Commercially available 4-nitroindole <b>28</b> reacted with 3-methoxybenzeneboronic acid <b>29</b> via coupling to create intermediate <b>30</b>. The indole core was reduced selectively by sodium cyanoborohydride to give compound <b>31</b> with the indoline scaffold. After reduction and the subsequent condensation with substituted benzenesulfonyl chloride, compound <b>32</b> was transformed to compounds <b>33a–f</b>, respectively. Followed by alkylation and saponification yielded target compounds <b>11a–11f</b> with the indoline core. <b>12</b> was synthesized similar to <b>11a–11f</b>, while the intermediate <b>30</b> was not reduced.</div><figure id="sch3" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Target Compound <b>11a–11f</b> and <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cu(AcO)<sub>2</sub>, TEA, DCM, r.t. 4 h, 70%; (b) NaBH<sub>3</sub>CN, TFA, DCM, 0 °C to r.t. 2 h, 66%; (c) H<sub>2</sub>, Pd/C, MeOH, r.t. 2 h; (d) pyridine, THF, r.t. 10 h, 50–70%; (e) BrCH<sub>2</sub>COOCH<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 2 h, 70–85%; (f) LiOH, MeOH/H<sub>2</sub>O, 10 h, 70–80%.</p></p></figure><div class="NLM_p">Analogue <b>13</b> with the 1,2,3,4-tetrahydroquinoline core was synthesized according to <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Commercially available 5-nitroquinoline <b>35</b> was reduced selectively by Fe(OTf)<sub>2</sub> in the presence of Hantzsch ester to give compound <b>36</b> with the 1,2,3,4-tetrahydroquinoline core. After reduction, sulfonylation, alkylation, and saponification, the target compound <b>13</b> with 1,2,3,4-tetrahydroquinoline scaffold was obtained.</div><figure id="sch4" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0017.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Target Compound <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Fe(OTf)<sub>2</sub>, Hantzsch ester, CHCl<sub>3</sub>, 40 °C, 4 h, 60%; (b) Cu(AcO)<sub>2</sub>, TEA, DCM, r.t. 4 h, 55%; (c) H<sub>2</sub>, Pd/C, MeOH, r.t. 2 h; (d) pyridine, THF, r.t. 4 h, 52%; (e) BrCH<sub>2</sub>COOCH<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 2 h, 75%; (f) LiOH, MeOH/H<sub>2</sub>O, 10 h, 76%.</p></p></figure><div class="NLM_p">Analogues <b>14a–14c</b> were synthesized according to <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Compound <b>41</b> was prepared by <i>tert</i>-butyloxycarbonyl (Boc) protection of the 4-nitroindole <b>28</b>. <b>41</b> was reduced by hydrogen and Pd/C at 60 °C and subsequent sulfonylation with 2,4,6-trimethylphenylsulfonyl chloride gave compound <b>42</b>. Nucleophilic substitution of NH of <b>42</b> by methyl bromoacetate afforded compound <b>43</b>, and subsequent deprotection of the Boc group with CF<sub>3</sub>COOH in dichloromethane (DCM) solution produced compound <b>44</b>. Nucleophilic substitution of NH of compound <b>44</b> by 3-methoxybenzoyl chloride, 3-methoxybenzenesulfonyl chloride, or 3-methoxybenzyl bromide in the presence of sodium hydride in <i>N</i>,<i>N</i>-dimethylformamide solution gave corresponding intermediates, and the subsequent hydrolysis of the methyl ester produced the final compounds <b>14a–14c</b>. Analogues with the indoline core and substituted benzyl groups <b>14d–14z</b> were synthesized according to the similar procedure of <b>14c</b>.</div><figure id="sch5" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0018.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Target Compound <b>14a–14c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, TEA, DCM, r.t., 2 h, 71%; (b) H<sub>2</sub>, Pd/C, MeOH, 60 °C, 10 h; (c) pyridine, THF, r.t. 4 h, 53% (d) BrCH<sub>2</sub>COOCH<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 2 h, 75%; (e) CF<sub>3</sub>COOH, DCM, r.t., 1 h, 75%; (f) NaH, DMF, 60 °C, 2–6 h, 40–80%; (g) LiOH, MeOH/H<sub>2</sub>O, 1–6 h, 60–90%.</p></p></figure><div class="NLM_p">Analogues <b>16a–16e</b> with the indoline core and acyl sulfonamides were synthesized according to <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. First, 4-nitroindole <b>28</b> was reduced by sodium cyanoborohydride to give compound <b>45</b>. Next, compound <b>47</b> was prepared starting from methyl 2-(3-methoxyphenyl) acetate <b>46</b>, which was reacted with the NH of <b>45</b> to afford compound <b>48</b>. Subsequent hydrolysis of the methyl ester produced monocarboxylic acid <b>49</b>. The carboxy group of <b>49</b> was reacted with substituted benzene sulfonamides to give intermediates <b>50a–u</b>. Then, the nitro groups of <b>50a–u</b> were reduced by reductive tin(II)dichloride dehydrate (SnCl<sub>2</sub>) followed by sulfonylation to obtain compounds <b>52a–u</b>. After alkylation and saponification, target acyl sulfonamides analogues <b>16a–16e</b> with monocarboxylic acid were yielded. The NH of intermediate <b>44</b> was reacted with <b>47</b> to give compound <b>54</b>, and the subsequent hydrolysis of the ester groups produced target compounds <b>15</b>. Analogues <b>16d–16z</b> were synthesized according to the similar procedure of <b>16a</b>.</div><figure id="sch6" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0019.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Target Compound <b>15</b> and <b>16a–16e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaBH<sub>3</sub>CN, TFA, DCM, r.t. 2 h, 75%; (b) NBS, AIBN, CCl<sub>4</sub>, 80 °C, 4 h, 65%; (c) NaH, DMF, r.t. 4 h, 50%; (d) LiOH, MeOH/H<sub>2</sub>O, r.t. 2 h, 80%; (e) substituted sulfonamides, EDCI, DMAP, DCM, 35 °C, 2–6 h, 30–70%; (f) SnCl<sub>2</sub>, EA, 80 °C, 4 h; (g) pyridine, THF, 80 °C, 4 h, 30–65%; (h) K<sub>2</sub>CO<sub>3</sub>, DMF, r.t. 4 h, 58–82%; (i) LiOH, MeOH/H<sub>2</sub>O, r.t. 2 h, 60–86%.</p></p></figure><div class="NLM_p">Analogues <b>17a–17h</b> with diacyl sulfonamides were synthesized according to <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>. The nitro group of <b>55</b> was reduced by SnCl<sub>2</sub>, and the subsequent condensation with substituted benzenesulfonyl chloride gave compounds <b>56a–m</b>, respectively. Alkylation and saponification followed by nucleophilic substitution yielded target compounds <b>17a–17h</b> without the carboxyl group.</div><figure id="sch7" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0020.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Target Compound <b>17a–17h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SnCl<sub>2</sub>, EA, 80 °C, 4 h, 65%; (b) pyridine, THF, 80 °C, 4 h, 30–65%; (c) K<sub>2</sub>CO<sub>3</sub>, DMF, r.t. 4 h, 58–82%; (d) LiOH, MeOH/H<sub>2</sub>O, r.t. 2 h, 60–86%; (e) EDCI, DMAP, DCM, 35 °C, 2–6 h, 30–70%.</p></p></figure><div class="NLM_p">Analogues <b>18a–18e</b> and <b>19a–19i</b> were synthesized according to <a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>. Intermediate <b>58b</b> was reacted with substituted sulfonamides to give corresponding target compounds <b>18a–18e</b> and <b>19a–19i</b>.</div><figure id="sch8" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0021.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Target Compound <b>18a–18e</b> and <b>19a–19i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EDCI, DMAP, DCM, 35 °C, 2–6 h, 30–70%.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this paper, we described a series of Keap1-Nrf2 PPI inhibitors with the indoline core instead of the naphthalene scaffold. The introduction of acylsulfonamides to the indoline scaffold furnished inhibitors with sub-micromolar IC<sub>50</sub> values. Further SAR optimization led to the discovery of inhibitor <b>19a</b> with potent Keap1 inhibitory activity as well as promising drug-like properties, making it a valuable asset for further research. Furthermore, we have described its ability to activate the Nrf2-ARE pathway in cells and protect the H9c2 cell against LPS-induced injury, and these Nrf2 activation and protective effects of <b>19a</b> have also been confirmed <i>in vivo</i>. We hope our work can provide useful implications for the design of more drug-like Nrf2 activators and promote the therapeutic application of Keap1-Nrf2 PPI inhibitors.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02282" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02282" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> General Procedures</h3><div class="NLM_p">The synthesis of target compounds is shown in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch8" aria-label="8">8</a>. Reactions were monitored by thin-layer chromatography on 0.25 mm silica gel plates (GF254) and visualized under UV light. Melting points were determined with a Melt-Temp II apparatus. The <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were measured on a Bruker AV-300 instrument using deuterated solvents with tetramethylsilane as the internal standard. ESI-mass and high-resolution mass spectra (HRMS) were recorded on a Water Q-Tof micro mass spectrometer. The purity (≥95%) of the compounds was verified by HPLC performed on an Agilent C18 (4.6 mm × 150 mm, 3.5 μm) column using a mixture of solvent methanol/water 90:10 or 85:15 with 1‰ TFA at a flow rate of 0.5 mL/min and peak detection at 254 nm.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-(Mesitylsulfonyl)-<i>N</i>-(5-((3-methoxyphenyl) amino)-2-methylphenyl)glycine (<b>10a</b>)</h4><div class="NLM_p last">To a solution of LiOH (240 mg, 10.0 mmol) in MeOH/H<sub>2</sub>O (5/5 mL) was added <b>27a</b> (480 mg, 1.0 mmol). The reaction mixture was stirred at room temperature overnight, then quenched with 2 M hydrochloric acid to pH 2, and diluted with 50 mL of water. The precipitate was removed by filtration and washed with 5 × 10 mL water and then dried overnight in a vacuum desiccator, yielding target product <b>10a</b>, yield 72%; mp: 129–131 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.81 (s, 1H), 8.21 (s, 1H), 7.38 (d, <i>J</i> = 2.4 Hz, 1H), 7.06 (t, <i>J</i> = 8.1 Hz, 1H), 7.00 (d, <i>J</i> = 7.9 Hz, 3H), 6.90 (dd, <i>J</i> = 8.2, 2.4 Hz, 1H), 6.58 (t, <i>J</i> = 2.2 Hz, 1H), 6.49 (dd, <i>J</i> = 7.8, 2.0 Hz, 1H), 6.37 (dd, <i>J</i> = 8.0, 2.3 Hz, 1H), 4.54 (s, 1H), 4.20 (s, 1H), 2.28 (s, 6H), 2.24 (s, 3H), 1.69 (s, 3H); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.76, 160.70, 145.19, 142.63, 141.64, 139.93, 139.67, 137.91, 134.60, 132.23, 131.87, 130.27, 129.39, 120.95, 119.12, 108.74, 105.73, 101.70, 55.28, 52.76, 24.57, 23.36, 20.87, 18.49, 16.51; HRMS (ESI): found 469.1791 (C<sub>25</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub>S [M + H]<sup>+</sup>, requires 469.1791); HPLC (90:10 methanol/water): <i>t</i><sub>R</sub> = 6.10 min, 98.5%.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-(Mesitylsulfonyl)-<i>N</i>-(1-(3-methoxyphenyl)indolin-4-yl) glycine (<b>11a</b>)</h4><div class="NLM_p last">To a solution of LiOH (0.5 g) in MeOH/H<sub>2</sub>O (10/3 mL) was added <b>34a</b> (500 mg, 1.0 mmol). The reaction mixture was stirred at room temperature overnight, then quenched with 2 M hydrochloric acid to pH 2, and diluted with 50 mL of water. The precipitate was removed by filtration and washed with 5 × 10 mL water and then dried overnight in a vacuum desiccator, which gave product <b>11a</b> as a white solid 360 mg, yield 75%; mp 125–127 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.81 (s, 1H), 7.24 (t, <i>J</i> = 8.2 Hz, 1H), 7.06–6.95 (m, 4H), 6.80–6.75 (m, 1H), 6.73–6.69 (m, 1H), 6.68 (d, <i>J</i> = 2.3 Hz, 1H), 6.57 (s, 1H), 4.40 (s, 2H), 3.75 (s, 3H), 3.73 (s, 2H), 2.70 (d, <i>J</i> = 8.3 Hz, 2H), 2.34 (d, <i>J</i> = 9.3 Hz, 6H), 2.22 (s, 3H); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.54, 159.60, 156.85, 152.24, 142.31, 139.97, 135.68, 134.06, 132.78, 132.13, 131.94, 131.35, 130.06, 129.52, 128.59, 127.13, 121.33, 120.95, 114.84, 113.97, 113.57, 56.22, 55.47, 23.08, 21.92, 20.82; HRMS (ESI): found 481.1789 (C<sub>26</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub>S [M + H]<sup>+</sup>, requires 481.1791); HPLC (85:15 methanol/water): <i>t</i><sub>R</sub> = 4.15 min, 98.8%.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-(Mesitylsulfonyl)-<i>N</i>-(1-(3-methoxybenzyl) indolin-4-yl)glycine (<b>14c</b>)</h4><div class="NLM_p last"><b>14c</b> was synthesized according to the procedure of <b>11a</b>, white solid, yield 71%; mp 141–143 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.80 (s, 1H), 7.23 (d, <i>J</i> = 7.9 Hz, 1H), 6.94 (d, <i>J</i> = 7.3 Hz, 3H), 6.85–6.79 (m, 3H), 6.55 (t, <i>J</i> = 8.0 Hz, 2H), 4.34 (s, 2H), 4.20 (s, 2H), 3.72 (s, 3H), 3.68 (s, 1H), 2.46 (d, <i>J</i> = 6.3 Hz, 2H), 2.27 (s, 6H), 2.22 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.39, 169.80, 159.75, 152.20, 142.73, 140.08, 135.74, 135.61, 135.48, 134.98, 132.10, 131.06, 130.17, 128.15, 127.99, 121.21, 120.46, 114.97, 114.25, 106.95, 63.57, 55.56, 51.75, 49.90, 26.41, 23.09, 20.83; HRMS (ESI): found 495.1935 (C<sub>27</sub>H<sub>31</sub>N<sub>2</sub>O<sub>5</sub>S [M + H]<sup>+</sup>, requires 495.1948); HPLC (85:15 methanol/water): <i>t</i><sub>R</sub> = 4.22 min, 99.2%.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-(Mesitylsulfonyl)-<i>N</i>-(1-(1-(3-methoxyphenyl)-2-oxo-2-(phenylsulfonamido)ethyl)indolin-4-yl)glycine (<b>16a</b>)</h4><div class="NLM_p last"><b>16a</b> was synthesized according to the procedure of <b>15</b>, white solid, yield 74%; mp: 100–102 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.91 (s, 2H), 8.05 (s, 1H), 7.78 (d, <i>J</i> = 1.9 Hz, 1H), 7.29 (t, <i>J</i> = 7.9 Hz, 1H), 6.95 (d, <i>J</i> = 7.8 Hz, 1H), 6.90 (s, 1H), 6.70 (d, <i>J</i> = 10.3 Hz, 2H), 6.56 (d, <i>J</i> = 8.0 Hz, 1H), 6.23 (d, <i>J</i> = 7.9 Hz, 1H), 5.20 (s, 1H), 4.29 (s, 2H), 3.72 (s, 3H), 3.25 (d, <i>J</i> = 8.5 Hz, 1H), 2.66 (d, <i>J</i> = 8.2 Hz, 1H), 2.40 (s, 2H), 2.21 (s, 9H); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.66, 159.64, 156.86, 152.47, 147.25, 142.72, 140.04, 135.85, 133.53, 131.48, 131.37, 130.12, 128.52, 123.59, 121.38, 120.13, 114.91, 114.04, 113.58, 106.78, 63.10, 56.19, 55.46, 49.84, 26.32, 22.99, 21.91, 20.81; HRMS (ESI): found 678.1934 (C<sub>28</sub>H<sub>32</sub>N<sub>2</sub>NaO<sub>4</sub>S [M + Na]<sup>+</sup>, requires 678.1938); HPLC (85:15 methanol/water with 1‰ TFA): <i>t</i><sub>R</sub> = 5.21 min, 97.5%.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-(Mesitylsulfonyl)-<i>N</i>-(1-(2-((2-methoxy-4-methylphenyl)sulfonamido)-1-(3-methoxyphenyl)-2-oxoethyl)indolin-4-yl)glycine (<b>16w</b>)</h4><div class="NLM_p last"><b>16w</b> was synthesized according to the procedure of <b>15</b>, white solid, yield 78%; mp: 122–124 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.92 (s, 2H), 7.69 (d, <i>J</i> = 8.0 Hz, 1H), 7.28 (d, <i>J</i> = 7.9 Hz, 1H), 7.00–6.92 (m, 4H), 6.89 (s, 2H), 6.71 (d, <i>J</i> = 7.6 Hz, 1H), 6.65 (s, 1H), 6.57 (d, <i>J</i> = 8.0 Hz, 1H), 6.28 (d, <i>J</i> = 7.8 Hz, 1H), 5.22 (s, 1H), 4.29 (s, 2H), 3.69 (s, 3H), 3.64 (s, 3H), 3.60 (s, 2H), 3.25 (d, <i>J</i> = 8.6 Hz, 1H), 2.64 (d, <i>J</i> = 7.7 Hz, 1H), 2.37 (s, 3H), 2.20 (s, 9H), 2.04 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.15, 163.99, 163.73, 159.83, 156.60, 152.75, 147.58, 136.09, 134.49, 131.61, 131.32, 130.74, 130.22, 129.91, 129.72, 128.73, 128.30, 122.70, 121.56, 121.23, 118.32, 115.08, 114.50, 114.34, 114.15, 112.61, 108.26, 77.27, 68.39, 55.74, 55.64, 55.26, 29.71, 29.36, 27.03, 22.15; HRMS (ESI): found 722.2190 (C<sub>36</sub>H<sub>40</sub>N<sub>3</sub>O<sub>9</sub>S<sub>2</sub> [M + H]<sup>+</sup>, requires 722.2200); HPLC (85:15 methanol/water with 1‰ TFA): <i>t</i><sub>R</sub> = 5.16 min, 98.6%.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-((2-Methoxy-4-methylphenyl)sulfonyl)-2-(3-methoxyphenyl)-2-(4-((2,4,6-trimethyl-<i>N</i>-(2-oxo-2-(phenylsulfonamido)ethyl)phenyl)sulfonamido)indolin-1-yl)acetamide (<b>17a</b>)</h4><div class="NLM_p last"><b>58a</b> (721.0 mg, 1.0 mmol) was dissolved in 10 mL of distilled CH<sub>2</sub>Cl<sub>2</sub>. To this stirred solution, 2 equiv of EDCI and 2 equiv of DMAP and benzenesulfonamide (158 mg, 1.0 mmol) were added. The reaction was stirred for 4 h at 40 °C. The organic layer was extracted and washed with 2 × 20 ml of brine followed by 2 × 20 mL of H<sub>2</sub>O. The organics were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the crude material was purified by flash chromatography to afford the desired product as a white solid, yield 42%; mp 197–199 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.32 (s, 2H), 7.73 (d, <i>J</i> = 8.0 Hz, 1H), 7.71–7.65 (m, 2H), 7.45 (dt, <i>J</i> = 14.4, 7.0 Hz, 3H), 7.32 (t, <i>J</i> = 7.9 Hz, 1H), 7.05–6.92 (m, 3H), 6.86 (d, <i>J</i> = 7.1 Hz, 3H), 6.77 (d, <i>J</i> = 7.8 Hz, 1H), 6.71 (t, <i>J</i> = 2.0 Hz, 1H), 6.45 (d, <i>J</i> = 8.0 Hz, 1H), 6.24 (d, <i>J</i> = 7.8 Hz, 1H), 5.17 (s, 1H), 4.14 (s, 2H), 3.74 (s, 3H), 3.68 (s, 3H), 3.19 (q, <i>J</i> = 8.5 Hz, 2H), 2.41 (s, 2H), 2.36 (s, 3H), 2.22 (s, 3H), 2.18 (s, 6H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.24, 166.09, 164.06, 163.71, 159.81, 156.61, 152.73, 147.65, 135.97, 134.47, 131.62, 131.21, 130.80, 130.22, 129.90, 129.49, 128.70, 128.58, 128.34, 122.58, 121.57, 121.21, 118.39, 115.05, 114.51, 114.33, 114.24, 114.17, 112.60, 108.17, 77.28, 68.27, 55.75, 55.67, 55.61, 55.26, 54.96, 51.39, 29.71, 26.96, 23.57, 22.15; HRMS (ESI): found 883.2119 (C<sub>42</sub>H<sub>44</sub>N<sub>4</sub>NaO<sub>10</sub>S<sub>3</sub> [M + Na]<sup>+</sup>, requires 883.2111); HPLC (85:15 methanol/water with 1‰ TFA): <i>t</i><sub>R</sub> = 5.21 min, 97.8%.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-((2-Methoxy-4-methylphenyl)sulfonyl)-2-(4-((4-methoxy-<i>N</i>-(2-oxo-2-(phenylsulfonamido)ethyl)phenyl)sulfonamido)indolin-1-yl)-2-(3-methoxyphenyl)acetamide (<b>17b</b>)</h4><div class="NLM_p last"><b>17b</b> was synthesized according to the procedure of <b>17a</b>, white solid, yield 40%; mp 201–203 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.54 (s, 2H), 7.68 (d, <i>J</i> = 7.9 Hz, 1H), 7.63–7.56 (m, 2H), 7.51 (d, <i>J</i> = 8.9 Hz, 2H), 7.28 (t, <i>J</i> = 7.9 Hz, 1H), 7.04–6.95 (m, 3H), 6.91 (dq, <i>J</i> = 10.2, 3.6, 3.1 Hz, 4H), 6.82 (dd, <i>J</i> = 15.0, 7.5 Hz, 4H), 6.14 (d, <i>J</i> = 7.9 Hz, 1H), 6.00 (d, <i>J</i> = 8.1 Hz, 1H), 5.01 (s, 1H), 3.91 (d, <i>J</i> = 2.9 Hz, 2H), 3.82 (s, 3H), 3.78 (s, 3H), 3.71 (s, 3H), 3.64 (s, 2H), 2.82–2.72 (m, 2H), 2.37 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.91, 168.87, 163.00, 159.67, 156.88, 152.36, 147.19, 146.69, 145.97, 145.56, 145.11, 136.66, 136.30, 131.43, 130.84, 130.12, 129.94, 129.39, 128.91, 128.73, 128.32, 127.97, 127.50, 123.75, 121.51, 120.99, 118.08, 117.76, 114.59, 114.15, 113.57, 106.20, 56.19, 56.14, 55.51, 54.52, 29.46, 26.74, 21.93, 21.44; HRMS (ESI): found 871.1754 (C<sub>40</sub>H<sub>40</sub>N<sub>4</sub>NaO<sub>11</sub>S<sub>3</sub> [M + Na]<sup>+</sup>, requires 871.1747); HPLC (85:15 methanol/water with 1‰ TFA): <i>t</i><sub>R</sub> = 5.47 min, 99.1%.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-((2-Methoxy-4-methylphenyl)sulfonyl)-2-(4-((4-methoxy-<i>N</i>-(2-((4-methoxyphenyl)sulfonamido)-2-oxoethyl)phenyl)sulfonamido)indolin-1-yl)-2-(3-methoxyphenyl)acetamide (<b>19a</b>)</h4><div class="NLM_p last"><b>19a</b> was synthesized according to the procedure of <b>17a</b>, white solid, yield 53%; mp 186–188 °C. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 12.21 (s, 2H), 7.63 (d, <i>J</i> = 7.6 Hz, 1H), 7.56 (dd, <i>J</i> = 8.8, 3.1 Hz, 4H), 7.26 (s, 1H), 7.03 (d, <i>J</i> = 8.5 Hz, 2H), 6.96–6.83 (m, 6H), 6.75 (d, <i>J</i> = 9.5 Hz, 2H), 6.18 (d, <i>J</i> = 7.8 Hz, 2H), 5.94 (d, <i>J</i> = 8.2 Hz, 1H), 4.83 (s, 1H), 4.45 (s, 1H), 3.86 (s, 1H), 3.84 (s, 3H), 3.79 (d, <i>J</i> = 2.1 Hz, 3H), 3.73 (s, 3H), 3.65 (s, 3H), 3.19 (d, <i>J</i> = 3.9 Hz, 1H), 2.80 (s, 2H), 2.35 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.68, 167.18, 159.71, 152.35, 147.35, 144.96, 144.07, 143.09, 139.68, 136.79, 135.49, 134.06, 133.70, 131.40, 130.99, 130.16, 130.03, 129.98, 129.57, 129.54, 128.83, 128.12, 127.90, 127.73, 127.71, 127.61, 124.30, 121.50, 121.05, 115.03, 114.40, 113.61, 106.41, 63.52, 53.28, 50.26, 39.96, 29.44, 26.36, 21.91, 21.47; HRMS (ESI): found 901.1841 (C<sub>41</sub>H<sub>42</sub>N<sub>4</sub>NaO<sub>12</sub>S<sub>3</sub> [M + Na]<sup>+</sup>, requires 901.1853); HPLC (85:15 methanol/water with 1‰ TFA): <i>t</i><sub>R</sub> = 5.48 min, 98.4%.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Molecular Docking</h3><div class="NLM_p last">The LigandFit docking tool in Discovery Studio, which has been validated for this target previously,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> was used to predict the binding mode of the small-molecular inhibitors. The docking site was derived from the position of the small-molecular ligand co-crystallized in the binding site of Keap1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XMB">4XMB</a>).<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>In Vitro</i> Metabolic Stability in Human Liver Microsomes</h3><div class="NLM_p last">The metabolic stability of test compounds was assessed using human liver microsomes. Test compounds were preincubated with human microsomes (0.75 mg/mL) at 1 μM for 5 min at 37 °C in phosphate buffer (100 mM, pH 7.4). Then, 1 mM NADPH was added to initiate the reaction. After incubation for different times (0, 5, 15, 30, and 45 min) at 37 °C, cold acetonitrile was added to precipitate the protein. Then, the samples were centrifuged, and the supernatants were analyzed by LC–MS/MS.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> CYP450 Inhibition</h3><div class="NLM_p last">The CYP450 inhibition activities of <b>19a</b> on the five major isozymes (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4) were evaluated. For each assay, equal volumes (25 μL) of diluted microsomes (0.2 mg/mL final), <b>19a</b>, or the positive control inhibitors (10 μM final, DMSO as the negative control), specific substrates of the isozymes (10 μM final, 7-ethoxycoumarin, sulfaphenazole, omeprazole, promethazine, and fluconazole for CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4, respectively) were preincubated at 37 °C for 5 min. Then, 25 μL of NADPH (1 mM, final) was added to initiate the reaction. After 20 min of incubation, 100 μL of cold acetonitrile was added to terminate the reaction. The samples were centrifuged, and the supernatants were analyzed by LC–MS/MS to determine the metabolites. The inhibition rate was calculated using the following equation: inhibition rate (%) = [1 – (formation of the metabolite in the presence of tested compound)/(formation of the metabolite of negative control)] × 100%.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> PAMPA Evaluation</h3><div class="NLM_p last">Permeability coefficients were determined on a PAMPA Explorer instrument (pION). The detailed experimental procedures have been reported previously.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Briefly, the test compound was diluted with donor buffer at pH 7.4 and placed in the donor side and allowed to permeate to the acceptor side through the artificial membrane over a 4 h incubation at 25 °C. After incubation, the “sandwich” plate was separated. The donor and acceptor solutions were then measured with a UV plate reader, and the permeability value was calculated by pION software.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Cell Culture Conditions</h3><div class="NLM_p last">HepG2 cells stably transfected with a luciferase reporter (HepG2-ARE-C8)<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> were kindly provided by Professor Dr. A. N. Tony Kong (Rutgers University, Piscataway, NJ) and Prof. Rong Hu (China Pharmaceutical University, Nanjing). Cells were cultured in modified RPMI-1640 medium (Gibco, Invitrogen Corp., USA) with 10% fetal bovine serum (FBS) (Gibco, Invitrogen Corp., USA) and penicillin/streptomycin in a 37 °C incubator with 5% CO<sub>2</sub>. H9c2 cells were purchased from the Cell Bank of Shanghai, Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (Shanghai, China) and cultured in Dulbecco’s modified Eagle medium (Life Technology, 1645798) supplemented with 10% (v/v) FBS and penicillin/streptomycin.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Living Cell Microscopy</h3><div class="NLM_p last">H9c2 cells (density of 70–80% confluence per well) were seeded in 6-well plates for overnight incubation. Then, the cells were treated with test samples for indicated time. After treatment, cells were washed once with 2 mL of 10% PBS and stained with 10 μM cH2DCF-DA (S0033, Reactive Oxygen Species Assay Kit, Beyotime, China) in the dark at 37 °C for 20 min in DMEM medium Monoacidic free with FBS. Analysis was done with a fluorescence microscope (OLYMPUS DP72, Japan) equipped with a U-RFL-T power supply.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>In Vivo</i> Pharmacokinetics</h3><div class="NLM_p last">All animal experiments were performed in accordance with the protocols approved by the Institutional Animal Care and Use Committee of China Pharmaceutical University. All animals were appropriately used in a scientifically valid and ethical manner. The pharmacokinetic study of <b>19a</b> was conducted in rats. The rats were administered the test compound intravenously (i.v.) at 5 mg/kg. Blood samples were collected into heparinized Eppendorf tubes at 2 min, 5 min, 10 min, 20 min, 30 min, 1 h, 2 h, 4 h, 6 h, 8 h, 12 h, 24 h, and 36 h for intravenous injection plasma was separated from whole blood by centrifuging at 4 °C and 3000 rpm for 10 min. The plasma samples were analyzed by LC–MS/MS.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>In Vivo</i> LPS Model</h3><div class="NLM_p last">All animal experiments were performed in accordance with the protocols approved by the Institutional Animal Care and Use Committee of China Pharmaceutical University. All animals were appropriately used in a scientifically valid and ethical manner. Male C57BL/6 mice (6–8 weeks old) were maintained in standard conditions (12/12 h light/dark cycle, 22 ± 3 °C, relative humidity of 40%) for 3 days before the experiments and fed with a standard laboratory rodent diet and water. Mice were given free access to diet and water during the course of experiments. Mice were divided into four groups (eight animals in each group): control group, LPS (Sigma-Aldrich, St. Louis, no. L4130) group (15 mg/kg), LPS (15 mg/kg) + <b>19a</b> (10 mg/kg) group, and LPS (15 mg/kg) + <b>19a</b> (40 mg/kg) group. LPS and compound <b>19a</b> were suspended in saline prior to administration. C57BL/6 mice were injected intraperitoneally (i.p.) with various doses of <b>19a</b> (10 mg/kg, 40 mg/kg) or saline once a day for totally 3 days, followed by i.p. injection of 15 mg/kg of LPS. The mice were sacrificed 12 h after LPS challenge. Blood samples and hearts of the mice were collected for the follow-up experiments.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01116" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01116?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01116</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01116/suppl_file/jm0c01116_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Characterization of the representative intermediates, characterization of the target compounds, Keap1 Kelch domain expression and purification, FP competition assay, binding mode of compound <b>15</b> with Keap1, determination of thermodynamic data based on tracer displacement assay, ITC assay, BLI assay, ARE-luciferase activity assay, cell viability assay, RNA extraction and qRT-PCR analysis, Western blot analysis, IL-1β, IL-6, and TNF-α production, evaluation of GSH/GSSG ratio, detection of ROS level, animal experiments, statistical analysis and <sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS and HPLC spectra for representative target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01116/suppl_file/jm0c01116_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01116/suppl_file/jm0c01116_si_001.csv">jm0c01116_si_001.csv (9.76 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01116/suppl_file/jm0c01116_si_002.pdf">jm0c01116_si_002.pdf (3.6 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01116" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18406" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18406" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi-Dong You</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory
of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and
Optimization, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School
of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8587-0122" title="Orcid link">http://orcid.org/0000-0002-8587-0122</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#453c2a303421057473766b262a28"><span class="__cf_email__" data-cfemail="71081e040015314047425f121e1c">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zheng-Yu Jiang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory
of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and
Optimization, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School
of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1671-1582" title="Orcid link">http://orcid.org/0000-0002-1671-1582</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#83e9eae2ede4f9ebe6ede4faf6e0f3f6c3b2b5b0ade0ecee"><span class="__cf_email__" data-cfemail="18727179767f62707d767f616d7b686d58292e2b367b7775">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hai-Shan Zhou</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory
of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and
Optimization, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School
of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lv-Bin Hu</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory
of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and
Optimization, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School
of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Han Zhang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory
of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and
Optimization, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School
of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wen-Xin Shan</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory
of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and
Optimization, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School
of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Wang</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory
of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and
Optimization, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School
of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xue Li</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory
of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and
Optimization, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School
of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tian Liu</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory
of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and
Optimization, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School
of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Zhao</span> - <span class="hlFld-Affiliation affiliation">State Key Laboratory
of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and
Optimization, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, School
of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This study was supported by Projects 81773581, 81773639, and 81930100 of the National Natural Science Foundation of China, National Science & Technology Major Project “Key New Drug Creation and Manufacturing Program”, China (nos. 2018ZX09711002 and 2017ZX09302003), the Priority Academic Program Development of Jiangsu Higher Education Institutions, CPU2018GY02 of Double First Class Innovation Team of China Pharmaceutical University, the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (no. SKLNMZZ202003); Program for Outstanding Scientific and Technological Innovation Team of Jiangsu Higher Education, the “Qing Lan” Project of Jiangsu Province, and the Young Elite Scientists Sponsorship Program by CAST.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">Nrf2</td><td class="NLM_def"><p class="first last">nuclear factor erythroid 2-related factor 2</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">RNS</td><td class="NLM_def"><p class="first last">reactive nitrogen species</p></td></tr><tr><td class="NLM_term">ARE</td><td class="NLM_def"><p class="first last">antioxidant response element</p></td></tr><tr><td class="NLM_term">Keap1</td><td class="NLM_def"><p class="first last">Kelch-like ECH-associated protein 1</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fluoresce polarization</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethyl fumarate</p></td></tr><tr><td class="NLM_term">SFN</td><td class="NLM_def"><p class="first last">sulforaphane</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">isothermal titration calorimetry</p></td></tr><tr><td class="NLM_term">BLI</td><td class="NLM_def"><p class="first last">biolayer interferometry</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">SOD</td><td class="NLM_def"><p class="first last">superoxide dismutase</p></td></tr><tr><td class="NLM_term">HO-1</td><td class="NLM_def"><p class="first last">heme oxygen-1</p></td></tr><tr><td class="NLM_term">NQO-1</td><td class="NLM_def"><p class="first last">NAD(P)H dehydrogenase (quinone) 1</p></td></tr><tr><td class="NLM_term">GCLM</td><td class="NLM_def"><p class="first last">glutamate-cysteine ligase regulatory subunit</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12440" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12440" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 75 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress: a concept in redox biology and medicine</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2015.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.redox.2015.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=25588755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVGltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=180-183&author=H.+Sies&title=Oxidative+stress%3A+a+concept+in+redox+biology+and+medicine&doi=10.1016%2Fj.redox.2015.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress: a concept in redox biology and medicine</span></div><div class="casAuthors">Sies, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">180-183</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">"Oxidative stress" as a concept in redox biol. and medicine has been formulated in 1985; at the beginning of 2015, approx. 138,000 PubMed entries show for this term.  This concept has its merits and its pitfalls.  Among the merits is the notion, elicited by the combined two terms of (i) aerobic metab. as a steady-state redox balance and (ii) the assocd. potential strains in the balance as denoted by the term, stress, evoking biol. stress responses.  Current research on mol. redox switches governing oxidative stress responses is in full bloom.  The fundamental importance of linking redox shifts to phosphorylation/dephosphorylation signaling is being more fully appreciated, thanks to major advances in methodol.  Among the pitfalls is the fact that the underlying mol. details are to be worked out in each particular case, which is bvious for a global concept, but which is sometimes overlooked.  This can lead to indiscriminate use of the term, oxidative stress, without clear relation to redox chem.  The major role in antioxidant defense is fulfilled by antioxidant enzymes, not by small-mol. antioxidant compds.  The field of oxidative stress research embraces chem., biochem., cell biol., physiol. and pathophysiol., all the way to medicine and health and disease research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnLeGag99E8LVg90H21EOLACvtfcHk0lgKDLCHy9tgJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVGltA%253D%253D&md5=f6f8a5f836c1826e5486971bdab95ff0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2015.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2015.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DSies%26aufirst%3DH.%26atitle%3DOxidative%2520stress%253A%2520a%2520concept%2520in%2520redox%2520biology%2520and%2520medicine%26jtitle%3DRedox%2520Biol.%26date%3D2015%26volume%3D4%26spage%3D180%26epage%3D183%26doi%3D10.1016%2Fj.redox.2015.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. P.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species (ROS) as pleiotropic physiological signalling agents</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1038/s41580-020-0230-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1038%2Fs41580-020-0230-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=32231263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFKhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=363-383&author=H.+Siesauthor=D.+P.+Jones&title=Reactive+oxygen+species+%28ROS%29+as+pleiotropic+physiological+signalling+agents&doi=10.1038%2Fs41580-020-0230-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species (ROS) as pleiotropic physiological signalling agents</span></div><div class="casAuthors">Sies, Helmut; Jones, Dean P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">363-383</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: 'Reactive oxygen species' (ROS) is an umbrella term for an array of derivs. of mol. oxygen that occur as a normal attribute of aerobic life.  Elevated formation of the different ROS leads to mol. damage, denoted as 'oxidative distress'.  Here we focus on ROS at physiol. levels and their central role in redox signalling via different post-translational modifications, denoted as 'oxidative eustress'.  Two species, hydrogen peroxide (H2O2) and the superoxide anion radical (O2·-), are key redox signalling agents generated under the control of growth factors and cytokines by more than 40 enzymes, prominently including NADPH oxidases and the mitochondrial electron transport chain.  At the low physiol. levels in the nanomolar range, H2O2 is the major agent signalling through specific protein targets, which engage in metabolic regulation and stress responses to support cellular adaptation to a changing environment and stress.  In addn., several other reactive species are involved in redox signalling, for instance nitric oxide, hydrogen sulfide and oxidized lipids.  Recent methodol. advances permit the assessment of mol. interactions of specific ROS mols. with specific targets in redox signalling pathways.  Accordingly, major advances have occurred in understanding the role of these oxidants in physiol. and disease, including the nervous, cardiovascular and immune systems, skeletal muscle and metabolic regulation as well as ageing and cancer.  In the past, unspecific elimination of ROS by use of low mol. mass antioxidant compds. was not successful in counteracting disease initiation and progression in clin. trials.  However, controlling specific ROS-mediated signalling pathways by selective targeting offers a perspective for a future of more refined redox medicine.  This includes enzymic defense systems such as those controlled by the stress-response transcription factors NRF2 and nuclear factor-κB, the role of trace elements such as selenium, the use of redox drugs and the modulation of environmental factors collectively known as the exposome (for example, nutrition, lifestyle and irradn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUOGVldjysxrVg90H21EOLACvtfcHk0lgKDLCHy9tgJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFKhtrY%253D&md5=52e3327385f2c2910d1ffc5f4062eb77</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fs41580-020-0230-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41580-020-0230-3%26sid%3Dliteratum%253Aachs%26aulast%3DSies%26aufirst%3DH.%26aulast%3DJones%26aufirst%3DD.%2BP.%26atitle%3DReactive%2520oxygen%2520species%2520%2528ROS%2529%2520as%2520pleiotropic%2520physiological%2520signalling%2520agents%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2020%26volume%3D21%26spage%3D363%26epage%3D383%26doi%3D10.1038%2Fs41580-020-0230-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. P.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-061516-045037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1146%2Fannurev-biochem-061516-045037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=28441057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFels70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2017&pages=715-748&author=H.+Siesauthor=C.+Berndtauthor=D.+P.+Jones&title=Oxidative+stress&doi=10.1146%2Fannurev-biochem-061516-045037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress</span></div><div class="casAuthors">Sies, Helmut; Berndt, Carsten; Jones, Dean P.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">715-748</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">Oxidative stress is two sided: Whereas excessive oxidant challenge causes damage to biomols., maintenance of a physiol. level of oxidant challenge, termed oxidative eustress, is essential for governing life processes through redox signaling.  Recent interest has focused on the intricate ways by which redox signaling integrates these converse properties.  Redox balance is maintained by prevention, interception, and repair, and concomitantly the regulatory potential of mol. thiol-driven master switches such as Nrf2/Keap1 or NF-κB/IκB is used for system-wide oxidative stress response.  Nonradical species such as hydrogen peroxide (H2O2) or singlet mol. oxygen, rather than free-radical species, perform major second messenger functions.  Chemokine-controlled NADPH oxidases and metabolically controlled mitochondrial sources of H2O2 as well as glutathione- and thioredoxin-related pathways, with powerful enzymic back-up systems, are responsible for fine-tuning physiol. redox signaling.  This makes for a rich research field spanning from biochem. and cell biol. into nutritional sciences, environmental medicine, and mol. knowledge-based redox medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqYthGbEMU0LVg90H21EOLACvtfcHk0lgK0QKlQbjQYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFels70%253D&md5=910b7e9fa8ebd3b7dba6497f8212d4de</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-061516-045037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-061516-045037%26sid%3Dliteratum%253Aachs%26aulast%3DSies%26aufirst%3DH.%26aulast%3DBerndt%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DD.%2BP.%26atitle%3DOxidative%2520stress%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2017%26volume%3D86%26spage%3D715%26epage%3D748%26doi%3D10.1146%2Fannurev-biochem-061516-045037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, C. A.</span></span> <span> </span><span class="NLM_article-title">Redoxins as gatekeepers of the transcriptional oxidative stress response</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">101104</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2019.101104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.redox.2019.101104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=30690320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFersr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=101104&author=B.+L.+Hopkinsauthor=C.+A.+Neumann&title=Redoxins+as+gatekeepers+of+the+transcriptional+oxidative+stress+response&doi=10.1016%2Fj.redox.2019.101104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Redoxins as gatekeepers of the transcriptional oxidative stress response</span></div><div class="casAuthors">Hopkins, Barbara L.; Neumann, Carola A.</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101104</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Transcription factors control the rate of transcription of genetic information from DNA to mRNA, by binding specific DNA sequences in promoter regions.  Transcriptional gene control is a rate-limiting process that is tightly regulated and based on transient environmental signals which are translated into long-term changes in gene transcription.  Post-translational modifications (PTMs) on transcription factors by phosphorylation or acetylation have profound effects not only on sub-cellular localization but also on substrate specificity through changes in DNA binding capacity.  During times of cellular stress, specific transcription factors are in place to help protect the cell from damage by initiating the transcription of antioxidant response genes.  Here we discuss PTMs caused by reactive oxygen species (ROS), such as H2O2, that can expeditiously regulate the activation of transcription factors involved in the oxidative stress response.  Part of this rapid regulation are proteins involved in H2O2-related redn. and oxidn. (redox) reactions such as redoxins, H2O2 scavengers described to interact with transcription factors.  Redoxins have highly reactive cysteines of rate consts. around 6-10-1 s-1 that engage in nucleophilic substitution of a thiol-disulfide with another thiol in inter-disulfide exchange reactions.  We propose here that H2O2 signal transduction induced inter-disulfide exchange reactions between redoxin cysteines and cysteine thiols of transcription factors to allow for rapid and precise on and off switching of transcription factor activity.  Thus, redoxins are essential modulators of stress response pathways beyond H2O2 scavenging capacity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOZ6uptNlkJrVg90H21EOLACvtfcHk0lgK0QKlQbjQYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFersr8%253D&md5=4737bb069212b67c503f0043212e57d4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2019.101104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2019.101104%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DB.%2BL.%26aulast%3DNeumann%26aufirst%3DC.%2BA.%26atitle%3DRedoxins%2520as%2520gatekeepers%2520of%2520the%2520transcriptional%2520oxidative%2520stress%2520response%26jtitle%3DRedox%2520Biol.%26date%3D2019%26volume%3D21%26spage%3D101104%26doi%3D10.1016%2Fj.redox.2019.101104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswal, S.</span></span> <span> </span><span class="NLM_article-title">Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1146/annurev.pharmtox.46.120604.141046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1146%2Fannurev.pharmtox.46.120604.141046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=16968214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1altrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=89-116&author=T.+W.+Kenslerauthor=N.+Wakabayashiauthor=S.+Biswal&title=Cell+survival+responses+to+environmental+stresses+via+the+Keap1-Nrf2-ARE+pathway&doi=10.1146%2Fannurev.pharmtox.46.120604.141046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway</span></div><div class="casAuthors">Kensler, Thomas W.; Wakabayashi, Nobunao; Biswal, Shyam</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-116</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Keap1-Nrf2-ARE signaling plays a significant role in protecting cells from endogenous and exogenous stresses.  The development of Nrf2 knockout mice has provided key insights into the toxicol. importance of this pathway.  These mice are more sensitive to the hepatic, pulmonary, ovarian, and neurotoxic consequences of acute exposures to environmental agents and drugs, inflammatory stresses, as well as chronic exposures to cigarette smoke and other carcinogens.  Under quiescent conditions, the transcription factor Nrf2 interacts with the actin-anchored protein Keap1, largely localized in the cytoplasm.  This quenching interaction maintains low basal expression of Nrf2-regulated genes.  However, upon recognition of chem. signals imparted by oxidative and electrophilic mols., Nrf2 is released from Keap1, escapes proteasomal degrdn., translocates to the nucleus, and transactivates the expression of several dozen cytoprotective genes that enhance cell survival.  This review highlights the key elements in this adaptive response to protection against acute and chronic cell injury provoked by environmental stresses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAmRpcXFLXq7Vg90H21EOLACvtfcHk0lhtOJFZA-J6hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1altrg%253D&md5=eee9260ebe6186b82da647701a10c7e2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.46.120604.141046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.46.120604.141046%26sid%3Dliteratum%253Aachs%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DBiswal%26aufirst%3DS.%26atitle%3DCell%2520survival%2520responses%2520to%2520environmental%2520stresses%2520via%2520the%2520Keap1-Nrf2-ARE%2520pathway%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D89%26epage%3D116%26doi%3D10.1146%2Fannurev.pharmtox.46.120604.141046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span> <span> </span><span class="NLM_article-title">The Keap1-Nrf2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1169</span>– <span class="NLM_lpage">1203</span>, <span class="refDoi"> DOI: 10.1152/physrev.00023.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1152%2Fphysrev.00023.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=29717933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvFektrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2018&pages=1169-1203&author=M.+Yamamotoauthor=T.+W.+Kenslerauthor=H.+Motohashi&title=The+Keap1-Nrf2+system%3A+a+thiol-based+sensor-effector+apparatus+for+maintaining+redox+homeostasis&doi=10.1152%2Fphysrev.00023.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis</span></div><div class="casAuthors">Yamamoto, Masayuki; Kensler, Thomas W.; Motohashi, Hozumi</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1169-1203</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">1522-1210</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The Kelch-like ECH-assocd. protein 1-NF-E2-related factor 2 (KEAP1-NRF2) system forms the major node of cellular and organismal defense against oxidative and electrophilic stresses of both exogenous and endogenous origins.  KEAP1 acts as a cysteine thiol-rich sensor of redox insults, whereas NRF2 is a transcription factor that robustly transduces chem. signals to regulate a battery of cytoprotective genes.  KEAP1 represses NRF2 activity under quiescent conditions, whereas NRF2 is liberated from KEAP1-mediated repression on exposure to stresses.  The rapid inducibility of a response based on a derepression mechanism is an important feature of the KEAP1-NRF2 system.  Recent studies have unveiled the complexities of the functional contributions of the KEAP1-NRF2 system and defined its broader involvement in biol. processes, including cell proliferation and differentiation, as well as cytoprotection.  In this review, we describe historical milestones in the initial characterization of the KEAP1-NRF2 system and provide a comprehensive overview of the mol. mechanisms governing the functions of KEAP1 and NRF2, as well as their roles in physiol. and pathol.  We also refer to the clin. significance of the KEAP1-NRF2 system as an important prophylactic and therapeutic target for various diseases, particularly aging-related disorders.  We believe that controlled harnessing of the KEAP1-NRF2 system is a key to healthy aging and well-being in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohbdKIhBBbkLVg90H21EOLACvtfcHk0lhtOJFZA-J6hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvFektrc%253D&md5=906947c8ad97c48f60e46bc44103664a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00023.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00023.2017%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DMotohashi%26aufirst%3DH.%26atitle%3DThe%2520Keap1-Nrf2%2520system%253A%2520a%2520thiol-based%2520sensor-effector%2520apparatus%2520for%2520maintaining%2520redox%2520homeostasis%26jtitle%3DPhysiol.%2520Rev.%26date%3D2018%26volume%3D98%26spage%3D1169%26epage%3D1203%26doi%3D10.1152%2Fphysrev.00023.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raghunath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundarraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagarajan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arfuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perumal, E.</span></span> <span> </span><span class="NLM_article-title">Antioxidant response elements: Discovery, classes, regulation and potential applications</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2018.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.redox.2018.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=29775961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsFyisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=297-314&author=A.+Raghunathauthor=K.+Sundarrajauthor=R.+Nagarajanauthor=F.+Arfusoauthor=J.+Bianauthor=A.+P.+Kumarauthor=G.+Sethiauthor=E.+Perumal&title=Antioxidant+response+elements%3A+Discovery%2C+classes%2C+regulation+and+potential+applications&doi=10.1016%2Fj.redox.2018.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant response elements: Discovery, classes, regulation and potential applications</span></div><div class="casAuthors">Raghunath, Azhwar; Sundarraj, Kiruthika; Nagarajan, Raju; Arfuso, Frank; Bian, Jinsong; Kumar, Alan P.; Sethi, Gautam; Perumal, Ekambaram</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">297-314</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Exposure to antioxidants and xenobiotics triggers the expression of a myriad of genes encoding antioxidant proteins, detoxifying enzymes, and xenobiotic transporters to offer protection against oxidative stress.  This articulated universal mechanism is regulated through the cis-acting elements in an array of Nrf2 target genes called antioxidant response elements (AREs), which play a crit. role in redox homeostasis.  Though the Keap1/Nrf2/ARE system involves many players, AREs hold the key in transcriptional regulation of cytoprotective genes.  ARE-mediated reporter constructs have been widely used, including xenobiotics profiling and Nrf2 activator screening.  The complexity of AREs is brought by the presence of other regulatory elements within the AREs.  The diversity in the ARE sequences not only bring regulatory selectivity of diverse transcription factors, but also confer functional complexity in the Keap1/Nrf2/ARE pathway.  The different transcription factors either homodimerize or heterodimerize to bind the AREs.  Depending on the nature of partners, they may activate or suppress the transcription.  Attention is required for deeper mechanistic understanding of ARE-mediated gene regulation.  The computational methods of identification and anal. of AREs are still in their infancy.  Investigations are required to know whether epigenetics mechanism plays a role in the regulation of genes mediated through AREs.  The polymorphisms in the AREs leading to oxidative stress related diseases are warranted.  A thorough understanding of AREs will pave the way for the development of therapeutic agents against cancer, neurodegenerative, cardiovascular, metabolic and other diseases with oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSoPiaGGwAKrVg90H21EOLACvtfcHk0ljLLwUqd4UDrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsFyisr4%253D&md5=39420cc829e32fea49b404be47aad9e6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2018.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2018.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DRaghunath%26aufirst%3DA.%26aulast%3DSundarraj%26aufirst%3DK.%26aulast%3DNagarajan%26aufirst%3DR.%26aulast%3DArfuso%26aufirst%3DF.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DA.%2BP.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DPerumal%26aufirst%3DE.%26atitle%3DAntioxidant%2520response%2520elements%253A%2520Discovery%252C%2520classes%252C%2520regulation%2520and%2520potential%2520applications%26jtitle%3DRedox%2520Biol.%26date%3D2018%26volume%3D17%26spage%3D297%26epage%3D314%26doi%3D10.1016%2Fj.redox.2018.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">The Nrf2 regulatory network provides an interface between redox and intermediary metabolism</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2014.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.tibs.2014.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=24647116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksVWrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=199-218&author=J.+D.+Hayesauthor=A.+T.+Dinkova-Kostova&title=The+Nrf2+regulatory+network+provides+an+interface+between+redox+and+intermediary+metabolism&doi=10.1016%2Fj.tibs.2014.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The Nrf2 regulatory network provides an interface between redox and intermediary metabolism</span></div><div class="casAuthors">Hayes, John D.; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">199-218</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2, also called Nfe2l2) is a transcription factor that regulates the cellular redox status.  Nrf2 is controlled through a complex transcriptional/epigenetic and post-translational network that ensures its activity increases during redox perturbation, inflammation, growth factor stimulation and nutrient/energy fluxes, thereby enabling the factor to orchestrate adaptive responses to diverse forms of stress.  Besides mediating stress-stimulated induction of antioxidant and detoxification genes, Nrf2 contributes to adaptation by upregulating the repair and degrdn. of damaged macromols., and by modulating intermediary metab.  In the latter case, Nrf2 inhibits lipogenesis, supports β-oxidn. of fatty acids, facilitates flux through the pentose phosphate pathway, and increases NADPH regeneration and purine biosynthesis; these observations suggest Nrf2 directs metabolic reprogramming during stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLTtgJA1rMbVg90H21EOLACvtfcHk0ljLLwUqd4UDrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksVWrtLg%253D&md5=790c66c48218229dc5531d24aefaceef</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2014.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2014.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DThe%2520Nrf2%2520regulatory%2520network%2520provides%2520an%2520interface%2520between%2520redox%2520and%2520intermediary%2520metabolism%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2014%26volume%3D39%26spage%3D199%26epage%3D218%26doi%3D10.1016%2Fj.tibs.2014.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giampieri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pistollato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittalà, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallarino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atanasov, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. M.</span></span> <span> </span><span class="NLM_article-title">Nrf2 as regulator of innate immunity: A molecular Swiss army knife!</span>. <i>Adv</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">370</span>, <span class="refDoi"> DOI: 10.1016/j.biotechadv.2017.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.biotechadv.2017.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVCktLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2018&pages=358-370&author=M.+Battinoauthor=F.+Giampieriauthor=F.+Pistollatoauthor=A.+Suredaauthor=M.+R.+de+Oliveiraauthor=V.+Pittal%C3%A0author=F.+Fallarinoauthor=S.+F.+Nabaviauthor=A.+G.+Atanasovauthor=S.+M.+Nabavi&title=Nrf2+as+regulator+of+innate+immunity%3A+A+molecular+Swiss+army+knife%21&doi=10.1016%2Fj.biotechadv.2017.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 as regulator of innate immunity: A molecular Swiss army knife!</span></div><div class="casAuthors">Battino, Maurizio; Giampieri, Francesca; Pistollato, Francesca; Sureda, Antoni; de Oliveira, Marcos Roberto; Pittala, Valeria; Fallarino, Francesca; Nabavi, Seyed Fazel; Atanasov, Atanas Georgiev; Nabavi, Seyed Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology Advances</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">358-370</span>CODEN:
                <span class="NLM_cas:coden">BIADDD</span>;
        ISSN:<span class="NLM_cas:issn">0734-9750</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Organisms are constantly exposed to a broad range of pathol. and stress-inducing agents, allergens and environmental chems. that can induce infections, toxicity or other undesirable reactions.  Our immune system has evolved over time in order to efficiently respond to these exogenous insults and maintain homeostasis.  In particular, the innate immune system acts as primary barrier to prevent the entrance of invasive agents or allergens.  This system is comprised of a diversity of cell types that are rapidly activated by recognition of common structures present in many potential pathogens known as pathogen-assocd. mol. patterns (PAMPs).  The nuclear factor erythroid 2 related factor 2 (Nrf2) is a relevant basic leucine zipper (bZIP) transcription factor that is essential in the regulation of cell cycle homeostasis, cytoprotection, and innate immunity when cells are under stressful conditions.  Although the role of Nrf2 in activating the expression of protective genes - such as antioxidant or anti-inflammatory - is known, its role in innate immunity and immune-related gene expression remains not yet clear.  The present review summarizes current knowledge on Nrf2 signaling pathway structure and activity under both physiol. state and upon oxidative stress.  In addn., the relation between Nrf2 signaling pathway and the innate immune system is discussed, highlighting the potential therapeutic effects of diverse natural and synthetic compds. as Nrf2 regulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOXg1Vd2SIzbVg90H21EOLACvtfcHk0ljLLwUqd4UDrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVCktLnP&md5=e516646dab60025f553abfcabc3498f2</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.biotechadv.2017.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biotechadv.2017.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DBattino%26aufirst%3DM.%26aulast%3DGiampieri%26aufirst%3DF.%26aulast%3DPistollato%26aufirst%3DF.%26aulast%3DSureda%26aufirst%3DA.%26aulast%3Dde%2BOliveira%26aufirst%3DM.%2BR.%26aulast%3DPittal%25C3%25A0%26aufirst%3DV.%26aulast%3DFallarino%26aufirst%3DF.%26aulast%3DNabavi%26aufirst%3DS.%2BF.%26aulast%3DAtanasov%26aufirst%3DA.%2BG.%26aulast%3DNabavi%26aufirst%3DS.%2BM.%26atitle%3DNrf2%2520as%2520regulator%2520of%2520innate%2520immunity%253A%2520A%2520molecular%2520Swiss%2520army%2520knife%2521%26jtitle%3DAdv%26date%3D2018%26volume%3D36%26spage%3D358%26epage%3D370%26doi%3D10.1016%2Fj.biotechadv.2017.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of the negative regulator of Nrf2, Keap1: a historical overview</span>. <i>Antioxidants Redox Signal.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1665</span>– <span class="NLM_lpage">1678</span>, <span class="refDoi"> DOI: 10.1089/ars.2010.3222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1089%2Fars.2010.3222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=20446768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A280%3ADC%252BC3cfpslCqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1665-1678&author=K.+Itohauthor=J.+Mimuraauthor=M.+Yamamoto&title=Discovery+of+the+negative+regulator+of+Nrf2%2C+Keap1%3A+a+historical+overview&doi=10.1089%2Fars.2010.3222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the negative regulator of Nrf2, Keap1: a historical overview</span></div><div class="casAuthors">Itoh Ken; Mimura Junsei; Yamamoto Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & redox signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1665-78</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">An antioxidant response element (ARE) or an electrophile responsive element (EpRE) regulate the transcriptional induction of a battery of drug-detoxifying enzymes that are protective against electrophiles.  Based on the high similarity of the ARE consensus sequence to an erythroid gene regulatory element NF-E2 binding site, we have found that the transcription factor Nrf2 is indispensable for the ARE-mediated induction of drug-metabolizing enzymes.  Recent genome-wide analysis demonstrated that Nrf2 regulates hundreds of genes that are involved in the cytoprotective response against oxidative stress.  In-depth analysis of Nrf2 regulatory mechanisms has led us to the discovery of a novel protein, which we have named Keap1.  Keap1 suppresses Nrf2 activity by specifically binding to its evolutionarily conserved N-terminal Neh2 regulatory domain.  In this review article, we summarize the findings and observations that have lead to the discovery of the Nrf2-Keap1 system.  Furthermore, we briefly discuss the function of the Nrf2-Keap1 system under the regulation of the endogenous electrophilic compound 15-deoxy-Δ12(,)14-prostaglandin J2.  We propose that Nrf2-Keap1 plays a significant physiological role in the response to endogenous, environmental, and pharmacological electrophiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRyZscOwEJn96_dlEzl_fBafW6udTcc2eZNRoH_j3wiA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfpslCqtg%253D%253D&md5=8fd2db3b1c2b6d249ba2c2453af1b339</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3222%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DMimura%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520the%2520negative%2520regulator%2520of%2520Nrf2%252C%2520Keap1%253A%2520a%2520historical%2520overview%26jtitle%3DAntioxidants%2520Redox%2520Signal.%26date%3D2010%26volume%3D13%26spage%3D1665%26epage%3D1678%26doi%3D10.1089%2Fars.2010.3222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of the Keap1-Nrf2 system</span>. <i>Free Radic. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.freeradbiomed.2015.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26117331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Cku7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=93-100&author=T.+Suzukiauthor=M.+Yamamoto&title=Molecular+basis+of+the+Keap1-Nrf2+system&doi=10.1016%2Fj.freeradbiomed.2015.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of the Keap1-Nrf2 system</span></div><div class="casAuthors">Suzuki, Takafumi; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">93-100</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nrf2 (NF-E2-related factor 2) is a master regulator of cellular responses against environmental stresses.  Nrf2 induces the expression of detoxification and antioxidant enzymes, and Keap1 (Kelch-like ECH-assocd. protein 1), an adaptor subunit of Cullin 3-based E3 ubiquitin ligase, regulates Nrf2 activity.  Keap1 also acts as a sensor for oxidative and electrophilic stresses.  Keap1 retains multiple sensor cysteine residues that detect various stress stimuli.  Increasing attention has been paid to the roles that Nrf2 plays in the protection of our bodies against drug toxicity and stress-induced diseases.  On the other hand, Nrf2 is found to promote both oncogenesis and cancer cell resistance against chemotherapeutic drugs.  Thus, although Nrf2 acts to protect our body from deleterious stresses, cancer cells hijack the Nrf2 activity to support their malignant growth.  Nrf2 has emerged as a new therapeutic target, and both inducers and inhibitors of Nrf2 are awaited.  Studies challenging the mol. basis of the Keap1-Nrf2 system functions are now critically important to improve translational studies of the system.  Indeed, recent studies identified cross talk between Nrf2 and other signaling pathways, which provides new insights into the mechanisms by which the Keap1-Nrf2 system serves as a potent regulator of our health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3SXIMvWYgU7Vg90H21EOLACvtfcHk0liy_bnpO4UCrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Cku7bL&md5=893e5dbf9b3cfe85fd30590a4a93b49c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DMolecular%2520basis%2520of%2520the%2520Keap1-Nrf2%2520system%26jtitle%3DFree%2520Radic.%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D93%26epage%3D100%26doi%3D10.1016%2Fj.freeradbiomed.2015.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sihvola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levonen, A.-L.</span></span> <span> </span><span class="NLM_article-title">Keap1 as the redox sensor of the antioxidant response</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>617</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2016.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.abb.2016.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=27769838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOmsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=617&publication_year=2017&pages=94-100&author=V.+Sihvolaauthor=A.-L.+Levonen&title=Keap1+as+the+redox+sensor+of+the+antioxidant+response&doi=10.1016%2Fj.abb.2016.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 as the redox sensor of the antioxidant response</span></div><div class="casAuthors">Sihvola, Virve; Levonen, Anna-Liisa</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">617</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">94-100</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) and products of their reactions with cellular macromols. such as unsatd. fatty acids have been implicated to be important regulators of signalling processes via oxidn. or alkylation of redox active thiol residues in target proteins.  One of key redox-sensitive signalling proteins mediating the response to oxidant stress is Keap1 (Kelch-like erythroid cell-derived protein with CNC homol. [ECH]-assocd. protein 1), which is a neg. regulator of transcription factor Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) and the central hub for sensing endogenous and environmental oxidative and electrophilic stress.  In this review, we provide an overview of the mechanisms by which Keap1 orchestrates the antioxidant response and how the system can be targeted for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoedzLPG-iE6rVg90H21EOLACvtfcHk0liy_bnpO4UCrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOmsbbJ&md5=91157b893774abab7a68b463c05e558a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2016.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2016.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DSihvola%26aufirst%3DV.%26aulast%3DLevonen%26aufirst%3DA.-L.%26atitle%3DKeap1%2520as%2520the%2520redox%2520sensor%2520of%2520the%2520antioxidant%2520response%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2017%26volume%3D617%26spage%3D94%26epage%3D100%26doi%3D10.1016%2Fj.abb.2016.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">16817</span>– <span class="NLM_lpage">16824</span>, <span class="refDoi"> DOI: 10.1074/jbc.r117.800169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1074%2Fjbc.R117.800169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=28842501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GjsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=16817-16824&author=T.+Suzukiauthor=M.+Yamamoto&title=Stress-sensing+mechanisms+and+the+physiological+roles+of+the+Keap1-Nrf2+system+during+cellular+stress&doi=10.1074%2Fjbc.r117.800169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress</span></div><div class="casAuthors">Suzuki, Takafumi; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">16817-16824</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Transcription factor Nrf2 (NF-E2-related factor 2) is a master regulator of cellular responses against environmental stresses.  Nrf2 induces the expression of detoxification and antioxidant enzymes and suppresses the induction of pro-inflammatory cytokine genes.  Keap1 (Kelch-like ECH-assocd. protein 1) is an adaptor subunit of Cullin 3-based E3 ubiquitin ligase.  Keap1 regulates the activity of Nrf2 and acts as a sensor for oxidative and electrophilic stresses.  In this review, we discuss the mol. mechanisms by which the Keap1-Nrf2 system senses and regulates the cellular response to environmental stresses.  In particular, we focus on the multiple stress-sensing mechanisms of Keap1 and novel regulatory functions of Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx_R4Q7mWl67Vg90H21EOLACvtfcHk0liy_bnpO4UCrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GjsrzN&md5=478e4b84f6fd7f1cd79546b6f452b7d7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R117.800169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R117.800169%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DStress-sensing%2520mechanisms%2520and%2520the%2520physiological%2520roles%2520of%2520the%2520Keap1-Nrf2%2520system%2520during%2520cellular%2520stress%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D16817%26epage%3D16824%26doi%3D10.1074%2Fjbc.r117.800169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">The molecular mechanisms regulating the Keap1-Nrf2 pathway</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>40</i></span>, <span class="NLM_elocation-id">e00099</span> <span class="refDoi"> DOI: 10.1128/MCB.00099-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1128%2FMCB.00099-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=32284348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFSktb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2020&author=L.+Bairdauthor=M.+Yamamoto&title=The+molecular+mechanisms+regulating+the+Keap1-Nrf2+pathway&doi=10.1128%2FMCB.00099-20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular mechanisms regulating the KEAP1-NRF2 pathway</span></div><div class="casAuthors">Baird, Liam; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">e00099-20</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">1098-5549</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The KEAP1-NRF2 pathway is the principal protective response to oxidative and electrophilic stresses.  Under homeostatic conditions, KEAP1 forms part of an E3 ubiquitin ligase, which tightly regulates the activity of the transcription factor NRF2 by targeting it for ubiquitination and proteasome-dependent degrdn.  In response to stress, an intricate mol. mechanism facilitated by sensor cysteines within KEAP1 allows NRF2 to escape ubiquitination, accumulate within the cell, and translocate to the nucleus, where it can promote its antioxidant transcription program.  Recent advances have revealed that KEAP1 contains multiple stress sensors and inactivation modalities, which together allow diverse cellular inputs, from oxidative stress and cellular metabolites to dysregulated autophagy, to regulate NRF2 activity.  This integration of the KEAP1-NRF2 system into multiple cellular signaling and metabolic pathways places NRF2 activation as a crit. regulatory node in many disease phenotypes and suggests that the pharmaceutical modulation of NRF2's cytoprotective activity will be beneficial for human health in a broad range of noncommunicable diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOVYF0sz4V7LVg90H21EOLACvtfcHk0lhJp7vQndHJ8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFSktb7P&md5=ca9ed34b0dff136afdc31d1e9e745833</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FMCB.00099-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00099-20%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DThe%2520molecular%2520mechanisms%2520regulating%2520the%2520Keap1-Nrf2%2520pathway%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2020%26volume%3D40%26doi%3D10.1128%2FMCB.00099-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madden, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itzhaki, L. S.</span></span> <span> </span><span class="NLM_article-title">Structural and mechanistic insights into the Keap1-Nrf2 system as a route to drug discovery</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>1868</i></span>,  <span class="NLM_fpage">140405</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2020.140405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.bbapap.2020.140405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXms12iurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1868&publication_year=2020&pages=140405&author=S.+K.+Maddenauthor=L.+S.+Itzhaki&title=Structural+and+mechanistic+insights+into+the+Keap1-Nrf2+system+as+a+route+to+drug+discovery&doi=10.1016%2Fj.bbapap.2020.140405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and mechanistic insights into the Keap1-Nrf2 system as a route to drug discovery</span></div><div class="casAuthors">Madden, Sarah K.; Itzhaki, Laura S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">1868</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">140405</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The proteins Keap1 and Nrf2 together act as a cytoprotective mechanism that enables cells to overcome electrophilic and oxidative stress.  Research has shown that manipulating this system by modulating the Keap1-Nrf2 interaction either through inhibition at the binding interface or via the covalent modification of Keap1 could provide a powerful therapeutic strategy for a range of diseases.  However, despite intensive investigation of the system and significant progress in the development of inhibitory small mols., there is still much to learn about the pathways assocd. with the Keap1-Nrf2 system and the structural details underpinning its mechanism of action.  In this review, we discuss how a deeper understanding could prove revolutionary in the development of new inhibitors and activators as well as guiding how to best harness Keap1 for targeted protein degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCbjWpa_4RfLVg90H21EOLACvtfcHk0lhJp7vQndHJ8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXms12iurk%253D&md5=e0bd208ef9a351f741ca9b081d9a14b4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2020.140405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2020.140405%26sid%3Dliteratum%253Aachs%26aulast%3DMadden%26aufirst%3DS.%2BK.%26aulast%3DItzhaki%26aufirst%3DL.%2BS.%26atitle%3DStructural%2520and%2520mechanistic%2520insights%2520into%2520the%2520Keap1-Nrf2%2520system%2520as%2520a%2520route%2520to%2520drug%2520discovery%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2020%26volume%3D1868%26spage%3D140405%26doi%3D10.1016%2Fj.bbapap.2020.140405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span> <span> </span><span class="NLM_article-title">The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">924</span>– <span class="NLM_lpage">963</span>, <span class="refDoi"> DOI: 10.1002/med.21396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1002%2Fmed.21396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=27192495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSms7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=924-963&author=M.-C.+Luauthor=J.-A.+Jiauthor=Z.-Y.+Jiangauthor=Q.-D.+You&title=The+Keap1-Nrf2-ARE+pathway+as+a+potential+preventive+and+therapeutic+target%3A+an+update&doi=10.1002%2Fmed.21396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update</span></div><div class="casAuthors">Lu, Meng-Chen; Ji, Jian-Ai; Jiang, Zheng-Yu; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">924-963</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Keap1-Nrf2-ARE ((Kelch-like ECH-Assocg. protein 1) nuclear factor erythroid 2 related factor 2-antioxidant response element) pathway is one of the most important defense mechanisms against oxidative and/or electrophilic stresses, and it is closely assocd. with inflammatory diseases, including cancer, neurodegenerative diseases, cardiovascular diseases, and aging.  In recent years, progress has been made in strategies aimed at modulating the Keap1-Nrf2-ARE pathway.  The Nrf2 activator DMF (Dimethylfumarates) has been approved by the FDA as a new first-line oral drug to treat patients with relapsing forms of multiple sclerosis, while a phase 3 study of another promising candidate, CDDO-Me, was terminated for safety reasons.  Directly inhibiting Keap1-Nrf2 protein-protein interactions as a novel Nrf2-modulating strategy has many advantages over using electrophilic Nrf2 activators.  The development of Keap1-Nrf2 protein-protein interaction inhibitors has become a topic of intense research, and potent inhibitors of this target have been identified.  In addn., inhibiting Nrf2 activity has attracted an increasing amt. of attention because it may provide an alternative cancer therapy.  This review summarizes the mol. mechanisms and biol. functions of the Keap1-Nrf2-ARE system.  The main focus of this review is on recent progress in studies of agents that target the Keap1-Nrf2-ARE pathway and the therapeutic applications of such agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFT_JWBNP5w7Vg90H21EOLACvtfcHk0lhJp7vQndHJ8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSms7bL&md5=b5514acfaaa6ecb31efe0d75387dd56e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fmed.21396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21396%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DJi%26aufirst%3DJ.-A.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26aulast%3DYou%26aufirst%3DQ.-D.%26atitle%3DThe%2520Keap1-Nrf2-ARE%2520pathway%2520as%2520a%2520potential%2520preventive%2520and%2520therapeutic%2520target%253A%2520an%2520update%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2016%26volume%3D36%26spage%3D924%26epage%3D963%26doi%3D10.1002%2Fmed.21396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousin, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumsey, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attucks, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levonen, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1038/s41573-018-0008-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1038%2Fs41573-018-0008-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=30610225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlslKlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=295-317&author=A.+Cuadradoauthor=A.+I.+Rojoauthor=G.+Wellsauthor=J.+D.+Hayesauthor=S.+P.+Cousinauthor=W.+L.+Rumseyauthor=O.+C.+Attucksauthor=S.+Franklinauthor=A.-L.+Levonenauthor=T.+W.+Kenslerauthor=A.+T.+Dinkova-Kostova&title=Therapeutic+targeting+of+the+NRF2+and+KEAP1+partnership+in+chronic+diseases&doi=10.1038%2Fs41573-018-0008-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases</span></div><div class="casAuthors">Cuadrado, Antonio; Rojo, Ana I.; Wells, Geoffrey; Hayes, John D.; Cousin, Sharon P.; Rumsey, William L.; Attucks, Otis C.; Franklin, Stephen; Levonen, Anna-Liisa; Kensler, Thomas W.; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  The transcription factor NF-E2 p45-related factor 2 (NRF2; encoded by NFE2L2) and its principal neg. regulator, the E3 ligase adaptor Kelch-like ECH-assocd. protein 1 (KEAP1), are crit. in the maintenance of redox, metabolic and protein homeostasis, as well as the regulation of inflammation.  Thus, NRF2 activation provides cytoprotection against numerous pathologies including chronic diseases of the lung and liver; autoimmune, neurodegenerative and metabolic disorders; and cancer initiation.  One NRF2 activator has received clin. approval and several electrophilic modifiers of the cysteine-based sensor KEAP1 and inhibitors of its interaction with NRF2 are now in clin. development.  However, challenges regarding target specificity, pharmacodynamic properties, efficacy and safety remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW9hICH7_1WbVg90H21EOLACvtfcHk0lhJp7vQndHJ8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlslKlsr0%253D&md5=ce3b8d39cd759418444f6e375ee1a38c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fs41573-018-0008-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41573-018-0008-x%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DRojo%26aufirst%3DA.%2BI.%26aulast%3DWells%26aufirst%3DG.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DCousin%26aufirst%3DS.%2BP.%26aulast%3DRumsey%26aufirst%3DW.%2BL.%26aulast%3DAttucks%26aufirst%3DO.%2BC.%26aulast%3DFranklin%26aufirst%3DS.%26aulast%3DLevonen%26aufirst%3DA.-L.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DTherapeutic%2520targeting%2520of%2520the%2520NRF2%2520and%2520KEAP1%2520partnership%2520in%2520chronic%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2019%26volume%3D18%26spage%3D295%26epage%3D317%26doi%3D10.1038%2Fs41573-018-0008-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bista, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hronowsky, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollate, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellrichmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brück, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goelz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukashev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, R.</span></span> <span> </span><span class="NLM_article-title">Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">678</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1093/brain/awq386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1093%2Fbrain%2Fawq386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=21354971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A280%3ADC%252BC3M3it1alsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2011&pages=678-692&author=R.+A.+Linkerauthor=D.-H.+Leeauthor=S.+Ryanauthor=A.+M.+van+Damauthor=R.+Conradauthor=P.+Bistaauthor=W.+Zengauthor=X.+Hronowskyauthor=A.+Bukoauthor=S.+Chollateauthor=G.+Ellrichmannauthor=W.+Br%C3%BCckauthor=K.+Dawsonauthor=S.+Goelzauthor=S.+Wieseauthor=R.+H.+Scannevinauthor=M.+Lukashevauthor=R.+Gold&title=Fumaric+acid+esters+exert+neuroprotective+effects+in+neuroinflammation+via+activation+of+the+Nrf2+antioxidant+pathway&doi=10.1093%2Fbrain%2Fawq386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway</span></div><div class="casAuthors">Linker Ralf A; Lee De-Hyung; Ryan Sarah; van Dam Anne M; Conrad Rebecca; Bista Pradeep; Zeng Weike; Hronowsky Xiaoping; Buko Alex; Chollate Sowmya; Ellrichmann Gisa; Bruck Wolfgang; Dawson Kate; Goelz Susan; Wiese Stefan; Scannevin Robert H; Lukashev Matvey; Gold Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">Pt 3</span>),
    <span class="NLM_cas:pages">678-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammation and oxidative stress are thought to promote tissue damage in multiple sclerosis.  Thus, novel therapeutics enhancing cellular resistance to free radicals could prove useful for multiple sclerosis treatment.  BG00012 is an oral formulation of dimethylfumarate.  In a phase II multiple sclerosis trial, BG00012 demonstrated beneficial effects on relapse rate and magnetic resonance imaging markers indicative of inflammation as well as axonal destruction.  First we have studied effects of dimethylfumarate on the disease course, central nervous system, tissue integrity and the molecular mechanism of action in an animal model of chronic multiple sclerosis: myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis in C57BL/6 mice.  In the chronic phase of experimental autoimmune encephalomyelitis, preventive or therapeutic application of dimethylfumarate ameliorated the disease course and improved preservation of myelin, axons and neurons.  In vitro, the application of fumarates increased murine neuronal survival and protected human or rodent astrocytes against oxidative stress.  Application of dimethylfumarate led to stabilization of the transcription factor nuclear factor (erythroid-derived 2)-related factor 2, activation of nuclear factor (erythroid-derived 2)-related factor 2-dependent transcriptional activity and accumulation of NADP(H) quinoline oxidoreductase-1 as a prototypical target gene.  Furthermore, the immediate metabolite of dimethylfumarate, monomethylfumarate, leads to direct modification of the inhibitor of nuclear factor (erythroid-derived 2)-related factor 2, Kelch-like ECH-associated protein 1, at cysteine residue 151.  In turn, increased levels of nuclear factor (erythroid-derived 2)-related factor 2 and reduced protein nitrosylation were detected in the central nervous sytem of dimethylfumarate-treated mice.  Nuclear factor (erythroid-derived 2)-related factor 2 was also upregulated in the spinal cord of autopsy specimens from untreated patients with multiple sclerosis.  In dimethylfumarate-treated mice suffering from experimental autoimmune encephalomyelitis, increased immunoreactivity for nuclear factor (erythroid-derived 2)-related factor 2 was detected by confocal microscopy in neurons of the motor cortex and the brainstem as well as in oligodendrocytes and astrocytes.  In mice deficient for nuclear factor (erythroid-derived 2)-related factor 2 on the same genetic background, the dimethylfumarate mediated beneficial effects on clinical course, axon preservation and astrocyte activation were almost completely abolished thus proving the functional relevance of this transcription factor for the neuroprotective mechanism of action.  We conclude that the ability of dimethylfumarate to activate nuclear factor (erythroid-derived 2)-related factor 2 may offer a novel cytoprotective modality that further augments the natural antioxidant responses in multiple sclerosis tissue and is not yet targeted by other multiple sclerosis therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAUtIRbYJEbB0LsK7uFuY7fW6udTcc2eZKAfbiVcCVZrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3it1alsw%253D%253D&md5=d113bf628d25500b5c612938a7571fd9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawq386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawq386%26sid%3Dliteratum%253Aachs%26aulast%3DLinker%26aufirst%3DR.%2BA.%26aulast%3DLee%26aufirst%3DD.-H.%26aulast%3DRyan%26aufirst%3DS.%26aulast%3Dvan%2BDam%26aufirst%3DA.%2BM.%26aulast%3DConrad%26aufirst%3DR.%26aulast%3DBista%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DHronowsky%26aufirst%3DX.%26aulast%3DBuko%26aufirst%3DA.%26aulast%3DChollate%26aufirst%3DS.%26aulast%3DEllrichmann%26aufirst%3DG.%26aulast%3DBr%25C3%25BCck%26aufirst%3DW.%26aulast%3DDawson%26aufirst%3DK.%26aulast%3DGoelz%26aufirst%3DS.%26aulast%3DWiese%26aufirst%3DS.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DLukashev%26aufirst%3DM.%26aulast%3DGold%26aufirst%3DR.%26atitle%3DFumaric%2520acid%2520esters%2520exert%2520neuroprotective%2520effects%2520in%2520neuroinflammation%2520via%2520activation%2520of%2520the%2520Nrf2%2520antioxidant%2520pathway%26jtitle%3DBrain%26date%3D2011%26volume%3D134%26spage%3D678%26epage%3D692%26doi%3D10.1093%2Fbrain%2Fawq386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span> <span> </span><span class="NLM_article-title">Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">8137</span>– <span class="NLM_lpage">8151</span>, <span class="refDoi"> DOI: 10.1128/mcb.23.22.8137-8151.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1128%2FMCB.23.22.8137-8151.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=14585973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=8137-8151&author=D.+D.+Zhangauthor=M.+Hannink&title=Distinct+cysteine+residues+in+Keap1+are+required+for+Keap1-dependent+ubiquitination+of+Nrf2+and+for+stabilization+of+Nrf2+by+chemopreventive+agents+and+oxidative+stress&doi=10.1128%2Fmcb.23.22.8137-8151.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress</span></div><div class="casAuthors">Zhang, Donna D.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8137-8151</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A common feature of diverse chemopreventive agents is the ability to activate expression of a genetic program that protects cells from reactive chem. species that if left unchecked would cause mutagenic DNA damage.  The bZIP transcription factor Nrf2 has emerged as a key regulator of this cancer-preventive genetic program.  Nrf2 is normally sequestered in the cytoplasm by a protein known as Keap1.  Chemopreventive agents allow Nrf2 to escape from Keap1-mediated repression, although the mol. mechanism(s) responsible for activation of Nrf2 is not understood.  In this report, we demonstrate that Keap1 does not passively sequester Nrf2 in the cytoplasm but actively targets Nrf2 for ubiquitination and degrdn. by the proteasome under basal culture conditions.  We have identified two crit. cysteine residues in Keap1, C273 and C288, that are required for Keap1-dependent ubiquitination of Nrf2.  Both sulforaphane, a chemopreventive isothiocyanate, and oxidative stress enable Nrf2 to escape Keap1-dependent degrdn., leading to stabilization of Nrf2, increased nuclear localization of Nrf2, and activation of Nrf2-dependent cancer-protective genes.  We have identified a third cysteine residue in Keap1, C151, that is uniquely required for inhibition of Keap1-dependent degrdn. of Nrf2 by sulforaphane and oxidative stress.  This cysteine residue is also required for a novel posttranslational modification to Keap1 that is induced by oxidative stress.  We propose that Keap1 is a component of a novel E3 ubiquitin ligase complex that is specifically targeted for inhibition by both chemopreventive agents and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqys54qQ6MlRLVg90H21EOLACvtfcHk0lgkvb2EzrIXtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D&md5=9287849578d0a6b7a6d52b67e3c65190</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.22.8137-8151.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.22.8137-8151.2003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DDistinct%2520cysteine%2520residues%2520in%2520Keap1%2520are%2520required%2520for%2520Keap1-dependent%2520ubiquitination%2520of%2520Nrf2%2520and%2520for%2520stabilization%2520of%2520Nrf2%2520by%2520chemopreventive%2520agents%2520and%2520oxidative%2520stress%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D8137%26epage%3D8151%26doi%3D10.1128%2Fmcb.23.22.8137-8151.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pergola, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raskin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toto, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huff, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audhya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ-Schmidt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warnock, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Investigators, B. S.</span></span> <span> </span><span class="NLM_article-title">Bardoxolone methyl and kidney function in CKD with type 2 diabetes</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1105351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1056%2Fnejmoa1105351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=21699484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpslSnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2011&pages=327-336&author=P.+E.+Pergolaauthor=P.+Raskinauthor=R.+D.+Totoauthor=C.+J.+Meyerauthor=J.+W.+Huffauthor=E.+B.+Grossmanauthor=M.+Krauthauthor=S.+Ruizauthor=P.+Audhyaauthor=H.+Christ-Schmidtauthor=J.+Wittesauthor=D.+G.+Warnockauthor=B.+S.+Investigators&title=Bardoxolone+methyl+and+kidney+function+in+CKD+with+type+2+diabetes&doi=10.1056%2Fnejmoa1105351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Bardoxolone methyl and kidney function in CKD with type 2 diabetes</span></div><div class="casAuthors">Pergola, Pablo E.; Raskin, Philip; Toto, Robert D.; Meyer, Colin J.; Huff, J. Warren; Grossman, Eric B.; Krauth, Melissa; Ruiz, Stacey; Audhya, Paul; Christ-Schmidt, Heidi; Wittes, Janet; Warnock, David G.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">327-336</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Chronic kidney disease (CKD) assocd. with type 2 diabetes is the leading cause of kidney failure, with both inflammation and oxidative stress contributing to disease progression.  Bardoxolone Me, an oral antioxidant inflammation modulator, has shown efficacy in patients with CKD and type 2 diabetes in short-term studies, but longer-term effects sand dose response have not been detd.  Methods: In this phase 2, double-blind, randomized, placebo-controlled trial, we assigned 227 adults with CKD (defined as an estd. glomerular filtration rate [GFR] of 20 to 45 mL per min per 1.73 m2 of body-surface area) in a 1:1:1:1 ratio to receive placebo or bardoxolone Me at a target dose of 25, 75, or 150 mg once daily.  The primary outcome was the change from baseline in the estd. GFR with bardoxolone Me, as compared with placebo, at 24 wk; a secondary outcome was the change at 52 wk.  Results: Patients receiving bardoxolone Me had significant increases in the mean (±SD) estd. GFR, as compared with placebo, at 24 wk (with between-group differences per min per 1.73 m2 of 8.2 ± 1.5 mL in the 25-mg group, 11.4 ± 1.5 mL in the 75-mg group, and 10.4 ± 1.5 mL in the 150-mg group; P < 0.001).  The increases were maintained through week 52, with significant differences per min per 1.73 m2 of 5.8 ± 1.8 mL, 10.5 ± 1.8 mL, and 9.3 ± 1.9 mL, resp.  Muscle spasms, were generally mild and dose-related.  Hypomagnesemia, mild increases in alanine aminotransferase levels, and gastrointestinal effects were more common among patients receiving bardoxolone Me.  Conclusions: Bardoxolone Me was assocd. with improvement in the estd. GFR in patients with advanced CKD and type 2 diabetes at 24 wk.  The improvement persisted at 52 wk, suggesting that bardoxolone Me may have promise for the treatment of CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcbGTG2V2X9LVg90H21EOLACvtfcHk0lgwzw4Pgnqcfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpslSnsrs%253D&md5=9f4f2bb5e020129e58dc47437fcab8a7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1105351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1105351%26sid%3Dliteratum%253Aachs%26aulast%3DPergola%26aufirst%3DP.%2BE.%26aulast%3DRaskin%26aufirst%3DP.%26aulast%3DToto%26aufirst%3DR.%2BD.%26aulast%3DMeyer%26aufirst%3DC.%2BJ.%26aulast%3DHuff%26aufirst%3DJ.%2BW.%26aulast%3DGrossman%26aufirst%3DE.%2BB.%26aulast%3DKrauth%26aufirst%3DM.%26aulast%3DRuiz%26aufirst%3DS.%26aulast%3DAudhya%26aufirst%3DP.%26aulast%3DChrist-Schmidt%26aufirst%3DH.%26aulast%3DWittes%26aufirst%3DJ.%26aulast%3DWarnock%26aufirst%3DD.%2BG.%26aulast%3DInvestigators%26aufirst%3DB.%2BS.%26atitle%3DBardoxolone%2520methyl%2520and%2520kidney%2520function%2520in%2520CKD%2520with%2520type%25202%2520diabetes%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D365%26spage%3D327%26epage%3D336%26doi%3D10.1056%2Fnejmoa1105351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-p.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-f.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.-q.</span></span> <span> </span><span class="NLM_article-title">Nrf2 activator RTA-408 protects against ozone-induced acute asthma exacerbation by suppressing ROS and γδT17 cells</span>. <i>Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1843</span>– <span class="NLM_lpage">1856</span>, <span class="refDoi"> DOI: 10.1007/s10753-019-01046-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1007%2Fs10753-019-01046-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31256292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1yktr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2019&pages=1843-1856&author=J.-h.+Zhangauthor=X.+Yangauthor=Y.-p.+Chenauthor=J.-f.+Zhangauthor=C.-q.+Li&title=Nrf2+activator+RTA-408+protects+against+ozone-induced+acute+asthma+exacerbation+by+suppressing+ROS+and+%CE%B3%CE%B4T17+cells&doi=10.1007%2Fs10753-019-01046-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 Activator RTA-408 Protects Against Ozone-Induced Acute Asthma Exacerbation by Suppressing ROS and γδT17 Cells</span></div><div class="casAuthors">Zhang, Jing-hong; Yang, Xia; Chen, Yi-ping; Zhang, Jian-feng; Li, Chao-qian</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1843-1856</span>CODEN:
                <span class="NLM_cas:coden">INFLD4</span>;
        ISSN:<span class="NLM_cas:issn">0360-3997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Ozone is a strong oxidant in air pollution that exacerbates respiratory disorders and is a major risk factor for acute asthma exacerbation.  Ozone can induce reactive oxygen species (ROS) and airway neutrophilic inflammation.  In addn., γδT17 cells contribute to IL-17A prodn. upon ozone challenge, resulting in neutrophilic inflammation.  It is known, however, that Nrf2 can ameliorate oxidative stress.  We therefore investigated whether RTA-408, an Nrf2 activator, can attenuate airway inflammation and inhibit ROS prodn. and whether this effect involves γδT17 cells.  Balb/c mice were sensitized/challenged with OVA and followed by ozone exposure.  We investigated the effect of Nrf2 activator RTA-408 on airway hyperresponsiveness, neutrophilic airway inflammation, cytokine/chemokine prodn., and OVA-specific IgE level in a mouse model of O3 induced asthma exacerbation.  Furthermore MDA and GSH levels in lung and intracellular ROS were measured.  IL-17+ γδT cell percentage by flow cytometer was detd.  Nrf2 protein expression by western blot was also examd.  We obsd. that RTA-408 attenuated ROS release during ozone-induced asthma exacerbation and suppressed neutrophil lung infiltration.  RTA-408 decreased pro-inflammatory cytokine prodn. and reduced the percentage of IL-17+ γδT cells.  Thus, our results suggest that RTA-408 does attenuate airway inflammation in a murine model of ozone-induced asthma exacerbation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGOVSc2GnhUrVg90H21EOLACvtfcHk0lgwzw4Pgnqcfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1yktr%252FO&md5=aabc7446b14f7907fbaa58678a43759a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs10753-019-01046-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10753-019-01046-6%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.-h.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.-p.%26aulast%3DZhang%26aufirst%3DJ.-f.%26aulast%3DLi%26aufirst%3DC.-q.%26atitle%3DNrf2%2520activator%2520RTA-408%2520protects%2520against%2520ozone-induced%2520acute%2520asthma%2520exacerbation%2520by%2520suppressing%2520ROS%2520and%2520%25CE%25B3%25CE%25B4T17%2520cells%26jtitle%3DInflammation%26date%3D2019%26volume%3D42%26spage%3D1843%26epage%3D1856%26doi%3D10.1007%2Fs10753-019-01046-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostov, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canning, P.</span></span> <span> </span><span class="NLM_article-title">Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>617</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2016.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.abb.2016.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=27497696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlags7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=617&publication_year=2017&pages=84-93&author=A.+T.+Dinkova-Kostovaauthor=R.+V.+Kostovauthor=P.+Canning&title=Keap1%2C+the+cysteine-based+mammalian+intracellular+sensor+for+electrophiles+and+oxidants&doi=10.1016%2Fj.abb.2016.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Kostov, Rumen V.; Canning, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">617</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">84-93</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Kelch-like ECH assocd. protein 1 (Keap1) is a component of a Cullin3-based Cullin-RING E3 ubiquitin ligase (CRL) multisubunit protein complex.  Within the CRL, homodimeric Keap1 functions as the Cullin3 adaptor, and importantly, it is also the crit. component of the E3 ligase that performs the substrate recognition.  The best-characterized substrate of Keap1 is transcription factor NF-E2 p45-related factor 2 (Nrf2), which orchestrates an elaborate transcriptional program in response to environmental challenges caused by oxidants, electrophiles and pro-inflammatory agents, allowing adaptation and survival under stress conditions.  Keap1 is equipped with reactive cysteine residues that act as sensors for endogenously produced and exogenously encountered small mols. (termed inducers), which have a characteristic chem. signature, reactivity with sulfhydryl groups.  Inducers modify the cysteine sensors of Keap1 and impair its ability to target Nrf2 for ubiquitination and degrdn.  Consequently, Nrf2 accumulates, enters the nucleus and drives the transcription of its target genes, which encode a large network of cytoprotective proteins.  Here we summarize the early studies leading to the prediction of the existence of Keap1, followed by the discovery of Keap1 as the main neg. regulator of Nrf2.  We then describe the available structural information on Keap1, its assembly with Cullin3, and its interaction with Nrf2.  We also discuss the multiple cysteine sensors of Keap1 that allow for detection of a wide range of endogenous and environmental inducers, and provide fine-tuning and tight control of the Keap1/Nrf2 stress-sensing response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI8YYxE9xg4LVg90H21EOLACvtfcHk0lgwzw4Pgnqcfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlags7jF&md5=eedfc91fa4e91f74df618231a01af182</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2016.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2016.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DKostov%26aufirst%3DR.%2BV.%26aulast%3DCanning%26aufirst%3DP.%26atitle%3DKeap1%252C%2520the%2520cysteine-based%2520mammalian%2520intracellular%2520sensor%2520for%2520electrophiles%2520and%2520oxidants%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2017%26volume%3D617%26spage%3D84%26epage%3D93%26doi%3D10.1016%2Fj.abb.2016.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Zeeuw, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audhya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakris, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ-Schmidt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsberry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambers Heerspink, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parving, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toto, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaziri, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrolstad, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chertow, G. M.</span></span> <span> </span><span class="NLM_article-title">Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">2492</span>– <span class="NLM_lpage">2503</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1306033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1056%2Fnejmoa1306033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=24206459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=2492-2503&author=D.+de+Zeeuwauthor=T.+Akizawaauthor=P.+Audhyaauthor=G.+L.+Bakrisauthor=M.+Chinauthor=H.+Christ-Schmidtauthor=A.+Goldsberryauthor=M.+Houserauthor=M.+Krauthauthor=H.+J.+Lambers+Heerspinkauthor=J.+J.+McMurrayauthor=C.+J.+Meyerauthor=H.-H.+Parvingauthor=G.+Remuzziauthor=R.+D.+Totoauthor=N.+D.+Vaziriauthor=C.+Wannerauthor=J.+Wittesauthor=D.+Wrolstadauthor=G.+M.+Chertow&title=Bardoxolone+methyl+in+type+2+diabetes+and+stage+4+chronic+kidney+disease&doi=10.1056%2Fnejmoa1306033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease</span></div><div class="casAuthors">de Zeeuw, Dick; Akizawa, Tadao; Audhya, Paul; Bakris, George L.; Chin, Melanie; Christ-Schmidt, Heidi; Goldsberry, Angie; Houser, Mark; Krauth, Melissa; Lambers Heerspink, Hiddo J.; McMurray, John J.; Meyer, Colin J.; Parving, Hans-Henrik; Remuzzi, Giuseppe; Toto, Robert D.; Vaziri, Nosratola D.; Wanner, Christoph; Wittes, Janet; Wrolstad, Danielle; Chertow, Glenn M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2492-2503</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Although inhibitors of the renin-angiotensin-aldosterone system can slow the progression of diabetic kidney disease, the residual risk is high.  Whether nuclear I factor (erythroid-derived 2)-related factor 2 activators further reduce this risk is unknown.  METHODS: We randomly assigned 2185 patients with type 2 diabetes mellitus and stage 4 chronic kidney disease (estd. glomerular filtration rate [GFR], 15 to <30 mL per min per 1.73 m2 of body-surface area) to bardoxolone Me, at a daily dose of 20 mg, or placebo.  The primary composite outcome was end-stage renal disease (ESRD) or death from cardiovascular causes.  RESULTS: The sponsor and the steering committee terminated the trial on the recommendation of the independent data and safety monitoring committee; the median follow-up was 9 mo.  A total of 69 of 1088 patients (6%) randomly assigned to bardoxolone Me and 69 of 1097 (6%) randomly assigned to placebo had a primary composite outcome (hazard ratio in the bardoxolone Me group vs. the placebo group, 0.98; 95% confidence interval [CI], 0.70 to 1.37; P = 0.92).  In the bardoxolone Me group, ESRD developed in 43 patients, and 27 patients died from cardiovascular causes; in the placebo group, ESRD developed In 51 patients, and 19 patients died from cardiovascular causes.  A total of 96 patients in the bardoxolone Me group were hospitalized for heart failure or died from heart failure, as compared with 55 in the placebo group (hazard ratio, 1.83; 95% CI, 1.32 to 2.55; P < 0.001).  Estd. GFR, blood pressure, and the urinary albumin-to-creatinine ratio increased significantly and body wt. decreased significantly in the bardoxolone Me group, as compared with the placebo group.  CONCLUSIONS: Among patients with type 2 diabetes mellitus and stage 4 chronic kidney disease, bardoxolone Me did not reduce the risk of ESRD or death from cardiovascular causes.  A higher rate of cardiovascular events with bardoxolone Me than with placebo prompted termination of the trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomI6Z9q4C0LLVg90H21EOLACvtfcHk0lhO2Nz9IK-lww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKqs74%253D&md5=1bcc997b57ba700423e0549a617231b5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1306033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1306033%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BZeeuw%26aufirst%3DD.%26aulast%3DAkizawa%26aufirst%3DT.%26aulast%3DAudhya%26aufirst%3DP.%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DChin%26aufirst%3DM.%26aulast%3DChrist-Schmidt%26aufirst%3DH.%26aulast%3DGoldsberry%26aufirst%3DA.%26aulast%3DHouser%26aufirst%3DM.%26aulast%3DKrauth%26aufirst%3DM.%26aulast%3DLambers%2BHeerspink%26aufirst%3DH.%2BJ.%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%26aulast%3DMeyer%26aufirst%3DC.%2BJ.%26aulast%3DParving%26aufirst%3DH.-H.%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DToto%26aufirst%3DR.%2BD.%26aulast%3DVaziri%26aufirst%3DN.%2BD.%26aulast%3DWanner%26aufirst%3DC.%26aulast%3DWittes%26aufirst%3DJ.%26aulast%3DWrolstad%26aufirst%3DD.%26aulast%3DChertow%26aufirst%3DG.%2BM.%26atitle%3DBardoxolone%2520methyl%2520in%2520type%25202%2520diabetes%2520and%2520stage%25204%2520chronic%2520kidney%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D2492%26epage%3D2503%26doi%3D10.1056%2Fnejmoa1306033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abed, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albanyan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2015.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.apsb.2015.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26579458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A280%3ADC%252BC28rgtlOkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=285-299&author=D.+A.+Abedauthor=M.+Goldsteinauthor=H.+Albanyanauthor=H.+Jinauthor=L.+Hu&title=Discovery+of+direct+inhibitors+of+Keap1-Nrf2+protein-protein+interaction+as+potential+therapeutic+and+preventive+agents&doi=10.1016%2Fj.apsb.2015.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents</span></div><div class="casAuthors">Abed Dhulfiqar Ali; Goldstein Melanie; Albanyan Haifa; Jin Huijuan; Hu Longqin</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">285-99</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">The Keap1-Nrf2-ARE pathway is an important antioxidant defense mechanism that protects cells from oxidative stress and the Keap1-Nrf2 protein-protein interaction (PPI) has become an important drug target to upregulate the expression of ARE-controlled cytoprotective oxidative stress response enzymes in the development of therapeutic and preventive agents for a number of diseases and conditions.  However, most known Nrf2 activators/ARE inducers are indirect inhibitors of Keap1-Nrf2 PPI and they are electrophilic species that act by modifying the sulfhydryl groups of Keap1 s cysteine residues.  The electrophilicity of these indirect inhibitors may cause "off-target" side effects by reacting with cysteine residues of other important cellular proteins.  Efforts have recently been focused on the development of direct inhibitors of Keap1-Nrf2 PPI.  This article reviews these recent research efforts including the development of high throughput screening assays, the discovery of peptide and small molecule direct inhibitors, and the biophysical characterization of the binding of these inhibitors to the target Keap1 Kelch domain protein.  These non-covalent direct inhibitors of Keap1-Nrf2 PPI could potentially be developed into effective therapeutic or preventive agents for a variety of diseases and conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-qtzzXrDFl5Pq5LRczm8ffW6udTcc2eZFX0RDDWIJDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgtlOkuw%253D%253D&md5=a22499ab91854a1038e0f18fee0886e3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2015.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2015.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DAbed%26aufirst%3DD.%2BA.%26aulast%3DGoldstein%26aufirst%3DM.%26aulast%3DAlbanyan%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520direct%2520inhibitors%2520of%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520as%2520potential%2520therapeutic%2520and%2520preventive%2520agents%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2015%26volume%3D5%26spage%3D285%26epage%3D299%26doi%3D10.1016%2Fj.apsb.2015.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speltz, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2261</span>– <span class="NLM_lpage">2268</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.bmcl.2015.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=25937010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslehs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2261-2268&author=B.+G.+Richardsonauthor=A.+D.+Jainauthor=T.+E.+Speltzauthor=T.+W.+Moore&title=Non-electrophilic+modulators+of+the+canonical+Keap1%2FNrf2+pathway&doi=10.1016%2Fj.bmcl.2015.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway</span></div><div class="casAuthors">Richardson, B. G.; Jain, A. D.; Speltz, T. E.; Moore, T. W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2261-2268</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nrf2 is the major transcription factor that regulates many of the cytoprotective enzymes involved in the adaptive stress response.  Modulation of Nrf2 could be therapeutically useful in a no. of disease states.  Activation can occur through either an electrophilic or non-electrophilic mechanism.  To date, most of the research has focused on electrophilic Nrf2 activators, but there is increasing interest in non-electrophilic modulators of Nrf2.  This Digest examines the current selection of small mols. that modulate Nrf2 through non-electrophilic mechanisms, and it highlights new opportunities for this important therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojMkBabiNYC7Vg90H21EOLACvtfcHk0lhO2Nz9IK-lww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslehs7c%253D&md5=2e5ec64ce19ef7805892ea70a240c7df</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DSpeltz%26aufirst%3DT.%2BE.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DNon-electrophilic%2520modulators%2520of%2520the%2520canonical%2520Keap1%252FNrf2%2520pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2261%26epage%3D2268%26doi%3D10.1016%2Fj.bmcl.2015.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) protein–protein interaction inhibitors: achievements, challenges, and future directions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10837</span>– <span class="NLM_lpage">10858</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00586</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00586" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10837-10858&author=Z.+Jiangauthor=M.+Luauthor=Q.+You&title=Discovery+and+development+of+Kelch-like+ECH-Associated+Protein+1.+Nuclear+Factor+Erythroid+2-Related+Factor+2+%28KEAP1%3ANRF2%29+protein%E2%80%93protein+interaction+inhibitors%3A+achievements%2C+challenges%2C+and+future+directions&doi=10.1021%2Facs.jmedchem.6b00586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10837-10858</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The transcription factor Nrf2 is the primary regulator of the cellular defense system, and enhancing Nrf2 activity has potential usages in various diseases, esp. chronic age-related and inflammatory diseases.  Recently, directly targeting Keap1-Nrf2 protein-protein interaction (PPI) has been an emerging strategy to selectively and effectively activate Nrf2.  This Perspective summarizes the progress in the discovery and development of Keap1-Nrf2 PPI inhibitors, including the Keap1-Nrf2 regulatory mechanisms, biochem. techniques for inhibitor identification, and approaches for identifying peptide and small-mol. inhibitors, as well as discusses privileged structures and future directions for further development of Keap1-Nrf2 PPI inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCuMv4k9xi9LVg90H21EOLACvtfcHk0li5FwtWRLIEbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO&md5=487aa677ae8a86d71e2b15561656b0b7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00586%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3DDiscovery%2520and%2520development%2520of%2520Kelch-like%2520ECH-Associated%2520Protein%25201.%2520Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528KEAP1%253ANRF2%2529%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitors%253A%2520achievements%252C%2520challenges%252C%2520and%2520future%2520directions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10837%26epage%3D10858%26doi%3D10.1021%2Facs.jmedchem.6b00586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span> <span> </span><span class="NLM_article-title">Small molecules inhibiting Keap1–Nrf2 protein–protein interactions: a novel approach to activate Nrf2 function</span>. <i>Med. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">286</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1039/c6md00500d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1039%2FC6MD00500D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=286-294&author=C.+Zhuangauthor=Z.+Wuauthor=C.+Xingauthor=Z.+Miao&title=Small+molecules+inhibiting+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interactions%3A+a+novel+approach+to+activate+Nrf2+function&doi=10.1039%2Fc6md00500d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2FC6MD00500D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00500D%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DXing%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DZ.%26atitle%3DSmall%2520molecules%2520inhibiting%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interactions%253A%2520a%2520novel%2520approach%2520to%2520activate%2520Nrf2%2520function%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D286%26epage%3D294%26doi%3D10.1039%2Fc6md00500d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pallesen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span> <span> </span><span class="NLM_article-title">Non-covalent small-molecule Kelch-like ECH-Associated Protein 1 - Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) inhibitors and their potential for targeting CNS diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8088</span>– <span class="NLM_lpage">8103</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00358</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00358" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt12hsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8088-8103&author=J.+S.+Pallesenauthor=K.+T.+Tranauthor=A.+Bach&title=Non-covalent+small-molecule+Kelch-like+ECH-Associated+Protein+1+-+Nuclear+Factor+Erythroid+2-Related+Factor+2+%28Keap1-Nrf2%29+inhibitors+and+their+potential+for+targeting+CNS+diseases&doi=10.1021%2Facs.jmedchem.8b00358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases</span></div><div class="casAuthors">Pallesen, Jakob S.; Tran, Kim T.; Bach, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8088-8103</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) has a protective effect against oxidative stress and plays a major role in inflammation and central nervous system (CNS) diseases.  Inhibition of the protein-protein interaction (PPI) between Nrf2 and its repressor protein, Kelch-like ECH-assocd. protein 1 (Keap1), leads to translocation of Nrf2 from the cytosol to the nucleus and expression of detoxifying antioxidant enzymes.  To date, several non-covalent small-mol. Keap1-Nrf2 inhibitors have been identified; however, many of them contain carboxylic acids and are rather large in size, which likely prevents or decreases CNS permeability.  This Perspective describes current small-mol. Keap1-Nrf2 inhibitors with exptl. evidence for the ability to inhibit the Keap1-Nrf2 interaction by binding to Keap1 in a non-covalent manner.  Binding data, biostructural studies, and biol. activity are summarized for the inhibitors, and their potential as CNS tool compds. is discussed by analyzing physicochem. properties, including CNS multiparameter optimization (MPO) scoring algorithms.  Finally, several strategies for identifying CNS-targeting Keap1 inhibitors are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAnObBnG8ca7Vg90H21EOLACvtfcHk0li5FwtWRLIEbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt12hsb8%253D&md5=0492259af2532169001a1d4ef532fdbb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00358%26sid%3Dliteratum%253Aachs%26aulast%3DPallesen%26aufirst%3DJ.%2BS.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DBach%26aufirst%3DA.%26atitle%3DNon-covalent%2520small-molecule%2520Kelch-like%2520ECH-Associated%2520Protein%25201%2520-%2520Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528Keap1-Nrf2%2529%2520inhibitors%2520and%2520their%2520potential%2520for%2520targeting%2520CNS%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8088%26epage%3D8103%26doi%3D10.1021%2Facs.jmedchem.8b00358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallesen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solbak, S. M. Ø.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguayo-Orozco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmona, R. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span> <span> </span><span class="NLM_article-title">A comparative assessment study of known small-molecule Keap1-Nrf2 protein-protein interaction inhibitors: chemical synthesis, binding properties, and cellular activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8028</span>– <span class="NLM_lpage">8052</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00723</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00723" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFOqt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8028-8052&author=K.+T.+Tranauthor=J.+S.+Pallesenauthor=S.+M.+%C3%98.+Solbakauthor=D.+Narayananauthor=A.+Baigauthor=J.+Zangauthor=A.+Aguayo-Orozcoauthor=R.+M.+C.+Carmonaauthor=A.+D.+Garciaauthor=A.+Bach&title=A+comparative+assessment+study+of+known+small-molecule+Keap1-Nrf2+protein-protein+interaction+inhibitors%3A+chemical+synthesis%2C+binding+properties%2C+and+cellular+activity&doi=10.1021%2Facs.jmedchem.9b00723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity</span></div><div class="casAuthors">Tran, Kim T.; Pallesen, Jakob S.; Solbak, Sara M. Oe.; Narayanan, Dilip; Baig, Amina; Zang, Jie; Aguayo-Orozco, Alejandro; Carmona, Rosa M. C.; Garcia, Anthony D.; Bach, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8028-8052</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibiting the protein-protein interaction (PPI) between the transcription factor Nrf2 and its repressor protein Keap1 has emerged as a promising strategy to target oxidative stress in diseases, including central nervous system (CNS) disorders.  Numerous non-covalent small-mol. Keap1-Nrf2 PPI inhibitors have been reported to date, but many feature suboptimal physicochem. properties for permeating the blood-brain barrier, while others contain problematic structural moieties.  Here, we present the first side-by-side assessment of all reported Keap1-Nrf2 PPI inhibitor classes using fluorescence polarization, thermal shift assay, and surface plasmon resonance-and further evaluate the compds. in an NQO1 induction cell assay and in counter tests for nonspecific activities.  Surprisingly, half of the compds. were inactive or deviated substantially from reported activities, while we confirm the cross-assay activities for others.  Through this study, we have identified the most promising Keap1-Nrf2 inhibitors that can serve as pharmacol. probes or starting points for developing CNS-active Keap1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX8UEx5LbA87Vg90H21EOLACvtfcHk0ljckEKdzcoOAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFOqt73P&md5=a80925ac602d3b3e4cae05bf5454ff34</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00723%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DPallesen%26aufirst%3DJ.%2BS.%26aulast%3DSolbak%26aufirst%3DS.%2BM.%2B%25C3%2598.%26aulast%3DNarayanan%26aufirst%3DD.%26aulast%3DBaig%26aufirst%3DA.%26aulast%3DZang%26aufirst%3DJ.%26aulast%3DAguayo-Orozco%26aufirst%3DA.%26aulast%3DCarmona%26aufirst%3DR.%2BM.%2BC.%26aulast%3DGarcia%26aufirst%3DA.%2BD.%26aulast%3DBach%26aufirst%3DA.%26atitle%3DA%2520comparative%2520assessment%2520study%2520of%2520known%2520small-molecule%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520inhibitors%253A%2520chemical%2520synthesis%252C%2520binding%2520properties%252C%2520and%2520cellular%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8028%26epage%3D8052%26doi%3D10.1021%2Facs.jmedchem.9b00723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, W.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span> <span> </span><span class="NLM_article-title">A natural product-like inhibitor of NEDD8-activating enzyme</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2511</span>– <span class="NLM_lpage">2513</span>, <span class="refDoi"> DOI: 10.1039/c0cc04927a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1039%2Fc0cc04927a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=21240405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitVCmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=2511-2513&author=C.-H.+Leungauthor=D.+S.-H.+Chanauthor=H.+Yangauthor=R.+Abagyanauthor=S.+M.-Y.+Leeauthor=G.-Y.+Zhuauthor=W.-F.+Fongauthor=D.-L.+Ma&title=A+natural+product-like+inhibitor+of+NEDD8-activating+enzyme&doi=10.1039%2Fc0cc04927a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A natural product-like inhibitor of NEDD8-activating enzyme</span></div><div class="casAuthors">Leung, Chung-Hang; Chan, Daniel Shiu-Hin; Yang, Hui; Abagyan, Ruben; Lee, Simon Ming-Yuen; Zhu, Guo-Yuan; Fong, Wang-Fun; Ma, Dik-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2511-2513</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The natural product-like 6,6''-biapigenin has been identified as only the second inhibitor of NEDD8-activating enzyme using virtual screening.  This compd. was active in enzyme and cell-based assays, with potency in the micromolar range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIgh-oaWCxuLVg90H21EOLACvtfcHk0ljckEKdzcoOAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitVCmt7s%253D&md5=8783a238deaf9306f1bdaca88ab0575e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fc0cc04927a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0cc04927a%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DC.-H.%26aulast%3DChan%26aufirst%3DD.%2BS.-H.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DS.%2BM.-Y.%26aulast%3DZhu%26aufirst%3DG.-Y.%26aulast%3DFong%26aufirst%3DW.-F.%26aulast%3DMa%26aufirst%3DD.-L.%26atitle%3DA%2520natural%2520product-like%2520inhibitor%2520of%2520NEDD8-activating%2520enzyme%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D2511%26epage%3D2513%26doi%3D10.1039%2Fc0cc04927a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span> <span> </span><span class="NLM_article-title">Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e1293</span> <span class="refDoi"> DOI: 10.1038/cddis.2014.250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1038%2Fcddis.2014.250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=24922077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslCgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=L.-J.+Liuauthor=K.-H.+Leungauthor=D.+S.-H.+Chanauthor=Y.-T.+Wangauthor=D.-L.+Maauthor=C.-H.+Leung&title=Identification+of+a+natural+product-like+STAT3+dimerization+inhibitor+by+structure-based+virtual+screening&doi=10.1038%2Fcddis.2014.250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening</span></div><div class="casAuthors">Liu, L-J.; Leung, K-H.; Chan, D. S-H.; Wang, Y-T.; Ma, D-L.; Leung, C-H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1293</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">STAT3 regulates a variety of genes involved with cell proliferation, differentiation, apoptosis, angiogenesis, metastasis, inflammation, and immunity.  The purpose of this study was to apply mol. docking techniques to identify STAT3 inhibitors from a database of over 90 000 natural product and natural product-like compds.  The virtual screening campaign furnished 14 hit compds., from which compd. 1 emerged as a top candidate.  Compd. 1 inhibited STAT3 DNA-binding activity in vitro and attenuated STAT3-directed transcription in cellulo with selectivity over STAT1 and with comparable potency to the well-known STAT3 inhibitor S3I-201.  Furthermore, compd. 1 inhibited STAT3 dimerization and decreased STAT3 phosphorylation in cells without affecting STAT1 dimerization and phosphorylation.  Compd. 1 also exhibited selective anti-proliferative activity against cancer cells over normal cells in vitro.  Mol. docking anal. suggested that compd. 1 might putatively function as an inhibitor of STAT3 dimerization by binding to the SH2 domain.  This study also validates the use of in silico techniques to identify inhibitors of protein-protein interactions, which are typically considered difficult to target with small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFD1r2695sVrVg90H21EOLACvtfcHk0ljckEKdzcoOAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslCgs7w%253D&md5=aaf182350853d7020285bd47ea4126e4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.250%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.-J.%26aulast%3DLeung%26aufirst%3DK.-H.%26aulast%3DChan%26aufirst%3DD.%2BS.-H.%26aulast%3DWang%26aufirst%3DY.-T.%26aulast%3DMa%26aufirst%3DD.-L.%26aulast%3DLeung%26aufirst%3DC.-H.%26atitle%3DIdentification%2520of%2520a%2520natural%2520product-like%2520STAT3%2520dimerization%2520inhibitor%2520by%2520structure-based%2520virtual%2520screening%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26doi%3D10.1038%2Fcddis.2014.250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chacko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bose, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapenna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattanayak, S. P.</span></span> <span> </span><span class="NLM_article-title">Structure based multitargeted molecular docking analysis of selected furanocoumarins against breast cancer</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">15743</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-52162-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1038%2Fs41598-019-52162-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31673107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A280%3ADC%252BB3Mjjsl2quw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=15743&author=R.+Acharyaauthor=S.+Chackoauthor=P.+Boseauthor=A.+Lapennaauthor=S.+P.+Pattanayak&title=Structure+based+multitargeted+molecular+docking+analysis+of+selected+furanocoumarins+against+breast+cancer&doi=10.1038%2Fs41598-019-52162-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Multitargeted Molecular Docking Analysis of Selected Furanocoumarins against Breast Cancer</span></div><div class="casAuthors">Acharya Reetuparna; Bose Pritha; Pattanayak Shakti Prasad; Chacko Shinu; Chacko Shinu; Lapenna Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15743</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Breast cancer is one of the biggest global dilemmas and its current therapy is to target the hormone receptors by the use of partial agonists/antagonists.  Potent drugs for breast cancer treatment are Tamoxifen, Trastuzumab, Paclitaxel, etc. which show adverse effects and resistance in patients.  The aim of the study has been on certain phytochemicals which has potent actions on ERα, PR, EGFR and mTOR inhibition.  The current study is performed by the use of molecular docking as protein-ligand interactions play a vital role in drug design.  The 3D structures of ERα, PR, EGFR and mTOR were obtained from the protein data bank and docked with 23 3D PubChem structures of furanocoumarin compounds using FlexX.  Drug-likeness property was checked by applying the Lipinski's rule of five on the furanocoumarins to evaluate anti-breast cancer activity.  Antagonist and inhibition assay of ERα, EGFR and mTOR respectively has been performed using appropriate in-vitro techniques.  The results confirm that Xanthotoxol has the best docking score for breast cancer followed by Bergapten, Angelicin, Psoralen and Isoimperatorin.  Further, the in-vitro results also validate the molecular docking analysis.  This study suggests that the selected furanocoumarins can be further investigated and evaluated for breast cancer treatment and management strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlQaJ6D1nt2DW1zwg2yUK5fW6udTcc2eaBix2nrrEoOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3Mjjsl2quw%253D%253D&md5=d7e618f28c3961179af885330777bc97</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-52162-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-52162-0%26sid%3Dliteratum%253Aachs%26aulast%3DAcharya%26aufirst%3DR.%26aulast%3DChacko%26aufirst%3DS.%26aulast%3DBose%26aufirst%3DP.%26aulast%3DLapenna%26aufirst%3DA.%26aulast%3DPattanayak%26aufirst%3DS.%2BP.%26atitle%3DStructure%2520based%2520multitargeted%2520molecular%2520docking%2520analysis%2520of%2520selected%2520furanocoumarins%2520against%2520breast%2520cancer%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D15743%26doi%3D10.1038%2Fs41598-019-52162-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dos Santos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliva, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andricopulo, A.</span></span> <span> </span><span class="NLM_article-title">Molecular docking and structure-based drug design strategies</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">13384</span>– <span class="NLM_lpage">13421</span>, <span class="refDoi"> DOI: 10.3390/molecules200713384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.3390%2Fmolecules200713384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26205061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1OjtLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=13384-13421&author=L.+Ferreiraauthor=R.+Dos+Santosauthor=G.+Olivaauthor=A.+Andricopulo&title=Molecular+docking+and+structure-based+drug+design+strategies&doi=10.3390%2Fmolecules200713384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular docking and structure-based drug design strategies</span></div><div class="casAuthors">Ferreira, Leonardo G.; dos Santos, Ricardo N.; Oliva, Glaucius; Andricopulo, Adriano D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">13384-13421</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Pharmaceutical research has successfully incorporated a wealth of mol. modeling methods, within a variety of drug discovery programs, to study complex biol. and chem. systems.  The integration of computational and exptl. strategies has been of great value in the identification and development of novel promising compds.  Broadly used in modern drug design, mol. docking methods explore the ligand conformations adopted within the binding sites of macromol. targets.  This approach also ests. the ligand-receptor binding free energy by evaluating crit. phenomena involved in the intermol. recognition process.  Today, as a variety of docking algorithms are available, an understanding of the advantages and limitations of each method is of fundamental importance in the development of effective strategies and the generation of relevant results.  The purpose of this review is to examine current mol. docking strategies used in drug discovery and medicinal chem., exploring the advances in the field and the role played by the integration of structure- and ligand-based methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf5La9X0Wng7Vg90H21EOLACvtfcHk0ljTrGPooSS7jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1OjtLzJ&md5=b5f70b90e45098d0f0252a2926f9671e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3390%2Fmolecules200713384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules200713384%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DL.%26aulast%3DDos%2BSantos%26aufirst%3DR.%26aulast%3DOliva%26aufirst%3DG.%26aulast%3DAndricopulo%26aufirst%3DA.%26atitle%3DMolecular%2520docking%2520and%2520structure-based%2520drug%2520design%2520strategies%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26spage%3D13384%26epage%3D13421%26doi%3D10.3390%2Fmolecules200713384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1002/med.21257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1002%2Fmed.21257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=22549716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=687-726&author=S.+Mageshauthor=Y.+Chenauthor=L.+Hu&title=Small+molecule+modulators+of+Keap1-Nrf2-ARE+pathway+as+potential+preventive+and+therapeutic+agents&doi=10.1002%2Fmed.21257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents</span></div><div class="casAuthors">Magesh, Sadagopan; Chen, Yu; Hu, Longqin</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">687-726</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Kelch-like ECH-assocd. protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response elements (ARE) pathway represents one of the most important cellular defense mechanisms against oxidative stress and xenobiotic damage.  Activation of Nrf2 signaling induces the transcriptional regulation of ARE-dependent expression of various detoxifying and antioxidant defense enzymes and proteins.  Keap1-Nrf2-ARE signaling has become an attractive target for the prevention and treatment of oxidative stress-related diseases and conditions including cancer, neurodegenerative, cardiovascular, metabolic, and inflammatory diseases.  Over the last few decades, numerous Nrf2 inducers have been developed and some of them are currently undergoing clin. trials.  Recently, overactivation of Nrf2 has been implicated in cancer progression as well as in drug resistance to cancer chemotherapy.  Thus, Nrf2 inhibitors could potentially be used to improve the effectiveness of cancer therapy.  Herein, we review the signaling mechanism of Keap1-Nrf2-ARE pathway, its disease relevance, and currently known classes of small mol. modulators.  We also discuss several aspects of Keap1-Nrf2 interaction, Nrf2-based peptide inhibitor design, and the screening assays currently used for the discovery of direct inhibitors of Keap1-Nrf2 interaction. © 2012 Wiley Periodicals, Inc.  Med Res Rev., 32, No. 4, 687-726, 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhLmdkuTSh7Vg90H21EOLACvtfcHk0ljTrGPooSS7jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D&md5=2104d731cb251e0d9b6d2ad73a735175</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fmed.21257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21257%26sid%3Dliteratum%253Aachs%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DSmall%2520molecule%2520modulators%2520of%2520Keap1-Nrf2-ARE%2520pathway%2520as%2520potential%2520preventive%2520and%2520therapeutic%2520agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D687%26epage%3D726%26doi%3D10.1002%2Fmed.21257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canning, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorrell, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, A. N.</span></span> <span> </span><span class="NLM_article-title">Structural basis of Keap1 interactions with Nrf2</span>. <i>Free Radic. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.05.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.freeradbiomed.2015.05.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26057936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=101-107&author=P.+Canningauthor=F.+J.+Sorrellauthor=A.+N.+Bullock&title=Structural+basis+of+Keap1+interactions+with+Nrf2&doi=10.1016%2Fj.freeradbiomed.2015.05.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of KEAP1 interactions with Nrf2</span></div><div class="casAuthors">Canning, Peter; Sorrell, Fiona J.; Bullock, Alex N.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">101-107</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  KEAP1 is a highly redox-sensitive member of the BTB-Kelch family that assembles with the Cul3 protein to form a Cullin-RING E3 ligase complex for the degrdn. of Nrf2.  Oxidative stress disables KEAP1, allowing Nrf2 protein levels to accumulate for the transactivation of crit. stress response genes.  Consequently, the KEAP1-Nrf2 system is extensively pursued for the development of protein-protein interaction inhibitors that will stabilize Nrf2 for therapeutic effect in conditions of neurodegeneration, inflammation, and cancer.  Here we review current progress toward the structure detn. of KEAP1 and its protein complexes with Cul3, Nrf2 substrate, and small-mol. antagonists.  Together the available structures establish a rational three-dimensional model to explain the two-site binding of Nrf2 as well as its efficient ubiquitination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwBBMS70b7hbVg90H21EOLACvtfcHk0ljTrGPooSS7jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7rK&md5=12b7b36caa16cf3cd3d95d84162eed80</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DCanning%26aufirst%3DP.%26aulast%3DSorrell%26aufirst%3DF.%2BJ.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26atitle%3DStructural%2520basis%2520of%2520Keap1%2520interactions%2520with%2520Nrf2%26jtitle%3DFree%2520Radic.%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D101%26epage%3D107%26doi%3D10.1016%2Fj.freeradbiomed.2015.05.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span> <span> </span><span class="NLM_article-title">Investigation of the intermolecular recognition mechanism between the E3 ubiquitin ligase Keap1 and substrate based on multiple substrates analysis</span>. <i>J. Comput. Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1233</span>– <span class="NLM_lpage">1245</span>, <span class="refDoi"> DOI: 10.1007/s10822-014-9799-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1007%2Fs10822-014-9799-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=25301376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsleku7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1233-1245&author=Z.-Y.+Jiangauthor=L.-L.+Xuauthor=M.-C.+Luauthor=Y.+Panauthor=H.-Z.+Huangauthor=X.-J.+Zhangauthor=H.-P.+Sunauthor=Q.-D.+You&title=Investigation+of+the+intermolecular+recognition+mechanism+between+the+E3+ubiquitin+ligase+Keap1+and+substrate+based+on+multiple+substrates+analysis&doi=10.1007%2Fs10822-014-9799-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the intermolecular recognition mechanism between the E3 ubiquitin ligase Keap1 and substrate based on multiple substrates analysis</span></div><div class="casAuthors">Jiang, Zheng-Yu; Xu, Li-Li; Lu, Meng-Chen; Pan, Yang; Huang, Hao-Ze; Zhang, Xiao-Jin; Sun, Hao-Peng; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1233-1245</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">E3 ubiquitin ligases are attractive drug targets due to their specificity to the ubiquitin machinery.  However, the development of E3 ligase inhibitors has proven challenging for the fact that they must disrupt protein-protein interactions (PPIs).  The E3 ligase involved in interactome provide new hope for the discovery of the E3 ligase inhibitors.  These currently known natural binding partners of the E3 ligase can benefit the discovery of other unknown substrates and also the E3 ligase inhibitors.  Herein, we present a novel strategy that using multiple substrates to elucidate the mol. recognition mechanism of E3 ubiquitin ligase.  Mol. dynamics simulation, mol. mechanics-generalized born surface area (MM-GBSA) binding energy calcn. and energy decompn. scheme were incorporated to evaluate the quant. contributions of sub-pocket and per-residue to binding.  In this case, Kelch-like ECH-assocd. protein-1 (Keap1), a substrate adaptor component of the Cullin-RING ubiquitin ligases complex, is applied for the investigation of how it recognize its substrates, esp. Nrf2, a master regulator of the antioxidant response.  By analyzing multiple substrates binding determinants, we found that both the polar sub-pockets (P1 and P2) and the nonpolar sub-pockets (P4 and P5) of Keap1 can make remarkable contributions to intermol. interactions.  This finding stresses the requirement for substrates to interact with the polar and nonpolar sub-pockets simultaneously.  The results discussed in this paper not only show the binding determinants of the Keap1 substrates but also provide valuable implications for both Keap1 substrate discovery and PPI inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppReS77bpky7Vg90H21EOLACvtfcHk0ljlLrTb_1XGGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsleku7zI&md5=359ff305f89c6a69cca48f60d019c765</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs10822-014-9799-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-014-9799-y%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.-Y.%26aulast%3DXu%26aufirst%3DL.-L.%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DH.-Z.%26aulast%3DZhang%26aufirst%3DX.-J.%26aulast%3DSun%26aufirst%3DH.-P.%26aulast%3DYou%26aufirst%3DQ.-D.%26atitle%3DInvestigation%2520of%2520the%2520intermolecular%2520recognition%2520mechanism%2520between%2520the%2520E3%2520ubiquitin%2520ligase%2520Keap1%2520and%2520substrate%2520based%2520on%2520multiple%2520substrates%2520analysis%26jtitle%3DJ.%2520Comput.%2520Aided%2520Mol.%2520Des.%26date%3D2014%26volume%3D28%26spage%3D1233%26epage%3D1245%26doi%3D10.1007%2Fs10822-014-9799-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Bakry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laoruchupong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction</span>. <i>Free Radic. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.10.486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.freeradbiomed.2011.10.486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=22107959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsVyhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=444-451&author=R.+Hancockauthor=H.+C.+Bertrandauthor=T.+Tsujitaauthor=S.+Nazauthor=A.+El-Bakryauthor=J.+Laoruchupongauthor=J.+D.+Hayesauthor=G.+Wells&title=Peptide+inhibitors+of+the+Keap1-Nrf2+protein-protein+interaction&doi=10.1016%2Fj.freeradbiomed.2011.10.486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction</span></div><div class="casAuthors">Hancock, Rowena; Bertrand, Helene C.; Tsujita, Tadayuki; Naz, Shama; El-Bakry, Ayman; Laoruchupong, Jitnueng; Hayes, John D.; Wells, Geoff</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">444-451</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Disruption of the interaction between the ubiquitination facilitator protein Keap1 and the cap'n'collar basic-region leucine-zipper transcription factor Nrf2 is a potential strategy to enhance expression of antioxidant and free radical detoxification gene products regulated by Nrf2.  Agents that disrupt this protein-protein interaction may be useful pharmacol. probes and future cancer-chemopreventive agents.  We describe the structure-activity relationships for a series of peptides based upon regions of the Nrf2 Neh2 domain, of varying length and sequence, that interact with the Keap1 Kelch domain and disrupt the interaction with Nrf2.  We have also investigated sequestosome-1 (p62) and prothymosin-α sequences that have been reported to interact with Keap1.  To achieve this we have developed a high-throughput fluorescence polarization (FP) assay to screen inhibitors.  In addn. to screening synthetic peptides, we have used a phage display library approach to identify putative peptide ligands with non-native sequence motifs.  Candidate peptides from the phage display library screening protocol were evaluated in the FP assay to quantify their binding activity.  Hybrid peptides based upon the Nrf2 "ETGE" motif and the sequestosome-1 "Keap1-interaction region" have superior binding activity compared to either native peptide alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrdLfQUd3TrVg90H21EOLACvtfcHk0ljlLrTb_1XGGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsVyhtA%253D%253D&md5=e48014219fb0738c2af6cb8301d73968</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.10.486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.10.486%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DR.%26aulast%3DBertrand%26aufirst%3DH.%2BC.%26aulast%3DTsujita%26aufirst%3DT.%26aulast%3DNaz%26aufirst%3DS.%26aulast%3DEl-Bakry%26aufirst%3DA.%26aulast%3DLaoruchupong%26aufirst%3DJ.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DWells%26aufirst%3DG.%26atitle%3DPeptide%2520inhibitors%2520of%2520the%2520Keap1-Nrf2%2520protein-protein%2520interaction%26jtitle%3DFree%2520Radic.%2520Biol.%2520Med.%26date%3D2012%26volume%3D52%26spage%3D444%26epage%3D451%26doi%3D10.1016%2Fj.freeradbiomed.2011.10.486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaap, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activity</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3553</span>– <span class="NLM_lpage">3557</span>, <span class="refDoi"> DOI: 10.1039/c3ob40249e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1039%2Fc3ob40249e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=23615671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlaitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=3553-3557&author=R.+Hancockauthor=M.+Schaapauthor=H.+Pfisterauthor=G.+Wells&title=Peptide+inhibitors+of+the+Keap1-Nrf2+protein-protein+interaction+with+improved+binding+and+cellular+activity&doi=10.1039%2Fc3ob40249e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activity</span></div><div class="casAuthors">Hancock, Rowena; Schaap, Marjolein; Pfister, Helene; Wells, Geoff</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3553-3557</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Inhibitors of the Keap1-Nrf2 protein-protein interaction (PPI) have been proposed as potential anti-inflammatory and cancer chemopreventive agents.  Such compds. have the potential to increase the intracellular concns. of Nrf2 in a reversible manner and consequently increase the expression of a battery of gene products with antioxidant response elements (AREs) in their promoter region.  In this manuscript we describe the development of peptide inhibitors with modified C- and N-termini and reduced overall charge.  The activity of the compds. in inhibiting the PPI and in cellular assays of Nrf2 function are described.  Compd. 10 has potent activity (IC50 = 22 nM) in a cell-free fluorescence polarisation assay and induced the expression of Nrf2 dependent gene products in cells, suggesting that it has potential as a lead mol. for the development of peptidomimetic inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX5B_aGg-CqrVg90H21EOLACvtfcHk0ljlLrTb_1XGGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlaitbk%253D&md5=e372946c8f18dd21b91ade80212bcdec</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2Fc3ob40249e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ob40249e%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DR.%26aulast%3DSchaap%26aufirst%3DM.%26aulast%3DPfister%26aufirst%3DH.%26aulast%3DWells%26aufirst%3DG.%26atitle%3DPeptide%2520inhibitors%2520of%2520the%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520with%2520improved%2520binding%2520and%2520cellular%2520activity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D3553%26epage%3D3557%26doi%3D10.1039%2Fc3ob40249e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">Binding thermodynamics and kinetics guided optimization of potent Keap1–Nrf2 peptide inhibitors</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">85983</span>– <span class="NLM_lpage">85987</span>, <span class="refDoi"> DOI: 10.1039/c5ra16262a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1039%2FC5RA16262A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKku7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=85983-85987&author=M.-C.+Luauthor=Z.-Y.+Chenauthor=Y.-L.+Wangauthor=Y.-L.+Jiangauthor=Z.-W.+Yuanauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=Binding+thermodynamics+and+kinetics+guided+optimization+of+potent+Keap1%E2%80%93Nrf2+peptide+inhibitors&doi=10.1039%2Fc5ra16262a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Binding thermodynamics and kinetics guided optimization of potent Keap1-Nrf2 peptide inhibitors</span></div><div class="casAuthors">Lu, Meng-Chen; Chen, Zhi-Yun; Wang, Ya-Lou; Jiang, Yong-Lin; Yuan, Zhen-Wei; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">105</span>),
    <span class="NLM_cas:pages">85983-85987</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Activation of Nrf2 by directly inhibiting the Keap1-Nrf2 Protein-Protein Interaction (PPI) has gained research interest with regard to developing novel agents for treating inflammatory related diseases.  In this study, computational methods were used to guide the rational activity improvement of peptide Keap1-Nrf2 inhibitors and to explore the Keap1 binding cavity.  Terminal hydrophobic residues and Tyr residue replacements were introduced into the novel peptides.  The exptl. values of these peptides further confirmed the potential binding sites explored by the MD simulation.  Finally, the most promising, peptide 5 with an intracyclic conformation showed a Kd value of 2.8 nM when binding to Keap1 and an IC50 value of 9.4 nM in the Keap1-Nrf2 PPI fluorescence polarization assay.  It proved that the active conformation locking strategy is quite useful in Keap1-Nrf2 PPI inhibitor design.  It also provided a useful probe to investigate the Keap1-Nrf2 PPI system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPU2Ia8EiYKbVg90H21EOLACvtfcHk0ljlLrTb_1XGGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKku7vI&md5=08fe1cca6a9360f35978faa1b3f000af</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1039%2FC5RA16262A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA16262A%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DChen%26aufirst%3DZ.-Y.%26aulast%3DWang%26aufirst%3DY.-L.%26aulast%3DJiang%26aufirst%3DY.-L.%26aulast%3DYuan%26aufirst%3DZ.-W.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DBinding%2520thermodynamics%2520and%2520kinetics%2520guided%2520optimization%2520of%2520potent%2520Keap1%25E2%2580%2593Nrf2%2520peptide%2520inhibitors%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D85983%26epage%3D85987%26doi%3D10.1039%2Fc5ra16262a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sogabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadotani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, J.-i.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Kelch-like ECH-associated protein 1-inhibitory tetrapeptide and its structural characterization</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>486</i></span>,  <span class="NLM_fpage">620</span>– <span class="NLM_lpage">625</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2017.03.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.bbrc.2017.03.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=28315327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltVWqtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2017&pages=620-625&author=S.+Sogabeauthor=K.+Sakamotoauthor=Y.+Kamadaauthor=A.+Kadotaniauthor=Y.+Fukudaauthor=J.-i.+Sakamoto&title=Discovery+of+a+Kelch-like+ECH-associated+protein+1-inhibitory+tetrapeptide+and+its+structural+characterization&doi=10.1016%2Fj.bbrc.2017.03.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Kelch-like ECH-associated protein 1-inhibitory tetrapeptide and its structural characterization</span></div><div class="casAuthors">Sogabe, Satoshi; Sakamoto, Kotaro; Kamada, Yusuke; Kadotani, Akito; Fukuda, Yasunori; Sakamoto, Jun-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">486</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">620-625</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Keap1 constitutively binds to the transcription factor Nrf2 to promote its degrdn., resulting in neg. modulation of genes involved in cellular protection against oxidative stress.  Keap1 is increasingly recognized as an attractive target for treating diseases involving oxidative stress, including cancer, atherosclerosis, diabetes, arthritis, and neurodegeneration.  We used phage-display peptide screening to identify a tetrapeptide showing moderate binding affinity, which inhibits the interaction between Nrf2 and Keap1.  The tetrapeptide does not include an ETGE motif, which is a commonly found consensus sequence in known peptidic inhibitors.  In addn. to affinity parameters, IC50, KD, and thermodn. parameters, the crystal structure of the complex was detd. to elucidate the binding conformation.  The binding interactions resemble those of known small-mol. inhibitors as opposed to those of substrates and peptidic inhibitors.  Although the tetrapeptide's affinity is not very high, our results may help facilitate the designing of small-mol. inhibitors during lead generation in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRwfG6x0hNurVg90H21EOLACvtfcHk0ljjwXBRDvk7Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltVWqtbo%253D&md5=977e96b181570d788deaa0ee3b3f8652</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2017.03.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2017.03.038%26sid%3Dliteratum%253Aachs%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DKamada%26aufirst%3DY.%26aulast%3DKadotani%26aufirst%3DA.%26aulast%3DFukuda%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DJ.-i.%26atitle%3DDiscovery%2520of%2520a%2520Kelch-like%2520ECH-associated%2520protein%25201-inhibitory%2520tetrapeptide%2520and%2520its%2520structural%2520characterization%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D486%26spage%3D620%26epage%3D625%26doi%3D10.1016%2Fj.bbrc.2017.03.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of a head-to-tail cyclic peptide as the Keap1-Nrf2 protein-protein interaction inhibitor with high cell potency</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">1578</span>– <span class="NLM_lpage">1589</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.10.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.ejmech.2017.10.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=29117896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyrt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=1578-1589&author=M.-C.+Luauthor=Q.+Jiaoauthor=T.+Liuauthor=S.-J.+Tanauthor=H.-S.+Zhouauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=Discovery+of+a+head-to-tail+cyclic+peptide+as+the+Keap1-Nrf2+protein-protein+interaction+inhibitor+with+high+cell+potency&doi=10.1016%2Fj.ejmech.2017.10.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a head-to-tail cyclic peptide as the Keap1-Nrf2 protein-protein interaction inhibitor with high cell potency</span></div><div class="casAuthors">Lu, Meng-Chen; Jiao, Qiong; Liu, Tian; Tan, Shi-Jie; Zhou, Hai-Shan; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1578-1589</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Directly disrupting Keap1-Nrf2 protein-protein interaction (PPI) has emerged as a novel way to activate Nrf2.  Peptide Keap1-Nrf2 PPI inhibitors have been reported with high Keap1 binding affinity.  However, these peptide inhibitors show weak activity in cells.  In this study, the head-to-tail cyclic strategy was applied in the development of peptide inhibitors.  The privileged residue sequence with minimal acidic residues was used as the template for the cyclic peptide, and the appropriate conjugation method was designed based on the peptide-Keap1 binding mode.  The glycine was introduced as the linker to connect both sides, which can avoid the terminal charge, enhance the peptide stability and constrain the binding conformation simultaneously.  The obtained novel cyclic peptide 3 showed high binding affinity with Keap1 and possessed high potency in Nrf2 activation at cellular level.  We also showed that peptide 3 exhibited effective anti-inflammatory effects in mouse RAW 264.7 cells by activating the Nrf2-regulated defense system and enhancing the antioxidant capacity.  This study proved that the head-to-tail cyclic strategy is quite useful in improving the cell potency of peptide Keap1-Nrf2 inhibitors and provided a possible way to develop drug-like peptides as therapeutic Nrf2 activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSQuf13RdntbVg90H21EOLACvtfcHk0ljjwXBRDvk7Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyrt73J&md5=ce1906541b5d2ece410b891d3ffe1084</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.10.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.10.052%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DJiao%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DS.-J.%26aulast%3DZhou%26aufirst%3DH.-S.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DDiscovery%2520of%2520a%2520head-to-tail%2520cyclic%2520peptide%2520as%2520the%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520inhibitor%2520with%2520high%2520cell%2520potency%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D143%26spage%3D1578%26epage%3D1589%26doi%3D10.1016%2Fj.ejmech.2017.10.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Georgakopoulos, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talapatra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatliff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozielski, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Modified peptide inhibitors of the Keap1-Nrf2 protein-protein interaction incorporating unnatural amino acids</span>. <i>Chembiochem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1810</span>– <span class="NLM_lpage">1816</span>, <span class="refDoi"> DOI: 10.1002/cbic.201800170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1002%2Fcbic.201800170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=29927029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlaqs7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=1810-1816&author=N.+D.+Georgakopoulosauthor=S.+K.+Talapatraauthor=J.+Gatliffauthor=F.+Kozielskiauthor=G.+Wells&title=Modified+peptide+inhibitors+of+the+Keap1-Nrf2+protein-protein+interaction+incorporating+unnatural+amino+acids&doi=10.1002%2Fcbic.201800170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Modified Peptide Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction Incorporating Unnatural Amino Acids</span></div><div class="casAuthors">Georgakopoulos, Nikolaos D.; Talapatra, Sandeep K.; Gatliff, Jemma; Kozielski, Frank; Wells, Geoff</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1810-1816</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Noncovalent inhibitors of the Keap1-Nrf2 protein-protein interaction (PPI) have therapeutic potential in a range of disease states including neurodegenerative diseases (Parkinson's and Alzheimer's diseases), chronic obstructive pulmonary disease and various inflammatory conditions.  By stalling Keap1-mediated ubiquitination of Nrf2, such compds. can enhance Nrf2 transcriptional activity and activate the expression of a range of genes with antioxidant response elements in their promoter regions.  Keap1 inhibitors based on peptide and small-mol. templates have been identified.  In this paper we develop the structure-activity relationships of the peptide series and identify a group of ligands incorporating unnatural amino acids that demonstrate improved binding affinity in fluorescence polarisation, differential scanning fluorimetry and isothermal titrn. calorimetry assays.  These modified peptides have the potential for further development into peptidomimetic chem. probes to explore the role of Nrf2 in disease and as potential lead structures for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRqJ1SUlY53LVg90H21EOLACvtfcHk0ljjwXBRDvk7Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlaqs7bO&md5=781038e48434448c55348c0d10eae2f6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201800170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201800170%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgakopoulos%26aufirst%3DN.%2BD.%26aulast%3DTalapatra%26aufirst%3DS.%2BK.%26aulast%3DGatliff%26aufirst%3DJ.%26aulast%3DKozielski%26aufirst%3DF.%26aulast%3DWells%26aufirst%3DG.%26atitle%3DModified%2520peptide%2520inhibitors%2520of%2520the%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520incorporating%2520unnatural%2520amino%2520acids%26jtitle%3DChembiochem%26date%3D2018%26volume%3D19%26spage%3D1810%26epage%3D1816%26doi%3D10.1002%2Fcbic.201800170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span> <span> </span><span class="NLM_article-title">Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1080/13543776.2020.1715365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1080%2F13543776.2020.1715365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31922884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlCnt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=209-225&author=H.+Zhouauthor=Y.+Wangauthor=Q.+Youauthor=Z.+Jiang&title=Recent+progress+in+the+development+of+small+molecule+Nrf2+activators%3A+a+patent+review+%282017-present%29&doi=10.1080%2F13543776.2020.1715365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present)</span></div><div class="casAuthors">Zhou, Haishan; Wang, Yan; You, Qidong; Jiang, Zhengyu</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-225</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Transcription factor Nrf2 is first line of defense against plethora of environmental or endogenous deviations in redox metab., proteostasis, inflammation, etc.  Therefore, pharmacol. activation of Nrf2 is potential therapeutic approach for several diseases related to oxidative stress and inflammation, such as cancer, cardiovascular, and neurodegenerative diseases.  Authors first describe biol. function of Nrf2 and mol. regulatory mechanism of Keap1-Nrf2-ARE ((Kelch-like ECH-Assocg. protein 1)-Nrf2-(antioxidant response element)).  Then, they review recent progress of covalent activators and non-covalent Keap1-Nrf2 protein-protein interaction inhibitors from patents and publications in 2017-present, consisting of new chem. mols., structure optimization of reported activators and progress in preclin. or clin. trials.  Despite significant achievements in development of Nrf2 activators, selectivity is primary consideration.  Due to reacting with redox-sensitive cysteines in proteins except for Keap1, electrophilic activators often exhibit off-target effects.  For Keap1-Nrf2 PPI inhibitors, how to enhance in vivo efficacy and/or penetrate blood-brain barrier to reach central nervous system is also challenging.  Fragment-based drug discovery, carboxylic acid bioisosteric replacement and prodrug approach might be used to circumvent this challenge.  Moreover, possibility of cancer risk caused by Nrf2 activation needs to be considered carefully.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF0YqRGP3WP7Vg90H21EOLACvtfcHk0lhqgOR60Jy5QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlCnt7c%253D&md5=7441d04e642844ddca28cb842cd1f61e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1080%2F13543776.2020.1715365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2020.1715365%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DZ.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520small%2520molecule%2520Nrf2%2520activators%253A%2520a%2520patent%2520review%2520%25282017-present%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2020%26volume%3D30%26spage%3D209%26epage%3D225%26doi%3D10.1080%2F13543776.2020.1715365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hui, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlstetter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilken, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terjung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nassar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duh, E. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the Keap1-Nrf2 protein-protein interaction protects retinal cells and ameliorates retinal ischemia-reperfusion injury</span>. <i>Free Radic. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2019.10.414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.freeradbiomed.2019.10.414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31669760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFehtL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2020&pages=181-188&author=Q.+Huiauthor=M.+Karlstetterauthor=Z.+Xuauthor=J.+Yangauthor=L.+Zhouauthor=H.+M.+Eilkenauthor=C.+Terjungauthor=H.+Choauthor=J.+Gongauthor=M.+J.+Laiauthor=K.+Nassarauthor=E.+J.+Duh&title=Inhibition+of+the+Keap1-Nrf2+protein-protein+interaction+protects+retinal+cells+and+ameliorates+retinal+ischemia-reperfusion+injury&doi=10.1016%2Fj.freeradbiomed.2019.10.414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Keap1-Nrf2 protein-protein interaction protects retinal cells and ameliorates retinal ischemia-reperfusion injury</span></div><div class="casAuthors">Hui, Qiaoyan; Karlstetter, Marcus; Xu, Zhenhua; Yang, Jing; Zhou, Lingli; Eilken, Hanna M.; Terjung, Carsten; Cho, Hongkwan; Gong, Junsong; Lai, Michael J.; Nassar, Khaled; Duh, Elia J.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">181-188</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Nrf2-Keap1 pathway regulates transcription of a wide array of antioxidant and cytoprotective genes and offers crit. protection against oxidative stress.  This pathway has demonstrated benefit for a variety of retinal conditions.  Retinal ischemia plays a pivotal role in many vision threatening diseases.  Retinal vascular endothelial cells are an important participant in ischemic injury.  In this setting, Nrf2 provides a protective pathway via amelioration of oxidative stress and inflammation.  In this study, we investigated a potent small mol. inhibitor of the Nrf2-Keap1 protein-protein interaction (PPI), CPUY192018, for its therapeutic potential in retinal cells and retinal ischemia-reperfusion injury.  In human retinal endothelial cells (HREC), treatment with CPUY192018 increased Nrf2 protein levels and nuclear translocation, stimulated Nrf2-ARE-induced transcriptional capacity, and induced Nrf2 target gene expression.  Furthermore, CPUY192018 protected HREC against oxidative stress and inflammatory activation.  CPUY192018 also activated Nrf2 and suppressed inflammatory response in macrophages.  In the retinal ischemia-reperfusion (I/R) model, administration of CPUY192018 induced Nrf2 target gene activation in the retina.  Both systemic and topical treatment with CPUY192018 rescued visual function after ischemia-reperfusion injury.  Taken together, these findings indicate that small mol. Keap1-Nrf2 PPI inhibitors can activate the Nrf2 pathway in the retina and provide protection against retinal ischemic and inflammatory injury, suggesting Keap1-Nrf2 PPI inhibition in the treatment of retinal conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3eILAsrfhwbVg90H21EOLACvtfcHk0lhqgOR60Jy5QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFehtL7K&md5=2ac3e94df8c81b4219e9c5b62480bfa2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2019.10.414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2019.10.414%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DQ.%26aulast%3DKarlstetter%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DEilken%26aufirst%3DH.%2BM.%26aulast%3DTerjung%26aufirst%3DC.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DM.%2BJ.%26aulast%3DNassar%26aufirst%3DK.%26aulast%3DDuh%26aufirst%3DE.%2BJ.%26atitle%3DInhibition%2520of%2520the%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520protects%2520retinal%2520cells%2520and%2520ameliorates%2520retinal%2520ischemia-reperfusion%2520injury%26jtitle%3DFree%2520Radic.%2520Biol.%2520Med.%26date%3D2020%26volume%3D146%26spage%3D181%26epage%3D188%26doi%3D10.1016%2Fj.freeradbiomed.2019.10.414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, M.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-kappaB activation</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">101266</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2019.101266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.redox.2019.101266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31279986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlahtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=101266&author=M.-C.+Luauthor=J.+Zhaoauthor=Y.-T.+Liuauthor=T.+Liuauthor=M.-M.+Taoauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=CPUY192018%2C+a+potent+inhibitor+of+the+Keap1-Nrf2+protein-protein+interaction%2C+alleviates+renal+inflammation+in+mice+by+restricting+oxidative+stress+and+NF-kappaB+activation&doi=10.1016%2Fj.redox.2019.101266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-κB activation</span></div><div class="casAuthors">Lu, Meng-Chen; Zhao, Jing; Liu, Yu-Ting; Liu, Tian; Tao, Meng-Min; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101266</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Keap1-Nrf2-ARE pathway regulates the constitutive and inducible transcription of various genes that encode detoxification enzymes, antioxidant proteins and anti-inflammatory proteins and has pivotal roles in the defense against cellular oxidative stress.  In this study, we investigated the therapeutic potential of CPUY192018, a potent small-mol. inhibitor of the Keap1-Nrf2 protein-protein interaction (PPI), in renal inflammation.  In human proximal tubular epithelial HK-2 cells, CPUY192018 treatment significantly increased Nrf2 protein level and Nrf2 nuclear translocation, which enhanced Nrf2-ARE transcription capacity and the downstream protein content in a Nrf2 dependent manner.  In lipopolysaccharide (LPS)-challenged human HK-2 cells, CPUY192018 exhibited cytoprotective effects by enhancing the Nrf2-ARE regulated antioxidant system and diminished the LPS-induced inflammatory response by hindering the ROS-mediated activation of the NF-κB pathway.  In the LPS-induced mouse model of chronic renal inflammation, by activating Nrf2, CPUY192018 treatment balanced renal oxidative stress and suppressed inflammatory responses.  Hence, administration of CPUY192018 reduced kidney damage and ameliorated pathol. alterations of the glomerulus.  Taken together, our study suggested that small-mol. Keap1-Nrf2 PPI inhibitors can activate the Nrf2-based cytoprotective system and protect the kidney from inflammatory injury, raising a potential application of Keap1-Nrf2 PPI inhibitors in the treatment of inflammatory kidney disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0SJrXQhvzS7Vg90H21EOLACvtfcHk0lhqgOR60Jy5QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlahtL7O&md5=0f9fbdd03df93594539445b77c983b86</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2019.101266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2019.101266%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DTao%26aufirst%3DM.-M.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DCPUY192018%252C%2520a%2520potent%2520inhibitor%2520of%2520the%2520Keap1-Nrf2%2520protein-protein%2520interaction%252C%2520alleviates%2520renal%2520inflammation%2520in%2520mice%2520by%2520restricting%2520oxidative%2520stress%2520and%2520NF-kappaB%2520activation%26jtitle%3DRedox%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D101266%26doi%3D10.1016%2Fj.redox.2019.101266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">26585</span>, <span class="refDoi"> DOI: 10.1038/srep26585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1038%2Fsrep26585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=27215610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos12lsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=26585&author=M.-C.+Luauthor=J.-A.+Jiauthor=Y.-L.+Jiangauthor=Z.-Y.+Chenauthor=Z.-W.+Yuanauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=An+inhibitor+of+the+Keap1-Nrf2+protein-protein+interaction+protects+NCM460+colonic+cells+and+alleviates+experimental+colitis&doi=10.1038%2Fsrep26585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis</span></div><div class="casAuthors">Lu, Meng-Chen; Ji, Jian-Ai; Jiang, Yong-Lin; Chen, Zhi-Yun; Yuan, Zhen-Wei; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26585</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ulcerative colitis (UC) is a chronic relapsing-remitting form of inflammatory bowel disease (IBD) that increases the risk of colorectal cancer, the third most common malignancy in humans.  Oxidative stress is a risk factor for the development of UC.  The Keap1-Nrf2-ARE pathway is one of the most important defensive mechanisms against oxidative and/or electrophilic stresses.  In this study, we identified CPUY192018 as a potent small-mol. inhibitor of the Keap1-Nrf2 PPI, investigated the cyto-protective effects of CPUY192018 on the NCM460 colonic cells and evaluated whether treatment with the inhibitor of the Keap1-Nrf2 PPI exerts protection on an established exptl. model of UC induced by dextran sodium sulfate (DSS).  Our study clearly demonstrated that CPUY192018 had a cytoprotective effect against DSS in both NCM460 cells and mouse colon via the activation of Nrf2 signaling.  These results suggested that activation of Nrf2 by directly inhibiting the Keap1-Nrf2 PPI may be beneficial as a treatment for UC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE93oXzGcDmrVg90H21EOLACvtfcHk0li2Lbuz6eVaHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos12lsLk%253D&md5=3dcdaff7589ff3014d50326d0a908382</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fsrep26585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep26585%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DJi%26aufirst%3DJ.-A.%26aulast%3DJiang%26aufirst%3DY.-L.%26aulast%3DChen%26aufirst%3DZ.-Y.%26aulast%3DYuan%26aufirst%3DZ.-W.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DAn%2520inhibitor%2520of%2520the%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520protects%2520NCM460%2520colonic%2520cells%2520and%2520alleviates%2520experimental%2520colitis%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D26585%26doi%3D10.1038%2Fsrep26585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hus, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hession, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugovskoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuervo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atmanene, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roecklin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukashev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvian, L.</span></span> <span> </span><span class="NLM_article-title">Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4011</span>– <span class="NLM_lpage">4019</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.bmc.2013.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=23647822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlSku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=4011-4019&author=D.+Marcotteauthor=W.+Zengauthor=J.-C.+Husauthor=A.+McKenzieauthor=C.+Hessionauthor=P.+Jinauthor=C.+Bergeronauthor=A.+Lugovskoyauthor=I.+Enyedyauthor=H.+Cuervoauthor=D.+Wangauthor=C.+Atmaneneauthor=D.+Roecklinauthor=M.+Vecchiauthor=V.+Vivatauthor=J.+Kraemerauthor=D.+Winklerauthor=V.+Hongauthor=J.+Chaoauthor=M.+Lukashevauthor=L.+Silvian&title=Small+molecules+inhibit+the+interaction+of+Nrf2+and+the+Keap1+Kelch+domain+through+a+non-covalent+mechanism&doi=10.1016%2Fj.bmc.2013.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism</span></div><div class="casAuthors">Marcotte, Douglas; Zeng, Weike; Hus, Jean-Christophe; McKenzie, Andres; Hession, Cathy; Jin, Ping; Bergeron, Chris; Lugovskoy, Alexey; Enyedy, Istvan; Cuervo, Hernan; Wang, Deping; Atmanene, Cedric; Roecklin, Dominique; Vecchi, Malgorzata; Vivat, Valerie; Kraemer, Joachim; Winkler, Dirk; Hong, Victor; Chao, Jianhua; Lukashev, Matvey; Silvian, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4011-4019</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Keap1 binds to the Nrf2 transcription factor to promote its degrdn., resulting in the loss of gene products that protect against oxidative stress.  While cell-active small mols. have been identified that modify cysteines in Keap1 and effect the Nrf2 dependent pathway, few act through a non-covalent mechanism.  We have identified and characterized several small mol. compds. that specifically bind to the Keap1 Kelch-DC domain as measured by NMR, native mass spectrometry and X-ray crystallog.  One compd. upregulates Nrf2 response genes measured by a luciferase cell reporter assay.  The non-covalent inhibition strategy presents a reasonable course of action to avoid toxic side-effects due to non-specific cysteine modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5KaDM3q3CeLVg90H21EOLACvtfcHk0li2Lbuz6eVaHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlSku7w%253D&md5=b49b42b1621c6f08fbb3449621e4b109</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DHus%26aufirst%3DJ.-C.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DHession%26aufirst%3DC.%26aulast%3DJin%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DC.%26aulast%3DLugovskoy%26aufirst%3DA.%26aulast%3DEnyedy%26aufirst%3DI.%26aulast%3DCuervo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DAtmanene%26aufirst%3DC.%26aulast%3DRoecklin%26aufirst%3DD.%26aulast%3DVecchi%26aufirst%3DM.%26aulast%3DVivat%26aufirst%3DV.%26aulast%3DKraemer%26aufirst%3DJ.%26aulast%3DWinkler%26aufirst%3DD.%26aulast%3DHong%26aufirst%3DV.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DLukashev%26aufirst%3DM.%26aulast%3DSilvian%26aufirst%3DL.%26atitle%3DSmall%2520molecules%2520inhibit%2520the%2520interaction%2520of%2520Nrf2%2520and%2520the%2520Keap1%2520Kelch%2520domain%2520through%2520a%2520non-covalent%2520mechanism%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D4011%26epage%3D4019%26doi%3D10.1016%2Fj.bmc.2013.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.-P.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2736</span>– <span class="NLM_lpage">2745</span>, <span class="refDoi"> DOI: 10.1021/jm5000529</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5000529" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2736-2745&author=Z.-Y.+Jiangauthor=M.-C.+Luauthor=L.+L.+Xuauthor=T.-T.+Yangauthor=M.-Y.+Xiauthor=X.-L.+Xuauthor=X.-K.+Guoauthor=X.-J.+Zhangauthor=Q.-D.+Youauthor=H.-P.+Sun&title=Discovery+of+potent+Keap1-Nrf2+protein-protein+interaction+inhibitor+based+on+molecular+binding+determinants+analysis&doi=10.1021%2Fjm5000529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; Xu, Li-Li; Yang, Ting-Ting; Xi, Mei-Yang; Xu, Xiao-Li; Guo, Xiao-Ke; Zhang, Xiao-Jin; You, Qi-Dong; Sun, Hao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2736-2745</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Keap1 is known to mediate the ubiquitination of Nrf2, a master regulator of the antioxidant response.  Directly interrupting the Keap1-Nrf2 interaction has been emerged as a promising strategy to develop novel class of antioxidant, antiinflammatory, and anticancer agents.  On the basis of the mol. binding determinants anal. of Keap1, we successfully designed and characterized the most potent protein-protein interaction (PPI) inhibitor of Keap1-Nrf2, compd. 2, with KD value of 3.59 nM binding to Keap1 for the first time to single-digit nanomolar.  Compd. 2 can effectively disrupt the Nrf2-Keap1 interaction with an EC50 of 28.6 nM in the fluorescence polarization assay.  It can also activate the Nrf2 transcription activity in the cell-based ARE-luciferase reporter assay in a dose-dependent manner.  The qRT-PCR results of Nrf2 transcription targets gave the consistent results.  These results confirm direct and highly efficient interruption of the Keap1-Nrf2 PPI can be fully achieved by small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRS8nWHc40ZrVg90H21EOLACvtfcHk0li2Lbuz6eVaHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D&md5=b5d43ac3973478ecc54e26c74435f2c4</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm5000529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5000529%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.-Y.%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DXu%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DT.-T.%26aulast%3DXi%26aufirst%3DM.-Y.%26aulast%3DXu%26aufirst%3DX.-L.%26aulast%3DGuo%26aufirst%3DX.-K.%26aulast%3DZhang%26aufirst%3DX.-J.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DSun%26aufirst%3DH.-P.%26atitle%3DDiscovery%2520of%2520potent%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520inhibitor%2520based%2520on%2520molecular%2520binding%2520determinants%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2736%26epage%3D2745%26doi%3D10.1021%2Fjm5000529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity and structure-property relationship and exploratory in vivo evaluation of the nanomolar Keap1-Nrf2 protein-protein interaction inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6410</span>– <span class="NLM_lpage">6421</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00185</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12ksb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6410-6421&author=Z.-Y.+Jiangauthor=L.+L.+Xuauthor=M.-C.+Luauthor=Z.-Y.+Chenauthor=Z.-W.+Yuanauthor=X.-L.+Xuauthor=X.-K.+Guoauthor=X.-J.+Zhangauthor=H.-P.+Sunauthor=Q.-D.+You&title=Structure-activity+and+structure-property+relationship+and+exploratory+in+vivo+evaluation+of+the+nanomolar+Keap1-Nrf2+protein-protein+interaction+inhibitor&doi=10.1021%2Facs.jmedchem.5b00185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity and Structure-Property Relationship and Exploratory in Vivo Evaluation of the Nanomolar Keap1-Nrf2 Protein-Protein Interaction Inhibitor</span></div><div class="casAuthors">Jiang, Zheng-Yu; Xu, Li-Li; Lu, Meng-Chen; Chen, Zhi-Yun; Yuan, Zhen-Wei; Xu, Xiao-Li; Guo, Xiao-Ke; Zhang, Xiao-Jin; Sun, Hao-Peng; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6410-6421</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Directly disrupting the Keap1-Nrf2 protein-protein interaction (PPI) is an effective way to activate Nrf2.  Using the potent Keap1-Nrf2 PPI inhibitor that was reported by our group, we conducted a preliminary investigation of the structure-activity and structure-property relationships of the ring systems to improve the drug-like properties.  Compd. 18e (I), which bore p-acetamido substituents on the side chain Ph rings, was the best choice for balancing PPI inhibition activity, physicochem. properties, and cellular Nrf2 activity.  Cell-based expts. with 18e showed that the Keap1-Nrf2 PPI inhibitor can activate Nrf2 and induce the expression of Nrf2 downstream proteins in an Nrf2-dependent manner.  An exploratory in vivo expt. was carried out to further evaluate the anti-inflammatory effects of 18e in a LPS-challenged mouse model.  The primary results indicated that 18e could reduce the level of circulating pro-inflammatory cytokines induced by LPS and relieve the inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzcdu5HL_rp7Vg90H21EOLACvtfcHk0lh0dSTJLxcJ0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12ksb7N&md5=458f0a612c34156a137759d99b741e3a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00185%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.-Y.%26aulast%3DXu%26aufirst%3DL.%2BL.%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DChen%26aufirst%3DZ.-Y.%26aulast%3DYuan%26aufirst%3DZ.-W.%26aulast%3DXu%26aufirst%3DX.-L.%26aulast%3DGuo%26aufirst%3DX.-K.%26aulast%3DZhang%26aufirst%3DX.-J.%26aulast%3DSun%26aufirst%3DH.-P.%26aulast%3DYou%26aufirst%3DQ.-D.%26atitle%3DStructure-activity%2520and%2520structure-property%2520relationship%2520and%2520exploratory%2520in%2520vivo%2520evaluation%2520of%2520the%2520nanomolar%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6410%26epage%3D6421%26doi%3D10.1021%2Facs.jmedchem.5b00185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">Polar recognition group study of Keap1-Nrf2 protein-protein interaction inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">835</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00407</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00407" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSrtLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=835-840&author=M.-C.+Luauthor=S.-J.+Tanauthor=J.-A.+Jiauthor=Z.-Y.+Chenauthor=Z.-W.+Yuanauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=Polar+recognition+group+study+of+Keap1-Nrf2+protein-protein+interaction+inhibitors&doi=10.1021%2Facsmedchemlett.5b00407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Polar Recognition Group Study of Keap1-Nrf2 Protein-Protein Interaction Inhibitors</span></div><div class="casAuthors">Lu, Meng-Chen; Tan, Shi-Jie; Ji, Jian-Ai; Chen, Zhi-Yun; Yuan, Zhen-Wei; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">835-840</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Directly disrupting the Keap1-Nrf2 protein-protein interaction (PPI) has emerged as an attractive way to activate Nrf2, and Keap1-Nrf2 PPI inhibitors have been proposed as potential agents to relieve inflammatory and oxidative stress diseases.  In this work, we investigated the diacetic moiety around the potent Keap1-Nrf2 PPI inhibitor DDO1018 (2), which was reported by our group previously.  Exploration of bioisosteric replacements afforded the ditetrazole analog 7, which maintains the potent PPI inhibition activity (IC50 = 15.8 nM) in an in vitro fluorescence polarization assay.  Physicochem. property detn. demonstrated that ditetrazole replacement can improve the drug-like property, including elevation of pKa, log D, and transcellular permeability.  Addnl., 7 is more efficacious than 2 on inducing the expression of Nrf2-dependent gene products in cells.  This study provides an alternative way to replace the diacetic moiety and occupy the polar subpockets in Keap1, which can benefit the subsequent development of Keap1-Nrf2 PPI inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreftVGJtgyi7Vg90H21EOLACvtfcHk0lh0dSTJLxcJ0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSrtLvM&md5=02c5c7d5082e77a1b5f32cecee3888ac</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00407%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DTan%26aufirst%3DS.-J.%26aulast%3DJi%26aufirst%3DJ.-A.%26aulast%3DChen%26aufirst%3DZ.-Y.%26aulast%3DYuan%26aufirst%3DZ.-W.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DPolar%2520recognition%2520group%2520study%2520of%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D835%26epage%3D840%26doi%3D10.1021%2Facsmedchemlett.5b00407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winkel, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margerie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szillat, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glombik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Güssregen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herling, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Knethen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmoll, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of RA839, a noncovalent small molecule binder to Keap1 and selective activator of Nrf2 signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">28446</span>– <span class="NLM_lpage">28455</span>, <span class="refDoi"> DOI: 10.1074/jbc.m115.678136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1074%2Fjbc.M115.678136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26459563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=28446-28455&author=A.+F.+Winkelauthor=C.+K.+Engelauthor=D.+Margerieauthor=A.+Kanntauthor=H.+Szillatauthor=H.+Glombikauthor=C.+Kallusauthor=S.+Rufauthor=S.+G%C3%BCssregenauthor=J.+Riedelauthor=A.+W.+Herlingauthor=A.+von+Knethenauthor=A.+Weigertauthor=B.+Br%C3%BCneauthor=D.+Schmoll&title=Characterization+of+RA839%2C+a+noncovalent+small+molecule+binder+to+Keap1+and+selective+activator+of+Nrf2+signaling&doi=10.1074%2Fjbc.m115.678136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling</span></div><div class="casAuthors">Winkel, Angelika F.; Engel, Christian K.; Margerie, Daniel; Kannt, Aimo; Szillat, Hauke; Glombik, Heiner; Kallus, Christopher; Ruf, Sven; Guessregen, Stefan; Riedel, Jens; Herling, Andreas W.; von Knethen, Andreas; Weigert, Andreas; Bruene, Bernhard; Schmoll, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">28446-28455</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The activation of the transcription factor NF-E2-related factor 2 (Nrf2) maintains cellular homeostasis in response to oxidative stress by the regulation of multiple cytoprotective genes.  Without stressors, the activity of Nrf2 is inhibited by its interaction with the Keap1 (kelch-like ECH-assocd. protein 1).  Here, we describe (3S)-1-[4-[(2,3,5,6-tetramethylphenyl) sulfonylamino]-1-naphthyl]pyrrolidine-3-carboxylic acid (RA839), a small mol. that binds noncovalently to the Nrf2-interacting kelch domain of Keap1 with a Kd of ∼6 μm, as demonstrated by x-ray co-crystn. and isothermal titrn. calorimetry.  Whole genome DNA arrays showed that at 10 μm RA839 significantly regulated 105 probe sets in bone marrow-derived macrophages.  Canonical pathway mapping of these probe sets revealed an activation of pathways linked with Nrf2 signaling.  These pathways were also activated after the activation of Nrf2 by the silencing of Keap1 expression.  RA839 regulated only two genes in Nrf2 knock-out macrophages.  Similar to the activation of Nrf2 by either silencing of Keap1 expression or by the reactive compd. 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid Me ester (CDDO-Me), RA839 prevented the induction of both inducible nitric-oxide synthase expression and nitric oxide release in response to lipopolysaccharides in macrophages.  In mice, RA839 acutely induced Nrf2 target gene expression in liver.  RA839 is a selective inhibitor of the Keap1/Nrf2 interaction and a useful tool compd. to study the biol. of Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqu4FlVebzcbVg90H21EOLACvtfcHk0lh0dSTJLxcJ0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsrjF&md5=082998a0e4685dc8622662270fbba223</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.678136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.678136%26sid%3Dliteratum%253Aachs%26aulast%3DWinkel%26aufirst%3DA.%2BF.%26aulast%3DEngel%26aufirst%3DC.%2BK.%26aulast%3DMargerie%26aufirst%3DD.%26aulast%3DKannt%26aufirst%3DA.%26aulast%3DSzillat%26aufirst%3DH.%26aulast%3DGlombik%26aufirst%3DH.%26aulast%3DKallus%26aufirst%3DC.%26aulast%3DRuf%26aufirst%3DS.%26aulast%3DG%25C3%25BCssregen%26aufirst%3DS.%26aulast%3DRiedel%26aufirst%3DJ.%26aulast%3DHerling%26aufirst%3DA.%2BW.%26aulast%3Dvon%2BKnethen%26aufirst%3DA.%26aulast%3DWeigert%26aufirst%3DA.%26aulast%3DBr%25C3%25BCne%26aufirst%3DB.%26aulast%3DSchmoll%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520RA839%252C%2520a%2520noncovalent%2520small%2520molecule%2520binder%2520to%2520Keap1%2520and%2520selective%2520activator%2520of%2520Nrf2%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D28446%26epage%3D28455%26doi%3D10.1074%2Fjbc.m115.678136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) protein-protein interaction inhibitor with natural proline structure as a cytoprotective agent against acetaminophen-induced hepatotoxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">6796</span>– <span class="NLM_lpage">6813</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00818</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00818" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlamsbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=6796-6813&author=M.-C.+Luauthor=X.+Zhangauthor=F.+Wuauthor=S.-J.+Tanauthor=J.+Zhaoauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=Discovery+of+a+potent+Kelch-Like+ECH-Associated+Protein+1-Nuclear+Factor+Erythroid+2-Related+Factor+2+%28Keap1-Nrf2%29+protein-protein+interaction+inhibitor+with+natural+proline+structure+as+a+cytoprotective+agent+against+acetaminophen-induced+hepatotoxicity&doi=10.1021%2Facs.jmedchem.9b00818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity</span></div><div class="casAuthors">Lu, Meng-Chen; Zhang, Xian; Wu, Feng; Tan, Shi-Jie; Zhao, Jing; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6796-6813</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transcription factor Nrf2 is a key regulator of cytoprotective system, and enhancing Nrf2 activity can protect cells from various insults and threats.  Directly disrupting Keap1-Nrf2 protein-protein interactions has been regarded as a promising way to activate Nrf2.  We reported here the first identification of amino acids as preferred substituents to design potent Keap1-Nrf2 inhibitors.  Comprehensive structure-activity anal. identified Pro as a preferred substituent, obtaining a potent inhibitor 35 with an IC50 of 43 nM in the competitive fluoresce polarization (FP) assay and a Kd value of 53.7 nM for Keap1 protein in the isothermal titrn. calorimetry (ITC) assay.  The Pro analog 35 exhibited tight and prolonged Keap1 binding in vitro and in cells, and treatment with 35 activated Nrf2-regulated cytoprotective response and antagonized acetaminophen-induced liver injury both in cellular and in vivo models.  This work not only provides a useful tool to further explore the therapeutic potential of Keap1-Nrf2 inhibition but also enriches the diversity of chem. structures suitable for the Keap1-Nrf2 interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp0coFO8KjUrVg90H21EOLACvtfcHk0ljnsAOxbpK4NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlamsbfI&md5=8b94633020a7f690c96bc774a5b52bf6</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00818%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DTan%26aufirst%3DS.-J.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520Kelch-Like%2520ECH-Associated%2520Protein%25201-Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528Keap1-Nrf2%2529%2520protein-protein%2520interaction%2520inhibitor%2520with%2520natural%2520proline%2520structure%2520as%2520a%2520cytoprotective%2520agent%2520against%2520acetaminophen-induced%2520hepatotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D6796%26epage%3D6813%26doi%3D10.1021%2Facs.jmedchem.9b00818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lazzara, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ankireddy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratia, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) inhibitors with high metabolic stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">6547</span>– <span class="NLM_lpage">6560</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01074</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01074" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2hs7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=6547-6560&author=P.+R.+Lazzaraauthor=B.+P.+Davidauthor=A.+Ankireddyauthor=B.+G.+Richardsonauthor=K.+Dyeauthor=K.+M.+Ratiaauthor=S.+P.+Reddyauthor=T.+W.+Moore&title=Isoquinoline+Kelch-like+ECH-Associated+Protein+1-Nuclear+Factor+%28Erythroid-Derived+2%29-like+2+%28KEAP1-NRF2%29+inhibitors+with+high+metabolic+stability&doi=10.1021%2Facs.jmedchem.9b01074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability</span></div><div class="casAuthors">Lazzara, Phillip R.; David, Brian P.; Ankireddy, Aparna; Richardson, Benjamin G.; Dye, Katherine; Ratia, Kiira M.; Reddy, Sekhar P.; Moore, Terry W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6547-6560</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pharmacol. activation of NRF2 (nuclear factor erythroid 2-related factor 2) arises from blocking the interaction of NRF2 with its neg. regulator, KEAP1 (Kelch-like ECH-assocd. protein 1).  We previously reported an isoquinoline-based NRF2 activator, but this compd. showed neg. logD7.4 and a -2 charge at physiol. pH, which may have limited its membrane permeability.  In this work, we report potent, metabolically stable analogs that result from replacing a carboxymethyl group at the 4-position with a fluoroalkyl group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-h7NrJliBXbVg90H21EOLACvtfcHk0ljnsAOxbpK4NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2hs7fL&md5=f12c11a0fb6d55bfbf015ecd9f77ad50</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01074%26sid%3Dliteratum%253Aachs%26aulast%3DLazzara%26aufirst%3DP.%2BR.%26aulast%3DDavid%26aufirst%3DB.%2BP.%26aulast%3DAnkireddy%26aufirst%3DA.%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DDye%26aufirst%3DK.%26aulast%3DRatia%26aufirst%3DK.%2BM.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DIsoquinoline%2520Kelch-like%2520ECH-Associated%2520Protein%25201-Nuclear%2520Factor%2520%2528Erythroid-Derived%25202%2529-like%25202%2520%2528KEAP1-NRF2%2529%2520inhibitors%2520with%2520high%2520metabolic%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D6547%26epage%3D6560%26doi%3D10.1021%2Facs.jmedchem.9b01074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potteti, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzara, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamatam, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skowron, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krunic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Replacement of a naphthalene scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8029</span>– <span class="NLM_lpage">8047</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01133</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01133" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFertbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8029-8047&author=B.+G.+Richardsonauthor=A.+D.+Jainauthor=H.+R.+Pottetiauthor=P.+R.+Lazzaraauthor=B.+P.+Davidauthor=C.+R.+Tamatamauthor=E.+Chomaauthor=K.+Skowronauthor=K.+Dyeauthor=Z.+Siddiquiauthor=Y.-T.+Wangauthor=A.+Krunicauthor=S.+P.+Reddyauthor=T.+W.+Moore&title=Replacement+of+a+naphthalene+scaffold+in+Kelch-like+ECH-Associated+Protein+1+%28KEAP1%29%2FNuclear+Factor+%28Erythroid-derived+2%29-like+2+%28NRF2%29+inhibitors&doi=10.1021%2Facs.jmedchem.8b01133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors</span></div><div class="casAuthors">Richardson, Benjamin G.; Jain, Atul D.; Potteti, Haranatha R.; Lazzara, Phillip R.; David, Brian P.; Tamatam, Chandra R.; Choma, Ewelina; Skowron, Kornelia; Dye, Katherine; Siddiqui, Zamia; Wang, Yue-Ting; Krunic, Aleksej; Reddy, Sekhar P.; Moore, Terry W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8029-8047</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activators of nuclear factor-erythroid 2-related factor 2 (NRF2) could lead to promising therapeutics for prevention and treatment of oxidative stress and inflammatory disorders.  Ubiquitination and subsequent degrdn. of the transcription factor NRF2 is mediated by Kelch-like ECH-assocd. protein-1 (KEAP1).  Inhibition of the KEAP1/NRF2 interaction with small mols. leads to NRF2 activation.  Previously, we and others described naphthalene-based NRF2 activators, but the 1,4-diaminonaphthalene scaffold may not represent a drug-like scaffold.  Paying particular attention to aq. soly., metabolic stability, potency, and mutagenicity, we modified a previously known, naphthalene-based nonelectrophilic NRF2 activator to give a series of non-naphthalene and heterocyclic scaffolds.  We found that, compared to previously reported naphthalene-based compds., a 1,4-isoquinoline scaffold provides a better mutagenic profile without sacrificing potency, stability, or soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP0I8lhXc6Q7Vg90H21EOLACvtfcHk0ljnsAOxbpK4NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFertbfE&md5=69c77e7ee6f55d87ca61ef78a734c964</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01133%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DPotteti%26aufirst%3DH.%2BR.%26aulast%3DLazzara%26aufirst%3DP.%2BR.%26aulast%3DDavid%26aufirst%3DB.%2BP.%26aulast%3DTamatam%26aufirst%3DC.%2BR.%26aulast%3DChoma%26aufirst%3DE.%26aulast%3DSkowron%26aufirst%3DK.%26aulast%3DDye%26aufirst%3DK.%26aulast%3DSiddiqui%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.-T.%26aulast%3DKrunic%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DReplacement%2520of%2520a%2520naphthalene%2520scaffold%2520in%2520Kelch-like%2520ECH-Associated%2520Protein%25201%2520%2528KEAP1%2529%252FNuclear%2520Factor%2520%2528Erythroid-derived%25202%2529-like%25202%2520%2528NRF2%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8029%26epage%3D8047%26doi%3D10.1021%2Facs.jmedchem.8b01133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span> <span> </span><span class="NLM_article-title">A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">101565</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2020.101565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.redox.2020.101565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=32422540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpsl2ht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2020&pages=101565&author=M.+Luauthor=X.+Zhangauthor=J.+Zhaoauthor=Q.+Youauthor=Z.+Jiang&title=A+hydrogen+peroxide+responsive+prodrug+of+Keap1-Nrf2+inhibitor+for+improving+oral+absorption+and+selective+activation+in+inflammatory+conditions&doi=10.1016%2Fj.redox.2020.101565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions</span></div><div class="casAuthors">Lu, Mengchen; Zhang, Xian; Zhao, Jing; You, Qidong; Jiang, Zhengyu</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101565</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Transcription factor Nuclear factor erythroid 2-related factor 2 (Nrf2) and its neg. regulator, the E3 ligase adaptor Kelch-like ECH-assocd. protein 1 (Keap1), control the redox and metabolic homeostasis and oxidative stress.  Inhibitors of Keap1-Nrf2 interaction are promising in oxidative stress related inflammatory diseases but now hit hurdles.  By utilizing thiazolidinone moiety to shield the key carboxyl pharmacophore in Keap1-Nrf2 inhibitor, a hydrogen peroxide (H2O2)-responsive prodrug pro2 was developed.  The prodrug modification improved the physicochem. properties and cell membrane permeability of the parent drug.  Pro2 was stable and stayed inactive under various physiol. conditions, while became active by stimulation of H2O2 or inflammation derived reactive oxygen species.  Moreover, pro2 exhibited proper pharmacokinetic profile suitable for oral administration and enhanced anti-inflammatory efficiency in vivo.  Thus, this novel prodrug approach may not only provide an important advance in the therapy of chronic inflammatory diseases with high level of H2O2, but also offer a fresh soln. to improve the drug-like and selectivity issues of Keap1-Nrf2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox6NmI2hfYILVg90H21EOLACvtfcHk0ljrJe-0W5v9Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpsl2ht7o%253D&md5=f110f0d0005af7265e0fde632eca1e88</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2020.101565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2020.101565%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DZ.%26atitle%3DA%2520hydrogen%2520peroxide%2520responsive%2520prodrug%2520of%2520Keap1-Nrf2%2520inhibitor%2520for%2520improving%2520oral%2520absorption%2520and%2520selective%2520activation%2520in%2520inflammatory%2520conditions%26jtitle%3DRedox%2520Biol.%26date%3D2020%26volume%3D34%26spage%3D101565%26doi%3D10.1016%2Fj.redox.2020.101565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wixted, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths-Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMenamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, H. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottom, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kou, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonchuk, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldser, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognese, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podolin, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span> <span> </span><span class="NLM_article-title">Monoacidic inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) protein-protein interaction with high cell potency identified by fragment-based discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3991</span>– <span class="NLM_lpage">4006</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00228</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00228" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Gjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3991-4006&author=T.+G.+Daviesauthor=W.+E.+Wixtedauthor=J.+E.+Coyleauthor=C.+Griffiths-Jonesauthor=K.+Hearnauthor=R.+McMenaminauthor=D.+Nortonauthor=S.+J.+Richauthor=C.+Richardsonauthor=G.+Saxtyauthor=H.+M.+G.+Willemsauthor=A.+J.-A.+Woolfordauthor=J.+E.+Cottomauthor=J.-P.+Kouauthor=J.+G.+Yonchukauthor=H.+G.+Feldserauthor=Y.+Sanchezauthor=J.+P.+Foleyauthor=B.+J.+Bologneseauthor=G.+Loganauthor=P.+L.+Podolinauthor=H.+Yanauthor=J.+F.+Callahanauthor=T.+D.+Heightmanauthor=J.+K.+Kerns&title=Monoacidic+inhibitors+of+the+Kelch-like+ECH-Associated+Protein+1%3A+Nuclear+Factor+Erythroid+2-Related+Factor+2+%28KEAP1%3ANRF2%29+protein-protein+interaction+with+high+cell+potency+identified+by+fragment-based+discovery&doi=10.1021%2Facs.jmedchem.6b00228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery</span></div><div class="casAuthors">Davies, Thomas G.; Wixted, William E.; Coyle, Joseph E.; Griffiths-Jones, Charlotte; Hearn, Keisha; McMenamin, Rachel; Norton, David; Rich, Sharna J.; Richardson, Caroline; Saxty, Gordon; Willems, Henriette M. G.; Woolford, Alison J.-A.; Cottom, Joshua E.; Kou, Jen-Pyng; Yonchuk, John G.; Feldser, Heidi G.; Sanchez, Yolanda; Foley, Joseph P.; Bolognese, Brian J.; Logan, Gregory; Podolin, Patricia L.; Yan, Hongxing; Callahan, James F.; Heightman, Tom D.; Kerns, Jeffrey K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3991-4006</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">KEAP1 is the key regulator of the NRF2-mediated cytoprotective response, and increasingly recognized as a target for diseases involving oxidative stress.  Pharmacol. intervention has focused on mols. that decrease NRF2-ubiquitination through covalent modification of KEAP1 cysteine residues, but such electrophilic compds. lack selectivity and may be assocd. with off-target toxicity.  We report here the first use of a fragment-based approach to directly target the KEAP1 Kelch-NRF2 interaction.  X-ray crystallog. screening identified three distinct "hot-spots" for fragment binding within the NRF2 binding pocket of KEAP1, allowing progression of a weak fragment hit to mols. with nanomolar affinity for KEAP1 while maintaining drug-like properties.  This work resulted in a promising lead compd. (I) which exhibits tight and selective binding to KEAP1, and activates the NRF2 antioxidant response in cellular and in vivo models, thereby providing a high quality chem. probe to explore the therapeutic potential of disrupting the KEAP1-NRF2 interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq-gfBTuYreLVg90H21EOLACvtfcHk0ljrJe-0W5v9Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Gjtr0%253D&md5=ae42cc9f06d14b340cb3a8f5d6c157a7</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00228%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DWixted%26aufirst%3DW.%2BE.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DGriffiths-Jones%26aufirst%3DC.%26aulast%3DHearn%26aufirst%3DK.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DNorton%26aufirst%3DD.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DWillems%26aufirst%3DH.%2BM.%2BG.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.-A.%26aulast%3DCottom%26aufirst%3DJ.%2BE.%26aulast%3DKou%26aufirst%3DJ.-P.%26aulast%3DYonchuk%26aufirst%3DJ.%2BG.%26aulast%3DFeldser%26aufirst%3DH.%2BG.%26aulast%3DSanchez%26aufirst%3DY.%26aulast%3DFoley%26aufirst%3DJ.%2BP.%26aulast%3DBolognese%26aufirst%3DB.%2BJ.%26aulast%3DLogan%26aufirst%3DG.%26aulast%3DPodolin%26aufirst%3DP.%2BL.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26atitle%3DMonoacidic%2520inhibitors%2520of%2520the%2520Kelch-like%2520ECH-Associated%2520Protein%25201%253A%2520Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528KEAP1%253ANRF2%2529%2520protein-protein%2520interaction%2520with%2520high%2520cell%2520potency%2520identified%2520by%2520fragment-based%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3991%26epage%3D4006%26doi%3D10.1021%2Facs.jmedchem.6b00228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capacci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, E. Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechantsreiter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, K.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">126852</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.126852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.bmcl.2019.126852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31898999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXis1Shsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=126852&author=B.+Maauthor=B.+Lucasauthor=A.+Capacciauthor=E.+Y.-S.+Linauthor=J.+H.+Jonesauthor=M.+Dechantsreiterauthor=I.+Enyedyauthor=D.+Marcotteauthor=G.+Xiaoauthor=B.+Liauthor=K.+Richter&title=Design%2C+synthesis+and+identification+of+novel%2C+orally+bioavailable+non-covalent+Nrf2+activators&doi=10.1016%2Fj.bmcl.2019.126852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activators</span></div><div class="casAuthors">Ma, Bin; Lucas, Brian; Capacci, Andrew; Lin, Edward Yin-Shiang; Jones, John Howard; Dechantsreiter, Michael; Enyedy, Istvan; Marcotte, Douglas; Xiao, Guangqing; Li, Bing; Richter, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">126852</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nrf2 is a transcription factor regulating expression of the Phase II Antioxidant Response and plays an important role in neuroprotection and detoxification.  Nrf2 activation is inhibited by interaction with Keap1.  Covalent Keap1 inhibitors such as di-Me fumarate (DMF) and RTA-408 are either on the market or in late stage clin. trials which implies potential benefit of Nrf2 activation.  Activation of Nrf2 by disrupting Nrf2-Keap1 interaction through a non-covalent small mol. is an attractive approach with the promise of greater selectivity.  However, there are no known non-covalent Nrf2 activators with acceptable pharmacokinetic properties to test the hypothesis in vivo.  Based on our early reported work, using structural-based design, followed by extensive SAR exploration, we have identified a novel series of non-covalent Nrf2 activators, with sub-nanomolar binding affinity on Keap1 and single digit nanomolar activity in an astrocyte assay.  A representative analog shows excellent oral PK and good Nrf2-dependent gene inductions in kidney.  These results provide a peripheral in vivo tool compd. to validate the biol. of non-covalent activation of Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUcCbLIX8re7Vg90H21EOLACvtfcHk0lgBALmzEBajgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXis1Shsw%253D%253D&md5=6a6416e40b8b1cbc6a4c6a7f8d91d4bb</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.126852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.126852%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DB.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DCapacci%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DE.%2BY.-S.%26aulast%3DJones%26aufirst%3DJ.%2BH.%26aulast%3DDechantsreiter%26aufirst%3DM.%26aulast%3DEnyedy%26aufirst%3DI.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DRichter%26aufirst%3DK.%26atitle%3DDesign%252C%2520synthesis%2520and%2520identification%2520of%2520novel%252C%2520orally%2520bioavailable%2520non-covalent%2520Nrf2%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D30%26spage%3D126852%26doi%3D10.1016%2Fj.bmcl.2019.126852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Błyszczuk, P.</span></span> <span> </span><span class="NLM_article-title">Myocarditis in humans and in experimental animal models</span>. <i>Front. Cardiovasc. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">64</span>, <span class="refDoi"> DOI: 10.3389/fcvm.2019.00064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.3389%2Ffcvm.2019.00064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31157241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A280%3ADC%252BB3M3isF2itg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&pages=64&author=P.+B%C5%82yszczuk&title=Myocarditis+in+humans+and+in+experimental+animal+models&doi=10.3389%2Ffcvm.2019.00064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Myocarditis in Humans and in Experimental Animal Models</span></div><div class="casAuthors">Blyszczuk Przemyslaw; Blyszczuk Przemyslaw</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in cardiovascular medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64</span>
        ISSN:<span class="NLM_cas:issn">2297-055X</span>.
    </div><div class="casAbstract">Myocarditis is defined as an inflammation of the cardiac muscle.  In humans, various infectious and non-infectious triggers induce myocarditis with a broad spectrum of histological presentations and clinical symptoms of the disease.  Myocarditis often resolves spontaneously, but some patients develop heart failure and require organ transplantation.  The need to understand cellular and molecular mechanisms of inflammatory heart diseases led to the development of mouse models for experimental myocarditis.  It has been shown that pathogenic agents inducing myocarditis in humans can often trigger the disease in mice.  Due to multiple etiologies of inflammatory heart diseases in humans, a number of different experimental approaches have been developed to induce myocarditis in mice.  Accordingly, experimental myocarditis in mice can be induced by infection with cardiotropic agents, such as coxsackievirus B3 and protozoan parasite Trypanosoma cruzi or by activating autoimmune responses against heart-specific antigens.  In certain models, myocarditis is followed by the phenotype of dilated cardiomyopathy and the end stage of heart failure.  This review describes the most commonly used mouse models of experimental myocarditis with a focus on the role of the innate and adaptive immune systems in induction and progression of the disease.  The review discusses also advantages and limitations of individual mouse models in the context of the clinical manifestation and the course of the disease in humans.  Finally, animal-free alternatives in myocarditis research are outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGiDsTSQcQp4YPsCkJIw00fW6udTcc2eaI5ZS_oLU8F7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3isF2itg%253D%253D&md5=2f309c5295da32a408114770d508c9f3</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.3389%2Ffcvm.2019.00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffcvm.2019.00064%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C5%2582yszczuk%26aufirst%3DP.%26atitle%3DMyocarditis%2520in%2520humans%2520and%2520in%2520experimental%2520animal%2520models%26jtitle%3DFront.%2520Cardiovasc.%2520Med.%26date%3D2019%26volume%3D6%26spage%3D64%26doi%3D10.3389%2Ffcvm.2019.00064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schultheiss, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kühl, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, L. T.</span></span> <span> </span><span class="NLM_article-title">The management of myocarditis</span>. <i>Eur. Heart J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2616</span>– <span class="NLM_lpage">2625</span>, <span class="refDoi"> DOI: 10.1093/eurheartj/ehr165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1093%2Feurheartj%2Fehr165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=21705357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A280%3ADC%252BC3MblsFymsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=2616-2625&author=H.-P.+Schultheissauthor=U.+K%C3%BChlauthor=L.+T.+Cooper&title=The+management+of+myocarditis&doi=10.1093%2Feurheartj%2Fehr165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">The management of myocarditis</span></div><div class="casAuthors">Schultheiss Heinz-Peter; Kuhl Uwe; Cooper Leslie T</div><div class="citationInfo"><span class="NLM_cas:title">European heart journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2616-25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite considerable advances in our understanding of myocarditis pathogenesis, the clinical management of myocarditis has changed relatively little in the last few years.  This review aims to help bridge the widening gap between recent mechanistic insights, which are largely derived from animal models, and their potential impact on disease burden.  We illustrate the pathogenetic mechanisms that are prime targets for novel therapeutic interventions.  Pathway and pathogen-specific molecular diagnostic tests have expanded the role for endomyocardial biopsy.  State of the art cardiac magnetic resonance imaging can now provide non-invasive tissue characterization and localize inflammatory infiltrates but imaging techniques are misleading if infectious agents are involved.  We emphasize the gaps in our current clinical knowledge, particularly with respect to aetiology-based therapy, and suggest opportunities for high impact, translational investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuHVXr62AKo4JKJbLTgsvCfW6udTcc2eaI5ZS_oLU8F7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MblsFymsQ%253D%253D&md5=80401a92bd4a5be5861e8e3446dba17d</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehr165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehr165%26sid%3Dliteratum%253Aachs%26aulast%3DSchultheiss%26aufirst%3DH.-P.%26aulast%3DK%25C3%25BChl%26aufirst%3DU.%26aulast%3DCooper%26aufirst%3DL.%2BT.%26atitle%3DThe%2520management%2520of%2520myocarditis%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2011%26volume%3D32%26spage%3D2616%26epage%3D2625%26doi%3D10.1093%2Feurheartj%2Fehr165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corsten, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymans, S.</span></span> <span> </span><span class="NLM_article-title">Inflammation in viral myocarditis: friend or foe?</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">426</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2012.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.molmed.2012.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=22726657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVShsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=426-437&author=M.+F.+Corstenauthor=B.+Schroenauthor=S.+Heymans&title=Inflammation+in+viral+myocarditis%3A+friend+or+foe%3F&doi=10.1016%2Fj.molmed.2012.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation in viral myocarditis: friend or foe?</span></div><div class="casAuthors">Corsten, Maarten F.; Schroen, Blanche; Heymans, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">426-437</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Viral myocarditis is an important cause of heart failure for which no specific treatments are available.  Direct viral injury to cardiac cells provokes an inflammatory response that significantly contributes to cardiac damage and ensuing morbidity.  Despite the central pathogenic role of autoimmune injury, broad inhibition of the inflammatory response does not result in patient benefit.  Many preclin. studies collectively emphasize that modulating distinct inflammatory signaling pathways may yield effective viral clearance while preserving cardiac structure.  This review aims to provide an overview of the sometimes contrasting observations from exptl. viral myocarditis models and to translate the lessons learned into opportunities for future investigations and therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOpeZLksEY0rVg90H21EOLACvtfcHk0lgBALmzEBajgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVShsb%252FI&md5=40465f827f1460c1dedb4fbeebec4065</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2012.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2012.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DCorsten%26aufirst%3DM.%2BF.%26aulast%3DSchroen%26aufirst%3DB.%26aulast%3DHeymans%26aufirst%3DS.%26atitle%3DInflammation%2520in%2520viral%2520myocarditis%253A%2520friend%2520or%2520foe%253F%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D426%26epage%3D437%26doi%3D10.1016%2Fj.molmed.2012.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buelna-Chontal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zazueta, C.</span></span> <span> </span><span class="NLM_article-title">Redox activation of Nrf2 & NF-κB: a double end sword?</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2548</span>– <span class="NLM_lpage">2557</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2013.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.cellsig.2013.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=23993959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1OqsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2013&pages=2548-2557&author=M.+Buelna-Chontalauthor=C.+Zazueta&title=Redox+activation+of+Nrf2+%26+NF-%CE%BAB%3A+a+double+end+sword%3F&doi=10.1016%2Fj.cellsig.2013.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Redox activation of Nrf2 & NF-κB: A double end sword?</span></div><div class="casAuthors">Buelna-Chontal, Mabel; Zazueta, Cecilia</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2548-2557</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Moderate concns. of reactive oxygen species (ROS) are produced by diverse sources under physiol. conditions.  At such low levels, these mols. may act as upstream mediators of relevant signaling pathways; however an increase in their concn. with respect to the antioxidant system activity, changes their redox signaling function into a deleterious role.  Thus, cell health depends, at least in part, on redox balance.  This review includes global aspects of oxygen chem., ROS generation, antioxidant system, and redox signaling.  It is also focused on the description of two relevant redox-sensitive transcription factors: nuclear factor erythroid 2-related factor 2 (Nrf2), which may be a potential target to confer cell protection, and nuclear factor κB (NF-κB), which is involved in deleterious effects in the cell.  Finally, recent findings on the interplay between both factors for the development of different pathologies are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ1-FNel9yGbVg90H21EOLACvtfcHk0liwV2VHz-g9lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1OqsbjL&md5=3b113790fef7976fd18dc40a2042113b</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2013.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2013.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DBuelna-Chontal%26aufirst%3DM.%26aulast%3DZazueta%26aufirst%3DC.%26atitle%3DRedox%2520activation%2520of%2520Nrf2%2520%2526%2520NF-%25CE%25BAB%253A%2520a%2520double%2520end%2520sword%253F%26jtitle%3DCell.%2520Signalling%26date%3D2013%26volume%3D25%26spage%3D2548%26epage%3D2557%26doi%3D10.1016%2Fj.cellsig.2013.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span> <span> </span><span class="NLM_article-title">Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis</span>. <i>Free Radic. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2018.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.freeradbiomed.2018.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=29428410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivVSmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2018&pages=228-237&author=N.+Mengauthor=H.+Tangauthor=H.+Zhangauthor=C.+Jiangauthor=L.+Suauthor=X.+Minauthor=W.+Zhangauthor=H.+Zhangauthor=Z.+Miaoauthor=W.+Zhangauthor=C.+Zhuang&title=Fragment-growing+guided+design+of+Keap1-Nrf2+protein-protein+interaction+inhibitors+for+targeting+myocarditis&doi=10.1016%2Fj.freeradbiomed.2018.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis</span></div><div class="casAuthors">Meng, Ning; Tang, Hua; Zhang, Hao; Jiang, Chengshi; Su, Li; Min, Xiao; Zhang, Wannian; Zhang, Hua; Miao, Zhenyuan; Zhang, Wen; Zhuang, Chunlin</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">228-237</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that block the Keap1-Nrf2 protein-protein interactions are being intensely pursued as a new therapeutic strategy for oxidative stress-related diseases, such as cancer, diabetes, Alzheimer's disease, arteriosclerosis, inflammation and myocarditis.  However, there are not enough studies on antioxidant treatments using small mols. in myocarditis.  The authors herein provided a series of novel hydronaphthoquinones as the Keap1-Nrf2 interaction inhibitors targeting LPS-induced myocarditis both in vitro and in vivo.  These compds. were designed through an in-silico fragment growing approach based on the previous reported compd.  The new compds. were predicted to form addnl. hydrogen bonds with the S363 residue, leading to higher inhibitory activity.  Among these new derivs., compds. I and II emerged as inhibitors with significant biochem. potency, as detd. by fluorescent anisotropy assay and confirmed by surface plasmon resonance (SPR) and differential scanning fluorometry (DSF) assays.  These inhibitors can dose-dependently protect the H9c2 cardiac cells against LPS-induced injury (100% at 2 μM and 4 μM) and effectively prolong survival or save the life of LPS-injured mice.  Mechanistic studies showed that these inhibitors could release Nrf2 in H9c2 cells and LPS-inflammatory mouse models and translocate into the nucleus in a dose-response manner, which significantly increased the downstream genes (HO-1, NQO-1) and the pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), while ROS prodn. dramatically decreased.  Their protective effects and the mechanism of action were further confirmed by siNrf2 transfected expt.  Collectively, the novel hydronaphthoquinones can be used as promising lead compds. for the study of Keap1-Nrf2 protein-protein interactions and further antimyocarditis drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox8LWG_bMTJLVg90H21EOLACvtfcHk0liwV2VHz-g9lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivVSmtrk%253D&md5=71299d349ff1e7ba6aa29967e9380ebe</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2018.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2018.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhuang%26aufirst%3DC.%26atitle%3DFragment-growing%2520guided%2520design%2520of%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520inhibitors%2520for%2520targeting%2520myocarditis%26jtitle%3DFree%2520Radic.%2520Biol.%2520Med.%26date%3D2018%26volume%3D117%26spage%3D228%26epage%3D237%26doi%3D10.1016%2Fj.freeradbiomed.2018.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muehlmann, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueiró Longo, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azevedo, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel small-molecule Keap1-Nrf2 PPI inhibitor with cytoprotective effects on LPS-induced cardiomyopathy</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1080/14756366.2018.1461856</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1080%2F14756366.2018.1461856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=29693453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotlGlu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=833-841&author=C.-S.+Jiangauthor=C.-L.+Zhuangauthor=K.+Zhuauthor=J.+Zhangauthor=L.+A.+Muehlmannauthor=J.+P.+Figueir%C3%B3+Longoauthor=R.+B.+Azevedoauthor=W.+Zhangauthor=N.+Mengauthor=H.+Zhang&title=Identification+of+a+novel+small-molecule+Keap1-Nrf2+PPI+inhibitor+with+cytoprotective+effects+on+LPS-induced+cardiomyopathy&doi=10.1080%2F14756366.2018.1461856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel small-molecule Keap1-Nrf2 PPI inhibitor with cytoprotective effects on LPS-induced cardiomyopathy</span></div><div class="casAuthors">Jiang, Cheng-Shi; Zhuang, Chun-Lin; Zhu, Kongkai; Zhang, Juan; Muehlmann, Luis Alexandre; Figueiro Longo, Joao Paulo; Azevedo, Ricardo Bentes; Zhang, Wen; Meng, Ning; Zhang, Hua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">833-841</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A new Keap1-Nrf2 protein-protein interaction (PPI) inhibitor ZJO1 (I) was identified from our compd. library by fluorescence polarization assay, surface plasmon resonance, mol. docking and mol. dynamics simulation. could in vitro trigger Nrf2 nuclear translocation, subsequently resulting in increased mRNA levels of Nrf2 target genes HO-1 and NQO1.  Meanwhile, suppressed LPS-induced prodn. of ROS and the mRNA levels of pro-inflammatory cytokines TNF-α, IL-1β and IL-6 in H9c2 cardiac cells.  Moreover, in an in vivo mouse model of septic cardiomyopathy induced by i.p. injection of lipopolysaccharide, demonstrated a cytoprotective effect, upregulated Nrf2 protein nuclear accumulation, and remarkably suppressed the abovementioned cytokine levels in cardiomyocytes.  The results presented herein provided a novel chemotype for the development of direct Keap1-Nrf2 PPI inhibitors and suggested that compd. is a promising drug lead for septic cardiomyopathy treatment. was identified as a new Keap1-Nrf2 PPI inhibitor and drug lead for septic cardiomyopathy treatment by in vitro and in vivo expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojU4MthYirhrVg90H21EOLACvtfcHk0liwV2VHz-g9lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotlGlu7g%253D&md5=d1b12b8580cf272fa33ffc0412de181d</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1080%2F14756366.2018.1461856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2018.1461856%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DC.-S.%26aulast%3DZhuang%26aufirst%3DC.-L.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMuehlmann%26aufirst%3DL.%2BA.%26aulast%3DFigueir%25C3%25B3%2BLongo%26aufirst%3DJ.%2BP.%26aulast%3DAzevedo%26aufirst%3DR.%2BB.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMeng%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520a%2520novel%2520small-molecule%2520Keap1-Nrf2%2520PPI%2520inhibitor%2520with%2520cytoprotective%2520effects%2520on%2520LPS-induced%2520cardiomyopathy%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2018%26volume%3D33%26spage%3D833%26epage%3D841%26doi%3D10.1080%2F14756366.2018.1461856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugam, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Challa, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litovsky, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devarajan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darley-Usmar, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajasekaran, N. S.</span></span> <span> </span><span class="NLM_article-title">Enhanced Keap1-Nrf2 signaling protects the myocardium from isoproterenol-induced pathological remodeling in mice</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">101212</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2019.101212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.redox.2019.101212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31155513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVyisr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=101212&author=G.+Shanmugamauthor=A.+K.+Challaauthor=S.+H.+Litovskyauthor=A.+Devarajanauthor=D.+Wangauthor=D.+P.+Jonesauthor=V.+M.+Darley-Usmarauthor=N.+S.+Rajasekaran&title=Enhanced+Keap1-Nrf2+signaling+protects+the+myocardium+from+isoproterenol-induced+pathological+remodeling+in+mice&doi=10.1016%2Fj.redox.2019.101212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced Keap1-Nrf2 signaling protects the myocardium from isoproterenol-induced pathological remodeling in mice</span></div><div class="casAuthors">Shanmugam, Gobinath; Challa, Anil Kumar; Litovsky, Silvio H.; Devarajan, Asokan; Wang, Ding; Jones, Dean P.; Darley-Usmar, Victor M.; Rajasekaran, Namakkal Soorappan</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101212</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2/Nrf2) is an inducible transcription factor that is essential for maintenance of redox signaling and in response to stress.  This suggests that if Nrf2 expression response could be enhanced for a defined physiol. pro-oxidant stress then it would be protective.  This has important implications for the therapeutic manipulation of the Keap1/Nrf2 signaling pathway which is now gaining a lot of attention.  We tested this hypothesis through the generation of Nrf2 transgene expression mouse model with and without isoproterenol-induced cardiac stress.  Cardiac-specific mouse Nrf2 transgenic (mNrf2-TG) and non-transgenic (NTG) mice were subjected to isoproterenol (ISO) treatment and assessed for myocardial structure, function (echocardiog. and electrocardiog.), and glutathione redox state.  Myocardial infarction and fibrosis along with increased inflammation leading to myocardial dysfunction was noted in NTG mice exposed to ISO, while mNrf2-TG hearts were resistant to the ISO insult.  Preservation of myocardial structure and function in the mNrf2-TG mice was assocd. with the enhanced Nrf2 expression displayed in these hearts with an increased basal and post-treatment expression of redox modulatory genes and an overall enhanced antioxidant status.  Of note, myocardium of ISO-treated TG mice displayed significantly increased stabilization of the KEAP1-NRF2 complex and enhanced release of NRF2 to the nucleus resulting in overall decreased pro-oxidant markers.  Taken together, we suggest that a basal enhanced Nrf2 expression in mouse heart results in maintenance of redox homeostasis and counteracts ISO-induced oxidative stress, and suppresses pathol. remodeling.  These data suggest that an alternative therapeutic approach to enhance the efficacy of the Keap1-Nrf2 system is to stimulate basal expression of Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5T410H6AfbbVg90H21EOLACvtfcHk0lii0i4WM-ATlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVyisr7K&md5=e7d47f497f5bb8a36febd64f85c41400</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2019.101212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2019.101212%26sid%3Dliteratum%253Aachs%26aulast%3DShanmugam%26aufirst%3DG.%26aulast%3DChalla%26aufirst%3DA.%2BK.%26aulast%3DLitovsky%26aufirst%3DS.%2BH.%26aulast%3DDevarajan%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DD.%2BP.%26aulast%3DDarley-Usmar%26aufirst%3DV.%2BM.%26aulast%3DRajasekaran%26aufirst%3DN.%2BS.%26atitle%3DEnhanced%2520Keap1-Nrf2%2520signaling%2520protects%2520the%2520myocardium%2520from%2520isoproterenol-induced%2520pathological%2520remodeling%2520in%2520mice%26jtitle%3DRedox%2520Biol.%26date%3D2019%26volume%3D27%26spage%3D101212%26doi%3D10.1016%2Fj.redox.2019.101212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">112734</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.ejmech.2020.112734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=32866756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslejtbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2020&pages=112734&author=M.-C.+Luauthor=H.-L.+Shaoauthor=T.+Liuauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=Discovery+of+2-oxy-2-phenylacetic+acid+substituted+naphthalene+sulfonamide+derivatives+as+potent+KEAP1-NRF2+protein-protein+interaction+inhibitors+for+inflammatory+conditions&doi=10.1016%2Fj.ejmech.2020.112734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions</span></div><div class="casAuthors">Lu, Meng-Chen; Shao, Hong-Li; Liu, Tian; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112734</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Nuclear factor erythroid 2-related factor 2 (NRF2) is a pleiotropic transcription factor which regulates the constitutive and inducible transcription of a wide array of genes and confers protection against a variety of pathologies.  Directly disrupting Kelch-like ECH-assocd. protein 1 (KEAP1)-NRF2 protein-protein interaction (PPI) has been explored as a promising strategy to activate NRF2.  We reported here the first identification of a series of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivs. as potent KEAP1-NRF2 inhibitors.  Our efforts led to the potent small mol. KEAP1-NRF2 inhibitor, 20c, which exhibited a Kd of 24 nM to KEAP1 and an IC50 of 75 nM in disrupting KEAP1-NRF2 interaction.  Subsequent biol. studies provided consistent evidence across mouse macrophage cell-based and in vivo models that 20c induced NRF2 target gene expression and enhanced downstream antioxidant and anti-inflammatory activities.  Our study not only demonstrated that small mol. KEAP1-NRF2 PPI inhibitors can be potential preventive and therapeutic agents for diseases and conditions involving oxidative stress and inflammation but also enriched the chem. diversity of the KEAP1-NRF2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGQ96pcrodTbVg90H21EOLACvtfcHk0lii0i4WM-ATlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslejtbjI&md5=5aba876131d7cedff34b9c270896d233</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112734%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DShao%26aufirst%3DH.-L.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DDiscovery%2520of%25202-oxy-2-phenylacetic%2520acid%2520substituted%2520naphthalene%2520sulfonamide%2520derivatives%2520as%2520potent%2520KEAP1-NRF2%2520protein-protein%2520interaction%2520inhibitors%2520for%2520inflammatory%2520conditions%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D207%26spage%3D112734%26doi%3D10.1016%2Fj.ejmech.2020.112734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ammazzalorso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Filippis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giampietro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amoroso, R.</span></span> <span> </span><span class="NLM_article-title">N-acylsulfonamides: Synthetic routes and biological potential in medicinal chemistry</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">1094</span>– <span class="NLM_lpage">1105</span>, <span class="refDoi"> DOI: 10.1111/cbdd.13043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1111%2Fcbdd.13043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=28632928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFCrurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2017&pages=1094-1105&author=A.+Ammazzalorsoauthor=B.+De+Filippisauthor=L.+Giampietroauthor=R.+Amoroso&title=N-acylsulfonamides%3A+Synthetic+routes+and+biological+potential+in+medicinal+chemistry&doi=10.1111%2Fcbdd.13043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylsulfonamides: Synthetic routes and biological potential in medicinal chemistry</span></div><div class="casAuthors">Ammazzalorso, Alessandra; De Filippis, Barbara; Giampietro, Letizia; Amoroso, Rosa</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1094-1105</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Sulfonamide is a common structural motif in naturally occurring and synthetic medicinal compds.  The rising interest in sulfonamides and N-acyl derivs. is attested by the large no. of drugs and lead compds. identified in last years, explored in different fields of medicinal chem. and showing biol. activity.  Many acylsulfonamide derivs. were designed and synthesized as isosteres of carboxylic acids, being the characteristics of these functional groups very close.  Starting from chem. routes to N-acylsulfonamides, this review explores compds. of pharmaceutical interest, developed as enzymic inhibitors or targeting receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGothOEJKbfp6rVg90H21EOLACvtfcHk0lii0i4WM-ATlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFCrurvO&md5=07ca438efbb7a20c9f13228d674b4ae4</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.13043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.13043%26sid%3Dliteratum%253Aachs%26aulast%3DAmmazzalorso%26aufirst%3DA.%26aulast%3DDe%2BFilippis%26aufirst%3DB.%26aulast%3DGiampietro%26aufirst%3DL.%26aulast%3DAmoroso%26aufirst%3DR.%26atitle%3DN-acylsulfonamides%253A%2520Synthetic%2520routes%2520and%2520biological%2520potential%2520in%2520medicinal%2520chemistry%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2017%26volume%3D90%26spage%3D1094%26epage%3D1105%26doi%3D10.1111%2Fcbdd.13043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nasiri, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullmann, D.</span></span> <span> </span><span class="NLM_article-title">Thermodynamic profiling of inhibitors of Nrf2:Keap1 interactions</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.11.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.bmcl.2015.11.082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26653613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGnu7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=526-529&author=H.+R.+Nasiriauthor=S.+Lingeauthor=D.+Ullmann&title=Thermodynamic+profiling+of+inhibitors+of+Nrf2%3AKeap1+interactions&doi=10.1016%2Fj.bmcl.2015.11.082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Thermodynamic profiling of inhibitors of Nrf2:Keap1 interactions</span></div><div class="casAuthors">Nasiri, Hamid R.; Linge, Sandra; Ullmann, Dirk</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">526-529</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Keap1 binds to the transcription factor Nrf2 and neg. modulates the expression of genes involved in cellular protection against oxidative stress.  Small mols. have been discovered to inhibit the Nrf2:Keap1 interactions and act as antagonists of Keap1.  The affinities of these small mols. are not very high and need further improvement in follow up hit-to-lead programs.  In addn. to the affinity parameters Ki, Kd, and IC50 thermodn. parameters provide useful information for the selection and optimization of these hit mols. at the early stage of the lead discovery process.  In this letter a tracer displacement assay was used to det. the thermodn. signature of some of the known inhibitors of the Nrf2:Keap1 interaction.  An optimized assay protocol is presented, which can be applied to other small mols. in hit-to-lead programs in a medium throughput manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon7pjAqVdeRLVg90H21EOLACvtfcHk0lhrGjKeM8iVPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGnu7bO&md5=424482b4285476bd24fad6587e5f713d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.11.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.11.082%26sid%3Dliteratum%253Aachs%26aulast%3DNasiri%26aufirst%3DH.%2BR.%26aulast%3DLinge%26aufirst%3DS.%26aulast%3DUllmann%26aufirst%3DD.%26atitle%3DThermodynamic%2520profiling%2520of%2520inhibitors%2520of%2520Nrf2%253AKeap1%2520interactions%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D526%26epage%3D529%26doi%3D10.1016%2Fj.bmcl.2015.11.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ladbury, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span> <span> </span><span class="NLM_article-title">Adding calorimetric data to decision making in lead discovery: a hot tip</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1038/nrd3054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1038%2Fnrd3054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=19960014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWjt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=23-27&author=J.+E.+Ladburyauthor=G.+Klebeauthor=E.+Freire&title=Adding+calorimetric+data+to+decision+making+in+lead+discovery%3A+a+hot+tip&doi=10.1038%2Fnrd3054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Adding calorimetric data to decision making in lead discovery: A hot tip</span></div><div class="casAuthors">Ladbury, John E.; Klebe, Gerhard; Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-27</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recognition of the limitations of high-throughput screening approaches in the discovery of candidate drugs has reawakened interest in structure-based and other rational design methods.  Here, the authors describe how isothermal titrn. calorimetry can be used to obtain thermodn. data on the binding of compds. to protein targets.  The authors propose that these data - particularly the change in enthalpy - could provide a valuable, complementary addn. to established tools for selecting compds. in lead discovery and for aiding lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph3qvp2E8fbLVg90H21EOLACvtfcHk0lhrGjKeM8iVPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWjt7bM&md5=e8446b6db983c35580e9010899eb40eb</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fnrd3054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3054%26sid%3Dliteratum%253Aachs%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DAdding%2520calorimetric%2520data%2520to%2520decision%2520making%2520in%2520lead%2520discovery%253A%2520a%2520hot%2520tip%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2010%26volume%3D9%26spage%3D23%26epage%3D27%26doi%3D10.1038%2Fnrd3054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ushiyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka-Yamamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanazawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takata, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtake, N.</span></span> <span> </span><span class="NLM_article-title">Lead identification of 8-(methylamino)-2-oxo-1,2-dihydroquinoline derivatives as DNA gyrase inhibitors: hit-to-lead generation involving thermodynamic evaluation</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">10145</span>– <span class="NLM_lpage">10159</span>, <span class="refDoi"> DOI: 10.1021/acsomega.0c00865</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.0c00865" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnslCitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2020&pages=10145-10159&author=F.+Ushiyamaauthor=H.+Amadaauthor=T.+Takeuchiauthor=N.+Tanaka-Yamamotoauthor=H.+Kanazawaauthor=K.+Nakanoauthor=M.+Mimaauthor=A.+Masukoauthor=I.+Takataauthor=K.+Hitakaauthor=K.+Iwamotoauthor=H.+Sugiyamaauthor=N.+Ohtake&title=Lead+identification+of+8-%28methylamino%29-2-oxo-1%2C2-dihydroquinoline+derivatives+as+DNA+gyrase+inhibitors%3A+hit-to-lead+generation+involving+thermodynamic+evaluation&doi=10.1021%2Facsomega.0c00865"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Identification of 8-(Methylamino)-2-oxo-1,2-dihydroquinoline Derivatives as DNA Gyrase Inhibitors: Hit-to-Lead Generation Involving Thermodynamic Evaluation</span></div><div class="casAuthors">Ushiyama, Fumihito; Amada, Hideaki; Takeuchi, Tomoki; Tanaka-Yamamoto, Nozomi; Kanazawa, Harumi; Nakano, Koichiro; Mima, Masashi; Masuko, Aiko; Takata, Iichiro; Hitaka, Kosuke; Iwamoto, Kunihiko; Sugiyama, Hiroyuki; Ohtake, Norikazu</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">10145-10159</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DNA gyrase and topoisomerase IV are well-validated pharmacol. targets, and quinolone antibacterial drugs are marketed as their representative inhibitors.  However, in recent years, resistance to these existing drugs has become a problem, and new chem. classes of antibiotics that can combat resistant strains of bacteria are strongly needed.  In this study, we applied our hit-to-lead (H2L) chem. for the identification of a new chem. class of GyrB/ParE inhibitors by efficient use of thermodn. parameters.  Investigation of the core fragments obtained by fragmentation of high-throughput screening hit compds. and subsequent expansion of the hit fragment was performed using isothermal titrn. calorimetry (ITC).  The 8-(methylamino)-2-oxo-1,2-dihydroquinoline deriv. 13e(I) showed potent activity against Escherichia coli DNA gyrase with an IC50 value of 0.0017 μM.  In this study, we demonstrated the use of ITC for primary fragment screening, followed by structural optimization to obtain lead compds., which advanced into further optimization for creating novel antibacterial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWceiwOsImgLVg90H21EOLACvtfcHk0lhiB2CndR-mPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnslCitbk%253D&md5=76e83290f377f51d39cef93770a9b387</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Facsomega.0c00865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.0c00865%26sid%3Dliteratum%253Aachs%26aulast%3DUshiyama%26aufirst%3DF.%26aulast%3DAmada%26aufirst%3DH.%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DTanaka-Yamamoto%26aufirst%3DN.%26aulast%3DKanazawa%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DK.%26aulast%3DMima%26aufirst%3DM.%26aulast%3DMasuko%26aufirst%3DA.%26aulast%3DTakata%26aufirst%3DI.%26aulast%3DHitaka%26aufirst%3DK.%26aulast%3DIwamoto%26aufirst%3DK.%26aulast%3DSugiyama%26aufirst%3DH.%26aulast%3DOhtake%26aufirst%3DN.%26atitle%3DLead%2520identification%2520of%25208-%2528methylamino%2529-2-oxo-1%252C2-dihydroquinoline%2520derivatives%2520as%2520DNA%2520gyrase%2520inhibitors%253A%2520hit-to-lead%2520generation%2520involving%2520thermodynamic%2520evaluation%26jtitle%3DACS%2520Omega%26date%3D2020%26volume%3D5%26spage%3D10145%26epage%3D10159%26doi%3D10.1021%2Facsomega.0c00865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geschwindner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span> <span> </span><span class="NLM_article-title">Ligand binding thermodynamics in drug discovery: still a hot tip?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6321</span>– <span class="NLM_lpage">6335</span>, <span class="refDoi"> DOI: 10.1021/jm501511f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501511f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFGitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6321-6335&author=S.+Geschwindnerauthor=J.+Ulanderauthor=P.+Johansson&title=Ligand+binding+thermodynamics+in+drug+discovery%3A+still+a+hot+tip%3F&doi=10.1021%2Fjm501511f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand Binding Thermodynamics in Drug Discovery: Still a Hot Tip?</span></div><div class="casAuthors">Geschwindner, Stefan; Ulander, Johan; Johansson, Patrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6321-6335</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of ligand binding thermodn. has been proposed as a potential success factor to accelerate drug discovery.  However, despite the intuitive appeal of optimizing binding enthalpy, a no. of factors complicate routine use of thermodn. data.  On a macroscopic level, a range of exptl. parameters including temp. and buffer choice significantly influence the obsd. thermodn. signatures.  On a microscopic level, solute effects, structural flexibility, and cooperativity lead to nonlinear changes in enthalpy.  This multifactorial character hides essential enthalpy contributions of intermol. contacts, making them exptl. nonobservable.  In this perspective, we present three case studies, reflect on some key factors affecting thermodn. signatures, and investigate their relation to the hydrophobic effect, enthalpy-entropy compensation, lipophilic ligand efficiency, and promiscuity.  The studies highlight that enthalpy and entropy cannot be used as direct end points but can together with calcns. increase our understanding of ligand binding and identify interesting outliers that do not behave as expected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr47fgLvr2PP7Vg90H21EOLACvtfcHk0lhiB2CndR-mPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFGitbs%253D&md5=686b213b9488bc51d2d6a07e391c6644</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm501511f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501511f%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DUlander%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DP.%26atitle%3DLigand%2520binding%2520thermodynamics%2520in%2520drug%2520discovery%253A%2520still%2520a%2520hot%2520tip%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6321%26epage%3D6335%26doi%3D10.1021%2Fjm501511f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span> <span> </span><span class="NLM_article-title">Do enthalpy and entropy distinguish first in class from best in class?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">869</span>– <span class="NLM_lpage">874</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2008.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.drudis.2008.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=18703160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCgu7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=869-874&author=E.+Freire&title=Do+enthalpy+and+entropy+distinguish+first+in+class+from+best+in+class%3F&doi=10.1016%2Fj.drudis.2008.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Do enthalpy and entropy distinguish first in class from best in class?</span></div><div class="casAuthors">Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19/20</span>),
    <span class="NLM_cas:pages">869-874</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A drug mol. should bind to its target with high affinity and selectivity.  Because the binding affinity is a combined function of the binding enthalpy and the binding entropy, extremely high affinity requires that both terms contribute favorably to binding.  The binding enthalpy, however, is notoriously more difficult to optimize than the binding entropy, a fact that has resulted in thermodynamically unbalanced mols. that do not achieve optimal potency.  In fact, with current technologies, the enthalpic optimization of drug candidates may take years and only appear in second-generation products.  Within that context, it is not surprising that structure/activity relationships (SARs) that explicitly incorporate the interplay between enthalpy and entropy and accelerate the optimization process are being developed and gaining popularity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5swEhu922BbVg90H21EOLACvtfcHk0lhiB2CndR-mPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCgu7fN&md5=357358107c5686a1863a83291c1cdd92</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2008.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2008.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DDo%2520enthalpy%2520and%2520entropy%2520distinguish%2520first%2520in%2520class%2520from%2520best%2520in%2520class%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D869%26epage%3D874%26doi%3D10.1016%2Fj.drudis.2008.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmikanth, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaithra, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro-Faria-Neto, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marathe, G. K.</span></span> <span> </span><span class="NLM_article-title">Sepsis: in search of cure</span>. <i>Inflammation Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">587</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.1007/s00011-016-0937-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1007%2Fs00011-016-0937-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26995266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFCmtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=587-602&author=C.+L.+Lakshmikanthauthor=S.+P.+Jacobauthor=V.+H.+Chaithraauthor=H.+C.+de+Castro-Faria-Netoauthor=G.+K.+Marathe&title=Sepsis%3A+in+search+of+cure&doi=10.1007%2Fs00011-016-0937-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Sepsis: in search of cure</span></div><div class="casAuthors">Lakshmikanth, Chikkamenahalli Lakshminarayana; Jacob, Shancy Petsel; Chaithra, Vyala Hanumanthareddy; de Castro-Faria-Neto, Hugo Caire; Marathe, Gopal Kedihithlu</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">587-602</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Introduction: Sepsis is a complex inflammatory disorder believed to originate from an infection by any types of microbes and/or their products.  It is the leading cause of death in intensive care units (ICUs) throughout the globe.  The mortality rates depend both on the severity of infection and the host's response to infection.  Methods: Literature survey on pathobiol. of sepsis in general and failure of more than hundred clin. trials conducted so far in search of a possible cure for sepsis resulted in the prepn. of this manuscript.  Findings: Sepsis lacks a suitable animal model that mimics human sepsis.  However, based on the results obtained in animal models of sepsis, clin. trials conducted so far have been disappointing.  Although involvement of multiple mediators and pathways in sepsis has been recognized, only few components are being targeted and this could be the major reason behind the failure of clin. trials.  Conclusion: Inability to recognize a single crit. mediator of sepsis may be the underlying cause for the poor therapeutic intervention of sepsis.  Therefore, sepsis is still considered as a disease-in search of cure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE-ssoMOjgf7Vg90H21EOLACvtfcHk0lj8WQQw0_2DXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFCmtLw%253D&md5=d1c35ca72492af904d543069144a46e4</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1007%2Fs00011-016-0937-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00011-016-0937-y%26sid%3Dliteratum%253Aachs%26aulast%3DLakshmikanth%26aufirst%3DC.%2BL.%26aulast%3DJacob%26aufirst%3DS.%2BP.%26aulast%3DChaithra%26aufirst%3DV.%2BH.%26aulast%3Dde%2BCastro-Faria-Neto%26aufirst%3DH.%2BC.%26aulast%3DMarathe%26aufirst%3DG.%2BK.%26atitle%3DSepsis%253A%2520in%2520search%2520of%2520cure%26jtitle%3DInflammation%2520Res.%26date%3D2016%26volume%3D65%26spage%3D587%26epage%3D602%26doi%3D10.1007%2Fs00011-016-0937-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">Leonurine alleviates LPS-induced myocarditis through suppressing the NF-κB signaling pathway</span>. <i>Toxicology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>422</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1016/j.tox.2019.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.tox.2019.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31005592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotVKnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=422&publication_year=2019&pages=1-13&author=R.+Wangauthor=D.+Liauthor=J.+Ouyangauthor=X.+Tianauthor=Y.+Zhaoauthor=X.+Pengauthor=S.+Liauthor=G.+Yuauthor=J.+Yang&title=Leonurine+alleviates+LPS-induced+myocarditis+through+suppressing+the+NF-%CE%BAB+signaling+pathway&doi=10.1016%2Fj.tox.2019.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Leonurine alleviates LPS-induced myocarditis through suppressing the NF-κB signaling pathway</span></div><div class="casAuthors">Wang, Ruiyu; Li, Dan; Ouyang, Jing; Tian, Xiaocui; Zhao, Yongpeng; Peng, Xin; Li, Siyu; Yu, Guiquan; Yang, Jiadan</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">422</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">TXCYAC</span>;
        ISSN:<span class="NLM_cas:issn">0300-483X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Myocarditis is a serious hazard to human life and is difficult to treat due to the proliferation of inflammatory lesions in the myocardium.  Leonurine (LE) is a plant phenolic alkaloid extd. from Herba leonuri that has demonstrated cardioprotective effects in many preclin. expts.  However, whether LE can be used for myocarditis therapy has not been reported.  We aimed to investigate the cardioprotective effects of LE on lipopolysaccharide (LPS)-induced myocarditis in vivo and vitro.  The possible mechanism involved was also further elucidated.  In vivo, C57BL/6 mice were exposed to LPS with or without LE.  We found out that LE effectively improved cardiac function and attenuated cardiomyocyte apoptosis in mice with myocarditis.  In addn., LPS-induced inflammatory and oxidative injuries in the myocardium were also reduced by LE administration.  In vitro, LPS simultaneously induced apoptosis and reduced the H9c2 cells viability, followed by elevation of intracellular reactive oxygen species (ROS) generation.  However, the abnormalities mentioned were preventable by LE pretreatment in a dose-dependent manner.  Both in vivo and in vitro, LPS activated the nuclear factor kappa B (NF-κB) signaling pathway in myocarditis, and LE inhibited the increased expression of phosphorylated iκBα and p65 (p-iκBα, p-p65).  Furthermore, the nuclear translocalization and nuclear protein expression of p65 in LPS-injured H9c2 cells were also suppressed by LE.  Our results demonstrated that LE exerts potent cardioprotective effects against myocarditis via anti-inflammatory and antioxidative mechanisms, possibly through blocking the activation of NF-κB pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvStSOBQbAtbVg90H21EOLACvtfcHk0lj8WQQw0_2DXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotVKnu7k%253D&md5=1748150aad2e82c8763a3488c7eb1628</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.tox.2019.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tox.2019.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DOuyang%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DLeonurine%2520alleviates%2520LPS-induced%2520myocarditis%2520through%2520suppressing%2520the%2520NF-%25CE%25BAB%2520signaling%2520pathway%26jtitle%3DToxicology%26date%3D2019%26volume%3D422%26spage%3D1%26epage%3D13%26doi%3D10.1016%2Fj.tox.2019.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potteti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kingsley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciano, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryuzoji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krunic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.08.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.ejmech.2015.08.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26363505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=252-268&author=A.+D.+Jainauthor=H.+Pottetiauthor=B.+G.+Richardsonauthor=L.+Kingsleyauthor=J.+P.+Lucianoauthor=A.+F.+Ryuzojiauthor=H.+Leeauthor=A.+Krunicauthor=A.+D.+Mesecarauthor=S.+P.+Reddyauthor=T.+W.+Moore&title=Probing+the+structural+requirements+of+non-electrophilic+naphthalene-based+Nrf2+activators&doi=10.1016%2Fj.ejmech.2015.08.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators</span></div><div class="casAuthors">Jain, Atul D.; Potteti, Haranatha; Richardson, Benjamin G.; Kingsley, Laura; Luciano, Julia P.; Ryuzoji, Aya F.; Lee, Hyun; Krunic, Aleksej; Mesecar, Andrew D.; Reddy, Sekhar P.; Moore, Terry W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">252-268</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Activation of the transcription factor Nrf2 has been posited to be a promising therapeutic strategy in a no. of inflammatory and oxidative stress diseases due to its regulation of detoxifying enzymes.  In this work, the authors have developed a comprehensive structure-activity relationship around a known, naphthalene-based nonelectrophilic activator of Nrf2, and the authors report highly potent nonelectrophilic activators of Nrf2.  Computational docking anal. of a subset of the compd. series demonstrates the importance of water mol. displacement for affinity, and the x-ray structure of di-amide I supports the computational anal.  One of the best compds., acid II, has an IC50 of 61 nM in a fluorescence anisotropy assay and a Kd of 120 nM in a surface plasmon resonance assay.  Addnl., the authors demonstrate that the Et ester of II is an efficacious inducer of Nrf2 target genes, exhibiting ex vivo efficacy similar to the well-known electrophilic activator, sulforaphane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzcvlMBGU0C7Vg90H21EOLACvtfcHk0lj8WQQw0_2DXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzJ&md5=750fd3ca47f1a122618942312390891b</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.08.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.08.049%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DPotteti%26aufirst%3DH.%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DKingsley%26aufirst%3DL.%26aulast%3DLuciano%26aufirst%3DJ.%2BP.%26aulast%3DRyuzoji%26aufirst%3DA.%2BF.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKrunic%26aufirst%3DA.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DProbing%2520the%2520structural%2520requirements%2520of%2520non-electrophilic%2520naphthalene-based%2520Nrf2%2520activators%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D103%26spage%3D252%26epage%3D268%26doi%3D10.1016%2Fj.ejmech.2015.08.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">Garcinia xanthones as orally active antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1021/jm301593r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301593r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12mtrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=276-292&author=X.+Zhangauthor=X.+Liauthor=H.+Sunauthor=X.+Wangauthor=L.+Zhaoauthor=Y.+Gaoauthor=X.+Liuauthor=S.+Zhangauthor=Y.+Wangauthor=Y.+Yangauthor=S.+Zengauthor=Q.+Guoauthor=Q.+You&title=Garcinia+xanthones+as+orally+active+antitumor+agents&doi=10.1021%2Fjm301593r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Garcinia Xanthones as Orally Active Antitumor Agents</span></div><div class="casAuthors">Zhang, Xiaojin; Li, Xiang; Sun, Haopeng; Wang, Xiaojian; Zhao, Li; Gao, Yuan; Liu, Xiaorong; Zhang, Shenglie; Wang, Yanyan; Yang, Yingrui; Zeng, Su; Guo, Qinglong; You, Qidong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">276-292</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using a newly developed strategy whose key step is the regioselective propargylation of hydroxyxanthone substrates, 99 structurally diverse Garcinia natural-product-like xanthones based on gambogic acid (I) were designed and synthesized and their in vitro antitumor activity was evaluated.  A set of 40 related compds. was chosen for detn. of their physicochem. properties including polar surface area, log D7.4, aq. soly., and permeability at pH 7.4.  In the light of the in vitro antitumor activity and the physicochem. properties, two compds. were advanced into in vivo efficacy expts.  The antitumor activity of compd. II, administered po, showed more potent in vivo oral antitumor activity than I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqJ6MSA783vrVg90H21EOLACvtfcHk0ljTPDeRe0pi8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12mtrrF&md5=b73d84edf3a627797da0d514abdc8e69</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm301593r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301593r%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3DGarcinia%2520xanthones%2520as%2520orally%2520active%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D276%26epage%3D292%26doi%3D10.1021%2Fjm301593r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jakob S. Pallesen, Dilip Narayanan, Kim T. Tran, Sara M. Ø. Solbak, Giuseppe Marseglia, Louis M. E. Sørensen, Lars J. Høj, Federico Munafò, Rosa M. C. Carmona, Anthony D. Garcia, Haritha L. Desu, Roberta Brambilla, Tommy N. Johansen, Grzegorz M. Popowicz, Michael Sattler, Michael Gajhede, <span class="NLM_string-name hlFld-ContribAuthor">Anders Bach</span>. </span><span class="cited-content_cbyCitation_article-title">Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4623-4661. <a href="https://doi.org/10.1021/acs.jmedchem.0c02094" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02094%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDeconstructing%252BNoncovalent%252BKelch-like%252BECH-Associated%252BProtein%252B1%252B%252528Keap1%252529%252BInhibitors%252Binto%252BFragments%252Bto%252BReconstruct%252BNew%252BPotent%252BCompounds%26aulast%3DPallesen%26aufirst%3DJakob%2BS.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D03122020%26date%3D05042021%26volume%3D64%26issue%3D8%26spage%3D4623%26epage%3D4661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Le  Zhang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Xu</span>, <span class="hlFld-ContribAuthor ">Haihu  Chen</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chengguo  Xing</span>, <span class="hlFld-ContribAuthor ">Zhuo  Qu</span>, <span class="hlFld-ContribAuthor ">Jianqiang  Yu</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injury. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113599. <a href="https://doi.org/10.1016/j.ejmech.2021.113599" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113599%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bmolecular%252Bhybridization%252Bdesign%252Bof%252BKeap1-Nrf2%252Binhibitors%252Bas%252Bnovel%252Bprotective%252Bagents%252Bof%252Bacute%252Blung%252Binjury%26aulast%3DZhang%26aufirst%3DLe%26date%3D2021%26volume%3D222%26spage%3D113599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dionysios V.  Chartoumpekis</span>, <span class="hlFld-ContribAuthor ">Chun-Yan  Fu</span>, <span class="hlFld-ContribAuthor ">Panos G.  Ziros</span>, <span class="hlFld-ContribAuthor ">Gerasimos P.  Sykiotis</span>. </span><span class="cited-content_cbyCitation_article-title">Patent Review (2017–2020) of the Keap1/Nrf2 Pathway Using PatSeer Pro: Focus on Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2020,</strong> <em>9 </em>
                                    (11)
                                     , 1138. <a href="https://doi.org/10.3390/antiox9111138" title="DOI URL">https://doi.org/10.3390/antiox9111138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox9111138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox9111138%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DPatent%252BReview%252B%2525282017%2525E2%252580%2525932020%252529%252Bof%252Bthe%252BKeap1%25252FNrf2%252BPathway%252BUsing%252BPatSeer%252BPro%25253A%252BFocus%252Bon%252BAutoimmune%252BDiseases%26aulast%3DChartoumpekis%26aufirst%3DDionysios%2BV.%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D11%26spage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0033.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic diagram for the regulation of Nrf2 activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of representative Nrf2 activators. (A) Subpockets of the Keap1 binding cavity based on the Keap1-Nrf2 ETGE complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1X2R">1X2R</a>); (B) electrophilic activators of Nrf2; (C) representative non-electrophilic Keap1-Nrf2 PPI inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design of compound <b>10a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design of indoline compound <b>11a</b> and initial SAR investigation of this structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Proposed binding mode of compound <b>14c</b> with Keap1 using molecular docking and design of acyl sulfonamide derivatives. (A) Binding mode of <b>14c</b> with Keap1 using a docking method. The docking site was derived from the position of the small-molecular ligand cocrystallized in the binding site of Keap1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XMB">4XMB</a>). The ligand is represented as sticks. Hydrogen bonds are represented by green dashed lines, and electrostatic interactions are represented by orange dashed lines. The π–π interactions are represented by pink dashed lines. The carbon atoms of small molecules and Keap1 residues are colored cyan and purple, respectively. (B) Design of acyl sulfonamide derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Proposed binding mode of compounds <b>16w</b> (A) and <b>19a</b> (B) with Keap1 using molecular docking. The docking site was derived from the position of the small-molecular ligand cocrystallized in the binding site of Keap1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XMB">4XMB</a>). The ligand is represented as sticks. Hydrogen bonds are represented by green dashed lines, and electrostatic interactions are represented by orange dashed lines. The π–π interactions are represented by pink dashed lines. The carbon atoms of small molecules and Keap1 residues are colored cyan and purple, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Keap1 Binding Properties of selected compounds. (A) ITC titration profiles of Keap1 Kelch Domain with compounds <b>15</b>, <b>16w</b>, and <b>19a</b> (<b>15</b>: 0.02 mM Keap1 Kelch domain was titrated with 0.2 mM compound <b>15</b>; <b>16w</b>: 0.02 mM Keap1 Kelch domain was titrated with 0.2 mM compound <b>16w</b>; <b>19a</b>: 0.02 mM Keap1 Kelch domain was titrated with 0.2 mM compound <b>19a</b>). The thermodynamic parameters of the interaction of Keap1 with compounds as determined by the ITC assay were listed in the table. <i>N</i> is the stoichiometric coefficient. <i>K</i><sub>d</sub> is the binding constant. Δ<i>H</i>, Δ<i>S</i>, and Δ<i>G</i> refer to the changes in binding enthalpy, entropy, and total Gibbs free energy, respectively. Δ<i>G</i> is calculated according to the equation Δ<i>G</i> = Δ<i>H</i> – <i>T</i>Δ<i>S</i>, where <i>T</i> is the absolute temperature used for the ITC experiment. (B) BLI dose–response curve reflecting the direct binding of <b>19a</b> to Keap1. The binding kinetics parameters were listed in the table. <i>K</i><sub>d</sub> value is calculated by <i>k</i><sub>dis</sub>/<i>k</i><sub>on</sub>. Concentrations: 100, 50, 20, and 5 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Nrf2 activation effects of <b>19a</b> on H9c2 cells. (A) Cells were exposed to <b>19a</b> at various concentrations for 12 h, (B) cells were exposed to 10 μM <b>19a</b> at various time points; the mRNA levels of Nrf2 and Nrf2-targeted genes were determined by qRT-PCR analysis. GAPDH was used to normalize the expression of these genes. Additional H9c2 cells were treated with DMSO for use as the blank control. The values shown are the means ± SEM (<i>n</i> = 3 independent observations). ***<i>p</i> < 0.001, **<i>p</i> < 0.01, and *<i>p</i> < 0.05, one-way ANOVA with Tukey–Kramer posttest. (C) Cells were exposed to <b>19a</b> at various concentrations for 12 h, (D) cells were exposed to 10 μM <b>19a</b> at various time points, the protein levels of Nrf2 and Nrf2-regulated proteins were determined by western blot analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effects of <b>19a</b> against LPS-induced injury in H9c2 cells. (A) Concentration-dependent protective effects of <b>19a</b> against the LPS-induced cell damage. Cells were pretreated with 0.1–10 μM <b>19a</b> for 12 h and then exposed to 1 μg/mL LPS for an additional 12 h. The cell viability was determined by the MTT assay. (B–D) Cells were pretreated with 1–10 μM <b>19a</b> for 12 h and then exposed to 1 μg/mL LPS for an additional 12 h, and the ratios of IL-1β (B), IL-6 (C), and TNF-α (D) were determined. The values shown are the means ± SEM (<i>n</i> = 3 independent observations). **<i>p</i> < 0.01 and ***<i>p</i> < 0.001, one-way ANOVA with the Tukey–Kramer post-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Antioxidative effects of <b>19a</b> against LPS-induced injury in H9c2 cells. (A) GSH/GSSG ratio in H9c2 cells was measured. The H9c2 cells were pretreated with 0.1–10 μM <b>19a</b> for 12 h and then exposed to 1 μg/mL LPS for an additional 12 h. The values shown are the means ± SEM (<i>n</i> = 3 independent observations). *<i>p</i> < 0.05, **<i>p</i> < 0.01, one-way ANOVA with Tukey–Kramer posttest. (B) Living cell microscopy. The H9c2 cells were pretreated with 10 μM <b>19a</b> for 12 h and then exposed to 1 μg/mL LPS for an additional 12 h. After this treatment, the H9c2 cells were stained with 10 μM cH2DCF-DA for 20 min at 37 °C and living cell fluorescence microscopy was performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Protective effects of <b>19a</b> against LPS-challenged damage in the mouse heart tissues. (A) Representative photomicrographs (400×) of H&E-stained heart sections from mice. The levels of serum IL-1β (B), IL-6 (C), and TNF-α (D) were measured (<i>n</i> = 8 mice/group). The values shown are the means ± SEM *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001, one-way ANOVA with the Tukey–Kramer post-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Antioxidative effects of <b>19a</b> against LPS-challenged damage in the mouse heart tissues. (A) Immunohistochemical detection of Nrf2 together with its target proteins HO-1, NQO1, and GCLM levels in the heart tissue from mice. Magnifications × 200. The ROS level (B) and the GSH/GSSG ratio (C) were measured in the mouse hearts. The values shown are the means ± SEM **<i>p</i> < 0.01, and ***<i>p</i> < 0.001, one-way ANOVA with the Tukey–Kramer post-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Target Compound <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>, Pd/C, MeOH, r.t., 2 h; (b) 2,4,6-trimethylphenylsulfonyl chloride, pyridine, THF, r.t., 10 h, 72%; (c) BrCH<sub>2</sub>COOCH<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 2 h, 74%; (d) LiOH, MeOH/H<sub>2</sub>O, 4 h, 75%.</p></p></figure><figure data-id="sch2" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Target Compound <b>10a–10i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Tf<sub>2</sub>O, TEA, DCM, 0 °C to r.t. 2 h, 60–75%; (b) Pd(AcO)<sub>2</sub>, Xantphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 38–75%; (c) H<sub>2</sub>, Pd/C, MeOH, r.t. 2 h; (d) 2,4,6-trimethylphenylsulfonyl chloride, pyridine, THF, r.t. 10 h, 50–70%; (e) BrCH<sub>2</sub>COOCH<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 2 h, 80–85%; (d) LiOH, MeOH/H<sub>2</sub>O, 4 h, 70–90%.</p></p></figure><figure data-id="sch3" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Target Compound <b>11a–11f</b> and <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cu(AcO)<sub>2</sub>, TEA, DCM, r.t. 4 h, 70%; (b) NaBH<sub>3</sub>CN, TFA, DCM, 0 °C to r.t. 2 h, 66%; (c) H<sub>2</sub>, Pd/C, MeOH, r.t. 2 h; (d) pyridine, THF, r.t. 10 h, 50–70%; (e) BrCH<sub>2</sub>COOCH<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 2 h, 70–85%; (f) LiOH, MeOH/H<sub>2</sub>O, 10 h, 70–80%.</p></p></figure><figure data-id="sch4" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0017.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Target Compound <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Fe(OTf)<sub>2</sub>, Hantzsch ester, CHCl<sub>3</sub>, 40 °C, 4 h, 60%; (b) Cu(AcO)<sub>2</sub>, TEA, DCM, r.t. 4 h, 55%; (c) H<sub>2</sub>, Pd/C, MeOH, r.t. 2 h; (d) pyridine, THF, r.t. 4 h, 52%; (e) BrCH<sub>2</sub>COOCH<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 2 h, 75%; (f) LiOH, MeOH/H<sub>2</sub>O, 10 h, 76%.</p></p></figure><figure data-id="sch5" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0018.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Target Compound <b>14a–14c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, TEA, DCM, r.t., 2 h, 71%; (b) H<sub>2</sub>, Pd/C, MeOH, 60 °C, 10 h; (c) pyridine, THF, r.t. 4 h, 53% (d) BrCH<sub>2</sub>COOCH<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 2 h, 75%; (e) CF<sub>3</sub>COOH, DCM, r.t., 1 h, 75%; (f) NaH, DMF, 60 °C, 2–6 h, 40–80%; (g) LiOH, MeOH/H<sub>2</sub>O, 1–6 h, 60–90%.</p></p></figure><figure data-id="sch6" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0019.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Target Compound <b>15</b> and <b>16a–16e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaBH<sub>3</sub>CN, TFA, DCM, r.t. 2 h, 75%; (b) NBS, AIBN, CCl<sub>4</sub>, 80 °C, 4 h, 65%; (c) NaH, DMF, r.t. 4 h, 50%; (d) LiOH, MeOH/H<sub>2</sub>O, r.t. 2 h, 80%; (e) substituted sulfonamides, EDCI, DMAP, DCM, 35 °C, 2–6 h, 30–70%; (f) SnCl<sub>2</sub>, EA, 80 °C, 4 h; (g) pyridine, THF, 80 °C, 4 h, 30–65%; (h) K<sub>2</sub>CO<sub>3</sub>, DMF, r.t. 4 h, 58–82%; (i) LiOH, MeOH/H<sub>2</sub>O, r.t. 2 h, 60–86%.</p></p></figure><figure data-id="sch7" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0020.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Target Compound <b>17a–17h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SnCl<sub>2</sub>, EA, 80 °C, 4 h, 65%; (b) pyridine, THF, 80 °C, 4 h, 30–65%; (c) K<sub>2</sub>CO<sub>3</sub>, DMF, r.t. 4 h, 58–82%; (d) LiOH, MeOH/H<sub>2</sub>O, r.t. 2 h, 60–86%; (e) EDCI, DMAP, DCM, 35 °C, 2–6 h, 30–70%.</p></p></figure><figure data-id="sch8" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/medium/jm0c01116_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0021.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Target Compound <b>18a–18e</b> and <b>19a–19i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c01116/20201019/images/large/jm0c01116_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01116&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EDCI, DMAP, DCM, 35 °C, 2–6 h, 30–70%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34213" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34213" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 75 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress: a concept in redox biology and medicine</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2015.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.redox.2015.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=25588755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVGltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=180-183&author=H.+Sies&title=Oxidative+stress%3A+a+concept+in+redox+biology+and+medicine&doi=10.1016%2Fj.redox.2015.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress: a concept in redox biology and medicine</span></div><div class="casAuthors">Sies, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">180-183</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">"Oxidative stress" as a concept in redox biol. and medicine has been formulated in 1985; at the beginning of 2015, approx. 138,000 PubMed entries show for this term.  This concept has its merits and its pitfalls.  Among the merits is the notion, elicited by the combined two terms of (i) aerobic metab. as a steady-state redox balance and (ii) the assocd. potential strains in the balance as denoted by the term, stress, evoking biol. stress responses.  Current research on mol. redox switches governing oxidative stress responses is in full bloom.  The fundamental importance of linking redox shifts to phosphorylation/dephosphorylation signaling is being more fully appreciated, thanks to major advances in methodol.  Among the pitfalls is the fact that the underlying mol. details are to be worked out in each particular case, which is bvious for a global concept, but which is sometimes overlooked.  This can lead to indiscriminate use of the term, oxidative stress, without clear relation to redox chem.  The major role in antioxidant defense is fulfilled by antioxidant enzymes, not by small-mol. antioxidant compds.  The field of oxidative stress research embraces chem., biochem., cell biol., physiol. and pathophysiol., all the way to medicine and health and disease research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnLeGag99E8LVg90H21EOLACvtfcHk0lhdtRm_Awu-nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVGltA%253D%253D&md5=f6f8a5f836c1826e5486971bdab95ff0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2015.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2015.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DSies%26aufirst%3DH.%26atitle%3DOxidative%2520stress%253A%2520a%2520concept%2520in%2520redox%2520biology%2520and%2520medicine%26jtitle%3DRedox%2520Biol.%26date%3D2015%26volume%3D4%26spage%3D180%26epage%3D183%26doi%3D10.1016%2Fj.redox.2015.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. P.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species (ROS) as pleiotropic physiological signalling agents</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1038/s41580-020-0230-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1038%2Fs41580-020-0230-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=32231263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFKhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=363-383&author=H.+Siesauthor=D.+P.+Jones&title=Reactive+oxygen+species+%28ROS%29+as+pleiotropic+physiological+signalling+agents&doi=10.1038%2Fs41580-020-0230-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species (ROS) as pleiotropic physiological signalling agents</span></div><div class="casAuthors">Sies, Helmut; Jones, Dean P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">363-383</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: 'Reactive oxygen species' (ROS) is an umbrella term for an array of derivs. of mol. oxygen that occur as a normal attribute of aerobic life.  Elevated formation of the different ROS leads to mol. damage, denoted as 'oxidative distress'.  Here we focus on ROS at physiol. levels and their central role in redox signalling via different post-translational modifications, denoted as 'oxidative eustress'.  Two species, hydrogen peroxide (H2O2) and the superoxide anion radical (O2·-), are key redox signalling agents generated under the control of growth factors and cytokines by more than 40 enzymes, prominently including NADPH oxidases and the mitochondrial electron transport chain.  At the low physiol. levels in the nanomolar range, H2O2 is the major agent signalling through specific protein targets, which engage in metabolic regulation and stress responses to support cellular adaptation to a changing environment and stress.  In addn., several other reactive species are involved in redox signalling, for instance nitric oxide, hydrogen sulfide and oxidized lipids.  Recent methodol. advances permit the assessment of mol. interactions of specific ROS mols. with specific targets in redox signalling pathways.  Accordingly, major advances have occurred in understanding the role of these oxidants in physiol. and disease, including the nervous, cardiovascular and immune systems, skeletal muscle and metabolic regulation as well as ageing and cancer.  In the past, unspecific elimination of ROS by use of low mol. mass antioxidant compds. was not successful in counteracting disease initiation and progression in clin. trials.  However, controlling specific ROS-mediated signalling pathways by selective targeting offers a perspective for a future of more refined redox medicine.  This includes enzymic defense systems such as those controlled by the stress-response transcription factors NRF2 and nuclear factor-κB, the role of trace elements such as selenium, the use of redox drugs and the modulation of environmental factors collectively known as the exposome (for example, nutrition, lifestyle and irradn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUOGVldjysxrVg90H21EOLACvtfcHk0lhdtRm_Awu-nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFKhtrY%253D&md5=52e3327385f2c2910d1ffc5f4062eb77</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fs41580-020-0230-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41580-020-0230-3%26sid%3Dliteratum%253Aachs%26aulast%3DSies%26aufirst%3DH.%26aulast%3DJones%26aufirst%3DD.%2BP.%26atitle%3DReactive%2520oxygen%2520species%2520%2528ROS%2529%2520as%2520pleiotropic%2520physiological%2520signalling%2520agents%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2020%26volume%3D21%26spage%3D363%26epage%3D383%26doi%3D10.1038%2Fs41580-020-0230-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. P.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-061516-045037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1146%2Fannurev-biochem-061516-045037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=28441057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFels70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2017&pages=715-748&author=H.+Siesauthor=C.+Berndtauthor=D.+P.+Jones&title=Oxidative+stress&doi=10.1146%2Fannurev-biochem-061516-045037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress</span></div><div class="casAuthors">Sies, Helmut; Berndt, Carsten; Jones, Dean P.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">715-748</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">Oxidative stress is two sided: Whereas excessive oxidant challenge causes damage to biomols., maintenance of a physiol. level of oxidant challenge, termed oxidative eustress, is essential for governing life processes through redox signaling.  Recent interest has focused on the intricate ways by which redox signaling integrates these converse properties.  Redox balance is maintained by prevention, interception, and repair, and concomitantly the regulatory potential of mol. thiol-driven master switches such as Nrf2/Keap1 or NF-κB/IκB is used for system-wide oxidative stress response.  Nonradical species such as hydrogen peroxide (H2O2) or singlet mol. oxygen, rather than free-radical species, perform major second messenger functions.  Chemokine-controlled NADPH oxidases and metabolically controlled mitochondrial sources of H2O2 as well as glutathione- and thioredoxin-related pathways, with powerful enzymic back-up systems, are responsible for fine-tuning physiol. redox signaling.  This makes for a rich research field spanning from biochem. and cell biol. into nutritional sciences, environmental medicine, and mol. knowledge-based redox medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqYthGbEMU0LVg90H21EOLACvtfcHk0liYI__ofgjOgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFels70%253D&md5=910b7e9fa8ebd3b7dba6497f8212d4de</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-061516-045037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-061516-045037%26sid%3Dliteratum%253Aachs%26aulast%3DSies%26aufirst%3DH.%26aulast%3DBerndt%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DD.%2BP.%26atitle%3DOxidative%2520stress%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2017%26volume%3D86%26spage%3D715%26epage%3D748%26doi%3D10.1146%2Fannurev-biochem-061516-045037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, C. A.</span></span> <span> </span><span class="NLM_article-title">Redoxins as gatekeepers of the transcriptional oxidative stress response</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">101104</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2019.101104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.redox.2019.101104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=30690320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFersr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=101104&author=B.+L.+Hopkinsauthor=C.+A.+Neumann&title=Redoxins+as+gatekeepers+of+the+transcriptional+oxidative+stress+response&doi=10.1016%2Fj.redox.2019.101104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Redoxins as gatekeepers of the transcriptional oxidative stress response</span></div><div class="casAuthors">Hopkins, Barbara L.; Neumann, Carola A.</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101104</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Transcription factors control the rate of transcription of genetic information from DNA to mRNA, by binding specific DNA sequences in promoter regions.  Transcriptional gene control is a rate-limiting process that is tightly regulated and based on transient environmental signals which are translated into long-term changes in gene transcription.  Post-translational modifications (PTMs) on transcription factors by phosphorylation or acetylation have profound effects not only on sub-cellular localization but also on substrate specificity through changes in DNA binding capacity.  During times of cellular stress, specific transcription factors are in place to help protect the cell from damage by initiating the transcription of antioxidant response genes.  Here we discuss PTMs caused by reactive oxygen species (ROS), such as H2O2, that can expeditiously regulate the activation of transcription factors involved in the oxidative stress response.  Part of this rapid regulation are proteins involved in H2O2-related redn. and oxidn. (redox) reactions such as redoxins, H2O2 scavengers described to interact with transcription factors.  Redoxins have highly reactive cysteines of rate consts. around 6-10-1 s-1 that engage in nucleophilic substitution of a thiol-disulfide with another thiol in inter-disulfide exchange reactions.  We propose here that H2O2 signal transduction induced inter-disulfide exchange reactions between redoxin cysteines and cysteine thiols of transcription factors to allow for rapid and precise on and off switching of transcription factor activity.  Thus, redoxins are essential modulators of stress response pathways beyond H2O2 scavenging capacity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOZ6uptNlkJrVg90H21EOLACvtfcHk0liYI__ofgjOgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFersr8%253D&md5=4737bb069212b67c503f0043212e57d4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2019.101104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2019.101104%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DB.%2BL.%26aulast%3DNeumann%26aufirst%3DC.%2BA.%26atitle%3DRedoxins%2520as%2520gatekeepers%2520of%2520the%2520transcriptional%2520oxidative%2520stress%2520response%26jtitle%3DRedox%2520Biol.%26date%3D2019%26volume%3D21%26spage%3D101104%26doi%3D10.1016%2Fj.redox.2019.101104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswal, S.</span></span> <span> </span><span class="NLM_article-title">Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1146/annurev.pharmtox.46.120604.141046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1146%2Fannurev.pharmtox.46.120604.141046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=16968214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1altrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=89-116&author=T.+W.+Kenslerauthor=N.+Wakabayashiauthor=S.+Biswal&title=Cell+survival+responses+to+environmental+stresses+via+the+Keap1-Nrf2-ARE+pathway&doi=10.1146%2Fannurev.pharmtox.46.120604.141046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway</span></div><div class="casAuthors">Kensler, Thomas W.; Wakabayashi, Nobunao; Biswal, Shyam</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-116</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Keap1-Nrf2-ARE signaling plays a significant role in protecting cells from endogenous and exogenous stresses.  The development of Nrf2 knockout mice has provided key insights into the toxicol. importance of this pathway.  These mice are more sensitive to the hepatic, pulmonary, ovarian, and neurotoxic consequences of acute exposures to environmental agents and drugs, inflammatory stresses, as well as chronic exposures to cigarette smoke and other carcinogens.  Under quiescent conditions, the transcription factor Nrf2 interacts with the actin-anchored protein Keap1, largely localized in the cytoplasm.  This quenching interaction maintains low basal expression of Nrf2-regulated genes.  However, upon recognition of chem. signals imparted by oxidative and electrophilic mols., Nrf2 is released from Keap1, escapes proteasomal degrdn., translocates to the nucleus, and transactivates the expression of several dozen cytoprotective genes that enhance cell survival.  This review highlights the key elements in this adaptive response to protection against acute and chronic cell injury provoked by environmental stresses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAmRpcXFLXq7Vg90H21EOLACvtfcHk0liYI__ofgjOgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1altrg%253D&md5=eee9260ebe6186b82da647701a10c7e2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.46.120604.141046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.46.120604.141046%26sid%3Dliteratum%253Aachs%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DBiswal%26aufirst%3DS.%26atitle%3DCell%2520survival%2520responses%2520to%2520environmental%2520stresses%2520via%2520the%2520Keap1-Nrf2-ARE%2520pathway%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D89%26epage%3D116%26doi%3D10.1146%2Fannurev.pharmtox.46.120604.141046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span> <span> </span><span class="NLM_article-title">The Keap1-Nrf2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1169</span>– <span class="NLM_lpage">1203</span>, <span class="refDoi"> DOI: 10.1152/physrev.00023.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1152%2Fphysrev.00023.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=29717933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvFektrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2018&pages=1169-1203&author=M.+Yamamotoauthor=T.+W.+Kenslerauthor=H.+Motohashi&title=The+Keap1-Nrf2+system%3A+a+thiol-based+sensor-effector+apparatus+for+maintaining+redox+homeostasis&doi=10.1152%2Fphysrev.00023.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis</span></div><div class="casAuthors">Yamamoto, Masayuki; Kensler, Thomas W.; Motohashi, Hozumi</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1169-1203</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">1522-1210</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The Kelch-like ECH-assocd. protein 1-NF-E2-related factor 2 (KEAP1-NRF2) system forms the major node of cellular and organismal defense against oxidative and electrophilic stresses of both exogenous and endogenous origins.  KEAP1 acts as a cysteine thiol-rich sensor of redox insults, whereas NRF2 is a transcription factor that robustly transduces chem. signals to regulate a battery of cytoprotective genes.  KEAP1 represses NRF2 activity under quiescent conditions, whereas NRF2 is liberated from KEAP1-mediated repression on exposure to stresses.  The rapid inducibility of a response based on a derepression mechanism is an important feature of the KEAP1-NRF2 system.  Recent studies have unveiled the complexities of the functional contributions of the KEAP1-NRF2 system and defined its broader involvement in biol. processes, including cell proliferation and differentiation, as well as cytoprotection.  In this review, we describe historical milestones in the initial characterization of the KEAP1-NRF2 system and provide a comprehensive overview of the mol. mechanisms governing the functions of KEAP1 and NRF2, as well as their roles in physiol. and pathol.  We also refer to the clin. significance of the KEAP1-NRF2 system as an important prophylactic and therapeutic target for various diseases, particularly aging-related disorders.  We believe that controlled harnessing of the KEAP1-NRF2 system is a key to healthy aging and well-being in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohbdKIhBBbkLVg90H21EOLACvtfcHk0lgi7QHyT5Pluw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvFektrc%253D&md5=906947c8ad97c48f60e46bc44103664a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00023.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00023.2017%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DMotohashi%26aufirst%3DH.%26atitle%3DThe%2520Keap1-Nrf2%2520system%253A%2520a%2520thiol-based%2520sensor-effector%2520apparatus%2520for%2520maintaining%2520redox%2520homeostasis%26jtitle%3DPhysiol.%2520Rev.%26date%3D2018%26volume%3D98%26spage%3D1169%26epage%3D1203%26doi%3D10.1152%2Fphysrev.00023.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raghunath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundarraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagarajan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arfuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perumal, E.</span></span> <span> </span><span class="NLM_article-title">Antioxidant response elements: Discovery, classes, regulation and potential applications</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2018.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.redox.2018.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=29775961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsFyisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=297-314&author=A.+Raghunathauthor=K.+Sundarrajauthor=R.+Nagarajanauthor=F.+Arfusoauthor=J.+Bianauthor=A.+P.+Kumarauthor=G.+Sethiauthor=E.+Perumal&title=Antioxidant+response+elements%3A+Discovery%2C+classes%2C+regulation+and+potential+applications&doi=10.1016%2Fj.redox.2018.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant response elements: Discovery, classes, regulation and potential applications</span></div><div class="casAuthors">Raghunath, Azhwar; Sundarraj, Kiruthika; Nagarajan, Raju; Arfuso, Frank; Bian, Jinsong; Kumar, Alan P.; Sethi, Gautam; Perumal, Ekambaram</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">297-314</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Exposure to antioxidants and xenobiotics triggers the expression of a myriad of genes encoding antioxidant proteins, detoxifying enzymes, and xenobiotic transporters to offer protection against oxidative stress.  This articulated universal mechanism is regulated through the cis-acting elements in an array of Nrf2 target genes called antioxidant response elements (AREs), which play a crit. role in redox homeostasis.  Though the Keap1/Nrf2/ARE system involves many players, AREs hold the key in transcriptional regulation of cytoprotective genes.  ARE-mediated reporter constructs have been widely used, including xenobiotics profiling and Nrf2 activator screening.  The complexity of AREs is brought by the presence of other regulatory elements within the AREs.  The diversity in the ARE sequences not only bring regulatory selectivity of diverse transcription factors, but also confer functional complexity in the Keap1/Nrf2/ARE pathway.  The different transcription factors either homodimerize or heterodimerize to bind the AREs.  Depending on the nature of partners, they may activate or suppress the transcription.  Attention is required for deeper mechanistic understanding of ARE-mediated gene regulation.  The computational methods of identification and anal. of AREs are still in their infancy.  Investigations are required to know whether epigenetics mechanism plays a role in the regulation of genes mediated through AREs.  The polymorphisms in the AREs leading to oxidative stress related diseases are warranted.  A thorough understanding of AREs will pave the way for the development of therapeutic agents against cancer, neurodegenerative, cardiovascular, metabolic and other diseases with oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSoPiaGGwAKrVg90H21EOLACvtfcHk0lgi7QHyT5Pluw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsFyisr4%253D&md5=39420cc829e32fea49b404be47aad9e6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2018.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2018.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DRaghunath%26aufirst%3DA.%26aulast%3DSundarraj%26aufirst%3DK.%26aulast%3DNagarajan%26aufirst%3DR.%26aulast%3DArfuso%26aufirst%3DF.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DA.%2BP.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DPerumal%26aufirst%3DE.%26atitle%3DAntioxidant%2520response%2520elements%253A%2520Discovery%252C%2520classes%252C%2520regulation%2520and%2520potential%2520applications%26jtitle%3DRedox%2520Biol.%26date%3D2018%26volume%3D17%26spage%3D297%26epage%3D314%26doi%3D10.1016%2Fj.redox.2018.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">The Nrf2 regulatory network provides an interface between redox and intermediary metabolism</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2014.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.tibs.2014.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=24647116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksVWrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=199-218&author=J.+D.+Hayesauthor=A.+T.+Dinkova-Kostova&title=The+Nrf2+regulatory+network+provides+an+interface+between+redox+and+intermediary+metabolism&doi=10.1016%2Fj.tibs.2014.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The Nrf2 regulatory network provides an interface between redox and intermediary metabolism</span></div><div class="casAuthors">Hayes, John D.; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">199-218</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2, also called Nfe2l2) is a transcription factor that regulates the cellular redox status.  Nrf2 is controlled through a complex transcriptional/epigenetic and post-translational network that ensures its activity increases during redox perturbation, inflammation, growth factor stimulation and nutrient/energy fluxes, thereby enabling the factor to orchestrate adaptive responses to diverse forms of stress.  Besides mediating stress-stimulated induction of antioxidant and detoxification genes, Nrf2 contributes to adaptation by upregulating the repair and degrdn. of damaged macromols., and by modulating intermediary metab.  In the latter case, Nrf2 inhibits lipogenesis, supports β-oxidn. of fatty acids, facilitates flux through the pentose phosphate pathway, and increases NADPH regeneration and purine biosynthesis; these observations suggest Nrf2 directs metabolic reprogramming during stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLTtgJA1rMbVg90H21EOLACvtfcHk0lgi7QHyT5Pluw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksVWrtLg%253D&md5=790c66c48218229dc5531d24aefaceef</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2014.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2014.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DThe%2520Nrf2%2520regulatory%2520network%2520provides%2520an%2520interface%2520between%2520redox%2520and%2520intermediary%2520metabolism%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2014%26volume%3D39%26spage%3D199%26epage%3D218%26doi%3D10.1016%2Fj.tibs.2014.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giampieri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pistollato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittalà, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallarino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atanasov, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. M.</span></span> <span> </span><span class="NLM_article-title">Nrf2 as regulator of innate immunity: A molecular Swiss army knife!</span>. <i>Adv</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">370</span>, <span class="refDoi"> DOI: 10.1016/j.biotechadv.2017.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.biotechadv.2017.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVCktLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2018&pages=358-370&author=M.+Battinoauthor=F.+Giampieriauthor=F.+Pistollatoauthor=A.+Suredaauthor=M.+R.+de+Oliveiraauthor=V.+Pittal%C3%A0author=F.+Fallarinoauthor=S.+F.+Nabaviauthor=A.+G.+Atanasovauthor=S.+M.+Nabavi&title=Nrf2+as+regulator+of+innate+immunity%3A+A+molecular+Swiss+army+knife%21&doi=10.1016%2Fj.biotechadv.2017.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 as regulator of innate immunity: A molecular Swiss army knife!</span></div><div class="casAuthors">Battino, Maurizio; Giampieri, Francesca; Pistollato, Francesca; Sureda, Antoni; de Oliveira, Marcos Roberto; Pittala, Valeria; Fallarino, Francesca; Nabavi, Seyed Fazel; Atanasov, Atanas Georgiev; Nabavi, Seyed Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology Advances</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">358-370</span>CODEN:
                <span class="NLM_cas:coden">BIADDD</span>;
        ISSN:<span class="NLM_cas:issn">0734-9750</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Organisms are constantly exposed to a broad range of pathol. and stress-inducing agents, allergens and environmental chems. that can induce infections, toxicity or other undesirable reactions.  Our immune system has evolved over time in order to efficiently respond to these exogenous insults and maintain homeostasis.  In particular, the innate immune system acts as primary barrier to prevent the entrance of invasive agents or allergens.  This system is comprised of a diversity of cell types that are rapidly activated by recognition of common structures present in many potential pathogens known as pathogen-assocd. mol. patterns (PAMPs).  The nuclear factor erythroid 2 related factor 2 (Nrf2) is a relevant basic leucine zipper (bZIP) transcription factor that is essential in the regulation of cell cycle homeostasis, cytoprotection, and innate immunity when cells are under stressful conditions.  Although the role of Nrf2 in activating the expression of protective genes - such as antioxidant or anti-inflammatory - is known, its role in innate immunity and immune-related gene expression remains not yet clear.  The present review summarizes current knowledge on Nrf2 signaling pathway structure and activity under both physiol. state and upon oxidative stress.  In addn., the relation between Nrf2 signaling pathway and the innate immune system is discussed, highlighting the potential therapeutic effects of diverse natural and synthetic compds. as Nrf2 regulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOXg1Vd2SIzbVg90H21EOLACvtfcHk0lgi7QHyT5Pluw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVCktLnP&md5=e516646dab60025f553abfcabc3498f2</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.biotechadv.2017.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biotechadv.2017.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DBattino%26aufirst%3DM.%26aulast%3DGiampieri%26aufirst%3DF.%26aulast%3DPistollato%26aufirst%3DF.%26aulast%3DSureda%26aufirst%3DA.%26aulast%3Dde%2BOliveira%26aufirst%3DM.%2BR.%26aulast%3DPittal%25C3%25A0%26aufirst%3DV.%26aulast%3DFallarino%26aufirst%3DF.%26aulast%3DNabavi%26aufirst%3DS.%2BF.%26aulast%3DAtanasov%26aufirst%3DA.%2BG.%26aulast%3DNabavi%26aufirst%3DS.%2BM.%26atitle%3DNrf2%2520as%2520regulator%2520of%2520innate%2520immunity%253A%2520A%2520molecular%2520Swiss%2520army%2520knife%2521%26jtitle%3DAdv%26date%3D2018%26volume%3D36%26spage%3D358%26epage%3D370%26doi%3D10.1016%2Fj.biotechadv.2017.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of the negative regulator of Nrf2, Keap1: a historical overview</span>. <i>Antioxidants Redox Signal.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1665</span>– <span class="NLM_lpage">1678</span>, <span class="refDoi"> DOI: 10.1089/ars.2010.3222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1089%2Fars.2010.3222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=20446768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A280%3ADC%252BC3cfpslCqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1665-1678&author=K.+Itohauthor=J.+Mimuraauthor=M.+Yamamoto&title=Discovery+of+the+negative+regulator+of+Nrf2%2C+Keap1%3A+a+historical+overview&doi=10.1089%2Fars.2010.3222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the negative regulator of Nrf2, Keap1: a historical overview</span></div><div class="casAuthors">Itoh Ken; Mimura Junsei; Yamamoto Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & redox signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1665-78</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">An antioxidant response element (ARE) or an electrophile responsive element (EpRE) regulate the transcriptional induction of a battery of drug-detoxifying enzymes that are protective against electrophiles.  Based on the high similarity of the ARE consensus sequence to an erythroid gene regulatory element NF-E2 binding site, we have found that the transcription factor Nrf2 is indispensable for the ARE-mediated induction of drug-metabolizing enzymes.  Recent genome-wide analysis demonstrated that Nrf2 regulates hundreds of genes that are involved in the cytoprotective response against oxidative stress.  In-depth analysis of Nrf2 regulatory mechanisms has led us to the discovery of a novel protein, which we have named Keap1.  Keap1 suppresses Nrf2 activity by specifically binding to its evolutionarily conserved N-terminal Neh2 regulatory domain.  In this review article, we summarize the findings and observations that have lead to the discovery of the Nrf2-Keap1 system.  Furthermore, we briefly discuss the function of the Nrf2-Keap1 system under the regulation of the endogenous electrophilic compound 15-deoxy-Δ12(,)14-prostaglandin J2.  We propose that Nrf2-Keap1 plays a significant physiological role in the response to endogenous, environmental, and pharmacological electrophiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRyZscOwEJn96_dlEzl_fBafW6udTcc2eZppsp8huKuKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfpslCqtg%253D%253D&md5=8fd2db3b1c2b6d249ba2c2453af1b339</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3222%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DMimura%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520the%2520negative%2520regulator%2520of%2520Nrf2%252C%2520Keap1%253A%2520a%2520historical%2520overview%26jtitle%3DAntioxidants%2520Redox%2520Signal.%26date%3D2010%26volume%3D13%26spage%3D1665%26epage%3D1678%26doi%3D10.1089%2Fars.2010.3222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of the Keap1-Nrf2 system</span>. <i>Free Radic. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.freeradbiomed.2015.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26117331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Cku7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=93-100&author=T.+Suzukiauthor=M.+Yamamoto&title=Molecular+basis+of+the+Keap1-Nrf2+system&doi=10.1016%2Fj.freeradbiomed.2015.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of the Keap1-Nrf2 system</span></div><div class="casAuthors">Suzuki, Takafumi; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">93-100</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nrf2 (NF-E2-related factor 2) is a master regulator of cellular responses against environmental stresses.  Nrf2 induces the expression of detoxification and antioxidant enzymes, and Keap1 (Kelch-like ECH-assocd. protein 1), an adaptor subunit of Cullin 3-based E3 ubiquitin ligase, regulates Nrf2 activity.  Keap1 also acts as a sensor for oxidative and electrophilic stresses.  Keap1 retains multiple sensor cysteine residues that detect various stress stimuli.  Increasing attention has been paid to the roles that Nrf2 plays in the protection of our bodies against drug toxicity and stress-induced diseases.  On the other hand, Nrf2 is found to promote both oncogenesis and cancer cell resistance against chemotherapeutic drugs.  Thus, although Nrf2 acts to protect our body from deleterious stresses, cancer cells hijack the Nrf2 activity to support their malignant growth.  Nrf2 has emerged as a new therapeutic target, and both inducers and inhibitors of Nrf2 are awaited.  Studies challenging the mol. basis of the Keap1-Nrf2 system functions are now critically important to improve translational studies of the system.  Indeed, recent studies identified cross talk between Nrf2 and other signaling pathways, which provides new insights into the mechanisms by which the Keap1-Nrf2 system serves as a potent regulator of our health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3SXIMvWYgU7Vg90H21EOLACvtfcHk0liw0yp_sFmWTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Cku7bL&md5=893e5dbf9b3cfe85fd30590a4a93b49c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DMolecular%2520basis%2520of%2520the%2520Keap1-Nrf2%2520system%26jtitle%3DFree%2520Radic.%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D93%26epage%3D100%26doi%3D10.1016%2Fj.freeradbiomed.2015.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sihvola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levonen, A.-L.</span></span> <span> </span><span class="NLM_article-title">Keap1 as the redox sensor of the antioxidant response</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>617</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2016.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.abb.2016.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=27769838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOmsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=617&publication_year=2017&pages=94-100&author=V.+Sihvolaauthor=A.-L.+Levonen&title=Keap1+as+the+redox+sensor+of+the+antioxidant+response&doi=10.1016%2Fj.abb.2016.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 as the redox sensor of the antioxidant response</span></div><div class="casAuthors">Sihvola, Virve; Levonen, Anna-Liisa</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">617</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">94-100</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) and products of their reactions with cellular macromols. such as unsatd. fatty acids have been implicated to be important regulators of signalling processes via oxidn. or alkylation of redox active thiol residues in target proteins.  One of key redox-sensitive signalling proteins mediating the response to oxidant stress is Keap1 (Kelch-like erythroid cell-derived protein with CNC homol. [ECH]-assocd. protein 1), which is a neg. regulator of transcription factor Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) and the central hub for sensing endogenous and environmental oxidative and electrophilic stress.  In this review, we provide an overview of the mechanisms by which Keap1 orchestrates the antioxidant response and how the system can be targeted for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoedzLPG-iE6rVg90H21EOLACvtfcHk0liw0yp_sFmWTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOmsbbJ&md5=91157b893774abab7a68b463c05e558a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2016.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2016.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DSihvola%26aufirst%3DV.%26aulast%3DLevonen%26aufirst%3DA.-L.%26atitle%3DKeap1%2520as%2520the%2520redox%2520sensor%2520of%2520the%2520antioxidant%2520response%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2017%26volume%3D617%26spage%3D94%26epage%3D100%26doi%3D10.1016%2Fj.abb.2016.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">16817</span>– <span class="NLM_lpage">16824</span>, <span class="refDoi"> DOI: 10.1074/jbc.r117.800169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1074%2Fjbc.R117.800169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=28842501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GjsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=16817-16824&author=T.+Suzukiauthor=M.+Yamamoto&title=Stress-sensing+mechanisms+and+the+physiological+roles+of+the+Keap1-Nrf2+system+during+cellular+stress&doi=10.1074%2Fjbc.r117.800169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress</span></div><div class="casAuthors">Suzuki, Takafumi; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">16817-16824</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Transcription factor Nrf2 (NF-E2-related factor 2) is a master regulator of cellular responses against environmental stresses.  Nrf2 induces the expression of detoxification and antioxidant enzymes and suppresses the induction of pro-inflammatory cytokine genes.  Keap1 (Kelch-like ECH-assocd. protein 1) is an adaptor subunit of Cullin 3-based E3 ubiquitin ligase.  Keap1 regulates the activity of Nrf2 and acts as a sensor for oxidative and electrophilic stresses.  In this review, we discuss the mol. mechanisms by which the Keap1-Nrf2 system senses and regulates the cellular response to environmental stresses.  In particular, we focus on the multiple stress-sensing mechanisms of Keap1 and novel regulatory functions of Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx_R4Q7mWl67Vg90H21EOLACvtfcHk0liU1ANV772XBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GjsrzN&md5=478e4b84f6fd7f1cd79546b6f452b7d7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R117.800169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R117.800169%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DStress-sensing%2520mechanisms%2520and%2520the%2520physiological%2520roles%2520of%2520the%2520Keap1-Nrf2%2520system%2520during%2520cellular%2520stress%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D16817%26epage%3D16824%26doi%3D10.1074%2Fjbc.r117.800169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">The molecular mechanisms regulating the Keap1-Nrf2 pathway</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>40</i></span>, <span class="NLM_elocation-id">e00099</span> <span class="refDoi"> DOI: 10.1128/MCB.00099-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1128%2FMCB.00099-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=32284348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFSktb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2020&author=L.+Bairdauthor=M.+Yamamoto&title=The+molecular+mechanisms+regulating+the+Keap1-Nrf2+pathway&doi=10.1128%2FMCB.00099-20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular mechanisms regulating the KEAP1-NRF2 pathway</span></div><div class="casAuthors">Baird, Liam; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">e00099-20</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">1098-5549</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The KEAP1-NRF2 pathway is the principal protective response to oxidative and electrophilic stresses.  Under homeostatic conditions, KEAP1 forms part of an E3 ubiquitin ligase, which tightly regulates the activity of the transcription factor NRF2 by targeting it for ubiquitination and proteasome-dependent degrdn.  In response to stress, an intricate mol. mechanism facilitated by sensor cysteines within KEAP1 allows NRF2 to escape ubiquitination, accumulate within the cell, and translocate to the nucleus, where it can promote its antioxidant transcription program.  Recent advances have revealed that KEAP1 contains multiple stress sensors and inactivation modalities, which together allow diverse cellular inputs, from oxidative stress and cellular metabolites to dysregulated autophagy, to regulate NRF2 activity.  This integration of the KEAP1-NRF2 system into multiple cellular signaling and metabolic pathways places NRF2 activation as a crit. regulatory node in many disease phenotypes and suggests that the pharmaceutical modulation of NRF2's cytoprotective activity will be beneficial for human health in a broad range of noncommunicable diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOVYF0sz4V7LVg90H21EOLACvtfcHk0liU1ANV772XBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFSktb7P&md5=ca9ed34b0dff136afdc31d1e9e745833</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FMCB.00099-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00099-20%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DThe%2520molecular%2520mechanisms%2520regulating%2520the%2520Keap1-Nrf2%2520pathway%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2020%26volume%3D40%26doi%3D10.1128%2FMCB.00099-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madden, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itzhaki, L. S.</span></span> <span> </span><span class="NLM_article-title">Structural and mechanistic insights into the Keap1-Nrf2 system as a route to drug discovery</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>1868</i></span>,  <span class="NLM_fpage">140405</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2020.140405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.bbapap.2020.140405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXms12iurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1868&publication_year=2020&pages=140405&author=S.+K.+Maddenauthor=L.+S.+Itzhaki&title=Structural+and+mechanistic+insights+into+the+Keap1-Nrf2+system+as+a+route+to+drug+discovery&doi=10.1016%2Fj.bbapap.2020.140405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and mechanistic insights into the Keap1-Nrf2 system as a route to drug discovery</span></div><div class="casAuthors">Madden, Sarah K.; Itzhaki, Laura S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">1868</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">140405</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The proteins Keap1 and Nrf2 together act as a cytoprotective mechanism that enables cells to overcome electrophilic and oxidative stress.  Research has shown that manipulating this system by modulating the Keap1-Nrf2 interaction either through inhibition at the binding interface or via the covalent modification of Keap1 could provide a powerful therapeutic strategy for a range of diseases.  However, despite intensive investigation of the system and significant progress in the development of inhibitory small mols., there is still much to learn about the pathways assocd. with the Keap1-Nrf2 system and the structural details underpinning its mechanism of action.  In this review, we discuss how a deeper understanding could prove revolutionary in the development of new inhibitors and activators as well as guiding how to best harness Keap1 for targeted protein degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCbjWpa_4RfLVg90H21EOLACvtfcHk0liU1ANV772XBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXms12iurk%253D&md5=e0bd208ef9a351f741ca9b081d9a14b4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2020.140405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2020.140405%26sid%3Dliteratum%253Aachs%26aulast%3DMadden%26aufirst%3DS.%2BK.%26aulast%3DItzhaki%26aufirst%3DL.%2BS.%26atitle%3DStructural%2520and%2520mechanistic%2520insights%2520into%2520the%2520Keap1-Nrf2%2520system%2520as%2520a%2520route%2520to%2520drug%2520discovery%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2020%26volume%3D1868%26spage%3D140405%26doi%3D10.1016%2Fj.bbapap.2020.140405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span> <span> </span><span class="NLM_article-title">The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">924</span>– <span class="NLM_lpage">963</span>, <span class="refDoi"> DOI: 10.1002/med.21396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1002%2Fmed.21396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=27192495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSms7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=924-963&author=M.-C.+Luauthor=J.-A.+Jiauthor=Z.-Y.+Jiangauthor=Q.-D.+You&title=The+Keap1-Nrf2-ARE+pathway+as+a+potential+preventive+and+therapeutic+target%3A+an+update&doi=10.1002%2Fmed.21396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update</span></div><div class="casAuthors">Lu, Meng-Chen; Ji, Jian-Ai; Jiang, Zheng-Yu; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">924-963</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Keap1-Nrf2-ARE ((Kelch-like ECH-Assocg. protein 1) nuclear factor erythroid 2 related factor 2-antioxidant response element) pathway is one of the most important defense mechanisms against oxidative and/or electrophilic stresses, and it is closely assocd. with inflammatory diseases, including cancer, neurodegenerative diseases, cardiovascular diseases, and aging.  In recent years, progress has been made in strategies aimed at modulating the Keap1-Nrf2-ARE pathway.  The Nrf2 activator DMF (Dimethylfumarates) has been approved by the FDA as a new first-line oral drug to treat patients with relapsing forms of multiple sclerosis, while a phase 3 study of another promising candidate, CDDO-Me, was terminated for safety reasons.  Directly inhibiting Keap1-Nrf2 protein-protein interactions as a novel Nrf2-modulating strategy has many advantages over using electrophilic Nrf2 activators.  The development of Keap1-Nrf2 protein-protein interaction inhibitors has become a topic of intense research, and potent inhibitors of this target have been identified.  In addn., inhibiting Nrf2 activity has attracted an increasing amt. of attention because it may provide an alternative cancer therapy.  This review summarizes the mol. mechanisms and biol. functions of the Keap1-Nrf2-ARE system.  The main focus of this review is on recent progress in studies of agents that target the Keap1-Nrf2-ARE pathway and the therapeutic applications of such agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFT_JWBNP5w7Vg90H21EOLACvtfcHk0liU1ANV772XBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSms7bL&md5=b5514acfaaa6ecb31efe0d75387dd56e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fmed.21396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21396%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DJi%26aufirst%3DJ.-A.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26aulast%3DYou%26aufirst%3DQ.-D.%26atitle%3DThe%2520Keap1-Nrf2-ARE%2520pathway%2520as%2520a%2520potential%2520preventive%2520and%2520therapeutic%2520target%253A%2520an%2520update%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2016%26volume%3D36%26spage%3D924%26epage%3D963%26doi%3D10.1002%2Fmed.21396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousin, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumsey, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attucks, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levonen, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1038/s41573-018-0008-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1038%2Fs41573-018-0008-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=30610225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlslKlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=295-317&author=A.+Cuadradoauthor=A.+I.+Rojoauthor=G.+Wellsauthor=J.+D.+Hayesauthor=S.+P.+Cousinauthor=W.+L.+Rumseyauthor=O.+C.+Attucksauthor=S.+Franklinauthor=A.-L.+Levonenauthor=T.+W.+Kenslerauthor=A.+T.+Dinkova-Kostova&title=Therapeutic+targeting+of+the+NRF2+and+KEAP1+partnership+in+chronic+diseases&doi=10.1038%2Fs41573-018-0008-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases</span></div><div class="casAuthors">Cuadrado, Antonio; Rojo, Ana I.; Wells, Geoffrey; Hayes, John D.; Cousin, Sharon P.; Rumsey, William L.; Attucks, Otis C.; Franklin, Stephen; Levonen, Anna-Liisa; Kensler, Thomas W.; Dinkova-Kostova, Albena T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  The transcription factor NF-E2 p45-related factor 2 (NRF2; encoded by NFE2L2) and its principal neg. regulator, the E3 ligase adaptor Kelch-like ECH-assocd. protein 1 (KEAP1), are crit. in the maintenance of redox, metabolic and protein homeostasis, as well as the regulation of inflammation.  Thus, NRF2 activation provides cytoprotection against numerous pathologies including chronic diseases of the lung and liver; autoimmune, neurodegenerative and metabolic disorders; and cancer initiation.  One NRF2 activator has received clin. approval and several electrophilic modifiers of the cysteine-based sensor KEAP1 and inhibitors of its interaction with NRF2 are now in clin. development.  However, challenges regarding target specificity, pharmacodynamic properties, efficacy and safety remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW9hICH7_1WbVg90H21EOLACvtfcHk0ljtR8Y9FqEMjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlslKlsr0%253D&md5=ce3b8d39cd759418444f6e375ee1a38c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fs41573-018-0008-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41573-018-0008-x%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DRojo%26aufirst%3DA.%2BI.%26aulast%3DWells%26aufirst%3DG.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DCousin%26aufirst%3DS.%2BP.%26aulast%3DRumsey%26aufirst%3DW.%2BL.%26aulast%3DAttucks%26aufirst%3DO.%2BC.%26aulast%3DFranklin%26aufirst%3DS.%26aulast%3DLevonen%26aufirst%3DA.-L.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DTherapeutic%2520targeting%2520of%2520the%2520NRF2%2520and%2520KEAP1%2520partnership%2520in%2520chronic%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2019%26volume%3D18%26spage%3D295%26epage%3D317%26doi%3D10.1038%2Fs41573-018-0008-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bista, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hronowsky, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollate, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellrichmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brück, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goelz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukashev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, R.</span></span> <span> </span><span class="NLM_article-title">Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">678</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1093/brain/awq386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1093%2Fbrain%2Fawq386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=21354971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A280%3ADC%252BC3M3it1alsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2011&pages=678-692&author=R.+A.+Linkerauthor=D.-H.+Leeauthor=S.+Ryanauthor=A.+M.+van+Damauthor=R.+Conradauthor=P.+Bistaauthor=W.+Zengauthor=X.+Hronowskyauthor=A.+Bukoauthor=S.+Chollateauthor=G.+Ellrichmannauthor=W.+Br%C3%BCckauthor=K.+Dawsonauthor=S.+Goelzauthor=S.+Wieseauthor=R.+H.+Scannevinauthor=M.+Lukashevauthor=R.+Gold&title=Fumaric+acid+esters+exert+neuroprotective+effects+in+neuroinflammation+via+activation+of+the+Nrf2+antioxidant+pathway&doi=10.1093%2Fbrain%2Fawq386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway</span></div><div class="casAuthors">Linker Ralf A; Lee De-Hyung; Ryan Sarah; van Dam Anne M; Conrad Rebecca; Bista Pradeep; Zeng Weike; Hronowsky Xiaoping; Buko Alex; Chollate Sowmya; Ellrichmann Gisa; Bruck Wolfgang; Dawson Kate; Goelz Susan; Wiese Stefan; Scannevin Robert H; Lukashev Matvey; Gold Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">Pt 3</span>),
    <span class="NLM_cas:pages">678-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammation and oxidative stress are thought to promote tissue damage in multiple sclerosis.  Thus, novel therapeutics enhancing cellular resistance to free radicals could prove useful for multiple sclerosis treatment.  BG00012 is an oral formulation of dimethylfumarate.  In a phase II multiple sclerosis trial, BG00012 demonstrated beneficial effects on relapse rate and magnetic resonance imaging markers indicative of inflammation as well as axonal destruction.  First we have studied effects of dimethylfumarate on the disease course, central nervous system, tissue integrity and the molecular mechanism of action in an animal model of chronic multiple sclerosis: myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis in C57BL/6 mice.  In the chronic phase of experimental autoimmune encephalomyelitis, preventive or therapeutic application of dimethylfumarate ameliorated the disease course and improved preservation of myelin, axons and neurons.  In vitro, the application of fumarates increased murine neuronal survival and protected human or rodent astrocytes against oxidative stress.  Application of dimethylfumarate led to stabilization of the transcription factor nuclear factor (erythroid-derived 2)-related factor 2, activation of nuclear factor (erythroid-derived 2)-related factor 2-dependent transcriptional activity and accumulation of NADP(H) quinoline oxidoreductase-1 as a prototypical target gene.  Furthermore, the immediate metabolite of dimethylfumarate, monomethylfumarate, leads to direct modification of the inhibitor of nuclear factor (erythroid-derived 2)-related factor 2, Kelch-like ECH-associated protein 1, at cysteine residue 151.  In turn, increased levels of nuclear factor (erythroid-derived 2)-related factor 2 and reduced protein nitrosylation were detected in the central nervous sytem of dimethylfumarate-treated mice.  Nuclear factor (erythroid-derived 2)-related factor 2 was also upregulated in the spinal cord of autopsy specimens from untreated patients with multiple sclerosis.  In dimethylfumarate-treated mice suffering from experimental autoimmune encephalomyelitis, increased immunoreactivity for nuclear factor (erythroid-derived 2)-related factor 2 was detected by confocal microscopy in neurons of the motor cortex and the brainstem as well as in oligodendrocytes and astrocytes.  In mice deficient for nuclear factor (erythroid-derived 2)-related factor 2 on the same genetic background, the dimethylfumarate mediated beneficial effects on clinical course, axon preservation and astrocyte activation were almost completely abolished thus proving the functional relevance of this transcription factor for the neuroprotective mechanism of action.  We conclude that the ability of dimethylfumarate to activate nuclear factor (erythroid-derived 2)-related factor 2 may offer a novel cytoprotective modality that further augments the natural antioxidant responses in multiple sclerosis tissue and is not yet targeted by other multiple sclerosis therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAUtIRbYJEbB0LsK7uFuY7fW6udTcc2eYVY8T1M3zEYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3it1alsw%253D%253D&md5=d113bf628d25500b5c612938a7571fd9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawq386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawq386%26sid%3Dliteratum%253Aachs%26aulast%3DLinker%26aufirst%3DR.%2BA.%26aulast%3DLee%26aufirst%3DD.-H.%26aulast%3DRyan%26aufirst%3DS.%26aulast%3Dvan%2BDam%26aufirst%3DA.%2BM.%26aulast%3DConrad%26aufirst%3DR.%26aulast%3DBista%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DHronowsky%26aufirst%3DX.%26aulast%3DBuko%26aufirst%3DA.%26aulast%3DChollate%26aufirst%3DS.%26aulast%3DEllrichmann%26aufirst%3DG.%26aulast%3DBr%25C3%25BCck%26aufirst%3DW.%26aulast%3DDawson%26aufirst%3DK.%26aulast%3DGoelz%26aufirst%3DS.%26aulast%3DWiese%26aufirst%3DS.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DLukashev%26aufirst%3DM.%26aulast%3DGold%26aufirst%3DR.%26atitle%3DFumaric%2520acid%2520esters%2520exert%2520neuroprotective%2520effects%2520in%2520neuroinflammation%2520via%2520activation%2520of%2520the%2520Nrf2%2520antioxidant%2520pathway%26jtitle%3DBrain%26date%3D2011%26volume%3D134%26spage%3D678%26epage%3D692%26doi%3D10.1093%2Fbrain%2Fawq386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span> <span> </span><span class="NLM_article-title">Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">8137</span>– <span class="NLM_lpage">8151</span>, <span class="refDoi"> DOI: 10.1128/mcb.23.22.8137-8151.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1128%2FMCB.23.22.8137-8151.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=14585973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=8137-8151&author=D.+D.+Zhangauthor=M.+Hannink&title=Distinct+cysteine+residues+in+Keap1+are+required+for+Keap1-dependent+ubiquitination+of+Nrf2+and+for+stabilization+of+Nrf2+by+chemopreventive+agents+and+oxidative+stress&doi=10.1128%2Fmcb.23.22.8137-8151.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress</span></div><div class="casAuthors">Zhang, Donna D.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8137-8151</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A common feature of diverse chemopreventive agents is the ability to activate expression of a genetic program that protects cells from reactive chem. species that if left unchecked would cause mutagenic DNA damage.  The bZIP transcription factor Nrf2 has emerged as a key regulator of this cancer-preventive genetic program.  Nrf2 is normally sequestered in the cytoplasm by a protein known as Keap1.  Chemopreventive agents allow Nrf2 to escape from Keap1-mediated repression, although the mol. mechanism(s) responsible for activation of Nrf2 is not understood.  In this report, we demonstrate that Keap1 does not passively sequester Nrf2 in the cytoplasm but actively targets Nrf2 for ubiquitination and degrdn. by the proteasome under basal culture conditions.  We have identified two crit. cysteine residues in Keap1, C273 and C288, that are required for Keap1-dependent ubiquitination of Nrf2.  Both sulforaphane, a chemopreventive isothiocyanate, and oxidative stress enable Nrf2 to escape Keap1-dependent degrdn., leading to stabilization of Nrf2, increased nuclear localization of Nrf2, and activation of Nrf2-dependent cancer-protective genes.  We have identified a third cysteine residue in Keap1, C151, that is uniquely required for inhibition of Keap1-dependent degrdn. of Nrf2 by sulforaphane and oxidative stress.  This cysteine residue is also required for a novel posttranslational modification to Keap1 that is induced by oxidative stress.  We propose that Keap1 is a component of a novel E3 ubiquitin ligase complex that is specifically targeted for inhibition by both chemopreventive agents and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqys54qQ6MlRLVg90H21EOLACvtfcHk0ljtR8Y9FqEMjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D&md5=9287849578d0a6b7a6d52b67e3c65190</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.22.8137-8151.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.22.8137-8151.2003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DDistinct%2520cysteine%2520residues%2520in%2520Keap1%2520are%2520required%2520for%2520Keap1-dependent%2520ubiquitination%2520of%2520Nrf2%2520and%2520for%2520stabilization%2520of%2520Nrf2%2520by%2520chemopreventive%2520agents%2520and%2520oxidative%2520stress%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D8137%26epage%3D8151%26doi%3D10.1128%2Fmcb.23.22.8137-8151.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pergola, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raskin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toto, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huff, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audhya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ-Schmidt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warnock, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Investigators, B. S.</span></span> <span> </span><span class="NLM_article-title">Bardoxolone methyl and kidney function in CKD with type 2 diabetes</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1105351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1056%2Fnejmoa1105351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=21699484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpslSnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2011&pages=327-336&author=P.+E.+Pergolaauthor=P.+Raskinauthor=R.+D.+Totoauthor=C.+J.+Meyerauthor=J.+W.+Huffauthor=E.+B.+Grossmanauthor=M.+Krauthauthor=S.+Ruizauthor=P.+Audhyaauthor=H.+Christ-Schmidtauthor=J.+Wittesauthor=D.+G.+Warnockauthor=B.+S.+Investigators&title=Bardoxolone+methyl+and+kidney+function+in+CKD+with+type+2+diabetes&doi=10.1056%2Fnejmoa1105351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Bardoxolone methyl and kidney function in CKD with type 2 diabetes</span></div><div class="casAuthors">Pergola, Pablo E.; Raskin, Philip; Toto, Robert D.; Meyer, Colin J.; Huff, J. Warren; Grossman, Eric B.; Krauth, Melissa; Ruiz, Stacey; Audhya, Paul; Christ-Schmidt, Heidi; Wittes, Janet; Warnock, David G.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">327-336</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Chronic kidney disease (CKD) assocd. with type 2 diabetes is the leading cause of kidney failure, with both inflammation and oxidative stress contributing to disease progression.  Bardoxolone Me, an oral antioxidant inflammation modulator, has shown efficacy in patients with CKD and type 2 diabetes in short-term studies, but longer-term effects sand dose response have not been detd.  Methods: In this phase 2, double-blind, randomized, placebo-controlled trial, we assigned 227 adults with CKD (defined as an estd. glomerular filtration rate [GFR] of 20 to 45 mL per min per 1.73 m2 of body-surface area) in a 1:1:1:1 ratio to receive placebo or bardoxolone Me at a target dose of 25, 75, or 150 mg once daily.  The primary outcome was the change from baseline in the estd. GFR with bardoxolone Me, as compared with placebo, at 24 wk; a secondary outcome was the change at 52 wk.  Results: Patients receiving bardoxolone Me had significant increases in the mean (±SD) estd. GFR, as compared with placebo, at 24 wk (with between-group differences per min per 1.73 m2 of 8.2 ± 1.5 mL in the 25-mg group, 11.4 ± 1.5 mL in the 75-mg group, and 10.4 ± 1.5 mL in the 150-mg group; P < 0.001).  The increases were maintained through week 52, with significant differences per min per 1.73 m2 of 5.8 ± 1.8 mL, 10.5 ± 1.8 mL, and 9.3 ± 1.9 mL, resp.  Muscle spasms, were generally mild and dose-related.  Hypomagnesemia, mild increases in alanine aminotransferase levels, and gastrointestinal effects were more common among patients receiving bardoxolone Me.  Conclusions: Bardoxolone Me was assocd. with improvement in the estd. GFR in patients with advanced CKD and type 2 diabetes at 24 wk.  The improvement persisted at 52 wk, suggesting that bardoxolone Me may have promise for the treatment of CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcbGTG2V2X9LVg90H21EOLACvtfcHk0lh_gzmAbIrdYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpslSnsrs%253D&md5=9f4f2bb5e020129e58dc47437fcab8a7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1105351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1105351%26sid%3Dliteratum%253Aachs%26aulast%3DPergola%26aufirst%3DP.%2BE.%26aulast%3DRaskin%26aufirst%3DP.%26aulast%3DToto%26aufirst%3DR.%2BD.%26aulast%3DMeyer%26aufirst%3DC.%2BJ.%26aulast%3DHuff%26aufirst%3DJ.%2BW.%26aulast%3DGrossman%26aufirst%3DE.%2BB.%26aulast%3DKrauth%26aufirst%3DM.%26aulast%3DRuiz%26aufirst%3DS.%26aulast%3DAudhya%26aufirst%3DP.%26aulast%3DChrist-Schmidt%26aufirst%3DH.%26aulast%3DWittes%26aufirst%3DJ.%26aulast%3DWarnock%26aufirst%3DD.%2BG.%26aulast%3DInvestigators%26aufirst%3DB.%2BS.%26atitle%3DBardoxolone%2520methyl%2520and%2520kidney%2520function%2520in%2520CKD%2520with%2520type%25202%2520diabetes%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D365%26spage%3D327%26epage%3D336%26doi%3D10.1056%2Fnejmoa1105351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-p.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-f.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.-q.</span></span> <span> </span><span class="NLM_article-title">Nrf2 activator RTA-408 protects against ozone-induced acute asthma exacerbation by suppressing ROS and γδT17 cells</span>. <i>Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1843</span>– <span class="NLM_lpage">1856</span>, <span class="refDoi"> DOI: 10.1007/s10753-019-01046-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1007%2Fs10753-019-01046-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31256292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1yktr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2019&pages=1843-1856&author=J.-h.+Zhangauthor=X.+Yangauthor=Y.-p.+Chenauthor=J.-f.+Zhangauthor=C.-q.+Li&title=Nrf2+activator+RTA-408+protects+against+ozone-induced+acute+asthma+exacerbation+by+suppressing+ROS+and+%CE%B3%CE%B4T17+cells&doi=10.1007%2Fs10753-019-01046-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 Activator RTA-408 Protects Against Ozone-Induced Acute Asthma Exacerbation by Suppressing ROS and γδT17 Cells</span></div><div class="casAuthors">Zhang, Jing-hong; Yang, Xia; Chen, Yi-ping; Zhang, Jian-feng; Li, Chao-qian</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1843-1856</span>CODEN:
                <span class="NLM_cas:coden">INFLD4</span>;
        ISSN:<span class="NLM_cas:issn">0360-3997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Ozone is a strong oxidant in air pollution that exacerbates respiratory disorders and is a major risk factor for acute asthma exacerbation.  Ozone can induce reactive oxygen species (ROS) and airway neutrophilic inflammation.  In addn., γδT17 cells contribute to IL-17A prodn. upon ozone challenge, resulting in neutrophilic inflammation.  It is known, however, that Nrf2 can ameliorate oxidative stress.  We therefore investigated whether RTA-408, an Nrf2 activator, can attenuate airway inflammation and inhibit ROS prodn. and whether this effect involves γδT17 cells.  Balb/c mice were sensitized/challenged with OVA and followed by ozone exposure.  We investigated the effect of Nrf2 activator RTA-408 on airway hyperresponsiveness, neutrophilic airway inflammation, cytokine/chemokine prodn., and OVA-specific IgE level in a mouse model of O3 induced asthma exacerbation.  Furthermore MDA and GSH levels in lung and intracellular ROS were measured.  IL-17+ γδT cell percentage by flow cytometer was detd.  Nrf2 protein expression by western blot was also examd.  We obsd. that RTA-408 attenuated ROS release during ozone-induced asthma exacerbation and suppressed neutrophil lung infiltration.  RTA-408 decreased pro-inflammatory cytokine prodn. and reduced the percentage of IL-17+ γδT cells.  Thus, our results suggest that RTA-408 does attenuate airway inflammation in a murine model of ozone-induced asthma exacerbation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGOVSc2GnhUrVg90H21EOLACvtfcHk0lh_gzmAbIrdYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1yktr%252FO&md5=aabc7446b14f7907fbaa58678a43759a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs10753-019-01046-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10753-019-01046-6%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.-h.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.-p.%26aulast%3DZhang%26aufirst%3DJ.-f.%26aulast%3DLi%26aufirst%3DC.-q.%26atitle%3DNrf2%2520activator%2520RTA-408%2520protects%2520against%2520ozone-induced%2520acute%2520asthma%2520exacerbation%2520by%2520suppressing%2520ROS%2520and%2520%25CE%25B3%25CE%25B4T17%2520cells%26jtitle%3DInflammation%26date%3D2019%26volume%3D42%26spage%3D1843%26epage%3D1856%26doi%3D10.1007%2Fs10753-019-01046-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostov, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canning, P.</span></span> <span> </span><span class="NLM_article-title">Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>617</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2016.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.abb.2016.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=27497696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlags7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=617&publication_year=2017&pages=84-93&author=A.+T.+Dinkova-Kostovaauthor=R.+V.+Kostovauthor=P.+Canning&title=Keap1%2C+the+cysteine-based+mammalian+intracellular+sensor+for+electrophiles+and+oxidants&doi=10.1016%2Fj.abb.2016.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Kostov, Rumen V.; Canning, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">617</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">84-93</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Kelch-like ECH assocd. protein 1 (Keap1) is a component of a Cullin3-based Cullin-RING E3 ubiquitin ligase (CRL) multisubunit protein complex.  Within the CRL, homodimeric Keap1 functions as the Cullin3 adaptor, and importantly, it is also the crit. component of the E3 ligase that performs the substrate recognition.  The best-characterized substrate of Keap1 is transcription factor NF-E2 p45-related factor 2 (Nrf2), which orchestrates an elaborate transcriptional program in response to environmental challenges caused by oxidants, electrophiles and pro-inflammatory agents, allowing adaptation and survival under stress conditions.  Keap1 is equipped with reactive cysteine residues that act as sensors for endogenously produced and exogenously encountered small mols. (termed inducers), which have a characteristic chem. signature, reactivity with sulfhydryl groups.  Inducers modify the cysteine sensors of Keap1 and impair its ability to target Nrf2 for ubiquitination and degrdn.  Consequently, Nrf2 accumulates, enters the nucleus and drives the transcription of its target genes, which encode a large network of cytoprotective proteins.  Here we summarize the early studies leading to the prediction of the existence of Keap1, followed by the discovery of Keap1 as the main neg. regulator of Nrf2.  We then describe the available structural information on Keap1, its assembly with Cullin3, and its interaction with Nrf2.  We also discuss the multiple cysteine sensors of Keap1 that allow for detection of a wide range of endogenous and environmental inducers, and provide fine-tuning and tight control of the Keap1/Nrf2 stress-sensing response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI8YYxE9xg4LVg90H21EOLACvtfcHk0lh_gzmAbIrdYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlags7jF&md5=eedfc91fa4e91f74df618231a01af182</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2016.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2016.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DKostov%26aufirst%3DR.%2BV.%26aulast%3DCanning%26aufirst%3DP.%26atitle%3DKeap1%252C%2520the%2520cysteine-based%2520mammalian%2520intracellular%2520sensor%2520for%2520electrophiles%2520and%2520oxidants%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2017%26volume%3D617%26spage%3D84%26epage%3D93%26doi%3D10.1016%2Fj.abb.2016.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Zeeuw, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audhya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakris, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ-Schmidt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsberry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambers Heerspink, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parving, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toto, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaziri, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrolstad, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chertow, G. M.</span></span> <span> </span><span class="NLM_article-title">Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">2492</span>– <span class="NLM_lpage">2503</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1306033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1056%2Fnejmoa1306033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=24206459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=2492-2503&author=D.+de+Zeeuwauthor=T.+Akizawaauthor=P.+Audhyaauthor=G.+L.+Bakrisauthor=M.+Chinauthor=H.+Christ-Schmidtauthor=A.+Goldsberryauthor=M.+Houserauthor=M.+Krauthauthor=H.+J.+Lambers+Heerspinkauthor=J.+J.+McMurrayauthor=C.+J.+Meyerauthor=H.-H.+Parvingauthor=G.+Remuzziauthor=R.+D.+Totoauthor=N.+D.+Vaziriauthor=C.+Wannerauthor=J.+Wittesauthor=D.+Wrolstadauthor=G.+M.+Chertow&title=Bardoxolone+methyl+in+type+2+diabetes+and+stage+4+chronic+kidney+disease&doi=10.1056%2Fnejmoa1306033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease</span></div><div class="casAuthors">de Zeeuw, Dick; Akizawa, Tadao; Audhya, Paul; Bakris, George L.; Chin, Melanie; Christ-Schmidt, Heidi; Goldsberry, Angie; Houser, Mark; Krauth, Melissa; Lambers Heerspink, Hiddo J.; McMurray, John J.; Meyer, Colin J.; Parving, Hans-Henrik; Remuzzi, Giuseppe; Toto, Robert D.; Vaziri, Nosratola D.; Wanner, Christoph; Wittes, Janet; Wrolstad, Danielle; Chertow, Glenn M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2492-2503</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Although inhibitors of the renin-angiotensin-aldosterone system can slow the progression of diabetic kidney disease, the residual risk is high.  Whether nuclear I factor (erythroid-derived 2)-related factor 2 activators further reduce this risk is unknown.  METHODS: We randomly assigned 2185 patients with type 2 diabetes mellitus and stage 4 chronic kidney disease (estd. glomerular filtration rate [GFR], 15 to <30 mL per min per 1.73 m2 of body-surface area) to bardoxolone Me, at a daily dose of 20 mg, or placebo.  The primary composite outcome was end-stage renal disease (ESRD) or death from cardiovascular causes.  RESULTS: The sponsor and the steering committee terminated the trial on the recommendation of the independent data and safety monitoring committee; the median follow-up was 9 mo.  A total of 69 of 1088 patients (6%) randomly assigned to bardoxolone Me and 69 of 1097 (6%) randomly assigned to placebo had a primary composite outcome (hazard ratio in the bardoxolone Me group vs. the placebo group, 0.98; 95% confidence interval [CI], 0.70 to 1.37; P = 0.92).  In the bardoxolone Me group, ESRD developed in 43 patients, and 27 patients died from cardiovascular causes; in the placebo group, ESRD developed In 51 patients, and 19 patients died from cardiovascular causes.  A total of 96 patients in the bardoxolone Me group were hospitalized for heart failure or died from heart failure, as compared with 55 in the placebo group (hazard ratio, 1.83; 95% CI, 1.32 to 2.55; P < 0.001).  Estd. GFR, blood pressure, and the urinary albumin-to-creatinine ratio increased significantly and body wt. decreased significantly in the bardoxolone Me group, as compared with the placebo group.  CONCLUSIONS: Among patients with type 2 diabetes mellitus and stage 4 chronic kidney disease, bardoxolone Me did not reduce the risk of ESRD or death from cardiovascular causes.  A higher rate of cardiovascular events with bardoxolone Me than with placebo prompted termination of the trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomI6Z9q4C0LLVg90H21EOLACvtfcHk0liR30AahtvhwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKqs74%253D&md5=1bcc997b57ba700423e0549a617231b5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1306033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1306033%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BZeeuw%26aufirst%3DD.%26aulast%3DAkizawa%26aufirst%3DT.%26aulast%3DAudhya%26aufirst%3DP.%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DChin%26aufirst%3DM.%26aulast%3DChrist-Schmidt%26aufirst%3DH.%26aulast%3DGoldsberry%26aufirst%3DA.%26aulast%3DHouser%26aufirst%3DM.%26aulast%3DKrauth%26aufirst%3DM.%26aulast%3DLambers%2BHeerspink%26aufirst%3DH.%2BJ.%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%26aulast%3DMeyer%26aufirst%3DC.%2BJ.%26aulast%3DParving%26aufirst%3DH.-H.%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DToto%26aufirst%3DR.%2BD.%26aulast%3DVaziri%26aufirst%3DN.%2BD.%26aulast%3DWanner%26aufirst%3DC.%26aulast%3DWittes%26aufirst%3DJ.%26aulast%3DWrolstad%26aufirst%3DD.%26aulast%3DChertow%26aufirst%3DG.%2BM.%26atitle%3DBardoxolone%2520methyl%2520in%2520type%25202%2520diabetes%2520and%2520stage%25204%2520chronic%2520kidney%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D2492%26epage%3D2503%26doi%3D10.1056%2Fnejmoa1306033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abed, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albanyan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2015.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.apsb.2015.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26579458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A280%3ADC%252BC28rgtlOkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=285-299&author=D.+A.+Abedauthor=M.+Goldsteinauthor=H.+Albanyanauthor=H.+Jinauthor=L.+Hu&title=Discovery+of+direct+inhibitors+of+Keap1-Nrf2+protein-protein+interaction+as+potential+therapeutic+and+preventive+agents&doi=10.1016%2Fj.apsb.2015.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents</span></div><div class="casAuthors">Abed Dhulfiqar Ali; Goldstein Melanie; Albanyan Haifa; Jin Huijuan; Hu Longqin</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">285-99</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">The Keap1-Nrf2-ARE pathway is an important antioxidant defense mechanism that protects cells from oxidative stress and the Keap1-Nrf2 protein-protein interaction (PPI) has become an important drug target to upregulate the expression of ARE-controlled cytoprotective oxidative stress response enzymes in the development of therapeutic and preventive agents for a number of diseases and conditions.  However, most known Nrf2 activators/ARE inducers are indirect inhibitors of Keap1-Nrf2 PPI and they are electrophilic species that act by modifying the sulfhydryl groups of Keap1 s cysteine residues.  The electrophilicity of these indirect inhibitors may cause "off-target" side effects by reacting with cysteine residues of other important cellular proteins.  Efforts have recently been focused on the development of direct inhibitors of Keap1-Nrf2 PPI.  This article reviews these recent research efforts including the development of high throughput screening assays, the discovery of peptide and small molecule direct inhibitors, and the biophysical characterization of the binding of these inhibitors to the target Keap1 Kelch domain protein.  These non-covalent direct inhibitors of Keap1-Nrf2 PPI could potentially be developed into effective therapeutic or preventive agents for a variety of diseases and conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-qtzzXrDFl5Pq5LRczm8ffW6udTcc2ebGRDsN7UpQ6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgtlOkuw%253D%253D&md5=a22499ab91854a1038e0f18fee0886e3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2015.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2015.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DAbed%26aufirst%3DD.%2BA.%26aulast%3DGoldstein%26aufirst%3DM.%26aulast%3DAlbanyan%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520direct%2520inhibitors%2520of%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520as%2520potential%2520therapeutic%2520and%2520preventive%2520agents%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2015%26volume%3D5%26spage%3D285%26epage%3D299%26doi%3D10.1016%2Fj.apsb.2015.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speltz, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2261</span>– <span class="NLM_lpage">2268</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.bmcl.2015.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=25937010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslehs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2261-2268&author=B.+G.+Richardsonauthor=A.+D.+Jainauthor=T.+E.+Speltzauthor=T.+W.+Moore&title=Non-electrophilic+modulators+of+the+canonical+Keap1%2FNrf2+pathway&doi=10.1016%2Fj.bmcl.2015.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway</span></div><div class="casAuthors">Richardson, B. G.; Jain, A. D.; Speltz, T. E.; Moore, T. W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2261-2268</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nrf2 is the major transcription factor that regulates many of the cytoprotective enzymes involved in the adaptive stress response.  Modulation of Nrf2 could be therapeutically useful in a no. of disease states.  Activation can occur through either an electrophilic or non-electrophilic mechanism.  To date, most of the research has focused on electrophilic Nrf2 activators, but there is increasing interest in non-electrophilic modulators of Nrf2.  This Digest examines the current selection of small mols. that modulate Nrf2 through non-electrophilic mechanisms, and it highlights new opportunities for this important therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojMkBabiNYC7Vg90H21EOLACvtfcHk0liR30AahtvhwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslehs7c%253D&md5=2e5ec64ce19ef7805892ea70a240c7df</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DSpeltz%26aufirst%3DT.%2BE.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DNon-electrophilic%2520modulators%2520of%2520the%2520canonical%2520Keap1%252FNrf2%2520pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2261%26epage%3D2268%26doi%3D10.1016%2Fj.bmcl.2015.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) protein–protein interaction inhibitors: achievements, challenges, and future directions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10837</span>– <span class="NLM_lpage">10858</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00586</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00586" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10837-10858&author=Z.+Jiangauthor=M.+Luauthor=Q.+You&title=Discovery+and+development+of+Kelch-like+ECH-Associated+Protein+1.+Nuclear+Factor+Erythroid+2-Related+Factor+2+%28KEAP1%3ANRF2%29+protein%E2%80%93protein+interaction+inhibitors%3A+achievements%2C+challenges%2C+and+future+directions&doi=10.1021%2Facs.jmedchem.6b00586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10837-10858</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The transcription factor Nrf2 is the primary regulator of the cellular defense system, and enhancing Nrf2 activity has potential usages in various diseases, esp. chronic age-related and inflammatory diseases.  Recently, directly targeting Keap1-Nrf2 protein-protein interaction (PPI) has been an emerging strategy to selectively and effectively activate Nrf2.  This Perspective summarizes the progress in the discovery and development of Keap1-Nrf2 PPI inhibitors, including the Keap1-Nrf2 regulatory mechanisms, biochem. techniques for inhibitor identification, and approaches for identifying peptide and small-mol. inhibitors, as well as discusses privileged structures and future directions for further development of Keap1-Nrf2 PPI inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCuMv4k9xi9LVg90H21EOLACvtfcHk0lg5YdA4ujQHOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO&md5=487aa677ae8a86d71e2b15561656b0b7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00586%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3DDiscovery%2520and%2520development%2520of%2520Kelch-like%2520ECH-Associated%2520Protein%25201.%2520Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528KEAP1%253ANRF2%2529%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitors%253A%2520achievements%252C%2520challenges%252C%2520and%2520future%2520directions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10837%26epage%3D10858%26doi%3D10.1021%2Facs.jmedchem.6b00586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span> <span> </span><span class="NLM_article-title">Small molecules inhibiting Keap1–Nrf2 protein–protein interactions: a novel approach to activate Nrf2 function</span>. <i>Med. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">286</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1039/c6md00500d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1039%2FC6MD00500D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=286-294&author=C.+Zhuangauthor=Z.+Wuauthor=C.+Xingauthor=Z.+Miao&title=Small+molecules+inhibiting+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interactions%3A+a+novel+approach+to+activate+Nrf2+function&doi=10.1039%2Fc6md00500d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2FC6MD00500D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00500D%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DXing%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DZ.%26atitle%3DSmall%2520molecules%2520inhibiting%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interactions%253A%2520a%2520novel%2520approach%2520to%2520activate%2520Nrf2%2520function%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D286%26epage%3D294%26doi%3D10.1039%2Fc6md00500d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pallesen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span> <span> </span><span class="NLM_article-title">Non-covalent small-molecule Kelch-like ECH-Associated Protein 1 - Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) inhibitors and their potential for targeting CNS diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8088</span>– <span class="NLM_lpage">8103</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00358</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00358" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt12hsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8088-8103&author=J.+S.+Pallesenauthor=K.+T.+Tranauthor=A.+Bach&title=Non-covalent+small-molecule+Kelch-like+ECH-Associated+Protein+1+-+Nuclear+Factor+Erythroid+2-Related+Factor+2+%28Keap1-Nrf2%29+inhibitors+and+their+potential+for+targeting+CNS+diseases&doi=10.1021%2Facs.jmedchem.8b00358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases</span></div><div class="casAuthors">Pallesen, Jakob S.; Tran, Kim T.; Bach, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8088-8103</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) has a protective effect against oxidative stress and plays a major role in inflammation and central nervous system (CNS) diseases.  Inhibition of the protein-protein interaction (PPI) between Nrf2 and its repressor protein, Kelch-like ECH-assocd. protein 1 (Keap1), leads to translocation of Nrf2 from the cytosol to the nucleus and expression of detoxifying antioxidant enzymes.  To date, several non-covalent small-mol. Keap1-Nrf2 inhibitors have been identified; however, many of them contain carboxylic acids and are rather large in size, which likely prevents or decreases CNS permeability.  This Perspective describes current small-mol. Keap1-Nrf2 inhibitors with exptl. evidence for the ability to inhibit the Keap1-Nrf2 interaction by binding to Keap1 in a non-covalent manner.  Binding data, biostructural studies, and biol. activity are summarized for the inhibitors, and their potential as CNS tool compds. is discussed by analyzing physicochem. properties, including CNS multiparameter optimization (MPO) scoring algorithms.  Finally, several strategies for identifying CNS-targeting Keap1 inhibitors are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAnObBnG8ca7Vg90H21EOLACvtfcHk0lg5YdA4ujQHOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt12hsb8%253D&md5=0492259af2532169001a1d4ef532fdbb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00358%26sid%3Dliteratum%253Aachs%26aulast%3DPallesen%26aufirst%3DJ.%2BS.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DBach%26aufirst%3DA.%26atitle%3DNon-covalent%2520small-molecule%2520Kelch-like%2520ECH-Associated%2520Protein%25201%2520-%2520Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528Keap1-Nrf2%2529%2520inhibitors%2520and%2520their%2520potential%2520for%2520targeting%2520CNS%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8088%26epage%3D8103%26doi%3D10.1021%2Facs.jmedchem.8b00358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallesen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solbak, S. M. Ø.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguayo-Orozco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmona, R. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span> <span> </span><span class="NLM_article-title">A comparative assessment study of known small-molecule Keap1-Nrf2 protein-protein interaction inhibitors: chemical synthesis, binding properties, and cellular activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8028</span>– <span class="NLM_lpage">8052</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00723</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00723" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFOqt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8028-8052&author=K.+T.+Tranauthor=J.+S.+Pallesenauthor=S.+M.+%C3%98.+Solbakauthor=D.+Narayananauthor=A.+Baigauthor=J.+Zangauthor=A.+Aguayo-Orozcoauthor=R.+M.+C.+Carmonaauthor=A.+D.+Garciaauthor=A.+Bach&title=A+comparative+assessment+study+of+known+small-molecule+Keap1-Nrf2+protein-protein+interaction+inhibitors%3A+chemical+synthesis%2C+binding+properties%2C+and+cellular+activity&doi=10.1021%2Facs.jmedchem.9b00723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity</span></div><div class="casAuthors">Tran, Kim T.; Pallesen, Jakob S.; Solbak, Sara M. Oe.; Narayanan, Dilip; Baig, Amina; Zang, Jie; Aguayo-Orozco, Alejandro; Carmona, Rosa M. C.; Garcia, Anthony D.; Bach, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8028-8052</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibiting the protein-protein interaction (PPI) between the transcription factor Nrf2 and its repressor protein Keap1 has emerged as a promising strategy to target oxidative stress in diseases, including central nervous system (CNS) disorders.  Numerous non-covalent small-mol. Keap1-Nrf2 PPI inhibitors have been reported to date, but many feature suboptimal physicochem. properties for permeating the blood-brain barrier, while others contain problematic structural moieties.  Here, we present the first side-by-side assessment of all reported Keap1-Nrf2 PPI inhibitor classes using fluorescence polarization, thermal shift assay, and surface plasmon resonance-and further evaluate the compds. in an NQO1 induction cell assay and in counter tests for nonspecific activities.  Surprisingly, half of the compds. were inactive or deviated substantially from reported activities, while we confirm the cross-assay activities for others.  Through this study, we have identified the most promising Keap1-Nrf2 inhibitors that can serve as pharmacol. probes or starting points for developing CNS-active Keap1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX8UEx5LbA87Vg90H21EOLACvtfcHk0lg5YdA4ujQHOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFOqt73P&md5=a80925ac602d3b3e4cae05bf5454ff34</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00723%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DPallesen%26aufirst%3DJ.%2BS.%26aulast%3DSolbak%26aufirst%3DS.%2BM.%2B%25C3%2598.%26aulast%3DNarayanan%26aufirst%3DD.%26aulast%3DBaig%26aufirst%3DA.%26aulast%3DZang%26aufirst%3DJ.%26aulast%3DAguayo-Orozco%26aufirst%3DA.%26aulast%3DCarmona%26aufirst%3DR.%2BM.%2BC.%26aulast%3DGarcia%26aufirst%3DA.%2BD.%26aulast%3DBach%26aufirst%3DA.%26atitle%3DA%2520comparative%2520assessment%2520study%2520of%2520known%2520small-molecule%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520inhibitors%253A%2520chemical%2520synthesis%252C%2520binding%2520properties%252C%2520and%2520cellular%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8028%26epage%3D8052%26doi%3D10.1021%2Facs.jmedchem.9b00723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, W.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span> <span> </span><span class="NLM_article-title">A natural product-like inhibitor of NEDD8-activating enzyme</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2511</span>– <span class="NLM_lpage">2513</span>, <span class="refDoi"> DOI: 10.1039/c0cc04927a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1039%2Fc0cc04927a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=21240405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitVCmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=2511-2513&author=C.-H.+Leungauthor=D.+S.-H.+Chanauthor=H.+Yangauthor=R.+Abagyanauthor=S.+M.-Y.+Leeauthor=G.-Y.+Zhuauthor=W.-F.+Fongauthor=D.-L.+Ma&title=A+natural+product-like+inhibitor+of+NEDD8-activating+enzyme&doi=10.1039%2Fc0cc04927a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A natural product-like inhibitor of NEDD8-activating enzyme</span></div><div class="casAuthors">Leung, Chung-Hang; Chan, Daniel Shiu-Hin; Yang, Hui; Abagyan, Ruben; Lee, Simon Ming-Yuen; Zhu, Guo-Yuan; Fong, Wang-Fun; Ma, Dik-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2511-2513</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The natural product-like 6,6''-biapigenin has been identified as only the second inhibitor of NEDD8-activating enzyme using virtual screening.  This compd. was active in enzyme and cell-based assays, with potency in the micromolar range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIgh-oaWCxuLVg90H21EOLACvtfcHk0lhS5q6vhKV4cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitVCmt7s%253D&md5=8783a238deaf9306f1bdaca88ab0575e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fc0cc04927a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0cc04927a%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DC.-H.%26aulast%3DChan%26aufirst%3DD.%2BS.-H.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DS.%2BM.-Y.%26aulast%3DZhu%26aufirst%3DG.-Y.%26aulast%3DFong%26aufirst%3DW.-F.%26aulast%3DMa%26aufirst%3DD.-L.%26atitle%3DA%2520natural%2520product-like%2520inhibitor%2520of%2520NEDD8-activating%2520enzyme%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D2511%26epage%3D2513%26doi%3D10.1039%2Fc0cc04927a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span> <span> </span><span class="NLM_article-title">Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e1293</span> <span class="refDoi"> DOI: 10.1038/cddis.2014.250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1038%2Fcddis.2014.250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=24922077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslCgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=L.-J.+Liuauthor=K.-H.+Leungauthor=D.+S.-H.+Chanauthor=Y.-T.+Wangauthor=D.-L.+Maauthor=C.-H.+Leung&title=Identification+of+a+natural+product-like+STAT3+dimerization+inhibitor+by+structure-based+virtual+screening&doi=10.1038%2Fcddis.2014.250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening</span></div><div class="casAuthors">Liu, L-J.; Leung, K-H.; Chan, D. S-H.; Wang, Y-T.; Ma, D-L.; Leung, C-H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1293</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">STAT3 regulates a variety of genes involved with cell proliferation, differentiation, apoptosis, angiogenesis, metastasis, inflammation, and immunity.  The purpose of this study was to apply mol. docking techniques to identify STAT3 inhibitors from a database of over 90 000 natural product and natural product-like compds.  The virtual screening campaign furnished 14 hit compds., from which compd. 1 emerged as a top candidate.  Compd. 1 inhibited STAT3 DNA-binding activity in vitro and attenuated STAT3-directed transcription in cellulo with selectivity over STAT1 and with comparable potency to the well-known STAT3 inhibitor S3I-201.  Furthermore, compd. 1 inhibited STAT3 dimerization and decreased STAT3 phosphorylation in cells without affecting STAT1 dimerization and phosphorylation.  Compd. 1 also exhibited selective anti-proliferative activity against cancer cells over normal cells in vitro.  Mol. docking anal. suggested that compd. 1 might putatively function as an inhibitor of STAT3 dimerization by binding to the SH2 domain.  This study also validates the use of in silico techniques to identify inhibitors of protein-protein interactions, which are typically considered difficult to target with small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFD1r2695sVrVg90H21EOLACvtfcHk0lhS5q6vhKV4cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslCgs7w%253D&md5=aaf182350853d7020285bd47ea4126e4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.250%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.-J.%26aulast%3DLeung%26aufirst%3DK.-H.%26aulast%3DChan%26aufirst%3DD.%2BS.-H.%26aulast%3DWang%26aufirst%3DY.-T.%26aulast%3DMa%26aufirst%3DD.-L.%26aulast%3DLeung%26aufirst%3DC.-H.%26atitle%3DIdentification%2520of%2520a%2520natural%2520product-like%2520STAT3%2520dimerization%2520inhibitor%2520by%2520structure-based%2520virtual%2520screening%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26doi%3D10.1038%2Fcddis.2014.250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chacko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bose, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapenna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattanayak, S. P.</span></span> <span> </span><span class="NLM_article-title">Structure based multitargeted molecular docking analysis of selected furanocoumarins against breast cancer</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">15743</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-52162-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1038%2Fs41598-019-52162-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31673107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A280%3ADC%252BB3Mjjsl2quw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=15743&author=R.+Acharyaauthor=S.+Chackoauthor=P.+Boseauthor=A.+Lapennaauthor=S.+P.+Pattanayak&title=Structure+based+multitargeted+molecular+docking+analysis+of+selected+furanocoumarins+against+breast+cancer&doi=10.1038%2Fs41598-019-52162-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Multitargeted Molecular Docking Analysis of Selected Furanocoumarins against Breast Cancer</span></div><div class="casAuthors">Acharya Reetuparna; Bose Pritha; Pattanayak Shakti Prasad; Chacko Shinu; Chacko Shinu; Lapenna Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15743</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Breast cancer is one of the biggest global dilemmas and its current therapy is to target the hormone receptors by the use of partial agonists/antagonists.  Potent drugs for breast cancer treatment are Tamoxifen, Trastuzumab, Paclitaxel, etc. which show adverse effects and resistance in patients.  The aim of the study has been on certain phytochemicals which has potent actions on ERα, PR, EGFR and mTOR inhibition.  The current study is performed by the use of molecular docking as protein-ligand interactions play a vital role in drug design.  The 3D structures of ERα, PR, EGFR and mTOR were obtained from the protein data bank and docked with 23 3D PubChem structures of furanocoumarin compounds using FlexX.  Drug-likeness property was checked by applying the Lipinski's rule of five on the furanocoumarins to evaluate anti-breast cancer activity.  Antagonist and inhibition assay of ERα, EGFR and mTOR respectively has been performed using appropriate in-vitro techniques.  The results confirm that Xanthotoxol has the best docking score for breast cancer followed by Bergapten, Angelicin, Psoralen and Isoimperatorin.  Further, the in-vitro results also validate the molecular docking analysis.  This study suggests that the selected furanocoumarins can be further investigated and evaluated for breast cancer treatment and management strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlQaJ6D1nt2DW1zwg2yUK5fW6udTcc2ebtIkGWSTm2BLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3Mjjsl2quw%253D%253D&md5=d7e618f28c3961179af885330777bc97</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-52162-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-52162-0%26sid%3Dliteratum%253Aachs%26aulast%3DAcharya%26aufirst%3DR.%26aulast%3DChacko%26aufirst%3DS.%26aulast%3DBose%26aufirst%3DP.%26aulast%3DLapenna%26aufirst%3DA.%26aulast%3DPattanayak%26aufirst%3DS.%2BP.%26atitle%3DStructure%2520based%2520multitargeted%2520molecular%2520docking%2520analysis%2520of%2520selected%2520furanocoumarins%2520against%2520breast%2520cancer%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D15743%26doi%3D10.1038%2Fs41598-019-52162-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dos Santos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliva, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andricopulo, A.</span></span> <span> </span><span class="NLM_article-title">Molecular docking and structure-based drug design strategies</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">13384</span>– <span class="NLM_lpage">13421</span>, <span class="refDoi"> DOI: 10.3390/molecules200713384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.3390%2Fmolecules200713384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26205061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1OjtLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=13384-13421&author=L.+Ferreiraauthor=R.+Dos+Santosauthor=G.+Olivaauthor=A.+Andricopulo&title=Molecular+docking+and+structure-based+drug+design+strategies&doi=10.3390%2Fmolecules200713384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular docking and structure-based drug design strategies</span></div><div class="casAuthors">Ferreira, Leonardo G.; dos Santos, Ricardo N.; Oliva, Glaucius; Andricopulo, Adriano D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">13384-13421</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Pharmaceutical research has successfully incorporated a wealth of mol. modeling methods, within a variety of drug discovery programs, to study complex biol. and chem. systems.  The integration of computational and exptl. strategies has been of great value in the identification and development of novel promising compds.  Broadly used in modern drug design, mol. docking methods explore the ligand conformations adopted within the binding sites of macromol. targets.  This approach also ests. the ligand-receptor binding free energy by evaluating crit. phenomena involved in the intermol. recognition process.  Today, as a variety of docking algorithms are available, an understanding of the advantages and limitations of each method is of fundamental importance in the development of effective strategies and the generation of relevant results.  The purpose of this review is to examine current mol. docking strategies used in drug discovery and medicinal chem., exploring the advances in the field and the role played by the integration of structure- and ligand-based methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf5La9X0Wng7Vg90H21EOLACvtfcHk0lgo_ZmiOviWvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1OjtLzJ&md5=b5f70b90e45098d0f0252a2926f9671e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3390%2Fmolecules200713384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules200713384%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DL.%26aulast%3DDos%2BSantos%26aufirst%3DR.%26aulast%3DOliva%26aufirst%3DG.%26aulast%3DAndricopulo%26aufirst%3DA.%26atitle%3DMolecular%2520docking%2520and%2520structure-based%2520drug%2520design%2520strategies%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26spage%3D13384%26epage%3D13421%26doi%3D10.3390%2Fmolecules200713384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1002/med.21257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1002%2Fmed.21257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=22549716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=687-726&author=S.+Mageshauthor=Y.+Chenauthor=L.+Hu&title=Small+molecule+modulators+of+Keap1-Nrf2-ARE+pathway+as+potential+preventive+and+therapeutic+agents&doi=10.1002%2Fmed.21257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents</span></div><div class="casAuthors">Magesh, Sadagopan; Chen, Yu; Hu, Longqin</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">687-726</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Kelch-like ECH-assocd. protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response elements (ARE) pathway represents one of the most important cellular defense mechanisms against oxidative stress and xenobiotic damage.  Activation of Nrf2 signaling induces the transcriptional regulation of ARE-dependent expression of various detoxifying and antioxidant defense enzymes and proteins.  Keap1-Nrf2-ARE signaling has become an attractive target for the prevention and treatment of oxidative stress-related diseases and conditions including cancer, neurodegenerative, cardiovascular, metabolic, and inflammatory diseases.  Over the last few decades, numerous Nrf2 inducers have been developed and some of them are currently undergoing clin. trials.  Recently, overactivation of Nrf2 has been implicated in cancer progression as well as in drug resistance to cancer chemotherapy.  Thus, Nrf2 inhibitors could potentially be used to improve the effectiveness of cancer therapy.  Herein, we review the signaling mechanism of Keap1-Nrf2-ARE pathway, its disease relevance, and currently known classes of small mol. modulators.  We also discuss several aspects of Keap1-Nrf2 interaction, Nrf2-based peptide inhibitor design, and the screening assays currently used for the discovery of direct inhibitors of Keap1-Nrf2 interaction. © 2012 Wiley Periodicals, Inc.  Med Res Rev., 32, No. 4, 687-726, 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhLmdkuTSh7Vg90H21EOLACvtfcHk0lgo_ZmiOviWvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D&md5=2104d731cb251e0d9b6d2ad73a735175</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fmed.21257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21257%26sid%3Dliteratum%253Aachs%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DSmall%2520molecule%2520modulators%2520of%2520Keap1-Nrf2-ARE%2520pathway%2520as%2520potential%2520preventive%2520and%2520therapeutic%2520agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D687%26epage%3D726%26doi%3D10.1002%2Fmed.21257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canning, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorrell, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, A. N.</span></span> <span> </span><span class="NLM_article-title">Structural basis of Keap1 interactions with Nrf2</span>. <i>Free Radic. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.05.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.freeradbiomed.2015.05.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26057936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=101-107&author=P.+Canningauthor=F.+J.+Sorrellauthor=A.+N.+Bullock&title=Structural+basis+of+Keap1+interactions+with+Nrf2&doi=10.1016%2Fj.freeradbiomed.2015.05.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of KEAP1 interactions with Nrf2</span></div><div class="casAuthors">Canning, Peter; Sorrell, Fiona J.; Bullock, Alex N.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">101-107</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  KEAP1 is a highly redox-sensitive member of the BTB-Kelch family that assembles with the Cul3 protein to form a Cullin-RING E3 ligase complex for the degrdn. of Nrf2.  Oxidative stress disables KEAP1, allowing Nrf2 protein levels to accumulate for the transactivation of crit. stress response genes.  Consequently, the KEAP1-Nrf2 system is extensively pursued for the development of protein-protein interaction inhibitors that will stabilize Nrf2 for therapeutic effect in conditions of neurodegeneration, inflammation, and cancer.  Here we review current progress toward the structure detn. of KEAP1 and its protein complexes with Cul3, Nrf2 substrate, and small-mol. antagonists.  Together the available structures establish a rational three-dimensional model to explain the two-site binding of Nrf2 as well as its efficient ubiquitination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwBBMS70b7hbVg90H21EOLACvtfcHk0lgo_ZmiOviWvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7rK&md5=12b7b36caa16cf3cd3d95d84162eed80</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DCanning%26aufirst%3DP.%26aulast%3DSorrell%26aufirst%3DF.%2BJ.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26atitle%3DStructural%2520basis%2520of%2520Keap1%2520interactions%2520with%2520Nrf2%26jtitle%3DFree%2520Radic.%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D101%26epage%3D107%26doi%3D10.1016%2Fj.freeradbiomed.2015.05.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span> <span> </span><span class="NLM_article-title">Investigation of the intermolecular recognition mechanism between the E3 ubiquitin ligase Keap1 and substrate based on multiple substrates analysis</span>. <i>J. Comput. Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1233</span>– <span class="NLM_lpage">1245</span>, <span class="refDoi"> DOI: 10.1007/s10822-014-9799-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1007%2Fs10822-014-9799-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=25301376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsleku7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1233-1245&author=Z.-Y.+Jiangauthor=L.-L.+Xuauthor=M.-C.+Luauthor=Y.+Panauthor=H.-Z.+Huangauthor=X.-J.+Zhangauthor=H.-P.+Sunauthor=Q.-D.+You&title=Investigation+of+the+intermolecular+recognition+mechanism+between+the+E3+ubiquitin+ligase+Keap1+and+substrate+based+on+multiple+substrates+analysis&doi=10.1007%2Fs10822-014-9799-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the intermolecular recognition mechanism between the E3 ubiquitin ligase Keap1 and substrate based on multiple substrates analysis</span></div><div class="casAuthors">Jiang, Zheng-Yu; Xu, Li-Li; Lu, Meng-Chen; Pan, Yang; Huang, Hao-Ze; Zhang, Xiao-Jin; Sun, Hao-Peng; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1233-1245</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">E3 ubiquitin ligases are attractive drug targets due to their specificity to the ubiquitin machinery.  However, the development of E3 ligase inhibitors has proven challenging for the fact that they must disrupt protein-protein interactions (PPIs).  The E3 ligase involved in interactome provide new hope for the discovery of the E3 ligase inhibitors.  These currently known natural binding partners of the E3 ligase can benefit the discovery of other unknown substrates and also the E3 ligase inhibitors.  Herein, we present a novel strategy that using multiple substrates to elucidate the mol. recognition mechanism of E3 ubiquitin ligase.  Mol. dynamics simulation, mol. mechanics-generalized born surface area (MM-GBSA) binding energy calcn. and energy decompn. scheme were incorporated to evaluate the quant. contributions of sub-pocket and per-residue to binding.  In this case, Kelch-like ECH-assocd. protein-1 (Keap1), a substrate adaptor component of the Cullin-RING ubiquitin ligases complex, is applied for the investigation of how it recognize its substrates, esp. Nrf2, a master regulator of the antioxidant response.  By analyzing multiple substrates binding determinants, we found that both the polar sub-pockets (P1 and P2) and the nonpolar sub-pockets (P4 and P5) of Keap1 can make remarkable contributions to intermol. interactions.  This finding stresses the requirement for substrates to interact with the polar and nonpolar sub-pockets simultaneously.  The results discussed in this paper not only show the binding determinants of the Keap1 substrates but also provide valuable implications for both Keap1 substrate discovery and PPI inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppReS77bpky7Vg90H21EOLACvtfcHk0lgo_ZmiOviWvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsleku7zI&md5=359ff305f89c6a69cca48f60d019c765</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs10822-014-9799-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-014-9799-y%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.-Y.%26aulast%3DXu%26aufirst%3DL.-L.%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DH.-Z.%26aulast%3DZhang%26aufirst%3DX.-J.%26aulast%3DSun%26aufirst%3DH.-P.%26aulast%3DYou%26aufirst%3DQ.-D.%26atitle%3DInvestigation%2520of%2520the%2520intermolecular%2520recognition%2520mechanism%2520between%2520the%2520E3%2520ubiquitin%2520ligase%2520Keap1%2520and%2520substrate%2520based%2520on%2520multiple%2520substrates%2520analysis%26jtitle%3DJ.%2520Comput.%2520Aided%2520Mol.%2520Des.%26date%3D2014%26volume%3D28%26spage%3D1233%26epage%3D1245%26doi%3D10.1007%2Fs10822-014-9799-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Bakry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laoruchupong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction</span>. <i>Free Radic. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.10.486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.freeradbiomed.2011.10.486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=22107959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsVyhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=444-451&author=R.+Hancockauthor=H.+C.+Bertrandauthor=T.+Tsujitaauthor=S.+Nazauthor=A.+El-Bakryauthor=J.+Laoruchupongauthor=J.+D.+Hayesauthor=G.+Wells&title=Peptide+inhibitors+of+the+Keap1-Nrf2+protein-protein+interaction&doi=10.1016%2Fj.freeradbiomed.2011.10.486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction</span></div><div class="casAuthors">Hancock, Rowena; Bertrand, Helene C.; Tsujita, Tadayuki; Naz, Shama; El-Bakry, Ayman; Laoruchupong, Jitnueng; Hayes, John D.; Wells, Geoff</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">444-451</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Disruption of the interaction between the ubiquitination facilitator protein Keap1 and the cap'n'collar basic-region leucine-zipper transcription factor Nrf2 is a potential strategy to enhance expression of antioxidant and free radical detoxification gene products regulated by Nrf2.  Agents that disrupt this protein-protein interaction may be useful pharmacol. probes and future cancer-chemopreventive agents.  We describe the structure-activity relationships for a series of peptides based upon regions of the Nrf2 Neh2 domain, of varying length and sequence, that interact with the Keap1 Kelch domain and disrupt the interaction with Nrf2.  We have also investigated sequestosome-1 (p62) and prothymosin-α sequences that have been reported to interact with Keap1.  To achieve this we have developed a high-throughput fluorescence polarization (FP) assay to screen inhibitors.  In addn. to screening synthetic peptides, we have used a phage display library approach to identify putative peptide ligands with non-native sequence motifs.  Candidate peptides from the phage display library screening protocol were evaluated in the FP assay to quantify their binding activity.  Hybrid peptides based upon the Nrf2 "ETGE" motif and the sequestosome-1 "Keap1-interaction region" have superior binding activity compared to either native peptide alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrdLfQUd3TrVg90H21EOLACvtfcHk0liM7Nut07D3HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsVyhtA%253D%253D&md5=e48014219fb0738c2af6cb8301d73968</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.10.486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.10.486%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DR.%26aulast%3DBertrand%26aufirst%3DH.%2BC.%26aulast%3DTsujita%26aufirst%3DT.%26aulast%3DNaz%26aufirst%3DS.%26aulast%3DEl-Bakry%26aufirst%3DA.%26aulast%3DLaoruchupong%26aufirst%3DJ.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DWells%26aufirst%3DG.%26atitle%3DPeptide%2520inhibitors%2520of%2520the%2520Keap1-Nrf2%2520protein-protein%2520interaction%26jtitle%3DFree%2520Radic.%2520Biol.%2520Med.%26date%3D2012%26volume%3D52%26spage%3D444%26epage%3D451%26doi%3D10.1016%2Fj.freeradbiomed.2011.10.486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaap, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activity</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3553</span>– <span class="NLM_lpage">3557</span>, <span class="refDoi"> DOI: 10.1039/c3ob40249e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1039%2Fc3ob40249e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=23615671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlaitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=3553-3557&author=R.+Hancockauthor=M.+Schaapauthor=H.+Pfisterauthor=G.+Wells&title=Peptide+inhibitors+of+the+Keap1-Nrf2+protein-protein+interaction+with+improved+binding+and+cellular+activity&doi=10.1039%2Fc3ob40249e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activity</span></div><div class="casAuthors">Hancock, Rowena; Schaap, Marjolein; Pfister, Helene; Wells, Geoff</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3553-3557</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Inhibitors of the Keap1-Nrf2 protein-protein interaction (PPI) have been proposed as potential anti-inflammatory and cancer chemopreventive agents.  Such compds. have the potential to increase the intracellular concns. of Nrf2 in a reversible manner and consequently increase the expression of a battery of gene products with antioxidant response elements (AREs) in their promoter region.  In this manuscript we describe the development of peptide inhibitors with modified C- and N-termini and reduced overall charge.  The activity of the compds. in inhibiting the PPI and in cellular assays of Nrf2 function are described.  Compd. 10 has potent activity (IC50 = 22 nM) in a cell-free fluorescence polarisation assay and induced the expression of Nrf2 dependent gene products in cells, suggesting that it has potential as a lead mol. for the development of peptidomimetic inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX5B_aGg-CqrVg90H21EOLACvtfcHk0liM7Nut07D3HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlaitbk%253D&md5=e372946c8f18dd21b91ade80212bcdec</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2Fc3ob40249e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ob40249e%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DR.%26aulast%3DSchaap%26aufirst%3DM.%26aulast%3DPfister%26aufirst%3DH.%26aulast%3DWells%26aufirst%3DG.%26atitle%3DPeptide%2520inhibitors%2520of%2520the%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520with%2520improved%2520binding%2520and%2520cellular%2520activity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D3553%26epage%3D3557%26doi%3D10.1039%2Fc3ob40249e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">Binding thermodynamics and kinetics guided optimization of potent Keap1–Nrf2 peptide inhibitors</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">85983</span>– <span class="NLM_lpage">85987</span>, <span class="refDoi"> DOI: 10.1039/c5ra16262a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1039%2FC5RA16262A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKku7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=85983-85987&author=M.-C.+Luauthor=Z.-Y.+Chenauthor=Y.-L.+Wangauthor=Y.-L.+Jiangauthor=Z.-W.+Yuanauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=Binding+thermodynamics+and+kinetics+guided+optimization+of+potent+Keap1%E2%80%93Nrf2+peptide+inhibitors&doi=10.1039%2Fc5ra16262a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Binding thermodynamics and kinetics guided optimization of potent Keap1-Nrf2 peptide inhibitors</span></div><div class="casAuthors">Lu, Meng-Chen; Chen, Zhi-Yun; Wang, Ya-Lou; Jiang, Yong-Lin; Yuan, Zhen-Wei; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">105</span>),
    <span class="NLM_cas:pages">85983-85987</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Activation of Nrf2 by directly inhibiting the Keap1-Nrf2 Protein-Protein Interaction (PPI) has gained research interest with regard to developing novel agents for treating inflammatory related diseases.  In this study, computational methods were used to guide the rational activity improvement of peptide Keap1-Nrf2 inhibitors and to explore the Keap1 binding cavity.  Terminal hydrophobic residues and Tyr residue replacements were introduced into the novel peptides.  The exptl. values of these peptides further confirmed the potential binding sites explored by the MD simulation.  Finally, the most promising, peptide 5 with an intracyclic conformation showed a Kd value of 2.8 nM when binding to Keap1 and an IC50 value of 9.4 nM in the Keap1-Nrf2 PPI fluorescence polarization assay.  It proved that the active conformation locking strategy is quite useful in Keap1-Nrf2 PPI inhibitor design.  It also provided a useful probe to investigate the Keap1-Nrf2 PPI system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPU2Ia8EiYKbVg90H21EOLACvtfcHk0liM7Nut07D3HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKku7vI&md5=08fe1cca6a9360f35978faa1b3f000af</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1039%2FC5RA16262A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA16262A%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DChen%26aufirst%3DZ.-Y.%26aulast%3DWang%26aufirst%3DY.-L.%26aulast%3DJiang%26aufirst%3DY.-L.%26aulast%3DYuan%26aufirst%3DZ.-W.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DBinding%2520thermodynamics%2520and%2520kinetics%2520guided%2520optimization%2520of%2520potent%2520Keap1%25E2%2580%2593Nrf2%2520peptide%2520inhibitors%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D85983%26epage%3D85987%26doi%3D10.1039%2Fc5ra16262a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sogabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadotani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, J.-i.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Kelch-like ECH-associated protein 1-inhibitory tetrapeptide and its structural characterization</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>486</i></span>,  <span class="NLM_fpage">620</span>– <span class="NLM_lpage">625</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2017.03.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.bbrc.2017.03.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=28315327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltVWqtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2017&pages=620-625&author=S.+Sogabeauthor=K.+Sakamotoauthor=Y.+Kamadaauthor=A.+Kadotaniauthor=Y.+Fukudaauthor=J.-i.+Sakamoto&title=Discovery+of+a+Kelch-like+ECH-associated+protein+1-inhibitory+tetrapeptide+and+its+structural+characterization&doi=10.1016%2Fj.bbrc.2017.03.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Kelch-like ECH-associated protein 1-inhibitory tetrapeptide and its structural characterization</span></div><div class="casAuthors">Sogabe, Satoshi; Sakamoto, Kotaro; Kamada, Yusuke; Kadotani, Akito; Fukuda, Yasunori; Sakamoto, Jun-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">486</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">620-625</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Keap1 constitutively binds to the transcription factor Nrf2 to promote its degrdn., resulting in neg. modulation of genes involved in cellular protection against oxidative stress.  Keap1 is increasingly recognized as an attractive target for treating diseases involving oxidative stress, including cancer, atherosclerosis, diabetes, arthritis, and neurodegeneration.  We used phage-display peptide screening to identify a tetrapeptide showing moderate binding affinity, which inhibits the interaction between Nrf2 and Keap1.  The tetrapeptide does not include an ETGE motif, which is a commonly found consensus sequence in known peptidic inhibitors.  In addn. to affinity parameters, IC50, KD, and thermodn. parameters, the crystal structure of the complex was detd. to elucidate the binding conformation.  The binding interactions resemble those of known small-mol. inhibitors as opposed to those of substrates and peptidic inhibitors.  Although the tetrapeptide's affinity is not very high, our results may help facilitate the designing of small-mol. inhibitors during lead generation in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRwfG6x0hNurVg90H21EOLACvtfcHk0lg2BAN7bsCteQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltVWqtbo%253D&md5=977e96b181570d788deaa0ee3b3f8652</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2017.03.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2017.03.038%26sid%3Dliteratum%253Aachs%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DKamada%26aufirst%3DY.%26aulast%3DKadotani%26aufirst%3DA.%26aulast%3DFukuda%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DJ.-i.%26atitle%3DDiscovery%2520of%2520a%2520Kelch-like%2520ECH-associated%2520protein%25201-inhibitory%2520tetrapeptide%2520and%2520its%2520structural%2520characterization%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D486%26spage%3D620%26epage%3D625%26doi%3D10.1016%2Fj.bbrc.2017.03.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of a head-to-tail cyclic peptide as the Keap1-Nrf2 protein-protein interaction inhibitor with high cell potency</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">1578</span>– <span class="NLM_lpage">1589</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.10.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.ejmech.2017.10.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=29117896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyrt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=1578-1589&author=M.-C.+Luauthor=Q.+Jiaoauthor=T.+Liuauthor=S.-J.+Tanauthor=H.-S.+Zhouauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=Discovery+of+a+head-to-tail+cyclic+peptide+as+the+Keap1-Nrf2+protein-protein+interaction+inhibitor+with+high+cell+potency&doi=10.1016%2Fj.ejmech.2017.10.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a head-to-tail cyclic peptide as the Keap1-Nrf2 protein-protein interaction inhibitor with high cell potency</span></div><div class="casAuthors">Lu, Meng-Chen; Jiao, Qiong; Liu, Tian; Tan, Shi-Jie; Zhou, Hai-Shan; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1578-1589</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Directly disrupting Keap1-Nrf2 protein-protein interaction (PPI) has emerged as a novel way to activate Nrf2.  Peptide Keap1-Nrf2 PPI inhibitors have been reported with high Keap1 binding affinity.  However, these peptide inhibitors show weak activity in cells.  In this study, the head-to-tail cyclic strategy was applied in the development of peptide inhibitors.  The privileged residue sequence with minimal acidic residues was used as the template for the cyclic peptide, and the appropriate conjugation method was designed based on the peptide-Keap1 binding mode.  The glycine was introduced as the linker to connect both sides, which can avoid the terminal charge, enhance the peptide stability and constrain the binding conformation simultaneously.  The obtained novel cyclic peptide 3 showed high binding affinity with Keap1 and possessed high potency in Nrf2 activation at cellular level.  We also showed that peptide 3 exhibited effective anti-inflammatory effects in mouse RAW 264.7 cells by activating the Nrf2-regulated defense system and enhancing the antioxidant capacity.  This study proved that the head-to-tail cyclic strategy is quite useful in improving the cell potency of peptide Keap1-Nrf2 inhibitors and provided a possible way to develop drug-like peptides as therapeutic Nrf2 activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSQuf13RdntbVg90H21EOLACvtfcHk0lg2BAN7bsCteQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyrt73J&md5=ce1906541b5d2ece410b891d3ffe1084</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.10.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.10.052%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DJiao%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DS.-J.%26aulast%3DZhou%26aufirst%3DH.-S.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DDiscovery%2520of%2520a%2520head-to-tail%2520cyclic%2520peptide%2520as%2520the%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520inhibitor%2520with%2520high%2520cell%2520potency%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D143%26spage%3D1578%26epage%3D1589%26doi%3D10.1016%2Fj.ejmech.2017.10.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Georgakopoulos, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talapatra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatliff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozielski, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Modified peptide inhibitors of the Keap1-Nrf2 protein-protein interaction incorporating unnatural amino acids</span>. <i>Chembiochem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1810</span>– <span class="NLM_lpage">1816</span>, <span class="refDoi"> DOI: 10.1002/cbic.201800170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1002%2Fcbic.201800170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=29927029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlaqs7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=1810-1816&author=N.+D.+Georgakopoulosauthor=S.+K.+Talapatraauthor=J.+Gatliffauthor=F.+Kozielskiauthor=G.+Wells&title=Modified+peptide+inhibitors+of+the+Keap1-Nrf2+protein-protein+interaction+incorporating+unnatural+amino+acids&doi=10.1002%2Fcbic.201800170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Modified Peptide Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction Incorporating Unnatural Amino Acids</span></div><div class="casAuthors">Georgakopoulos, Nikolaos D.; Talapatra, Sandeep K.; Gatliff, Jemma; Kozielski, Frank; Wells, Geoff</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1810-1816</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Noncovalent inhibitors of the Keap1-Nrf2 protein-protein interaction (PPI) have therapeutic potential in a range of disease states including neurodegenerative diseases (Parkinson's and Alzheimer's diseases), chronic obstructive pulmonary disease and various inflammatory conditions.  By stalling Keap1-mediated ubiquitination of Nrf2, such compds. can enhance Nrf2 transcriptional activity and activate the expression of a range of genes with antioxidant response elements in their promoter regions.  Keap1 inhibitors based on peptide and small-mol. templates have been identified.  In this paper we develop the structure-activity relationships of the peptide series and identify a group of ligands incorporating unnatural amino acids that demonstrate improved binding affinity in fluorescence polarisation, differential scanning fluorimetry and isothermal titrn. calorimetry assays.  These modified peptides have the potential for further development into peptidomimetic chem. probes to explore the role of Nrf2 in disease and as potential lead structures for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRqJ1SUlY53LVg90H21EOLACvtfcHk0lg2BAN7bsCteQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlaqs7bO&md5=781038e48434448c55348c0d10eae2f6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201800170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201800170%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgakopoulos%26aufirst%3DN.%2BD.%26aulast%3DTalapatra%26aufirst%3DS.%2BK.%26aulast%3DGatliff%26aufirst%3DJ.%26aulast%3DKozielski%26aufirst%3DF.%26aulast%3DWells%26aufirst%3DG.%26atitle%3DModified%2520peptide%2520inhibitors%2520of%2520the%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520incorporating%2520unnatural%2520amino%2520acids%26jtitle%3DChembiochem%26date%3D2018%26volume%3D19%26spage%3D1810%26epage%3D1816%26doi%3D10.1002%2Fcbic.201800170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span> <span> </span><span class="NLM_article-title">Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1080/13543776.2020.1715365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1080%2F13543776.2020.1715365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31922884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlCnt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=209-225&author=H.+Zhouauthor=Y.+Wangauthor=Q.+Youauthor=Z.+Jiang&title=Recent+progress+in+the+development+of+small+molecule+Nrf2+activators%3A+a+patent+review+%282017-present%29&doi=10.1080%2F13543776.2020.1715365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present)</span></div><div class="casAuthors">Zhou, Haishan; Wang, Yan; You, Qidong; Jiang, Zhengyu</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-225</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Transcription factor Nrf2 is first line of defense against plethora of environmental or endogenous deviations in redox metab., proteostasis, inflammation, etc.  Therefore, pharmacol. activation of Nrf2 is potential therapeutic approach for several diseases related to oxidative stress and inflammation, such as cancer, cardiovascular, and neurodegenerative diseases.  Authors first describe biol. function of Nrf2 and mol. regulatory mechanism of Keap1-Nrf2-ARE ((Kelch-like ECH-Assocg. protein 1)-Nrf2-(antioxidant response element)).  Then, they review recent progress of covalent activators and non-covalent Keap1-Nrf2 protein-protein interaction inhibitors from patents and publications in 2017-present, consisting of new chem. mols., structure optimization of reported activators and progress in preclin. or clin. trials.  Despite significant achievements in development of Nrf2 activators, selectivity is primary consideration.  Due to reacting with redox-sensitive cysteines in proteins except for Keap1, electrophilic activators often exhibit off-target effects.  For Keap1-Nrf2 PPI inhibitors, how to enhance in vivo efficacy and/or penetrate blood-brain barrier to reach central nervous system is also challenging.  Fragment-based drug discovery, carboxylic acid bioisosteric replacement and prodrug approach might be used to circumvent this challenge.  Moreover, possibility of cancer risk caused by Nrf2 activation needs to be considered carefully.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF0YqRGP3WP7Vg90H21EOLACvtfcHk0lg2BAN7bsCteQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlCnt7c%253D&md5=7441d04e642844ddca28cb842cd1f61e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1080%2F13543776.2020.1715365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2020.1715365%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DZ.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520small%2520molecule%2520Nrf2%2520activators%253A%2520a%2520patent%2520review%2520%25282017-present%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2020%26volume%3D30%26spage%3D209%26epage%3D225%26doi%3D10.1080%2F13543776.2020.1715365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hui, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlstetter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilken, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terjung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nassar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duh, E. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the Keap1-Nrf2 protein-protein interaction protects retinal cells and ameliorates retinal ischemia-reperfusion injury</span>. <i>Free Radic. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2019.10.414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.freeradbiomed.2019.10.414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31669760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFehtL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2020&pages=181-188&author=Q.+Huiauthor=M.+Karlstetterauthor=Z.+Xuauthor=J.+Yangauthor=L.+Zhouauthor=H.+M.+Eilkenauthor=C.+Terjungauthor=H.+Choauthor=J.+Gongauthor=M.+J.+Laiauthor=K.+Nassarauthor=E.+J.+Duh&title=Inhibition+of+the+Keap1-Nrf2+protein-protein+interaction+protects+retinal+cells+and+ameliorates+retinal+ischemia-reperfusion+injury&doi=10.1016%2Fj.freeradbiomed.2019.10.414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Keap1-Nrf2 protein-protein interaction protects retinal cells and ameliorates retinal ischemia-reperfusion injury</span></div><div class="casAuthors">Hui, Qiaoyan; Karlstetter, Marcus; Xu, Zhenhua; Yang, Jing; Zhou, Lingli; Eilken, Hanna M.; Terjung, Carsten; Cho, Hongkwan; Gong, Junsong; Lai, Michael J.; Nassar, Khaled; Duh, Elia J.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">181-188</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Nrf2-Keap1 pathway regulates transcription of a wide array of antioxidant and cytoprotective genes and offers crit. protection against oxidative stress.  This pathway has demonstrated benefit for a variety of retinal conditions.  Retinal ischemia plays a pivotal role in many vision threatening diseases.  Retinal vascular endothelial cells are an important participant in ischemic injury.  In this setting, Nrf2 provides a protective pathway via amelioration of oxidative stress and inflammation.  In this study, we investigated a potent small mol. inhibitor of the Nrf2-Keap1 protein-protein interaction (PPI), CPUY192018, for its therapeutic potential in retinal cells and retinal ischemia-reperfusion injury.  In human retinal endothelial cells (HREC), treatment with CPUY192018 increased Nrf2 protein levels and nuclear translocation, stimulated Nrf2-ARE-induced transcriptional capacity, and induced Nrf2 target gene expression.  Furthermore, CPUY192018 protected HREC against oxidative stress and inflammatory activation.  CPUY192018 also activated Nrf2 and suppressed inflammatory response in macrophages.  In the retinal ischemia-reperfusion (I/R) model, administration of CPUY192018 induced Nrf2 target gene activation in the retina.  Both systemic and topical treatment with CPUY192018 rescued visual function after ischemia-reperfusion injury.  Taken together, these findings indicate that small mol. Keap1-Nrf2 PPI inhibitors can activate the Nrf2 pathway in the retina and provide protection against retinal ischemic and inflammatory injury, suggesting Keap1-Nrf2 PPI inhibition in the treatment of retinal conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3eILAsrfhwbVg90H21EOLACvtfcHk0lien2Xn_nfdpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFehtL7K&md5=2ac3e94df8c81b4219e9c5b62480bfa2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2019.10.414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2019.10.414%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DQ.%26aulast%3DKarlstetter%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DEilken%26aufirst%3DH.%2BM.%26aulast%3DTerjung%26aufirst%3DC.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DM.%2BJ.%26aulast%3DNassar%26aufirst%3DK.%26aulast%3DDuh%26aufirst%3DE.%2BJ.%26atitle%3DInhibition%2520of%2520the%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520protects%2520retinal%2520cells%2520and%2520ameliorates%2520retinal%2520ischemia-reperfusion%2520injury%26jtitle%3DFree%2520Radic.%2520Biol.%2520Med.%26date%3D2020%26volume%3D146%26spage%3D181%26epage%3D188%26doi%3D10.1016%2Fj.freeradbiomed.2019.10.414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, M.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-kappaB activation</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">101266</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2019.101266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.redox.2019.101266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31279986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlahtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=101266&author=M.-C.+Luauthor=J.+Zhaoauthor=Y.-T.+Liuauthor=T.+Liuauthor=M.-M.+Taoauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=CPUY192018%2C+a+potent+inhibitor+of+the+Keap1-Nrf2+protein-protein+interaction%2C+alleviates+renal+inflammation+in+mice+by+restricting+oxidative+stress+and+NF-kappaB+activation&doi=10.1016%2Fj.redox.2019.101266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-κB activation</span></div><div class="casAuthors">Lu, Meng-Chen; Zhao, Jing; Liu, Yu-Ting; Liu, Tian; Tao, Meng-Min; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101266</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Keap1-Nrf2-ARE pathway regulates the constitutive and inducible transcription of various genes that encode detoxification enzymes, antioxidant proteins and anti-inflammatory proteins and has pivotal roles in the defense against cellular oxidative stress.  In this study, we investigated the therapeutic potential of CPUY192018, a potent small-mol. inhibitor of the Keap1-Nrf2 protein-protein interaction (PPI), in renal inflammation.  In human proximal tubular epithelial HK-2 cells, CPUY192018 treatment significantly increased Nrf2 protein level and Nrf2 nuclear translocation, which enhanced Nrf2-ARE transcription capacity and the downstream protein content in a Nrf2 dependent manner.  In lipopolysaccharide (LPS)-challenged human HK-2 cells, CPUY192018 exhibited cytoprotective effects by enhancing the Nrf2-ARE regulated antioxidant system and diminished the LPS-induced inflammatory response by hindering the ROS-mediated activation of the NF-κB pathway.  In the LPS-induced mouse model of chronic renal inflammation, by activating Nrf2, CPUY192018 treatment balanced renal oxidative stress and suppressed inflammatory responses.  Hence, administration of CPUY192018 reduced kidney damage and ameliorated pathol. alterations of the glomerulus.  Taken together, our study suggested that small-mol. Keap1-Nrf2 PPI inhibitors can activate the Nrf2-based cytoprotective system and protect the kidney from inflammatory injury, raising a potential application of Keap1-Nrf2 PPI inhibitors in the treatment of inflammatory kidney disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0SJrXQhvzS7Vg90H21EOLACvtfcHk0lien2Xn_nfdpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlahtL7O&md5=0f9fbdd03df93594539445b77c983b86</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2019.101266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2019.101266%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DTao%26aufirst%3DM.-M.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DCPUY192018%252C%2520a%2520potent%2520inhibitor%2520of%2520the%2520Keap1-Nrf2%2520protein-protein%2520interaction%252C%2520alleviates%2520renal%2520inflammation%2520in%2520mice%2520by%2520restricting%2520oxidative%2520stress%2520and%2520NF-kappaB%2520activation%26jtitle%3DRedox%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D101266%26doi%3D10.1016%2Fj.redox.2019.101266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">26585</span>, <span class="refDoi"> DOI: 10.1038/srep26585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1038%2Fsrep26585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=27215610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos12lsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=26585&author=M.-C.+Luauthor=J.-A.+Jiauthor=Y.-L.+Jiangauthor=Z.-Y.+Chenauthor=Z.-W.+Yuanauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=An+inhibitor+of+the+Keap1-Nrf2+protein-protein+interaction+protects+NCM460+colonic+cells+and+alleviates+experimental+colitis&doi=10.1038%2Fsrep26585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis</span></div><div class="casAuthors">Lu, Meng-Chen; Ji, Jian-Ai; Jiang, Yong-Lin; Chen, Zhi-Yun; Yuan, Zhen-Wei; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26585</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ulcerative colitis (UC) is a chronic relapsing-remitting form of inflammatory bowel disease (IBD) that increases the risk of colorectal cancer, the third most common malignancy in humans.  Oxidative stress is a risk factor for the development of UC.  The Keap1-Nrf2-ARE pathway is one of the most important defensive mechanisms against oxidative and/or electrophilic stresses.  In this study, we identified CPUY192018 as a potent small-mol. inhibitor of the Keap1-Nrf2 PPI, investigated the cyto-protective effects of CPUY192018 on the NCM460 colonic cells and evaluated whether treatment with the inhibitor of the Keap1-Nrf2 PPI exerts protection on an established exptl. model of UC induced by dextran sodium sulfate (DSS).  Our study clearly demonstrated that CPUY192018 had a cytoprotective effect against DSS in both NCM460 cells and mouse colon via the activation of Nrf2 signaling.  These results suggested that activation of Nrf2 by directly inhibiting the Keap1-Nrf2 PPI may be beneficial as a treatment for UC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE93oXzGcDmrVg90H21EOLACvtfcHk0lien2Xn_nfdpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos12lsLk%253D&md5=3dcdaff7589ff3014d50326d0a908382</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fsrep26585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep26585%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DJi%26aufirst%3DJ.-A.%26aulast%3DJiang%26aufirst%3DY.-L.%26aulast%3DChen%26aufirst%3DZ.-Y.%26aulast%3DYuan%26aufirst%3DZ.-W.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DAn%2520inhibitor%2520of%2520the%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520protects%2520NCM460%2520colonic%2520cells%2520and%2520alleviates%2520experimental%2520colitis%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D26585%26doi%3D10.1038%2Fsrep26585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hus, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hession, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugovskoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuervo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atmanene, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roecklin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukashev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvian, L.</span></span> <span> </span><span class="NLM_article-title">Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4011</span>– <span class="NLM_lpage">4019</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.bmc.2013.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=23647822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlSku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=4011-4019&author=D.+Marcotteauthor=W.+Zengauthor=J.-C.+Husauthor=A.+McKenzieauthor=C.+Hessionauthor=P.+Jinauthor=C.+Bergeronauthor=A.+Lugovskoyauthor=I.+Enyedyauthor=H.+Cuervoauthor=D.+Wangauthor=C.+Atmaneneauthor=D.+Roecklinauthor=M.+Vecchiauthor=V.+Vivatauthor=J.+Kraemerauthor=D.+Winklerauthor=V.+Hongauthor=J.+Chaoauthor=M.+Lukashevauthor=L.+Silvian&title=Small+molecules+inhibit+the+interaction+of+Nrf2+and+the+Keap1+Kelch+domain+through+a+non-covalent+mechanism&doi=10.1016%2Fj.bmc.2013.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism</span></div><div class="casAuthors">Marcotte, Douglas; Zeng, Weike; Hus, Jean-Christophe; McKenzie, Andres; Hession, Cathy; Jin, Ping; Bergeron, Chris; Lugovskoy, Alexey; Enyedy, Istvan; Cuervo, Hernan; Wang, Deping; Atmanene, Cedric; Roecklin, Dominique; Vecchi, Malgorzata; Vivat, Valerie; Kraemer, Joachim; Winkler, Dirk; Hong, Victor; Chao, Jianhua; Lukashev, Matvey; Silvian, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4011-4019</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Keap1 binds to the Nrf2 transcription factor to promote its degrdn., resulting in the loss of gene products that protect against oxidative stress.  While cell-active small mols. have been identified that modify cysteines in Keap1 and effect the Nrf2 dependent pathway, few act through a non-covalent mechanism.  We have identified and characterized several small mol. compds. that specifically bind to the Keap1 Kelch-DC domain as measured by NMR, native mass spectrometry and X-ray crystallog.  One compd. upregulates Nrf2 response genes measured by a luciferase cell reporter assay.  The non-covalent inhibition strategy presents a reasonable course of action to avoid toxic side-effects due to non-specific cysteine modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5KaDM3q3CeLVg90H21EOLACvtfcHk0lgzQ6NCKpCYrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlSku7w%253D&md5=b49b42b1621c6f08fbb3449621e4b109</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DHus%26aufirst%3DJ.-C.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DHession%26aufirst%3DC.%26aulast%3DJin%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DC.%26aulast%3DLugovskoy%26aufirst%3DA.%26aulast%3DEnyedy%26aufirst%3DI.%26aulast%3DCuervo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DAtmanene%26aufirst%3DC.%26aulast%3DRoecklin%26aufirst%3DD.%26aulast%3DVecchi%26aufirst%3DM.%26aulast%3DVivat%26aufirst%3DV.%26aulast%3DKraemer%26aufirst%3DJ.%26aulast%3DWinkler%26aufirst%3DD.%26aulast%3DHong%26aufirst%3DV.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DLukashev%26aufirst%3DM.%26aulast%3DSilvian%26aufirst%3DL.%26atitle%3DSmall%2520molecules%2520inhibit%2520the%2520interaction%2520of%2520Nrf2%2520and%2520the%2520Keap1%2520Kelch%2520domain%2520through%2520a%2520non-covalent%2520mechanism%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D4011%26epage%3D4019%26doi%3D10.1016%2Fj.bmc.2013.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.-P.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2736</span>– <span class="NLM_lpage">2745</span>, <span class="refDoi"> DOI: 10.1021/jm5000529</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5000529" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2736-2745&author=Z.-Y.+Jiangauthor=M.-C.+Luauthor=L.+L.+Xuauthor=T.-T.+Yangauthor=M.-Y.+Xiauthor=X.-L.+Xuauthor=X.-K.+Guoauthor=X.-J.+Zhangauthor=Q.-D.+Youauthor=H.-P.+Sun&title=Discovery+of+potent+Keap1-Nrf2+protein-protein+interaction+inhibitor+based+on+molecular+binding+determinants+analysis&doi=10.1021%2Fjm5000529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; Xu, Li-Li; Yang, Ting-Ting; Xi, Mei-Yang; Xu, Xiao-Li; Guo, Xiao-Ke; Zhang, Xiao-Jin; You, Qi-Dong; Sun, Hao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2736-2745</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Keap1 is known to mediate the ubiquitination of Nrf2, a master regulator of the antioxidant response.  Directly interrupting the Keap1-Nrf2 interaction has been emerged as a promising strategy to develop novel class of antioxidant, antiinflammatory, and anticancer agents.  On the basis of the mol. binding determinants anal. of Keap1, we successfully designed and characterized the most potent protein-protein interaction (PPI) inhibitor of Keap1-Nrf2, compd. 2, with KD value of 3.59 nM binding to Keap1 for the first time to single-digit nanomolar.  Compd. 2 can effectively disrupt the Nrf2-Keap1 interaction with an EC50 of 28.6 nM in the fluorescence polarization assay.  It can also activate the Nrf2 transcription activity in the cell-based ARE-luciferase reporter assay in a dose-dependent manner.  The qRT-PCR results of Nrf2 transcription targets gave the consistent results.  These results confirm direct and highly efficient interruption of the Keap1-Nrf2 PPI can be fully achieved by small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRS8nWHc40ZrVg90H21EOLACvtfcHk0lgzQ6NCKpCYrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D&md5=b5d43ac3973478ecc54e26c74435f2c4</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm5000529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5000529%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.-Y.%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DXu%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DT.-T.%26aulast%3DXi%26aufirst%3DM.-Y.%26aulast%3DXu%26aufirst%3DX.-L.%26aulast%3DGuo%26aufirst%3DX.-K.%26aulast%3DZhang%26aufirst%3DX.-J.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DSun%26aufirst%3DH.-P.%26atitle%3DDiscovery%2520of%2520potent%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520inhibitor%2520based%2520on%2520molecular%2520binding%2520determinants%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2736%26epage%3D2745%26doi%3D10.1021%2Fjm5000529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity and structure-property relationship and exploratory in vivo evaluation of the nanomolar Keap1-Nrf2 protein-protein interaction inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6410</span>– <span class="NLM_lpage">6421</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00185</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12ksb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6410-6421&author=Z.-Y.+Jiangauthor=L.+L.+Xuauthor=M.-C.+Luauthor=Z.-Y.+Chenauthor=Z.-W.+Yuanauthor=X.-L.+Xuauthor=X.-K.+Guoauthor=X.-J.+Zhangauthor=H.-P.+Sunauthor=Q.-D.+You&title=Structure-activity+and+structure-property+relationship+and+exploratory+in+vivo+evaluation+of+the+nanomolar+Keap1-Nrf2+protein-protein+interaction+inhibitor&doi=10.1021%2Facs.jmedchem.5b00185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity and Structure-Property Relationship and Exploratory in Vivo Evaluation of the Nanomolar Keap1-Nrf2 Protein-Protein Interaction Inhibitor</span></div><div class="casAuthors">Jiang, Zheng-Yu; Xu, Li-Li; Lu, Meng-Chen; Chen, Zhi-Yun; Yuan, Zhen-Wei; Xu, Xiao-Li; Guo, Xiao-Ke; Zhang, Xiao-Jin; Sun, Hao-Peng; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6410-6421</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Directly disrupting the Keap1-Nrf2 protein-protein interaction (PPI) is an effective way to activate Nrf2.  Using the potent Keap1-Nrf2 PPI inhibitor that was reported by our group, we conducted a preliminary investigation of the structure-activity and structure-property relationships of the ring systems to improve the drug-like properties.  Compd. 18e (I), which bore p-acetamido substituents on the side chain Ph rings, was the best choice for balancing PPI inhibition activity, physicochem. properties, and cellular Nrf2 activity.  Cell-based expts. with 18e showed that the Keap1-Nrf2 PPI inhibitor can activate Nrf2 and induce the expression of Nrf2 downstream proteins in an Nrf2-dependent manner.  An exploratory in vivo expt. was carried out to further evaluate the anti-inflammatory effects of 18e in a LPS-challenged mouse model.  The primary results indicated that 18e could reduce the level of circulating pro-inflammatory cytokines induced by LPS and relieve the inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzcdu5HL_rp7Vg90H21EOLACvtfcHk0lgzQ6NCKpCYrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12ksb7N&md5=458f0a612c34156a137759d99b741e3a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00185%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.-Y.%26aulast%3DXu%26aufirst%3DL.%2BL.%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DChen%26aufirst%3DZ.-Y.%26aulast%3DYuan%26aufirst%3DZ.-W.%26aulast%3DXu%26aufirst%3DX.-L.%26aulast%3DGuo%26aufirst%3DX.-K.%26aulast%3DZhang%26aufirst%3DX.-J.%26aulast%3DSun%26aufirst%3DH.-P.%26aulast%3DYou%26aufirst%3DQ.-D.%26atitle%3DStructure-activity%2520and%2520structure-property%2520relationship%2520and%2520exploratory%2520in%2520vivo%2520evaluation%2520of%2520the%2520nanomolar%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6410%26epage%3D6421%26doi%3D10.1021%2Facs.jmedchem.5b00185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">Polar recognition group study of Keap1-Nrf2 protein-protein interaction inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">835</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00407</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00407" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSrtLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=835-840&author=M.-C.+Luauthor=S.-J.+Tanauthor=J.-A.+Jiauthor=Z.-Y.+Chenauthor=Z.-W.+Yuanauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=Polar+recognition+group+study+of+Keap1-Nrf2+protein-protein+interaction+inhibitors&doi=10.1021%2Facsmedchemlett.5b00407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Polar Recognition Group Study of Keap1-Nrf2 Protein-Protein Interaction Inhibitors</span></div><div class="casAuthors">Lu, Meng-Chen; Tan, Shi-Jie; Ji, Jian-Ai; Chen, Zhi-Yun; Yuan, Zhen-Wei; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">835-840</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Directly disrupting the Keap1-Nrf2 protein-protein interaction (PPI) has emerged as an attractive way to activate Nrf2, and Keap1-Nrf2 PPI inhibitors have been proposed as potential agents to relieve inflammatory and oxidative stress diseases.  In this work, we investigated the diacetic moiety around the potent Keap1-Nrf2 PPI inhibitor DDO1018 (2), which was reported by our group previously.  Exploration of bioisosteric replacements afforded the ditetrazole analog 7, which maintains the potent PPI inhibition activity (IC50 = 15.8 nM) in an in vitro fluorescence polarization assay.  Physicochem. property detn. demonstrated that ditetrazole replacement can improve the drug-like property, including elevation of pKa, log D, and transcellular permeability.  Addnl., 7 is more efficacious than 2 on inducing the expression of Nrf2-dependent gene products in cells.  This study provides an alternative way to replace the diacetic moiety and occupy the polar subpockets in Keap1, which can benefit the subsequent development of Keap1-Nrf2 PPI inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreftVGJtgyi7Vg90H21EOLACvtfcHk0liPVO6HrSVL6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSrtLvM&md5=02c5c7d5082e77a1b5f32cecee3888ac</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00407%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DTan%26aufirst%3DS.-J.%26aulast%3DJi%26aufirst%3DJ.-A.%26aulast%3DChen%26aufirst%3DZ.-Y.%26aulast%3DYuan%26aufirst%3DZ.-W.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DPolar%2520recognition%2520group%2520study%2520of%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D835%26epage%3D840%26doi%3D10.1021%2Facsmedchemlett.5b00407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winkel, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margerie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szillat, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glombik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Güssregen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herling, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Knethen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmoll, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of RA839, a noncovalent small molecule binder to Keap1 and selective activator of Nrf2 signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">28446</span>– <span class="NLM_lpage">28455</span>, <span class="refDoi"> DOI: 10.1074/jbc.m115.678136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1074%2Fjbc.M115.678136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26459563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=28446-28455&author=A.+F.+Winkelauthor=C.+K.+Engelauthor=D.+Margerieauthor=A.+Kanntauthor=H.+Szillatauthor=H.+Glombikauthor=C.+Kallusauthor=S.+Rufauthor=S.+G%C3%BCssregenauthor=J.+Riedelauthor=A.+W.+Herlingauthor=A.+von+Knethenauthor=A.+Weigertauthor=B.+Br%C3%BCneauthor=D.+Schmoll&title=Characterization+of+RA839%2C+a+noncovalent+small+molecule+binder+to+Keap1+and+selective+activator+of+Nrf2+signaling&doi=10.1074%2Fjbc.m115.678136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling</span></div><div class="casAuthors">Winkel, Angelika F.; Engel, Christian K.; Margerie, Daniel; Kannt, Aimo; Szillat, Hauke; Glombik, Heiner; Kallus, Christopher; Ruf, Sven; Guessregen, Stefan; Riedel, Jens; Herling, Andreas W.; von Knethen, Andreas; Weigert, Andreas; Bruene, Bernhard; Schmoll, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">28446-28455</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The activation of the transcription factor NF-E2-related factor 2 (Nrf2) maintains cellular homeostasis in response to oxidative stress by the regulation of multiple cytoprotective genes.  Without stressors, the activity of Nrf2 is inhibited by its interaction with the Keap1 (kelch-like ECH-assocd. protein 1).  Here, we describe (3S)-1-[4-[(2,3,5,6-tetramethylphenyl) sulfonylamino]-1-naphthyl]pyrrolidine-3-carboxylic acid (RA839), a small mol. that binds noncovalently to the Nrf2-interacting kelch domain of Keap1 with a Kd of ∼6 μm, as demonstrated by x-ray co-crystn. and isothermal titrn. calorimetry.  Whole genome DNA arrays showed that at 10 μm RA839 significantly regulated 105 probe sets in bone marrow-derived macrophages.  Canonical pathway mapping of these probe sets revealed an activation of pathways linked with Nrf2 signaling.  These pathways were also activated after the activation of Nrf2 by the silencing of Keap1 expression.  RA839 regulated only two genes in Nrf2 knock-out macrophages.  Similar to the activation of Nrf2 by either silencing of Keap1 expression or by the reactive compd. 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid Me ester (CDDO-Me), RA839 prevented the induction of both inducible nitric-oxide synthase expression and nitric oxide release in response to lipopolysaccharides in macrophages.  In mice, RA839 acutely induced Nrf2 target gene expression in liver.  RA839 is a selective inhibitor of the Keap1/Nrf2 interaction and a useful tool compd. to study the biol. of Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqu4FlVebzcbVg90H21EOLACvtfcHk0liPVO6HrSVL6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsrjF&md5=082998a0e4685dc8622662270fbba223</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.678136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.678136%26sid%3Dliteratum%253Aachs%26aulast%3DWinkel%26aufirst%3DA.%2BF.%26aulast%3DEngel%26aufirst%3DC.%2BK.%26aulast%3DMargerie%26aufirst%3DD.%26aulast%3DKannt%26aufirst%3DA.%26aulast%3DSzillat%26aufirst%3DH.%26aulast%3DGlombik%26aufirst%3DH.%26aulast%3DKallus%26aufirst%3DC.%26aulast%3DRuf%26aufirst%3DS.%26aulast%3DG%25C3%25BCssregen%26aufirst%3DS.%26aulast%3DRiedel%26aufirst%3DJ.%26aulast%3DHerling%26aufirst%3DA.%2BW.%26aulast%3Dvon%2BKnethen%26aufirst%3DA.%26aulast%3DWeigert%26aufirst%3DA.%26aulast%3DBr%25C3%25BCne%26aufirst%3DB.%26aulast%3DSchmoll%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520RA839%252C%2520a%2520noncovalent%2520small%2520molecule%2520binder%2520to%2520Keap1%2520and%2520selective%2520activator%2520of%2520Nrf2%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D28446%26epage%3D28455%26doi%3D10.1074%2Fjbc.m115.678136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) protein-protein interaction inhibitor with natural proline structure as a cytoprotective agent against acetaminophen-induced hepatotoxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">6796</span>– <span class="NLM_lpage">6813</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00818</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00818" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlamsbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=6796-6813&author=M.-C.+Luauthor=X.+Zhangauthor=F.+Wuauthor=S.-J.+Tanauthor=J.+Zhaoauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=Discovery+of+a+potent+Kelch-Like+ECH-Associated+Protein+1-Nuclear+Factor+Erythroid+2-Related+Factor+2+%28Keap1-Nrf2%29+protein-protein+interaction+inhibitor+with+natural+proline+structure+as+a+cytoprotective+agent+against+acetaminophen-induced+hepatotoxicity&doi=10.1021%2Facs.jmedchem.9b00818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity</span></div><div class="casAuthors">Lu, Meng-Chen; Zhang, Xian; Wu, Feng; Tan, Shi-Jie; Zhao, Jing; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6796-6813</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transcription factor Nrf2 is a key regulator of cytoprotective system, and enhancing Nrf2 activity can protect cells from various insults and threats.  Directly disrupting Keap1-Nrf2 protein-protein interactions has been regarded as a promising way to activate Nrf2.  We reported here the first identification of amino acids as preferred substituents to design potent Keap1-Nrf2 inhibitors.  Comprehensive structure-activity anal. identified Pro as a preferred substituent, obtaining a potent inhibitor 35 with an IC50 of 43 nM in the competitive fluoresce polarization (FP) assay and a Kd value of 53.7 nM for Keap1 protein in the isothermal titrn. calorimetry (ITC) assay.  The Pro analog 35 exhibited tight and prolonged Keap1 binding in vitro and in cells, and treatment with 35 activated Nrf2-regulated cytoprotective response and antagonized acetaminophen-induced liver injury both in cellular and in vivo models.  This work not only provides a useful tool to further explore the therapeutic potential of Keap1-Nrf2 inhibition but also enriches the diversity of chem. structures suitable for the Keap1-Nrf2 interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp0coFO8KjUrVg90H21EOLACvtfcHk0liPVO6HrSVL6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlamsbfI&md5=8b94633020a7f690c96bc774a5b52bf6</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00818%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DTan%26aufirst%3DS.-J.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520Kelch-Like%2520ECH-Associated%2520Protein%25201-Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528Keap1-Nrf2%2529%2520protein-protein%2520interaction%2520inhibitor%2520with%2520natural%2520proline%2520structure%2520as%2520a%2520cytoprotective%2520agent%2520against%2520acetaminophen-induced%2520hepatotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D6796%26epage%3D6813%26doi%3D10.1021%2Facs.jmedchem.9b00818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lazzara, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ankireddy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratia, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) inhibitors with high metabolic stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">6547</span>– <span class="NLM_lpage">6560</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01074</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01074" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2hs7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=6547-6560&author=P.+R.+Lazzaraauthor=B.+P.+Davidauthor=A.+Ankireddyauthor=B.+G.+Richardsonauthor=K.+Dyeauthor=K.+M.+Ratiaauthor=S.+P.+Reddyauthor=T.+W.+Moore&title=Isoquinoline+Kelch-like+ECH-Associated+Protein+1-Nuclear+Factor+%28Erythroid-Derived+2%29-like+2+%28KEAP1-NRF2%29+inhibitors+with+high+metabolic+stability&doi=10.1021%2Facs.jmedchem.9b01074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability</span></div><div class="casAuthors">Lazzara, Phillip R.; David, Brian P.; Ankireddy, Aparna; Richardson, Benjamin G.; Dye, Katherine; Ratia, Kiira M.; Reddy, Sekhar P.; Moore, Terry W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6547-6560</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pharmacol. activation of NRF2 (nuclear factor erythroid 2-related factor 2) arises from blocking the interaction of NRF2 with its neg. regulator, KEAP1 (Kelch-like ECH-assocd. protein 1).  We previously reported an isoquinoline-based NRF2 activator, but this compd. showed neg. logD7.4 and a -2 charge at physiol. pH, which may have limited its membrane permeability.  In this work, we report potent, metabolically stable analogs that result from replacing a carboxymethyl group at the 4-position with a fluoroalkyl group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-h7NrJliBXbVg90H21EOLACvtfcHk0ljgqguSPuI8XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2hs7fL&md5=f12c11a0fb6d55bfbf015ecd9f77ad50</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01074%26sid%3Dliteratum%253Aachs%26aulast%3DLazzara%26aufirst%3DP.%2BR.%26aulast%3DDavid%26aufirst%3DB.%2BP.%26aulast%3DAnkireddy%26aufirst%3DA.%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DDye%26aufirst%3DK.%26aulast%3DRatia%26aufirst%3DK.%2BM.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DIsoquinoline%2520Kelch-like%2520ECH-Associated%2520Protein%25201-Nuclear%2520Factor%2520%2528Erythroid-Derived%25202%2529-like%25202%2520%2528KEAP1-NRF2%2529%2520inhibitors%2520with%2520high%2520metabolic%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D6547%26epage%3D6560%26doi%3D10.1021%2Facs.jmedchem.9b01074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potteti, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzara, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamatam, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skowron, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krunic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Replacement of a naphthalene scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8029</span>– <span class="NLM_lpage">8047</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01133</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01133" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFertbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8029-8047&author=B.+G.+Richardsonauthor=A.+D.+Jainauthor=H.+R.+Pottetiauthor=P.+R.+Lazzaraauthor=B.+P.+Davidauthor=C.+R.+Tamatamauthor=E.+Chomaauthor=K.+Skowronauthor=K.+Dyeauthor=Z.+Siddiquiauthor=Y.-T.+Wangauthor=A.+Krunicauthor=S.+P.+Reddyauthor=T.+W.+Moore&title=Replacement+of+a+naphthalene+scaffold+in+Kelch-like+ECH-Associated+Protein+1+%28KEAP1%29%2FNuclear+Factor+%28Erythroid-derived+2%29-like+2+%28NRF2%29+inhibitors&doi=10.1021%2Facs.jmedchem.8b01133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors</span></div><div class="casAuthors">Richardson, Benjamin G.; Jain, Atul D.; Potteti, Haranatha R.; Lazzara, Phillip R.; David, Brian P.; Tamatam, Chandra R.; Choma, Ewelina; Skowron, Kornelia; Dye, Katherine; Siddiqui, Zamia; Wang, Yue-Ting; Krunic, Aleksej; Reddy, Sekhar P.; Moore, Terry W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8029-8047</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activators of nuclear factor-erythroid 2-related factor 2 (NRF2) could lead to promising therapeutics for prevention and treatment of oxidative stress and inflammatory disorders.  Ubiquitination and subsequent degrdn. of the transcription factor NRF2 is mediated by Kelch-like ECH-assocd. protein-1 (KEAP1).  Inhibition of the KEAP1/NRF2 interaction with small mols. leads to NRF2 activation.  Previously, we and others described naphthalene-based NRF2 activators, but the 1,4-diaminonaphthalene scaffold may not represent a drug-like scaffold.  Paying particular attention to aq. soly., metabolic stability, potency, and mutagenicity, we modified a previously known, naphthalene-based nonelectrophilic NRF2 activator to give a series of non-naphthalene and heterocyclic scaffolds.  We found that, compared to previously reported naphthalene-based compds., a 1,4-isoquinoline scaffold provides a better mutagenic profile without sacrificing potency, stability, or soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP0I8lhXc6Q7Vg90H21EOLACvtfcHk0ljgqguSPuI8XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFertbfE&md5=69c77e7ee6f55d87ca61ef78a734c964</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01133%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DPotteti%26aufirst%3DH.%2BR.%26aulast%3DLazzara%26aufirst%3DP.%2BR.%26aulast%3DDavid%26aufirst%3DB.%2BP.%26aulast%3DTamatam%26aufirst%3DC.%2BR.%26aulast%3DChoma%26aufirst%3DE.%26aulast%3DSkowron%26aufirst%3DK.%26aulast%3DDye%26aufirst%3DK.%26aulast%3DSiddiqui%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.-T.%26aulast%3DKrunic%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DReplacement%2520of%2520a%2520naphthalene%2520scaffold%2520in%2520Kelch-like%2520ECH-Associated%2520Protein%25201%2520%2528KEAP1%2529%252FNuclear%2520Factor%2520%2528Erythroid-derived%25202%2529-like%25202%2520%2528NRF2%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8029%26epage%3D8047%26doi%3D10.1021%2Facs.jmedchem.8b01133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span> <span> </span><span class="NLM_article-title">A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">101565</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2020.101565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.redox.2020.101565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=32422540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpsl2ht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2020&pages=101565&author=M.+Luauthor=X.+Zhangauthor=J.+Zhaoauthor=Q.+Youauthor=Z.+Jiang&title=A+hydrogen+peroxide+responsive+prodrug+of+Keap1-Nrf2+inhibitor+for+improving+oral+absorption+and+selective+activation+in+inflammatory+conditions&doi=10.1016%2Fj.redox.2020.101565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions</span></div><div class="casAuthors">Lu, Mengchen; Zhang, Xian; Zhao, Jing; You, Qidong; Jiang, Zhengyu</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101565</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Transcription factor Nuclear factor erythroid 2-related factor 2 (Nrf2) and its neg. regulator, the E3 ligase adaptor Kelch-like ECH-assocd. protein 1 (Keap1), control the redox and metabolic homeostasis and oxidative stress.  Inhibitors of Keap1-Nrf2 interaction are promising in oxidative stress related inflammatory diseases but now hit hurdles.  By utilizing thiazolidinone moiety to shield the key carboxyl pharmacophore in Keap1-Nrf2 inhibitor, a hydrogen peroxide (H2O2)-responsive prodrug pro2 was developed.  The prodrug modification improved the physicochem. properties and cell membrane permeability of the parent drug.  Pro2 was stable and stayed inactive under various physiol. conditions, while became active by stimulation of H2O2 or inflammation derived reactive oxygen species.  Moreover, pro2 exhibited proper pharmacokinetic profile suitable for oral administration and enhanced anti-inflammatory efficiency in vivo.  Thus, this novel prodrug approach may not only provide an important advance in the therapy of chronic inflammatory diseases with high level of H2O2, but also offer a fresh soln. to improve the drug-like and selectivity issues of Keap1-Nrf2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox6NmI2hfYILVg90H21EOLACvtfcHk0ljgqguSPuI8XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpsl2ht7o%253D&md5=f110f0d0005af7265e0fde632eca1e88</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2020.101565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2020.101565%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DZ.%26atitle%3DA%2520hydrogen%2520peroxide%2520responsive%2520prodrug%2520of%2520Keap1-Nrf2%2520inhibitor%2520for%2520improving%2520oral%2520absorption%2520and%2520selective%2520activation%2520in%2520inflammatory%2520conditions%26jtitle%3DRedox%2520Biol.%26date%3D2020%26volume%3D34%26spage%3D101565%26doi%3D10.1016%2Fj.redox.2020.101565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wixted, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths-Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMenamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, H. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottom, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kou, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonchuk, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldser, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognese, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podolin, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span> <span> </span><span class="NLM_article-title">Monoacidic inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) protein-protein interaction with high cell potency identified by fragment-based discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3991</span>– <span class="NLM_lpage">4006</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00228</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00228" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Gjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3991-4006&author=T.+G.+Daviesauthor=W.+E.+Wixtedauthor=J.+E.+Coyleauthor=C.+Griffiths-Jonesauthor=K.+Hearnauthor=R.+McMenaminauthor=D.+Nortonauthor=S.+J.+Richauthor=C.+Richardsonauthor=G.+Saxtyauthor=H.+M.+G.+Willemsauthor=A.+J.-A.+Woolfordauthor=J.+E.+Cottomauthor=J.-P.+Kouauthor=J.+G.+Yonchukauthor=H.+G.+Feldserauthor=Y.+Sanchezauthor=J.+P.+Foleyauthor=B.+J.+Bologneseauthor=G.+Loganauthor=P.+L.+Podolinauthor=H.+Yanauthor=J.+F.+Callahanauthor=T.+D.+Heightmanauthor=J.+K.+Kerns&title=Monoacidic+inhibitors+of+the+Kelch-like+ECH-Associated+Protein+1%3A+Nuclear+Factor+Erythroid+2-Related+Factor+2+%28KEAP1%3ANRF2%29+protein-protein+interaction+with+high+cell+potency+identified+by+fragment-based+discovery&doi=10.1021%2Facs.jmedchem.6b00228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery</span></div><div class="casAuthors">Davies, Thomas G.; Wixted, William E.; Coyle, Joseph E.; Griffiths-Jones, Charlotte; Hearn, Keisha; McMenamin, Rachel; Norton, David; Rich, Sharna J.; Richardson, Caroline; Saxty, Gordon; Willems, Henriette M. G.; Woolford, Alison J.-A.; Cottom, Joshua E.; Kou, Jen-Pyng; Yonchuk, John G.; Feldser, Heidi G.; Sanchez, Yolanda; Foley, Joseph P.; Bolognese, Brian J.; Logan, Gregory; Podolin, Patricia L.; Yan, Hongxing; Callahan, James F.; Heightman, Tom D.; Kerns, Jeffrey K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3991-4006</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">KEAP1 is the key regulator of the NRF2-mediated cytoprotective response, and increasingly recognized as a target for diseases involving oxidative stress.  Pharmacol. intervention has focused on mols. that decrease NRF2-ubiquitination through covalent modification of KEAP1 cysteine residues, but such electrophilic compds. lack selectivity and may be assocd. with off-target toxicity.  We report here the first use of a fragment-based approach to directly target the KEAP1 Kelch-NRF2 interaction.  X-ray crystallog. screening identified three distinct "hot-spots" for fragment binding within the NRF2 binding pocket of KEAP1, allowing progression of a weak fragment hit to mols. with nanomolar affinity for KEAP1 while maintaining drug-like properties.  This work resulted in a promising lead compd. (I) which exhibits tight and selective binding to KEAP1, and activates the NRF2 antioxidant response in cellular and in vivo models, thereby providing a high quality chem. probe to explore the therapeutic potential of disrupting the KEAP1-NRF2 interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq-gfBTuYreLVg90H21EOLACvtfcHk0liiAy69MFmDuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Gjtr0%253D&md5=ae42cc9f06d14b340cb3a8f5d6c157a7</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00228%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DWixted%26aufirst%3DW.%2BE.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DGriffiths-Jones%26aufirst%3DC.%26aulast%3DHearn%26aufirst%3DK.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DNorton%26aufirst%3DD.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DWillems%26aufirst%3DH.%2BM.%2BG.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.-A.%26aulast%3DCottom%26aufirst%3DJ.%2BE.%26aulast%3DKou%26aufirst%3DJ.-P.%26aulast%3DYonchuk%26aufirst%3DJ.%2BG.%26aulast%3DFeldser%26aufirst%3DH.%2BG.%26aulast%3DSanchez%26aufirst%3DY.%26aulast%3DFoley%26aufirst%3DJ.%2BP.%26aulast%3DBolognese%26aufirst%3DB.%2BJ.%26aulast%3DLogan%26aufirst%3DG.%26aulast%3DPodolin%26aufirst%3DP.%2BL.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26atitle%3DMonoacidic%2520inhibitors%2520of%2520the%2520Kelch-like%2520ECH-Associated%2520Protein%25201%253A%2520Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528KEAP1%253ANRF2%2529%2520protein-protein%2520interaction%2520with%2520high%2520cell%2520potency%2520identified%2520by%2520fragment-based%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3991%26epage%3D4006%26doi%3D10.1021%2Facs.jmedchem.6b00228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capacci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, E. Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechantsreiter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, K.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">126852</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.126852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.bmcl.2019.126852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31898999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXis1Shsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=126852&author=B.+Maauthor=B.+Lucasauthor=A.+Capacciauthor=E.+Y.-S.+Linauthor=J.+H.+Jonesauthor=M.+Dechantsreiterauthor=I.+Enyedyauthor=D.+Marcotteauthor=G.+Xiaoauthor=B.+Liauthor=K.+Richter&title=Design%2C+synthesis+and+identification+of+novel%2C+orally+bioavailable+non-covalent+Nrf2+activators&doi=10.1016%2Fj.bmcl.2019.126852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activators</span></div><div class="casAuthors">Ma, Bin; Lucas, Brian; Capacci, Andrew; Lin, Edward Yin-Shiang; Jones, John Howard; Dechantsreiter, Michael; Enyedy, Istvan; Marcotte, Douglas; Xiao, Guangqing; Li, Bing; Richter, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">126852</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nrf2 is a transcription factor regulating expression of the Phase II Antioxidant Response and plays an important role in neuroprotection and detoxification.  Nrf2 activation is inhibited by interaction with Keap1.  Covalent Keap1 inhibitors such as di-Me fumarate (DMF) and RTA-408 are either on the market or in late stage clin. trials which implies potential benefit of Nrf2 activation.  Activation of Nrf2 by disrupting Nrf2-Keap1 interaction through a non-covalent small mol. is an attractive approach with the promise of greater selectivity.  However, there are no known non-covalent Nrf2 activators with acceptable pharmacokinetic properties to test the hypothesis in vivo.  Based on our early reported work, using structural-based design, followed by extensive SAR exploration, we have identified a novel series of non-covalent Nrf2 activators, with sub-nanomolar binding affinity on Keap1 and single digit nanomolar activity in an astrocyte assay.  A representative analog shows excellent oral PK and good Nrf2-dependent gene inductions in kidney.  These results provide a peripheral in vivo tool compd. to validate the biol. of non-covalent activation of Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUcCbLIX8re7Vg90H21EOLACvtfcHk0liiAy69MFmDuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXis1Shsw%253D%253D&md5=6a6416e40b8b1cbc6a4c6a7f8d91d4bb</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.126852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.126852%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DB.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DCapacci%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DE.%2BY.-S.%26aulast%3DJones%26aufirst%3DJ.%2BH.%26aulast%3DDechantsreiter%26aufirst%3DM.%26aulast%3DEnyedy%26aufirst%3DI.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DRichter%26aufirst%3DK.%26atitle%3DDesign%252C%2520synthesis%2520and%2520identification%2520of%2520novel%252C%2520orally%2520bioavailable%2520non-covalent%2520Nrf2%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D30%26spage%3D126852%26doi%3D10.1016%2Fj.bmcl.2019.126852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Błyszczuk, P.</span></span> <span> </span><span class="NLM_article-title">Myocarditis in humans and in experimental animal models</span>. <i>Front. Cardiovasc. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">64</span>, <span class="refDoi"> DOI: 10.3389/fcvm.2019.00064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.3389%2Ffcvm.2019.00064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31157241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A280%3ADC%252BB3M3isF2itg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&pages=64&author=P.+B%C5%82yszczuk&title=Myocarditis+in+humans+and+in+experimental+animal+models&doi=10.3389%2Ffcvm.2019.00064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Myocarditis in Humans and in Experimental Animal Models</span></div><div class="casAuthors">Blyszczuk Przemyslaw; Blyszczuk Przemyslaw</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in cardiovascular medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64</span>
        ISSN:<span class="NLM_cas:issn">2297-055X</span>.
    </div><div class="casAbstract">Myocarditis is defined as an inflammation of the cardiac muscle.  In humans, various infectious and non-infectious triggers induce myocarditis with a broad spectrum of histological presentations and clinical symptoms of the disease.  Myocarditis often resolves spontaneously, but some patients develop heart failure and require organ transplantation.  The need to understand cellular and molecular mechanisms of inflammatory heart diseases led to the development of mouse models for experimental myocarditis.  It has been shown that pathogenic agents inducing myocarditis in humans can often trigger the disease in mice.  Due to multiple etiologies of inflammatory heart diseases in humans, a number of different experimental approaches have been developed to induce myocarditis in mice.  Accordingly, experimental myocarditis in mice can be induced by infection with cardiotropic agents, such as coxsackievirus B3 and protozoan parasite Trypanosoma cruzi or by activating autoimmune responses against heart-specific antigens.  In certain models, myocarditis is followed by the phenotype of dilated cardiomyopathy and the end stage of heart failure.  This review describes the most commonly used mouse models of experimental myocarditis with a focus on the role of the innate and adaptive immune systems in induction and progression of the disease.  The review discusses also advantages and limitations of individual mouse models in the context of the clinical manifestation and the course of the disease in humans.  Finally, animal-free alternatives in myocarditis research are outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGiDsTSQcQp4YPsCkJIw00fW6udTcc2eYHfnJRxLBIGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3isF2itg%253D%253D&md5=2f309c5295da32a408114770d508c9f3</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.3389%2Ffcvm.2019.00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffcvm.2019.00064%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C5%2582yszczuk%26aufirst%3DP.%26atitle%3DMyocarditis%2520in%2520humans%2520and%2520in%2520experimental%2520animal%2520models%26jtitle%3DFront.%2520Cardiovasc.%2520Med.%26date%3D2019%26volume%3D6%26spage%3D64%26doi%3D10.3389%2Ffcvm.2019.00064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schultheiss, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kühl, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, L. T.</span></span> <span> </span><span class="NLM_article-title">The management of myocarditis</span>. <i>Eur. Heart J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2616</span>– <span class="NLM_lpage">2625</span>, <span class="refDoi"> DOI: 10.1093/eurheartj/ehr165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1093%2Feurheartj%2Fehr165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=21705357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A280%3ADC%252BC3MblsFymsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=2616-2625&author=H.-P.+Schultheissauthor=U.+K%C3%BChlauthor=L.+T.+Cooper&title=The+management+of+myocarditis&doi=10.1093%2Feurheartj%2Fehr165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">The management of myocarditis</span></div><div class="casAuthors">Schultheiss Heinz-Peter; Kuhl Uwe; Cooper Leslie T</div><div class="citationInfo"><span class="NLM_cas:title">European heart journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2616-25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite considerable advances in our understanding of myocarditis pathogenesis, the clinical management of myocarditis has changed relatively little in the last few years.  This review aims to help bridge the widening gap between recent mechanistic insights, which are largely derived from animal models, and their potential impact on disease burden.  We illustrate the pathogenetic mechanisms that are prime targets for novel therapeutic interventions.  Pathway and pathogen-specific molecular diagnostic tests have expanded the role for endomyocardial biopsy.  State of the art cardiac magnetic resonance imaging can now provide non-invasive tissue characterization and localize inflammatory infiltrates but imaging techniques are misleading if infectious agents are involved.  We emphasize the gaps in our current clinical knowledge, particularly with respect to aetiology-based therapy, and suggest opportunities for high impact, translational investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuHVXr62AKo4JKJbLTgsvCfW6udTcc2eYHfnJRxLBIGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MblsFymsQ%253D%253D&md5=80401a92bd4a5be5861e8e3446dba17d</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehr165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehr165%26sid%3Dliteratum%253Aachs%26aulast%3DSchultheiss%26aufirst%3DH.-P.%26aulast%3DK%25C3%25BChl%26aufirst%3DU.%26aulast%3DCooper%26aufirst%3DL.%2BT.%26atitle%3DThe%2520management%2520of%2520myocarditis%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2011%26volume%3D32%26spage%3D2616%26epage%3D2625%26doi%3D10.1093%2Feurheartj%2Fehr165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corsten, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymans, S.</span></span> <span> </span><span class="NLM_article-title">Inflammation in viral myocarditis: friend or foe?</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">426</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2012.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.molmed.2012.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=22726657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVShsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=426-437&author=M.+F.+Corstenauthor=B.+Schroenauthor=S.+Heymans&title=Inflammation+in+viral+myocarditis%3A+friend+or+foe%3F&doi=10.1016%2Fj.molmed.2012.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation in viral myocarditis: friend or foe?</span></div><div class="casAuthors">Corsten, Maarten F.; Schroen, Blanche; Heymans, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">426-437</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Viral myocarditis is an important cause of heart failure for which no specific treatments are available.  Direct viral injury to cardiac cells provokes an inflammatory response that significantly contributes to cardiac damage and ensuing morbidity.  Despite the central pathogenic role of autoimmune injury, broad inhibition of the inflammatory response does not result in patient benefit.  Many preclin. studies collectively emphasize that modulating distinct inflammatory signaling pathways may yield effective viral clearance while preserving cardiac structure.  This review aims to provide an overview of the sometimes contrasting observations from exptl. viral myocarditis models and to translate the lessons learned into opportunities for future investigations and therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOpeZLksEY0rVg90H21EOLACvtfcHk0ljOmrrx3wm7hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVShsb%252FI&md5=40465f827f1460c1dedb4fbeebec4065</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2012.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2012.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DCorsten%26aufirst%3DM.%2BF.%26aulast%3DSchroen%26aufirst%3DB.%26aulast%3DHeymans%26aufirst%3DS.%26atitle%3DInflammation%2520in%2520viral%2520myocarditis%253A%2520friend%2520or%2520foe%253F%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D426%26epage%3D437%26doi%3D10.1016%2Fj.molmed.2012.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buelna-Chontal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zazueta, C.</span></span> <span> </span><span class="NLM_article-title">Redox activation of Nrf2 & NF-κB: a double end sword?</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2548</span>– <span class="NLM_lpage">2557</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2013.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.cellsig.2013.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=23993959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1OqsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2013&pages=2548-2557&author=M.+Buelna-Chontalauthor=C.+Zazueta&title=Redox+activation+of+Nrf2+%26+NF-%CE%BAB%3A+a+double+end+sword%3F&doi=10.1016%2Fj.cellsig.2013.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Redox activation of Nrf2 & NF-κB: A double end sword?</span></div><div class="casAuthors">Buelna-Chontal, Mabel; Zazueta, Cecilia</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2548-2557</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Moderate concns. of reactive oxygen species (ROS) are produced by diverse sources under physiol. conditions.  At such low levels, these mols. may act as upstream mediators of relevant signaling pathways; however an increase in their concn. with respect to the antioxidant system activity, changes their redox signaling function into a deleterious role.  Thus, cell health depends, at least in part, on redox balance.  This review includes global aspects of oxygen chem., ROS generation, antioxidant system, and redox signaling.  It is also focused on the description of two relevant redox-sensitive transcription factors: nuclear factor erythroid 2-related factor 2 (Nrf2), which may be a potential target to confer cell protection, and nuclear factor κB (NF-κB), which is involved in deleterious effects in the cell.  Finally, recent findings on the interplay between both factors for the development of different pathologies are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ1-FNel9yGbVg90H21EOLACvtfcHk0ljOmrrx3wm7hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1OqsbjL&md5=3b113790fef7976fd18dc40a2042113b</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2013.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2013.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DBuelna-Chontal%26aufirst%3DM.%26aulast%3DZazueta%26aufirst%3DC.%26atitle%3DRedox%2520activation%2520of%2520Nrf2%2520%2526%2520NF-%25CE%25BAB%253A%2520a%2520double%2520end%2520sword%253F%26jtitle%3DCell.%2520Signalling%26date%3D2013%26volume%3D25%26spage%3D2548%26epage%3D2557%26doi%3D10.1016%2Fj.cellsig.2013.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span> <span> </span><span class="NLM_article-title">Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis</span>. <i>Free Radic. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2018.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.freeradbiomed.2018.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=29428410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivVSmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2018&pages=228-237&author=N.+Mengauthor=H.+Tangauthor=H.+Zhangauthor=C.+Jiangauthor=L.+Suauthor=X.+Minauthor=W.+Zhangauthor=H.+Zhangauthor=Z.+Miaoauthor=W.+Zhangauthor=C.+Zhuang&title=Fragment-growing+guided+design+of+Keap1-Nrf2+protein-protein+interaction+inhibitors+for+targeting+myocarditis&doi=10.1016%2Fj.freeradbiomed.2018.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis</span></div><div class="casAuthors">Meng, Ning; Tang, Hua; Zhang, Hao; Jiang, Chengshi; Su, Li; Min, Xiao; Zhang, Wannian; Zhang, Hua; Miao, Zhenyuan; Zhang, Wen; Zhuang, Chunlin</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">228-237</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that block the Keap1-Nrf2 protein-protein interactions are being intensely pursued as a new therapeutic strategy for oxidative stress-related diseases, such as cancer, diabetes, Alzheimer's disease, arteriosclerosis, inflammation and myocarditis.  However, there are not enough studies on antioxidant treatments using small mols. in myocarditis.  The authors herein provided a series of novel hydronaphthoquinones as the Keap1-Nrf2 interaction inhibitors targeting LPS-induced myocarditis both in vitro and in vivo.  These compds. were designed through an in-silico fragment growing approach based on the previous reported compd.  The new compds. were predicted to form addnl. hydrogen bonds with the S363 residue, leading to higher inhibitory activity.  Among these new derivs., compds. I and II emerged as inhibitors with significant biochem. potency, as detd. by fluorescent anisotropy assay and confirmed by surface plasmon resonance (SPR) and differential scanning fluorometry (DSF) assays.  These inhibitors can dose-dependently protect the H9c2 cardiac cells against LPS-induced injury (100% at 2 μM and 4 μM) and effectively prolong survival or save the life of LPS-injured mice.  Mechanistic studies showed that these inhibitors could release Nrf2 in H9c2 cells and LPS-inflammatory mouse models and translocate into the nucleus in a dose-response manner, which significantly increased the downstream genes (HO-1, NQO-1) and the pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), while ROS prodn. dramatically decreased.  Their protective effects and the mechanism of action were further confirmed by siNrf2 transfected expt.  Collectively, the novel hydronaphthoquinones can be used as promising lead compds. for the study of Keap1-Nrf2 protein-protein interactions and further antimyocarditis drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox8LWG_bMTJLVg90H21EOLACvtfcHk0lgXmO1T8gKxrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivVSmtrk%253D&md5=71299d349ff1e7ba6aa29967e9380ebe</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2018.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2018.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhuang%26aufirst%3DC.%26atitle%3DFragment-growing%2520guided%2520design%2520of%2520Keap1-Nrf2%2520protein-protein%2520interaction%2520inhibitors%2520for%2520targeting%2520myocarditis%26jtitle%3DFree%2520Radic.%2520Biol.%2520Med.%26date%3D2018%26volume%3D117%26spage%3D228%26epage%3D237%26doi%3D10.1016%2Fj.freeradbiomed.2018.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muehlmann, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueiró Longo, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azevedo, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel small-molecule Keap1-Nrf2 PPI inhibitor with cytoprotective effects on LPS-induced cardiomyopathy</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1080/14756366.2018.1461856</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1080%2F14756366.2018.1461856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=29693453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotlGlu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=833-841&author=C.-S.+Jiangauthor=C.-L.+Zhuangauthor=K.+Zhuauthor=J.+Zhangauthor=L.+A.+Muehlmannauthor=J.+P.+Figueir%C3%B3+Longoauthor=R.+B.+Azevedoauthor=W.+Zhangauthor=N.+Mengauthor=H.+Zhang&title=Identification+of+a+novel+small-molecule+Keap1-Nrf2+PPI+inhibitor+with+cytoprotective+effects+on+LPS-induced+cardiomyopathy&doi=10.1080%2F14756366.2018.1461856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel small-molecule Keap1-Nrf2 PPI inhibitor with cytoprotective effects on LPS-induced cardiomyopathy</span></div><div class="casAuthors">Jiang, Cheng-Shi; Zhuang, Chun-Lin; Zhu, Kongkai; Zhang, Juan; Muehlmann, Luis Alexandre; Figueiro Longo, Joao Paulo; Azevedo, Ricardo Bentes; Zhang, Wen; Meng, Ning; Zhang, Hua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">833-841</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A new Keap1-Nrf2 protein-protein interaction (PPI) inhibitor ZJO1 (I) was identified from our compd. library by fluorescence polarization assay, surface plasmon resonance, mol. docking and mol. dynamics simulation. could in vitro trigger Nrf2 nuclear translocation, subsequently resulting in increased mRNA levels of Nrf2 target genes HO-1 and NQO1.  Meanwhile, suppressed LPS-induced prodn. of ROS and the mRNA levels of pro-inflammatory cytokines TNF-α, IL-1β and IL-6 in H9c2 cardiac cells.  Moreover, in an in vivo mouse model of septic cardiomyopathy induced by i.p. injection of lipopolysaccharide, demonstrated a cytoprotective effect, upregulated Nrf2 protein nuclear accumulation, and remarkably suppressed the abovementioned cytokine levels in cardiomyocytes.  The results presented herein provided a novel chemotype for the development of direct Keap1-Nrf2 PPI inhibitors and suggested that compd. is a promising drug lead for septic cardiomyopathy treatment. was identified as a new Keap1-Nrf2 PPI inhibitor and drug lead for septic cardiomyopathy treatment by in vitro and in vivo expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojU4MthYirhrVg90H21EOLACvtfcHk0lgXmO1T8gKxrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotlGlu7g%253D&md5=d1b12b8580cf272fa33ffc0412de181d</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1080%2F14756366.2018.1461856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2018.1461856%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DC.-S.%26aulast%3DZhuang%26aufirst%3DC.-L.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMuehlmann%26aufirst%3DL.%2BA.%26aulast%3DFigueir%25C3%25B3%2BLongo%26aufirst%3DJ.%2BP.%26aulast%3DAzevedo%26aufirst%3DR.%2BB.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMeng%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520a%2520novel%2520small-molecule%2520Keap1-Nrf2%2520PPI%2520inhibitor%2520with%2520cytoprotective%2520effects%2520on%2520LPS-induced%2520cardiomyopathy%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2018%26volume%3D33%26spage%3D833%26epage%3D841%26doi%3D10.1080%2F14756366.2018.1461856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugam, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Challa, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litovsky, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devarajan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darley-Usmar, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajasekaran, N. S.</span></span> <span> </span><span class="NLM_article-title">Enhanced Keap1-Nrf2 signaling protects the myocardium from isoproterenol-induced pathological remodeling in mice</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">101212</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2019.101212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.redox.2019.101212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31155513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVyisr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=101212&author=G.+Shanmugamauthor=A.+K.+Challaauthor=S.+H.+Litovskyauthor=A.+Devarajanauthor=D.+Wangauthor=D.+P.+Jonesauthor=V.+M.+Darley-Usmarauthor=N.+S.+Rajasekaran&title=Enhanced+Keap1-Nrf2+signaling+protects+the+myocardium+from+isoproterenol-induced+pathological+remodeling+in+mice&doi=10.1016%2Fj.redox.2019.101212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced Keap1-Nrf2 signaling protects the myocardium from isoproterenol-induced pathological remodeling in mice</span></div><div class="casAuthors">Shanmugam, Gobinath; Challa, Anil Kumar; Litovsky, Silvio H.; Devarajan, Asokan; Wang, Ding; Jones, Dean P.; Darley-Usmar, Victor M.; Rajasekaran, Namakkal Soorappan</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101212</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2/Nrf2) is an inducible transcription factor that is essential for maintenance of redox signaling and in response to stress.  This suggests that if Nrf2 expression response could be enhanced for a defined physiol. pro-oxidant stress then it would be protective.  This has important implications for the therapeutic manipulation of the Keap1/Nrf2 signaling pathway which is now gaining a lot of attention.  We tested this hypothesis through the generation of Nrf2 transgene expression mouse model with and without isoproterenol-induced cardiac stress.  Cardiac-specific mouse Nrf2 transgenic (mNrf2-TG) and non-transgenic (NTG) mice were subjected to isoproterenol (ISO) treatment and assessed for myocardial structure, function (echocardiog. and electrocardiog.), and glutathione redox state.  Myocardial infarction and fibrosis along with increased inflammation leading to myocardial dysfunction was noted in NTG mice exposed to ISO, while mNrf2-TG hearts were resistant to the ISO insult.  Preservation of myocardial structure and function in the mNrf2-TG mice was assocd. with the enhanced Nrf2 expression displayed in these hearts with an increased basal and post-treatment expression of redox modulatory genes and an overall enhanced antioxidant status.  Of note, myocardium of ISO-treated TG mice displayed significantly increased stabilization of the KEAP1-NRF2 complex and enhanced release of NRF2 to the nucleus resulting in overall decreased pro-oxidant markers.  Taken together, we suggest that a basal enhanced Nrf2 expression in mouse heart results in maintenance of redox homeostasis and counteracts ISO-induced oxidative stress, and suppresses pathol. remodeling.  These data suggest that an alternative therapeutic approach to enhance the efficacy of the Keap1-Nrf2 system is to stimulate basal expression of Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5T410H6AfbbVg90H21EOLACvtfcHk0lgXmO1T8gKxrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVyisr7K&md5=e7d47f497f5bb8a36febd64f85c41400</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2019.101212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2019.101212%26sid%3Dliteratum%253Aachs%26aulast%3DShanmugam%26aufirst%3DG.%26aulast%3DChalla%26aufirst%3DA.%2BK.%26aulast%3DLitovsky%26aufirst%3DS.%2BH.%26aulast%3DDevarajan%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DD.%2BP.%26aulast%3DDarley-Usmar%26aufirst%3DV.%2BM.%26aulast%3DRajasekaran%26aufirst%3DN.%2BS.%26atitle%3DEnhanced%2520Keap1-Nrf2%2520signaling%2520protects%2520the%2520myocardium%2520from%2520isoproterenol-induced%2520pathological%2520remodeling%2520in%2520mice%26jtitle%3DRedox%2520Biol.%26date%3D2019%26volume%3D27%26spage%3D101212%26doi%3D10.1016%2Fj.redox.2019.101212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">112734</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.ejmech.2020.112734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=32866756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslejtbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2020&pages=112734&author=M.-C.+Luauthor=H.-L.+Shaoauthor=T.+Liuauthor=Q.-D.+Youauthor=Z.-Y.+Jiang&title=Discovery+of+2-oxy-2-phenylacetic+acid+substituted+naphthalene+sulfonamide+derivatives+as+potent+KEAP1-NRF2+protein-protein+interaction+inhibitors+for+inflammatory+conditions&doi=10.1016%2Fj.ejmech.2020.112734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions</span></div><div class="casAuthors">Lu, Meng-Chen; Shao, Hong-Li; Liu, Tian; You, Qi-Dong; Jiang, Zheng-Yu</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112734</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Nuclear factor erythroid 2-related factor 2 (NRF2) is a pleiotropic transcription factor which regulates the constitutive and inducible transcription of a wide array of genes and confers protection against a variety of pathologies.  Directly disrupting Kelch-like ECH-assocd. protein 1 (KEAP1)-NRF2 protein-protein interaction (PPI) has been explored as a promising strategy to activate NRF2.  We reported here the first identification of a series of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivs. as potent KEAP1-NRF2 inhibitors.  Our efforts led to the potent small mol. KEAP1-NRF2 inhibitor, 20c, which exhibited a Kd of 24 nM to KEAP1 and an IC50 of 75 nM in disrupting KEAP1-NRF2 interaction.  Subsequent biol. studies provided consistent evidence across mouse macrophage cell-based and in vivo models that 20c induced NRF2 target gene expression and enhanced downstream antioxidant and anti-inflammatory activities.  Our study not only demonstrated that small mol. KEAP1-NRF2 PPI inhibitors can be potential preventive and therapeutic agents for diseases and conditions involving oxidative stress and inflammation but also enriched the chem. diversity of the KEAP1-NRF2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGQ96pcrodTbVg90H21EOLACvtfcHk0liTiPLJbaaXmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslejtbjI&md5=5aba876131d7cedff34b9c270896d233</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112734%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DShao%26aufirst%3DH.-L.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DYou%26aufirst%3DQ.-D.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26atitle%3DDiscovery%2520of%25202-oxy-2-phenylacetic%2520acid%2520substituted%2520naphthalene%2520sulfonamide%2520derivatives%2520as%2520potent%2520KEAP1-NRF2%2520protein-protein%2520interaction%2520inhibitors%2520for%2520inflammatory%2520conditions%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D207%26spage%3D112734%26doi%3D10.1016%2Fj.ejmech.2020.112734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ammazzalorso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Filippis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giampietro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amoroso, R.</span></span> <span> </span><span class="NLM_article-title">N-acylsulfonamides: Synthetic routes and biological potential in medicinal chemistry</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">1094</span>– <span class="NLM_lpage">1105</span>, <span class="refDoi"> DOI: 10.1111/cbdd.13043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1111%2Fcbdd.13043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=28632928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFCrurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2017&pages=1094-1105&author=A.+Ammazzalorsoauthor=B.+De+Filippisauthor=L.+Giampietroauthor=R.+Amoroso&title=N-acylsulfonamides%3A+Synthetic+routes+and+biological+potential+in+medicinal+chemistry&doi=10.1111%2Fcbdd.13043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylsulfonamides: Synthetic routes and biological potential in medicinal chemistry</span></div><div class="casAuthors">Ammazzalorso, Alessandra; De Filippis, Barbara; Giampietro, Letizia; Amoroso, Rosa</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1094-1105</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Sulfonamide is a common structural motif in naturally occurring and synthetic medicinal compds.  The rising interest in sulfonamides and N-acyl derivs. is attested by the large no. of drugs and lead compds. identified in last years, explored in different fields of medicinal chem. and showing biol. activity.  Many acylsulfonamide derivs. were designed and synthesized as isosteres of carboxylic acids, being the characteristics of these functional groups very close.  Starting from chem. routes to N-acylsulfonamides, this review explores compds. of pharmaceutical interest, developed as enzymic inhibitors or targeting receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGothOEJKbfp6rVg90H21EOLACvtfcHk0liTiPLJbaaXmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFCrurvO&md5=07ca438efbb7a20c9f13228d674b4ae4</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.13043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.13043%26sid%3Dliteratum%253Aachs%26aulast%3DAmmazzalorso%26aufirst%3DA.%26aulast%3DDe%2BFilippis%26aufirst%3DB.%26aulast%3DGiampietro%26aufirst%3DL.%26aulast%3DAmoroso%26aufirst%3DR.%26atitle%3DN-acylsulfonamides%253A%2520Synthetic%2520routes%2520and%2520biological%2520potential%2520in%2520medicinal%2520chemistry%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2017%26volume%3D90%26spage%3D1094%26epage%3D1105%26doi%3D10.1111%2Fcbdd.13043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nasiri, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullmann, D.</span></span> <span> </span><span class="NLM_article-title">Thermodynamic profiling of inhibitors of Nrf2:Keap1 interactions</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.11.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.bmcl.2015.11.082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26653613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGnu7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=526-529&author=H.+R.+Nasiriauthor=S.+Lingeauthor=D.+Ullmann&title=Thermodynamic+profiling+of+inhibitors+of+Nrf2%3AKeap1+interactions&doi=10.1016%2Fj.bmcl.2015.11.082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Thermodynamic profiling of inhibitors of Nrf2:Keap1 interactions</span></div><div class="casAuthors">Nasiri, Hamid R.; Linge, Sandra; Ullmann, Dirk</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">526-529</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Keap1 binds to the transcription factor Nrf2 and neg. modulates the expression of genes involved in cellular protection against oxidative stress.  Small mols. have been discovered to inhibit the Nrf2:Keap1 interactions and act as antagonists of Keap1.  The affinities of these small mols. are not very high and need further improvement in follow up hit-to-lead programs.  In addn. to the affinity parameters Ki, Kd, and IC50 thermodn. parameters provide useful information for the selection and optimization of these hit mols. at the early stage of the lead discovery process.  In this letter a tracer displacement assay was used to det. the thermodn. signature of some of the known inhibitors of the Nrf2:Keap1 interaction.  An optimized assay protocol is presented, which can be applied to other small mols. in hit-to-lead programs in a medium throughput manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon7pjAqVdeRLVg90H21EOLACvtfcHk0liTiPLJbaaXmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGnu7bO&md5=424482b4285476bd24fad6587e5f713d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.11.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.11.082%26sid%3Dliteratum%253Aachs%26aulast%3DNasiri%26aufirst%3DH.%2BR.%26aulast%3DLinge%26aufirst%3DS.%26aulast%3DUllmann%26aufirst%3DD.%26atitle%3DThermodynamic%2520profiling%2520of%2520inhibitors%2520of%2520Nrf2%253AKeap1%2520interactions%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D526%26epage%3D529%26doi%3D10.1016%2Fj.bmcl.2015.11.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ladbury, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span> <span> </span><span class="NLM_article-title">Adding calorimetric data to decision making in lead discovery: a hot tip</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1038/nrd3054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1038%2Fnrd3054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=19960014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWjt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=23-27&author=J.+E.+Ladburyauthor=G.+Klebeauthor=E.+Freire&title=Adding+calorimetric+data+to+decision+making+in+lead+discovery%3A+a+hot+tip&doi=10.1038%2Fnrd3054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Adding calorimetric data to decision making in lead discovery: A hot tip</span></div><div class="casAuthors">Ladbury, John E.; Klebe, Gerhard; Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-27</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recognition of the limitations of high-throughput screening approaches in the discovery of candidate drugs has reawakened interest in structure-based and other rational design methods.  Here, the authors describe how isothermal titrn. calorimetry can be used to obtain thermodn. data on the binding of compds. to protein targets.  The authors propose that these data - particularly the change in enthalpy - could provide a valuable, complementary addn. to established tools for selecting compds. in lead discovery and for aiding lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph3qvp2E8fbLVg90H21EOLACvtfcHk0ljIHv_o3sIbxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWjt7bM&md5=e8446b6db983c35580e9010899eb40eb</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fnrd3054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3054%26sid%3Dliteratum%253Aachs%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DAdding%2520calorimetric%2520data%2520to%2520decision%2520making%2520in%2520lead%2520discovery%253A%2520a%2520hot%2520tip%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2010%26volume%3D9%26spage%3D23%26epage%3D27%26doi%3D10.1038%2Fnrd3054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ushiyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka-Yamamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanazawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takata, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtake, N.</span></span> <span> </span><span class="NLM_article-title">Lead identification of 8-(methylamino)-2-oxo-1,2-dihydroquinoline derivatives as DNA gyrase inhibitors: hit-to-lead generation involving thermodynamic evaluation</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">10145</span>– <span class="NLM_lpage">10159</span>, <span class="refDoi"> DOI: 10.1021/acsomega.0c00865</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.0c00865" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnslCitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2020&pages=10145-10159&author=F.+Ushiyamaauthor=H.+Amadaauthor=T.+Takeuchiauthor=N.+Tanaka-Yamamotoauthor=H.+Kanazawaauthor=K.+Nakanoauthor=M.+Mimaauthor=A.+Masukoauthor=I.+Takataauthor=K.+Hitakaauthor=K.+Iwamotoauthor=H.+Sugiyamaauthor=N.+Ohtake&title=Lead+identification+of+8-%28methylamino%29-2-oxo-1%2C2-dihydroquinoline+derivatives+as+DNA+gyrase+inhibitors%3A+hit-to-lead+generation+involving+thermodynamic+evaluation&doi=10.1021%2Facsomega.0c00865"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Identification of 8-(Methylamino)-2-oxo-1,2-dihydroquinoline Derivatives as DNA Gyrase Inhibitors: Hit-to-Lead Generation Involving Thermodynamic Evaluation</span></div><div class="casAuthors">Ushiyama, Fumihito; Amada, Hideaki; Takeuchi, Tomoki; Tanaka-Yamamoto, Nozomi; Kanazawa, Harumi; Nakano, Koichiro; Mima, Masashi; Masuko, Aiko; Takata, Iichiro; Hitaka, Kosuke; Iwamoto, Kunihiko; Sugiyama, Hiroyuki; Ohtake, Norikazu</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">10145-10159</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DNA gyrase and topoisomerase IV are well-validated pharmacol. targets, and quinolone antibacterial drugs are marketed as their representative inhibitors.  However, in recent years, resistance to these existing drugs has become a problem, and new chem. classes of antibiotics that can combat resistant strains of bacteria are strongly needed.  In this study, we applied our hit-to-lead (H2L) chem. for the identification of a new chem. class of GyrB/ParE inhibitors by efficient use of thermodn. parameters.  Investigation of the core fragments obtained by fragmentation of high-throughput screening hit compds. and subsequent expansion of the hit fragment was performed using isothermal titrn. calorimetry (ITC).  The 8-(methylamino)-2-oxo-1,2-dihydroquinoline deriv. 13e(I) showed potent activity against Escherichia coli DNA gyrase with an IC50 value of 0.0017 μM.  In this study, we demonstrated the use of ITC for primary fragment screening, followed by structural optimization to obtain lead compds., which advanced into further optimization for creating novel antibacterial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWceiwOsImgLVg90H21EOLACvtfcHk0ljIHv_o3sIbxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnslCitbk%253D&md5=76e83290f377f51d39cef93770a9b387</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Facsomega.0c00865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.0c00865%26sid%3Dliteratum%253Aachs%26aulast%3DUshiyama%26aufirst%3DF.%26aulast%3DAmada%26aufirst%3DH.%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DTanaka-Yamamoto%26aufirst%3DN.%26aulast%3DKanazawa%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DK.%26aulast%3DMima%26aufirst%3DM.%26aulast%3DMasuko%26aufirst%3DA.%26aulast%3DTakata%26aufirst%3DI.%26aulast%3DHitaka%26aufirst%3DK.%26aulast%3DIwamoto%26aufirst%3DK.%26aulast%3DSugiyama%26aufirst%3DH.%26aulast%3DOhtake%26aufirst%3DN.%26atitle%3DLead%2520identification%2520of%25208-%2528methylamino%2529-2-oxo-1%252C2-dihydroquinoline%2520derivatives%2520as%2520DNA%2520gyrase%2520inhibitors%253A%2520hit-to-lead%2520generation%2520involving%2520thermodynamic%2520evaluation%26jtitle%3DACS%2520Omega%26date%3D2020%26volume%3D5%26spage%3D10145%26epage%3D10159%26doi%3D10.1021%2Facsomega.0c00865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geschwindner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span> <span> </span><span class="NLM_article-title">Ligand binding thermodynamics in drug discovery: still a hot tip?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6321</span>– <span class="NLM_lpage">6335</span>, <span class="refDoi"> DOI: 10.1021/jm501511f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501511f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFGitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6321-6335&author=S.+Geschwindnerauthor=J.+Ulanderauthor=P.+Johansson&title=Ligand+binding+thermodynamics+in+drug+discovery%3A+still+a+hot+tip%3F&doi=10.1021%2Fjm501511f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand Binding Thermodynamics in Drug Discovery: Still a Hot Tip?</span></div><div class="casAuthors">Geschwindner, Stefan; Ulander, Johan; Johansson, Patrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6321-6335</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of ligand binding thermodn. has been proposed as a potential success factor to accelerate drug discovery.  However, despite the intuitive appeal of optimizing binding enthalpy, a no. of factors complicate routine use of thermodn. data.  On a macroscopic level, a range of exptl. parameters including temp. and buffer choice significantly influence the obsd. thermodn. signatures.  On a microscopic level, solute effects, structural flexibility, and cooperativity lead to nonlinear changes in enthalpy.  This multifactorial character hides essential enthalpy contributions of intermol. contacts, making them exptl. nonobservable.  In this perspective, we present three case studies, reflect on some key factors affecting thermodn. signatures, and investigate their relation to the hydrophobic effect, enthalpy-entropy compensation, lipophilic ligand efficiency, and promiscuity.  The studies highlight that enthalpy and entropy cannot be used as direct end points but can together with calcns. increase our understanding of ligand binding and identify interesting outliers that do not behave as expected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr47fgLvr2PP7Vg90H21EOLACvtfcHk0ljIHv_o3sIbxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFGitbs%253D&md5=686b213b9488bc51d2d6a07e391c6644</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm501511f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501511f%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DUlander%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DP.%26atitle%3DLigand%2520binding%2520thermodynamics%2520in%2520drug%2520discovery%253A%2520still%2520a%2520hot%2520tip%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6321%26epage%3D6335%26doi%3D10.1021%2Fjm501511f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span> <span> </span><span class="NLM_article-title">Do enthalpy and entropy distinguish first in class from best in class?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">869</span>– <span class="NLM_lpage">874</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2008.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.drudis.2008.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=18703160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCgu7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=869-874&author=E.+Freire&title=Do+enthalpy+and+entropy+distinguish+first+in+class+from+best+in+class%3F&doi=10.1016%2Fj.drudis.2008.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Do enthalpy and entropy distinguish first in class from best in class?</span></div><div class="casAuthors">Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19/20</span>),
    <span class="NLM_cas:pages">869-874</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A drug mol. should bind to its target with high affinity and selectivity.  Because the binding affinity is a combined function of the binding enthalpy and the binding entropy, extremely high affinity requires that both terms contribute favorably to binding.  The binding enthalpy, however, is notoriously more difficult to optimize than the binding entropy, a fact that has resulted in thermodynamically unbalanced mols. that do not achieve optimal potency.  In fact, with current technologies, the enthalpic optimization of drug candidates may take years and only appear in second-generation products.  Within that context, it is not surprising that structure/activity relationships (SARs) that explicitly incorporate the interplay between enthalpy and entropy and accelerate the optimization process are being developed and gaining popularity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5swEhu922BbVg90H21EOLACvtfcHk0ljLRVAzb_CWKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCgu7fN&md5=357358107c5686a1863a83291c1cdd92</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2008.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2008.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DDo%2520enthalpy%2520and%2520entropy%2520distinguish%2520first%2520in%2520class%2520from%2520best%2520in%2520class%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D869%26epage%3D874%26doi%3D10.1016%2Fj.drudis.2008.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmikanth, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaithra, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro-Faria-Neto, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marathe, G. K.</span></span> <span> </span><span class="NLM_article-title">Sepsis: in search of cure</span>. <i>Inflammation Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">587</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.1007/s00011-016-0937-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1007%2Fs00011-016-0937-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26995266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFCmtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=587-602&author=C.+L.+Lakshmikanthauthor=S.+P.+Jacobauthor=V.+H.+Chaithraauthor=H.+C.+de+Castro-Faria-Netoauthor=G.+K.+Marathe&title=Sepsis%3A+in+search+of+cure&doi=10.1007%2Fs00011-016-0937-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Sepsis: in search of cure</span></div><div class="casAuthors">Lakshmikanth, Chikkamenahalli Lakshminarayana; Jacob, Shancy Petsel; Chaithra, Vyala Hanumanthareddy; de Castro-Faria-Neto, Hugo Caire; Marathe, Gopal Kedihithlu</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">587-602</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Introduction: Sepsis is a complex inflammatory disorder believed to originate from an infection by any types of microbes and/or their products.  It is the leading cause of death in intensive care units (ICUs) throughout the globe.  The mortality rates depend both on the severity of infection and the host's response to infection.  Methods: Literature survey on pathobiol. of sepsis in general and failure of more than hundred clin. trials conducted so far in search of a possible cure for sepsis resulted in the prepn. of this manuscript.  Findings: Sepsis lacks a suitable animal model that mimics human sepsis.  However, based on the results obtained in animal models of sepsis, clin. trials conducted so far have been disappointing.  Although involvement of multiple mediators and pathways in sepsis has been recognized, only few components are being targeted and this could be the major reason behind the failure of clin. trials.  Conclusion: Inability to recognize a single crit. mediator of sepsis may be the underlying cause for the poor therapeutic intervention of sepsis.  Therefore, sepsis is still considered as a disease-in search of cure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE-ssoMOjgf7Vg90H21EOLACvtfcHk0ljLRVAzb_CWKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFCmtLw%253D&md5=d1c35ca72492af904d543069144a46e4</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1007%2Fs00011-016-0937-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00011-016-0937-y%26sid%3Dliteratum%253Aachs%26aulast%3DLakshmikanth%26aufirst%3DC.%2BL.%26aulast%3DJacob%26aufirst%3DS.%2BP.%26aulast%3DChaithra%26aufirst%3DV.%2BH.%26aulast%3Dde%2BCastro-Faria-Neto%26aufirst%3DH.%2BC.%26aulast%3DMarathe%26aufirst%3DG.%2BK.%26atitle%3DSepsis%253A%2520in%2520search%2520of%2520cure%26jtitle%3DInflammation%2520Res.%26date%3D2016%26volume%3D65%26spage%3D587%26epage%3D602%26doi%3D10.1007%2Fs00011-016-0937-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">Leonurine alleviates LPS-induced myocarditis through suppressing the NF-κB signaling pathway</span>. <i>Toxicology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>422</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1016/j.tox.2019.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.tox.2019.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=31005592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotVKnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=422&publication_year=2019&pages=1-13&author=R.+Wangauthor=D.+Liauthor=J.+Ouyangauthor=X.+Tianauthor=Y.+Zhaoauthor=X.+Pengauthor=S.+Liauthor=G.+Yuauthor=J.+Yang&title=Leonurine+alleviates+LPS-induced+myocarditis+through+suppressing+the+NF-%CE%BAB+signaling+pathway&doi=10.1016%2Fj.tox.2019.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Leonurine alleviates LPS-induced myocarditis through suppressing the NF-κB signaling pathway</span></div><div class="casAuthors">Wang, Ruiyu; Li, Dan; Ouyang, Jing; Tian, Xiaocui; Zhao, Yongpeng; Peng, Xin; Li, Siyu; Yu, Guiquan; Yang, Jiadan</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">422</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">TXCYAC</span>;
        ISSN:<span class="NLM_cas:issn">0300-483X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Myocarditis is a serious hazard to human life and is difficult to treat due to the proliferation of inflammatory lesions in the myocardium.  Leonurine (LE) is a plant phenolic alkaloid extd. from Herba leonuri that has demonstrated cardioprotective effects in many preclin. expts.  However, whether LE can be used for myocarditis therapy has not been reported.  We aimed to investigate the cardioprotective effects of LE on lipopolysaccharide (LPS)-induced myocarditis in vivo and vitro.  The possible mechanism involved was also further elucidated.  In vivo, C57BL/6 mice were exposed to LPS with or without LE.  We found out that LE effectively improved cardiac function and attenuated cardiomyocyte apoptosis in mice with myocarditis.  In addn., LPS-induced inflammatory and oxidative injuries in the myocardium were also reduced by LE administration.  In vitro, LPS simultaneously induced apoptosis and reduced the H9c2 cells viability, followed by elevation of intracellular reactive oxygen species (ROS) generation.  However, the abnormalities mentioned were preventable by LE pretreatment in a dose-dependent manner.  Both in vivo and in vitro, LPS activated the nuclear factor kappa B (NF-κB) signaling pathway in myocarditis, and LE inhibited the increased expression of phosphorylated iκBα and p65 (p-iκBα, p-p65).  Furthermore, the nuclear translocalization and nuclear protein expression of p65 in LPS-injured H9c2 cells were also suppressed by LE.  Our results demonstrated that LE exerts potent cardioprotective effects against myocarditis via anti-inflammatory and antioxidative mechanisms, possibly through blocking the activation of NF-κB pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvStSOBQbAtbVg90H21EOLACvtfcHk0ljLRVAzb_CWKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotVKnu7k%253D&md5=1748150aad2e82c8763a3488c7eb1628</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.tox.2019.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tox.2019.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DOuyang%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DLeonurine%2520alleviates%2520LPS-induced%2520myocarditis%2520through%2520suppressing%2520the%2520NF-%25CE%25BAB%2520signaling%2520pathway%26jtitle%3DToxicology%26date%3D2019%26volume%3D422%26spage%3D1%26epage%3D13%26doi%3D10.1016%2Fj.tox.2019.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potteti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kingsley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciano, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryuzoji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krunic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.08.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=10.1016%2Fj.ejmech.2015.08.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=26363505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=252-268&author=A.+D.+Jainauthor=H.+Pottetiauthor=B.+G.+Richardsonauthor=L.+Kingsleyauthor=J.+P.+Lucianoauthor=A.+F.+Ryuzojiauthor=H.+Leeauthor=A.+Krunicauthor=A.+D.+Mesecarauthor=S.+P.+Reddyauthor=T.+W.+Moore&title=Probing+the+structural+requirements+of+non-electrophilic+naphthalene-based+Nrf2+activators&doi=10.1016%2Fj.ejmech.2015.08.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators</span></div><div class="casAuthors">Jain, Atul D.; Potteti, Haranatha; Richardson, Benjamin G.; Kingsley, Laura; Luciano, Julia P.; Ryuzoji, Aya F.; Lee, Hyun; Krunic, Aleksej; Mesecar, Andrew D.; Reddy, Sekhar P.; Moore, Terry W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">252-268</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Activation of the transcription factor Nrf2 has been posited to be a promising therapeutic strategy in a no. of inflammatory and oxidative stress diseases due to its regulation of detoxifying enzymes.  In this work, the authors have developed a comprehensive structure-activity relationship around a known, naphthalene-based nonelectrophilic activator of Nrf2, and the authors report highly potent nonelectrophilic activators of Nrf2.  Computational docking anal. of a subset of the compd. series demonstrates the importance of water mol. displacement for affinity, and the x-ray structure of di-amide I supports the computational anal.  One of the best compds., acid II, has an IC50 of 61 nM in a fluorescence anisotropy assay and a Kd of 120 nM in a surface plasmon resonance assay.  Addnl., the authors demonstrate that the Et ester of II is an efficacious inducer of Nrf2 target genes, exhibiting ex vivo efficacy similar to the well-known electrophilic activator, sulforaphane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzcvlMBGU0C7Vg90H21EOLACvtfcHk0ljLRVAzb_CWKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzJ&md5=750fd3ca47f1a122618942312390891b</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.08.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.08.049%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DPotteti%26aufirst%3DH.%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DKingsley%26aufirst%3DL.%26aulast%3DLuciano%26aufirst%3DJ.%2BP.%26aulast%3DRyuzoji%26aufirst%3DA.%2BF.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKrunic%26aufirst%3DA.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DProbing%2520the%2520structural%2520requirements%2520of%2520non-electrophilic%2520naphthalene-based%2520Nrf2%2520activators%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D103%26spage%3D252%26epage%3D268%26doi%3D10.1016%2Fj.ejmech.2015.08.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">Garcinia xanthones as orally active antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1021/jm301593r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301593r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12mtrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=276-292&author=X.+Zhangauthor=X.+Liauthor=H.+Sunauthor=X.+Wangauthor=L.+Zhaoauthor=Y.+Gaoauthor=X.+Liuauthor=S.+Zhangauthor=Y.+Wangauthor=Y.+Yangauthor=S.+Zengauthor=Q.+Guoauthor=Q.+You&title=Garcinia+xanthones+as+orally+active+antitumor+agents&doi=10.1021%2Fjm301593r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Garcinia Xanthones as Orally Active Antitumor Agents</span></div><div class="casAuthors">Zhang, Xiaojin; Li, Xiang; Sun, Haopeng; Wang, Xiaojian; Zhao, Li; Gao, Yuan; Liu, Xiaorong; Zhang, Shenglie; Wang, Yanyan; Yang, Yingrui; Zeng, Su; Guo, Qinglong; You, Qidong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">276-292</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using a newly developed strategy whose key step is the regioselective propargylation of hydroxyxanthone substrates, 99 structurally diverse Garcinia natural-product-like xanthones based on gambogic acid (I) were designed and synthesized and their in vitro antitumor activity was evaluated.  A set of 40 related compds. was chosen for detn. of their physicochem. properties including polar surface area, log D7.4, aq. soly., and permeability at pH 7.4.  In the light of the in vitro antitumor activity and the physicochem. properties, two compds. were advanced into in vivo efficacy expts.  The antitumor activity of compd. II, administered po, showed more potent in vivo oral antitumor activity than I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqJ6MSA783vrVg90H21EOLACvtfcHk0lgIPtOXjOlBCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12mtrrF&md5=b73d84edf3a627797da0d514abdc8e69</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm301593r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301593r%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3DGarcinia%2520xanthones%2520as%2520orally%2520active%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D276%26epage%3D292%26doi%3D10.1021%2Fjm301593r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1X2R" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1X2R','PDB','1X2R'); return false;">PDB: 1X2R</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XMB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XMB','PDB','4XMB'); return false;">PDB: 4XMB</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i54"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01116">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_23433"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01116?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01116</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01116/suppl_file/jm0c01116_si_001.csv">CSV</a>)</p></li><li><p class="inline">Characterization of the representative intermediates, characterization of the target compounds, Keap1 Kelch domain expression and purification, FP competition assay, binding mode of compound <b>15</b> with Keap1, determination of thermodynamic data based on tracer displacement assay, ITC assay, BLI assay, ARE-luciferase activity assay, cell viability assay, RNA extraction and qRT-PCR analysis, Western blot analysis, IL-1β, IL-6, and TNF-α production, evaluation of GSH/GSSG ratio, detection of ROS level, animal experiments, statistical analysis and <sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS and HPLC spectra for representative target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01116/suppl_file/jm0c01116_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01116/suppl_file/jm0c01116_si_001.csv">jm0c01116_si_001.csv (9.76 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01116/suppl_file/jm0c01116_si_002.pdf">jm0c01116_si_002.pdf (3.6 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01116&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-19%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01116" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01116" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996ea0ec643dca","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
